Id,Title,Link
50000,"Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022–23 Influenza Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429824/
50001,"Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021–22 Influenza Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407757/
50002,"Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2020–21 Influenza Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439976/
50003,Vaccines for preventing influenza in the elderly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491101/
50004,"Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2019–20 Influenza Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713402/
50005,Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162156/
50006,Front Immunol. 2022; 13: 948031. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235355/
50007,Perceptions of Seasonal Influenza Vaccine Among U.S. Army Civilians and Dependents in the Kaiserslautern Military Community: A Mixed-Methods Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928713/
50008,H1N1 G4 swine influenza T cell epitope analysis in swine and human vaccines and circulating strains uncovers potential risk to swine and humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835423/
50009,"Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023–24 Influenza Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468199/
50010,MMWR Morb Mortal Wkly Rep. 2023 Oct 27; 72(43): 1170. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602618/
50011,Influenza and Universal Vaccine Research in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861666/
50012,"Safety, Immunogenicity, Efficacy and Effectiveness of Inactivated Influenza Vaccines in Healthy Pregnant Women and Children Under 5 Years: An Evidence-Based Clinical Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526930/
50013,"Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2018–19 Influenza Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107316/
50014,"Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 Influenza Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837399/
50015,Advances in Development and Application of Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313855/
50016,Adjuvanted influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861793/
50017,Cell culture-derived flu vaccine: Present and future,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149758/
50018,Message in a bottle: mRNA vaccination for influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027004/
50019,Better influenza vaccines: an industry perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023813/
50020,T Cell Immunity against Influenza: The Long Way from Animal Models Towards a Real-Life Universal Flu Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911237/
50021,Targeting Antigens for Universal Influenza Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225176/
50022,An Overview of Influenza Viruses and Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473132/
50023,Future epidemiological and economic impacts of universal influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789917/
50024,Proc Natl Acad Sci U S A. 2019 Oct 29; 116(44): 22409. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825289/
50025,"Influenza vaccines: Past, present, and future",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209895/
50026,The role of cell-mediated immunity against influenza and its implications for vaccine evaluation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424642/
50027,Flu Vaccine Uptake in Caregivers and Noncaregivers: Implications for Policy and Practice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856053/
50028,"Public Health–Driven Research and Innovation for Next-Generation Influenza Vaccines, European Union",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346458/
50029,Next-generation influenza vaccines: opportunities and challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223957/
50030,Nat Rev Drug Discov. 2020; 19(6): 427. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608473/
50031,Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960160/
50032,College students’ influenza vaccination adoption: Self-reported barriers and facilitators,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375805/
50033,Efficacy information influences intention to take COVID‐19 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420419/
50034,Novel Influenza Vaccines: From Research and Development (R&D) Challenges to Regulatory Responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610648/
50035,"Community awareness, use and preference for pandemic influenza vaccines in Pune, India",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635903/
50036,Using social media influencers to increase knowledge and positive attitudes toward the flu vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567389/
50037,Vaccines for preventing influenza in healthy adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491184/
50038,Influenza vaccines: Evaluation of the safety profile,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861790/
50039,Progress towards the Development of a Universal Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415875/
50040,Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901974/
50041,Progress in the Development of Universal Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551969/
50042,"Knowledge, attitude, and practice of seasonal influenza and influenza vaccine immunization among people visiting primary healthcare centers in Riyadh, Saudi Arabia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979468/
50043,An overview of the regulation of influenza vaccines in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947948/
50044,Reverse Genetics Approaches for the Development of Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297655/
50045,Vaccines for preventing influenza in healthy children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491174/
50046,Influenza Vaccines: Successes and Continuing Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482026/
50047,A SARS-CoV-2 and influenza double hit vaccine based on RBD-conjugated inactivated influenza A virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289656/
50048,"Tweeting the #flushot: Beliefs, Barriers, and Threats During Different Periods of the 2018 to 2019 Flu Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585887/
50049,"Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735377/
50050,Determinants of Trust in the Flu Vaccine for African Americans and Whites,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706780/
50051,Next-Generation Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327825/
50052,Novel Approaches for The Development of Live Attenuated Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409754/
50053,"Knowledge, Beliefs and Attitudes towards the Influenza Vaccine among Future Healthcare Workers in Poland",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926487/
50054,"Effectiveness, immunogenicity, and safety of influenza vaccines with MF59 adjuvant in healthy people of different age groups: A systematic review and meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035094/
50055,Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143275/
50056,Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963725/
50057,A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512791/
50058,Controlled Human Infection Models To Accelerate Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491212/
50059,Does repeated influenza vaccination attenuate effectiveness? A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780123/
50060,Engineered Nanoparticle Applications for Recombinant Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011859/
50061,Immune responses after live attenuated influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861782/
50062,"Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585490/
50063,Vaccination against influenza among Lebanese health care workers in the era of coronavirus disease 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763426/
50064,Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911902/
50065,Effect of aging on immunogenicity and efficacy of inactivated influenza vaccines in cotton rats Sigmodon hispidus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872023/
50066,"Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376509/
50067,Vaccine approaches conferring cross-protection against influenza viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005355/
50068,Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302365/
50069,"COVID-19 and Influenza Vaccination Campaign in a Research and University Hospital in Milan, Italy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180437/
50070,Parental Hesitancy About Routine Childhood and Influenza Vaccinations: A National Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329256/
50071,The Quest for a Truly Universal Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795694/
50072,Advances in Adjuvanted Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459454/
50073,Determinants of Flu Vaccine Uptake Among the General Population in Saudi Arabia: A Study Based on the Health Belief Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392738/
50074,Novel Platforms for the Development of a Universal Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877485/
50075,Influenza Vaccine Uptake in the Year After Concurrent vs Separate Influenza and Zoster Immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605484/
50076,Influenza vaccine format mediates distinct cellular and antibody responses in human immune organoids,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433940/
50077,Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043803/
50078,M2e-based universal influenza vaccines: a historical overview and new approaches to development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800501/
50079,New Technologies for Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694987/
50080,"Universal Flu mRNA Vaccine: Promises, Prospects, and Problems",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145388/
50081,Effectiveness of cell culture-based influenza vaccines compared with egg-based vaccines: What does the literature say?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134893/
50082,A universal influenza mRNA vaccine candidate boosts T cell responses and reduces zoonotic influenza virus disease in ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750153/
50083,Evaluation of knowledge and barriers of influenza vaccine uptake among university students in Saudi Arabia; a cross-sectional analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526417/
50084,Influenza virus and SARS-CoV-2 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722349/
50085,Precision Vaccine Development: Cues From Natural Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866702/
50086,Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411419/
50087,A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092311/
50088,Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous Australians,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522271/
50089,Determinants of influenza and COVID-19 vaccine intent or uptake in Lebanon: a scoping review of the literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404373/
50090,Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360993/
50091,"Effects of Prior Season Vaccination on Current Season Vaccine Effectiveness in the United States Flu Vaccine Effectiveness Network, 2012–2013 Through 2017–2018",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326585/
50092,"Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011–2012 to 2016–2017",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028105/
50093,Knowledge and Attitudes about the Flu Vaccine among Pregnant Women in the Valencian Community (Spain),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723429/
50094,Antigenic characterization of influenza and SARS-CoV-2 viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669429/
50095,Enhanced Safety Surveillance of Seasonal Quadrivalent Influenza Vaccines in English Primary Care: Interim Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096981/
50096,ISCOM-like Nanoparticles Formulated with Quillaja brasiliensis Saponins Are Promising Adjuvants for Seasonal Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621233/
50097,"Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598212/
50098,Evaluating the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to High-Dose Trivalent and Other Egg-Based Influenza Vaccines among Older Adults in the US during the 2017–2018 Influenza Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563546/
50099,Current Opinion in LAIV: A Matter of Parent Virus Choice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224562/
50100,Efficacy of trivalent influenza vaccine against laboratory-confirmed influenza among young children in a randomized trial in Bangladesh,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723570/
50101,"Report on the first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses Hong Kong SAR, China, 24–26 January 2013",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006778/
50102,The Epidemiology of Influenza and the Associated Vaccines Development in China: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692979/
50103,"Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118535/
50104,A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma-irradiated influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501930/
50105,Virol J. 2021; 18: 215. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565071/
50106,Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013–2014 in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837903/
50107,Analysis of the safety and immunogenicity profile of an azoximer bromide polymer-adjuvanted subunit influenza vaccine.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493399/
50108,"Barriers of Influenza Vaccination Intention and Behavior – A Systematic Review of Influenza Vaccine Hesitancy, 2005 – 2016",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5268454/
50109,Universal influenza vaccines: From viruses to nanoparticles,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300164/
50110,Acceptability of seasonal influenza vaccines among health care workers in Vietnam in 2017,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299129/
50111,"Social norms and vaccine uptake: College students’ COVID vaccination intentions, attitudes, and estimated peer norms and comparisons with influenza vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7965606/
50112,"Differences and Disparities in Seasonal Influenza Vaccine, Acceptance, Adverse Reactions, and Coverage by Age, Sex, Gender, and Race",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551304/
50113,A single-shot vaccine approach for the universal influenza A vaccine candidate M2e,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060463/
50114,Fighting flu: novel CD8+ T‐cell targets are required for future influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10867544/
50115,Recalling the Future: Immunological Memory Toward Unpredictable Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614380/
50116,Pandemic Influenza Vaccines: What did We Learn from the 2009 Pandemic and are We Better Prepared Now?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349738/
50117,"Awareness, knowledge and attitude toward influenza vaccination in several population groups in China: A cross-sectional study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624296/
50118,"Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677912/
50119,Antigenic characterization of influenza viruses produced using synthetic DNA and novel backbones,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940205/
50120,Flu Universal Vaccines: New Tricks on an Old Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459973/
50121,Factors influencing the immunogenicity of influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475607/
50122,Beyond clinical trials: Evolutionary and epidemiological considerations for development of a universal influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7514029/
50123,Making evidence-based selections of influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977436/
50124,Exploring Racial Influences on Flu Vaccine Attitudes and Behavior: Results of a National Survey of African American and White Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839483/
50125,Associations of COVID-19 risk perception with vaccine hesitancy over time for Italian residents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788320/
50126,Projected impact of a plant-derived vaccine on the burden of seasonal influenza in Canada,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437550/
50127,Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887936/
50128,H3N2 Mismatch of 2014–15 Northern Hemisphere Influenza Vaccines and Head-to-head Comparison between Human and Ferret Antisera derived Antigenic Maps,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607887/
50129,"Influenza Vaccination Uptake and Hesitancy among Healthcare Workers in Early 2021 at the Start of the COVID-19 Vaccine Rollout in Cape Town, South Africa",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332543/
50130,Age-specific effects of vaccine egg adaptation and immune priming on A(H3N2) antibody responses following influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262463/
50131,Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461427/
50132,Effectiveness of an intervention to overcome influenza vaccine hesitancy in specialty clinic patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333474/
50133,Towards a universal influenza vaccine: different approaches for one goal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785881/
50134,"Cellular immune responses of older adults to four influenza vaccines: Results of a randomized, controlled comparison",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612046/
50135,Why Glycosylation Matters in Building a Better Flu Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885707/
50136,Live Attenuated Cold-Adapted Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415297/
50137,Will the public take a universal influenza vaccine?: the need for social and behavioral science research,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482726/
50138,An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833064/
50139,Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712206/
50140,A Decade in Review: A Systematic Review of Universal Influenza Vaccines in Clinical Trials during the 2010 Decade,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589362/
50141,"Safety and Immunogenicity of an Egg-Cultivated Quadrivalent Inactivated Split-virion Influenza Vaccine (GC3110A) in Healthy Korean Children: a Randomized, Double-blinded, Active-controlled Phase III Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865052/
50142,Influenza Vaccines toward Universality through Nanoplatforms and Given by Microneedle Patches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690886/
50143,Metabolomic and transcriptomic signatures of influenza vaccine response in healthy young and older adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470889/
50144,Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18–64 Years: A Randomized Open-Label Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499731/
50145,Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137893/
50146,Cross reactivity of serum antibody responses elicited by DNA vaccines expressing HA antigens from H1N1 subtype influenza vaccines in the past 30 years,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906389/
50147,"Relative Effectiveness of High Dose versus Standard Dose Influenza Vaccines in Older Adult Outpatients over Four Seasons, 2015-16 to 2018-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508973/
50148,"A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094131/
50149,Global production capacity of seasonal and pandemic influenza vaccines in 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814984/
50150,The Interleukin-33–Group 2 Innate Lymphoid Cell Axis Represents a Potential Adjuvant Target To Increase the Cross-Protective Efficacy of Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549502/
50151,Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561127/
50152,Front Immunol. 2023; 14: 1283355. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523569/
50153,Can uptake of childhood influenza immunisation through schools and GP practices be increased through behaviourally-informed invitation letters and reminders: two pragmatic randomized controlled trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854224/
50154,Influenza vaccination in the elderly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861798/
50155,Review of Influenza Virus Vaccines: The Qualitative Nature of Immune Responses to Infection and Vaccination Is a Critical Consideration,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471734/
50156,Clinical Expectations for Better Influenza Virus Vaccines—Perspectives from the Young Investigators’ Point of View,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027204/
50157,STING agonist-containing microparticles improve seasonal influenza vaccine efficacy and durability in ferrets over standard adjuvant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136936/
50158,Influenza B: Prospects for the Development of Cross-Protective Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228933/
50159,"Influenza vaccination coverage among persons seeking outpatient medical care for acute respiratory infection in five States in the United States, 2011–2012 through 2018–2019",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573763/
50160,Protection of children against influenza: Emerging problems,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861800/
50161,The Effect of Combining the COVID-19 Vaccine with the Seasonal Influenza Vaccine on Reducing COVID-19 Vaccine Rejection Among Libyans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176301/
50162,Canadian older adults’ perceptions of effectiveness and value of regular and high-dose influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422457/
50163,HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530189/
50164,A perspective of nanoparticle universal influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650199/
50165,Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10747533/
50166,Influenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19: JACC State-of-the-Art Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535809/
50167,Relative Effectiveness of Cell-Cultured versus Egg-Based Seasonal Influenza Vaccines in Preventing Influenza-Related Outcomes in Subjects 18 Years Old or Older: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775496/
50168,Challenges of Making Effective Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529958/
50169,Prospects and Challenges in the Development of Universal Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563311/
50170,"Evaluation of a midwife-led, hospital based vaccination service for pregnant women",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872094/
50171,Challenges in implementing yearly enhanced safety surveillance of influenza vaccination in Europe: lessons learned and future perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930062/
50172,An Adenovirus-Vectored Influenza Vaccine Induces Durable Cross-Protective Hemagglutinin Stalk Antibody Responses in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580491/
50173,Seasonal Influenza Prevention and Control Progress in Latin America and the Caribbean in the Context of the Global Influenza Strategy and the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274756/
50174,The effect of sex on responses to influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078729/
50175,Targeting the hallmarks of aging to improve influenza vaccine responses in older adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189223/
50176,"Seasonal influenza vaccine policy, use and effectiveness in the tropics and subtropics – a systematic literature review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910173/
50177,A Novel Neuraminidase Virus-Like Particle Vaccine Offers Protection Against Heterologous H3N2 Influenza Virus Infection in the Porcine Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300842/
50178,Equine Influenza Virus and Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402878/
50179,Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751066/
50180,Next-Generation Influenza HA Immunogens and Adjuvants in Pursuit of a Broadly Protective Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064354/
50181,Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018–2019 and 2019–2020 calculated using a retrospective test-negative design,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026862/
50182,Concomitant administration of seasonal influenza and COVID-19 mRNA vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10798284/
50183,Seasonal influenza vaccination delivery through community pharmacists in England: evaluation of the London pilot,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762088/
50184,Parental Perspectives on Immunizations: Impact of the COVID-19 Pandemic on Childhood Vaccine Hesitancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299444/
50185,Healthcare Students' Flu Vaccine Uptake in the Last 5 Years and Future Vaccination Acceptance: Is There a Possible Association?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585752/
50186,Increasing Seasonal Influenza Vaccination among University Students: A Systematic Review of Programs Using a Social Marketing Perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223456/
50187,Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration Project,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347519/
50188,Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746457/
50189,"Evaluating socioeconomic inequalities in influenza vaccine uptake during the COVID-19 pandemic: A cohort study in Greater Manchester, England",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522043/
50190,THE ROLE OF RISK PERCEPTION IN FLU VACCINE BEHAVIOR AMONG AFRICAN AMERICAN AND WHITE ADULTS IN THE US,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842355/
50191,Methylglycol chitosan and a synthetic TLR4 agonist enhance immune responses to influenza vaccine administered sublingually,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609623/
50192,"Knowledge, attitudes, perceptions, and practice toward seasonal influenza and its vaccine: A cross-sectional study from a country of conflict",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970292/
50193,Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205527/
50194,Estimating Vaccine-Driven Selection in Seasonal Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165116/
50195,Value of an in-depth analysis of unpublished data on the safety of influenza vaccines in pregnant women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647814/
50196,Glycosylation generates an efficacious and immunogenic vaccine against H7N9 influenza virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757820/
50197,A hidden vulnerable population: Young children up-to-date on vaccine series recommendations except influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302445/
50198,"Not All Conservatives Are Vaccine Hesitant: Examining the Influence of Misinformation Exposure, Political Ideology, and Flu Vaccine Acceptance on COVID-19 Vaccine Hesitancy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052187/
50199,Adjuvant Effect of Type I Interferon Induced by Many but Not All Commercial Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855986/
50200,Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086587/
50201,Unlocking the Power of Influenza Vaccines for Pediatric Population: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10979318/
50202,Characterization of humoral and cellular immune features of gamma-irradiated influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899634/
50203,Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359798/
50204,The appropriateness of the use of influenza vaccines: Recommendations from the latest seasons in Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861775/
50205,Comparison of N-linked glycosylation on hemagglutinins derived from chicken embryos and MDCK cells: a case of the production of a trivalent seasonal influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088833/
50206,Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546595/
50207,Protective cellular and mucosal immune responses following nasal administration of a whole gamma-irradiated influenza A (subtype H1N1) vaccine adjuvanted with interleukin-28B in a mouse model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787640/
50208,Exhaled breath biomarkers of influenza infection and influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763390/
50209,Estimation of Relative Vaccine Effectiveness in Influenza: A Systematic Review of Methodology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983951/
50210,Assessment of the benefits of seasonal influenza vaccination: Elements of a framework to interpret estimates of vaccine effectiveness and support robust decision‐making and communication,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767949/
50211,Enhancing influenza vaccine immunogenicity and efficacy through infection mimicry using silk microneedles,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405573/
50212,Poor Vaccine Effectiveness against Influenza B-Related Severe Acute Respiratory Infection in a Temperate North Indian State (2019–2020): A Call for Further Data for Possible Vaccines with Closer Match,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540586/
50213,"Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453582/
50214,An (un)healthy social dilemma: a normative messaging field experiment with flu vaccinations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344251/
50215,Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912669/
50216,IL-21 enhances influenza vaccine responses in aged macaques with suppressed SIV infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564910/
50217,Progress in Developing Virus-like Particle Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093318/
50218,Nanoparticles and Antiviral Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10819235/
50219,Saliva as a useful tool for evaluating upper mucosal antibody response to influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820602/
50220,Quadrivalent cell culture influenza virus vaccine. Comparison to egg-derived vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482778/
50221,Systematic review of influenza vaccine effectiveness against laboratory-confirmed influenza among older adults living in aged care facilities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629430/
50222,Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494344/
50223,Potentiating Lung Mucosal Immunity Through Intranasal Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712562/
50224,Healthcare workers’ perceptions and experiences of communicating with people over 50 years of age about vaccination: a qualitative evidence synthesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407331/
50225,Broadly Reactive IgG Responses to Heterologous H5 Prime-Boost Influenza Vaccination Are Shaped by Antigenic Relatedness to Priming Strains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406322/
50226,"Silver lining of COVID-19: Heightened global interest in pneumococcal and influenza vaccines, an infodemiology study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315971/
50227,Ontology-Based Combinatorial Comparative Analysis of Adverse Events Associated with Killed and Live Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509157/
50228,Longitudinal Analysis of Neuraminidase and Hemagglutinin Antibodies to Influenza A Viruses after Immunization with Seasonal Inactivated Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675551/
50229,"Influenza hospitalizations in Australian children 2010–2019: The impact of medical comorbidities on outcomes, vaccine coverage, and effectiveness",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818821/
50230,Influenza vaccination in healthcare workers: A comprehensive critical appraisal of the literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861785/
50231,Intra-Seasonal Antibody Repertoire Analysis of a Patient Immunized with an MF59®-adjuvanted Pandemic 2009 H1N1 Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521956/
50232,Influenza Viruses: Innate Immunity and mRNA Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438292/
50233,Enhanced Immunogenicity of a Whole-Inactivated Influenza A Virus Vaccine Using Optimised Irradiation Conditions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652198/
50234,Influenza vaccine failure: Failure to protect or failure to understand?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330882/
50235,"Influenza vaccines: the potential benefits of cell-culture isolation
and manufacturing",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036483/
50236,Immunogenicity of seasonal inactivated influenza and inactivated polio vaccines among children in Senegal: results from a cluster-randomized trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936169/
50237,Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291233/
50238,The development and manufacture of influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514247/
50239,Bench-to-bedside review: Vaccine protection strategies during pandemic flu outbreaks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887121/
50240,Influenza vaccine: a review on current scenario and future prospects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686931/
50241,Association of parent influenza vaccination and early childhood vaccinations using linked electronic health record data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202113/
50242,Cost-effectiveness analysis of different seasonal influenza vaccines in the elderly Italian population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037461/
50243,Prospective associations of regional social media messages with attitudes and actual vaccination: A big data and survey study of the influenza vaccine in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415418/
50244,Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Postvaccination Sera,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850569/
50245,Oil-in-water emulsion adjuvants for pediatric influenza vaccines: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965081/
50246,Systems Biological Analysis of Immune Response to Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483643/
50247,Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244612/
50248,Review of Analyses Estimating Relative Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Three Consecutive US Influenza Seasons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228909/
50249,Immunological assessment of influenza vaccines and immune correlates of protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002926/
50250,"Analysis of Viral and Host Factors on Immunogenicity of 2018, 2019, and 2020 Southern Hemisphere Seasonal Trivalent Inactivated Influenza Vaccine in Adults in Brazil",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413331/
50251,Utilizing the Theory of Planned Behavior to determine the intentions to receive the influenza vaccine during COVID-19: A cross-sectional survey of US adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164359/
50252,Computational Approaches and Challenges to Developing Universal Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631137/
50253,"Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5–7 May 2014",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218335/
50254,Knowledge and perception regarding effectiveness in influenza vaccines among General Practitioners in Germany: A national survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643884/
50255,Influenza Vaccine Effectiveness in Older Adults Compared with Younger Adults Over Five Seasons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812289/
50256,Breaking down the monolith: Understanding flu vaccine uptake among African Americans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769118/
50257,"Recent Advances, Approaches and Challenges in the Development of Universal Influenza Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10957243/
50258,Evaluation of Multivalent H2 Influenza Pandemic Vaccines in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336516/
50259,The Role of Psychological Factors and Vaccine Conspiracy Beliefs in Influenza Vaccine Hesitancy and Uptake among Jordanian Healthcare Workers during the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413675/
50260,Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7030826/
50261,Epidemiology and burden of illness of seasonal influenza among the elderly in Japan: A systematic literature review and vaccine effectiveness meta‐analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902263/
50262,Low Seroprevalent Species D Adenovirus Vectors as Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749993/
50263,Influenza and Influenza Vaccine: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014756/
50264,Study of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI): study protocol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220521/
50265,"Effects of Vaccine Literacy, Health Beliefs, and Flu Vaccination on Perceived Physical Health Status among Under/Graduate Students",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141033/
50266,Influenza vaccines in immunosuppressed adults with cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491273/
50267,Heterologous prime-boost H1N1 vaccination exacerbates disease following challenge with a mismatched H1N2 influenza virus in the swine model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623127/
50268,"Estimates of Seasonal Influenza Burden That Could Be Averted by Improved Influenza Vaccines in the Australian Population Aged Under 65 Years, 2015–2019",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11026859/
50269,"Single-Component
Multilayered Self-Assembling Protein
Nanoparticles Displaying Extracellular Domains of Matrix Protein 2
as a Pan-influenza A Vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10722606/
50270,Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404371/
50271,Vaccine hesitancy and influenza beliefs among parents of children requiring a second dose of influenza vaccine in a season: An American Academy of Pediatrics (AAP) Pediatric Research in Office Settings (PROS) study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227621/
50272,IgA Responses Following Recurrent Influenza Virus Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249748/
50273,Influenza Vaccination Uptake in the General Italian Population during the 2020–2021 Flu Season: Data from the EPICOVID-19 Online Web-Based Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877796/
50274,The use of cell-mediated immunity for the evaluation of influenza vaccines: an upcoming necessity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605831/
50275,Bacteriophage T4 Vaccine Platform for Next-Generation Influenza Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546227/
50276,Influenza and COVID-19 Vaccine Concerns and Uptake Among Patients Cared for in a Safety-Net Health System,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716187/
50277,Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085005/
50278,"Active surveillance for safety monitoring of seasonal influenza vaccines in Italy, 2015/2016 season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303938/
50279,Identifying H1N1 and COVID-19 vaccine hesitancy or refusal among health care providers: a scoping review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173945/
50280,Predicting COVID‐19 and seasonal influenza vaccine uptake: The impact of fear and vasovagal symptoms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349497/
50281,"Impact of influenza, herpes zoster, and pneumococcal vaccinations on the incidence of cardiovascular events in subjects aged over 65 years: a systematic review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239224/
50282,Highly Conserved Influenza T cell epitopes Induce Broadly Protective Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690779/
50283,No evidence of a link between influenza vaccines and Guillain–Barre syndrome–associated antiganglioside antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595170/
50284,Seasonal influenza vaccine in immunocompromised persons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037456/
50285,DNA Vaccine that Targets Hemagglutinin to MHC Class II Molecules Rapidly Induces Antibody-Mediated Protection against Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3767367/
50286,Broadly Reactive H2 Hemagglutinin Vaccines Elicit Cross-Reactive Antibodies in Ferrets Preimmune to Seasonal Influenza A Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546680/
50287,Low Influenza Vaccine Effectiveness Against A(H3N2)-Associated Hospitalizations in 2016–2017 and 2017–2018 of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205618/
50288,Lessons from Next Generation Influenza Vaccines for Inflammatory Disease Therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719783/
50289,The use of test-negative controls to monitor vaccine effectiveness: a systematic review of methodology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888869/
50290,Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410868/
50291,Recent advances in influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194468/
50292,Vaccine mandates for healthcare workers beyond COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985724/
50293,"Universal Influenza Vaccines, a Dream to Be Realized Soon",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036552/
50294,Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891568/
50295,Understanding influenza vaccine perspectives and hesitancy in university students to promote increased vaccine uptake,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812243/
50296,Determinants of maternal influenza vaccination in the context of low- and middle-income countries: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791521/
50297,M2e-Based Influenza Vaccines with Nucleoprotein: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310010/
50298,A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517972/
50299,Nano/microparticle Formulations for Universal Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741137/
50300,Determinants of Influenza Vaccine Uptake in Patients With Cardiovascular Disease and Strategies for Improvement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475658/
50301,Vaccine promotion strategies in community pharmacy addressing vulnerable populations: a scoping review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518112/
50302,Debate on the compositions of influenza B in northern hemisphere seasonal influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819444/
50303,"Influenza A Virus Vaccination: Immunity, Protection, and Recent Advances Toward A Universal Vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565301/
50304,High Clinical Burden of Influenza Disease in Adults Aged ≥ 65 Years: Can We Do Better? A Systematic Literature Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930064/
50305,"Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada: A Canadian Immunization Research Network (CIRN) Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143060/
50306,Simultaneous Targeting of Multiple Hemagglutinins to APCs for Induction of Broad Immunity against Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834789/
50307,"Trends, Uptake, and Predictors of Influenza Vaccination Among Healthcare Practitioners During the COVID-19 Pandemic Flu Season (2020) and the Following Season (2021) in Saudi Arabia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450674/
50308,Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861528/
50309,Vaccines (Basel). 2023 Dec; 11(12): 1839. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10747401/
50310,One step closer to influenza vaccine inclusiveness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753274/
50311,Influenza Vaccines Differentially Regulate the Interferon Response in Human Dendritic Cell Subsets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484150/
50312,Pan-Influenza A Protection by Prime–Boost Vaccination with Cold-Adapted Live-Attenuated Influenza Vaccine in a Mouse Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799225/
50313,Factors Mediating Seasonal and Influenza A (H1N1) Vaccine Acceptance among Ethnically Diverse Populations in the Urban South,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522428/
50314,Acceptance Rate of Influenza Vaccination Among Patients with Type II Diabetes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930144/
50315,Understanding the Role of HLA Class I Molecules in the Immune Response to Influenza Infection and Rational Design of a Peptide-Based Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695287/
50316,Optimal Use of Vaccines for Control of Influenza A Virus in Swine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494241/
50317,Safety and Efficacy of CR6261 in an Influenza A H1N1 Healthy Human Challenge Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664469/
50318,Universal type/subtype-specific antibodies for quantitative analyses of neuraminidase in trivalent influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773574/
50319,Disgust as an emotional driver of vaccine attitudes and uptake? A mediation analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518846/
50320,Improvement of the Trivalent Inactivated Flu Vaccine Using PapMV Nanoparticles,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126827/
50321,"Spillover of Vaccine Hesitancy into Adult COVID-19 and Influenza: The Role of Race, Religion, and Political Affiliation in the United States",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966756/
50322,Influenza Vaccines: Challenges and Solutions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362519/
50323,Literature review of the epidemiology of influenza B disease in 15 countries in the Asia‐Pacific region,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907823/
50324,Seasonal Influenza Vaccine in Pregnant Women: Views and Experiences of Obstetrician–Gynecologists,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330280/
50325,Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011‐2016,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298285/
50326,Can primary care physician recommendation improve influenza vaccine uptake among older adults? A community health centre-based experimental study in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843923/
50327,"Relative Effectiveness of the Cell-Cultured Quadrivalent Influenza Vaccine Compared to Standard, Egg-derived Quadrivalent Influenza Vaccines in Preventing Influenza-like Illness in 2017–2018",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745007/
50328,Factors influencing healthcare professionals’ confidence in vaccination in Europe: a literature review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009961/
50329,"The FluPRINT dataset, a multidimensional analysis of the influenza vaccine imprint on the immune system",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803714/
50330,Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808216/
50331,Immune Responses in Pigs Vaccinated with Adjuvanted and Non-Adjuvanted A(H1N1)pdm/09 Influenza Vaccines Used in Human Immunization Programmes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302873/
50332,"Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077342/
50333,Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11020595/
50334,Flu Vaccine and Mortality in Hypertension: A Nationwide Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075279/
50335,Attitudes and perception of influenza vaccines among older people in Singapore: A qualitative study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130882/
50336,Assessment of Immunogenicity of Adjuvanted Quadrivalent Inactivated Influenza Vaccine in Healthy People and Patients With Common Variable Immune Deficiency,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466564/
50337,H5N1 influenza vaccine induces a less robust neutralizing antibody response than seasonal trivalent and H7N9 influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627238/
50338,Virus-like Particle Vaccines: A Prospective Panacea Against an Avian Influenza Panzootic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712863/
50339,Effect of seasonal influenza vaccination on influenza symptom severity among children in Hutterite communities: Follow‐up study of a randomized trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928063/
50340,Outlining recent updates on influenza therapeutics and vaccines: A comprehensive review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10848012/
50341,Long-Term Persistence of Cell-Mediated and Humoral Responses to A(H1N1)pdm09 Influenza Virus Vaccines and the Role of the AS03 Adjuvant System in Adults during Two Randomized Controlled Trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461372/
50342,"The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805858/
50343,Cross-Protection by Inactivated H5 Prepandemic Vaccine Seed Strains against Diverse Goose/Guangdong Lineage H5N1 Highly Pathogenic Avian Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925181/
50344,Sex differences in adverse events following seasonal influenza vaccines: a meta-analysis of randomised controlled trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646905/
50345,Meeting report and review: Immunological assays and correlates of protection for next‐generation influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040967/
50346,Advances in Infectious Disease Vaccine Adjuvants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316175/
50347,A comprehensive analysis of Italian web pages mentioning squalene-based influenza vaccine adjuvants reveals a high prevalence of misinformation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893210/
50348,Dysfunctional peripheral T follicular helper cells dominate in people with impaired influenza vaccine responses: Results from the FLORAH study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542545/
50349,Determinants of adherence to seasonal influenza vaccination among healthcare workers from an Italian region: results from a cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874132/
50350,"FLU-v, a Broad-Spectrum Influenza Vaccine, Induces Cross-Reactive Cellular Immune Responses in Humans Measured by Dual IFN-γ and Granzyme B ELISpot Assay",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505334/
50351,Attitudes of the General Public and General Practitioners in Five Countries towards Pandemic and Seasonal Influenza Vaccines during Season 2009/2010,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469560/
50352,Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653759/
50353,Live-Attenuated Influenza Vaccine Induces Tonsillar Follicular T Helper Cell Responses That Correlate With Antibody Induction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910880/
50354,"Attitudes, Perceptions and Practices of Influenza Vaccination in the Adult Population: Results of a Cross-Sectional Survey in Spain",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518428/
50355,An Antigenic Thrift-Based Approach to Influenza Vaccine Design,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235769/
50356,Animal Models Utilized for the Development of Influenza Virus Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310120/
50357,"Development of an adjuvanted nanoparticle vaccine against influenza virus, an in vitro study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410248/
50358,"Promising strategy for developing mRNA-based universal influenza virus vaccine for human population, poultry, and pigs– focus on the bigger picture",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618703/
50359,Estimation of the Effectiveness of Quadrivalent Influenza Vaccines by Distinguishing Between Influenza A (H1N1) pdm09 and Influenza A (H3N2) Using Rapid Influenza Diagnostic Tests During the 2018-2019 Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184079/
50360,IL‐21‐IgFc immunotherapy alters transcriptional landscape of lymph node cells leading to enhanced flu vaccine response in aging and SIV infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652303/
50361,The effect of respiratory viruses on immunogenicity and protection induced by a candidate universal influenza vaccine in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464343/
50362,Advances in intranasal vaccine delivery: A promising non-invasive route of immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173027/
50363,Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009–10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089179/
50364,Global Pandemic Preparedness: Optimizing Our Capabilities and the Influenza Experience,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024617/
50365,Influenza Vaccines: From Surveillance Through Production to Protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2843114/
50366,Mayo Clin Proc. 2010 Jun; 85(6): 595. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878265/
50367,A comparison of seasonal influenza and novel Covid-19 vaccine intentions: A cross-sectional survey of vaccine hesitant adults in England during the 2020 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621000/
50368,Standardisation of inactivated influenza vaccines—Learning from history,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820418/
50369,"A Glycolipid α-GalCer Derivative, 7DW8-5 as a Novel Mucosal Adjuvant for the Split Inactivated Influenza Vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230830/
50370,Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969546/
50371,Living Organ Donor Perspectives and Sources of Hesitancy about COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323843/
50372,Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213772/
50373,Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901503/
50374,Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783933/
50375,Evaluation of determinants of the serological response to the quadrivalent split‐inactivated influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073386/
50376,M2-Deficient Single-Replication Influenza Vaccine–Induced Immune Responses Associated With Protection Against Human Challenge With Highly Drifted H3N2 Influenza Strain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373152/
50377,AS03- and MF59-Adjuvanted Influenza Vaccines in Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733358/
50378,Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522684/
50379,Vaccines - safety in pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992376/
50380,TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828069/
50381,"Attitudes towards influenza, and COVID-19 vaccines during the COVID-19 pandemic among a representative sample of the Jewish Israeli population",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836312/
50382, Developments and current challenges in the process of cell culture-based seasonal influenza vaccine manufacture in Japan ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11043132/
50383,Promoting influenza vaccination: Insights from a qualitative meta-analysis of 14 years of influenza-related communications research by U.S. Centers for Disease Control and Prevention (CDC),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856146/
50384,Influenza vaccine uptake in Tunisia from two high-risk groups’ perception and attitudes: a qualitative study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466396/
50385,Progress on adenovirus-vectored universal influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514376/
50386,Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207162/
50387,R-DOTAP Cationic Lipid Nanoparticles Outperform Squalene-Based Adjuvant Systems in Elicitation of CD4 T Cells after Recombinant Influenza Hemagglutinin Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959843/
50388,Barriers Associated with the Uptake Ratio of Seasonal Flu Vaccine and Ways to Improve Influenza Vaccination Coverage among Young Health Care Workers in Poland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161323/
50389,Vaccines for preventing influenza in healthy children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478137/
50390,Cochrane Database Syst Rev. 2018; 2018(2): CD004879. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491174/
50391,Epitope specific T‐cell responses against influenza A in a healthy population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717245/
50392,Effects of Influenza Vaccination in the United States During the 2017–2018 Influenza Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188082/
50393,"Spatiotemporal Analysis of Influenza in China, 2005–2018",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928232/
50394,"An evaluation of an influenza vaccination campaign targeting pregnant women in 27 clinics in two provinces of South Africa, 2015 – 2018",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427945/
50395,Impaired memory B-cell recall responses in the elderly following recurrent influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341655/
50396,Public Interest in Distribution and Determinants of Influenza and Pneumonia Vaccination during the COVID-19 Pandemic: An Infodemiology and Cross-Sectional Study from China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623096/
50397,COVID-19 Vaccine Hesitancy and Its Determinants Among Adults with a History of Tobacco or Marijuana Use,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101333/
50398,Social media influencers can be used to deliver positive information about the flu vaccine: findings from a multi-year study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411386/
50399,Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861572/
50400,"Immunogenicity and Safety of an MF59-adjuvanted Quadrivalent Seasonal Influenza Vaccine in Young Children at High Risk of Influenza-associated Complications: A Phase III, Randomized, Observer-blind, Multicenter Clinical Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360101/
50401,Immune Control of Avian Influenza Virus Infection and Its Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058720/
50402,"The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4+ T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathway",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595497/
50403,"Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379643/
50404,Specific and Nonspecific Effects of Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11054884/
50405,Sequential vaccinations with divergent H1N1 influenza virus strains induce multi-H1 clade neutralizing antibodies in swine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679120/
50406,Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732363/
50407,"Comparison of Parental Report of Influenza Vaccination to Documented Records in Children Hospitalized With Acute Respiratory Illness, 2015–2016",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264279/
50408,Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes—Systematic Literature Review and Expert Consensus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621612/
50409,Subtype H3N2 Influenza A Viruses: An Unmet Challenge in the Western Pacific,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778411/
50410,"Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027712/
50411,The Nature of Immune Responses to Influenza Vaccination in High-Risk Populations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228336/
50412,Effectiveness of influenza and pneumococcal polysaccharide vaccines against influenza-related outcomes including pneumonia and acute exacerbation of cardiopulmonary diseases: Analysis by dominant viral subtype and vaccine matching,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283593/
50413,A boosting skin vaccination with dissolving microneedle patch encapsulating M2e vaccine broadens the protective efficacy of conventional influenza vaccines A novel prime-boost influenza vaccination stratagem,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567859/
50414,Enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757502/
50415,The effect of metformin on influenza vaccine responses in nondiabetic older adults: a pilot trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152024/
50416,Knowledge and attitudes towards influenza and influenza vaccination among pregnant women in Kenya,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526973/
50417,Development of a Universal Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327971/
50418,Development of PDA Nanoparticles for H9N2 Avian Influenza BPP-V/BP-IV Epitope Peptide Vaccines: Immunogenicity and Delivery Efficiency Improvement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353371/
50419,Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051070/
50420,Trends in Adult and Elderly Vaccination: Focus on Vaccination Practices in Tunisia and Morocco,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286557/
50421,Repeated Low-Dose Influenza Virus Infection Causes Severe Disease in Mice: a Model for Vaccine Evaluation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505666/
50422,"Universal or Specific? A Modeling-Based Comparison of Broad-Spectrum Influenza Vaccines against Conventional, Strain-Matched Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5157952/
50423,Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020694/
50424,New Kids on the Block: RNA-Based Influenza Virus Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027361/
50425,M2e conjugated gold nanoparticle influenza vaccine displays thermal stability at elevated temperatures and confers protection to ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036639/
50426,Cost-effectiveness of influenza vaccine strategies for the elderly in South Korea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347274/
50427,Effect of an Adenovirus-Vectored Universal Influenza Virus Vaccine on Pulmonary Pathophysiology in a Mouse Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104105/
50428,Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 months to 8 Years Old during 2011–2012 and 2012–2013: The Importance of Two Priming Doses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5218633/
50429,"Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871551/
50430,Harnessing Invariant NKT Cells to Improve Influenza Vaccines: A Pig Perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796018/
50431,"M2SR, a novel live Single Replication influenza virus vaccine, provides effective heterosubtypic protection in mice",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038585/
50432,Enhancing uptake of influenza maternal vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378696/
50433,Understanding the Barriers and Attitudes toward Influenza Vaccine Uptake in the Adult General Population: A Rapid Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861815/
50434,"The intersectional importance of race/ethnicity, disability, and age in flu vaccine uptake for U.S. adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425074/
50435,Evaluation of Flu Vaccination Coverage among Healthcare Workers during a 3 Years’ Study Period and Attitude towards Influenza and Potential COVID-19 Vaccination in the Context of the Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310181/
50436,"Perspectives of Older Adults on COVID-19 and Influenza Vaccination in Ontario, Canada",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693802/
50437,Seasonal Influenza Vaccine Impact on Pandemic H1N1 Vaccine Efficacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314138/
50438,Australian experience of the SH21 flu vaccination program during the COVID-19 vaccine program,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828056/
50439,Recombinant Adenoviruses Displaying Matrix 2 Ectodomain Epitopes on Their Fiber Proteins as Universal Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355597/
50440,Acceptance of influenza vaccination and associated factors among teachers in China: A cross-sectional study based on health belief model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10760392/
50441,Using the health belief model to identify barriers to seasonal influenza vaccination among Australian adults in 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404057/
50442,“You don’t trust a government vaccine”: Narratives of Institutional Trust and Influenza Vaccination among African American and White Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350921/
50443,Harnessing Local Immunity for an Effective Universal Swine Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454411/
50444,Effects of Influenza Vaccination in the United States During the 2018–2019 Influenza Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643742/
50445,MomsTalkShots: An Individually Tailored Educational Application for Maternal and Infant Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144831/
50446,Nanoparticles in influenza subunit vaccine development: Immunogenicity enhancement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928032/
50447,"Pandemic influenza vaccines: meeting the supply, distribution and deployment challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634681/
50448,Using Classification and Regression Tree Analysis to Explore Parental Influenza Vaccine Decisions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992466/
50449,Active surveillance for adverse events of influenza vaccine safety in elderly cancer patients using self-controlled tree-temporal scan statistic analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432531/
50450,Phylogenetic identification of influenza virus candidates for seasonal vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624341/
50451,Immunity and Protective Efficacy of Mannose Conjugated Chitosan-Based Influenza Nanovaccine in Maternal Antibody Positive Pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969509/
50452,"Live‐attenuated influenza vaccine effectiveness against hospitalization in children aged 2–6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14–2015/16",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343328/
50453,Assessment of virus interference in a test-negative study of influenza vaccine effectiveness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535302/
50454,"MomsTalkShots, tailored educational app, improves vaccine attitudes: a randomized controlled trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676851/
50455,Comparison of Adjuvants to Optimize Influenza Neutralizing Antibody Responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771022/
50456,Efforts to Improve the Seasonal Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027170/
50457,News Feature: Researchers getting closer to a “universal” flu vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812533/
50458,Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362976/
50459,Interventions to increase influenza vaccination rates of those 60 years and older in the community,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494593/
50460,Phase 1 Study of Pandemic H1 DNA Vaccine in Healthy Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401709/
50461,Influenza vaccines for preventing acute otitis media in infants and children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485791/
50462,Computationally Optimized Broadly Reactive H2 HA Influenza Vaccines Elicited Broadly Cross-Reactive Antibodies and Protected Mice from Viral Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944441/
50463,Vaccine-associated hypersensitivity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602527/
50464,"The swine flu vaccine, public attitudes, and researcher interpretations: a systematic review of qualitative research",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919843/
50465,"Influenza vaccination knowledge, attitudes, and practices among Tunisian elderly with chronic diseases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672335/
50466,Exploring the potential public health benefits of universal influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930083/
50467,Quadrivalent Vaccines for the Immunization of Adults against Influenza: A Systematic Review of Randomized Controlled Trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368426/
50468,"Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861806/
50469,Vaccine-associated attenuation of subjective severity among outpatients with influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638984/
50470,"“Prepandemic” Immunization for Novel Influenza Viruses, “Swine Flu” Vaccine, Guillain-Barré Syndrome, and the Detection of Rare Severe Adverse Events",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811391/
50471,"Reasons for low influenza vaccination coverage among adults in Puerto Rico, influenza season 2013–2014",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696625/
50472,Socio-demographic determinants of influenza vaccination uptake behavior: A nationwide cross-sectional study in Saudi Arabia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10712777/
50473,"Report from the World Health Organization’s third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8–10th June 2016",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131228/
50474,Determinants of influenza vaccine uptake and willingness to be vaccinated by pharmacists among the active adult population in Hungary: a cross-sectional exploratory study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967972/
50475,Adult preferences for influenza vaccines with lower likelihood of side effects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185916/
50476,Early prediction of antigenic transitions for influenza A/H3N2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048310/
50477,Economic benefits of sharing and redistributing influenza vaccines when shortages occurred,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645113/
50478,Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146233/
50479,"Disparities in co-payments for influenza vaccine among the elderly, during the COVID-19 pandemic in Japan",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940574/
50480,Enhancing Immunogenicity of Influenza Vaccine in the Elderly through Intradermal Vaccination: A Literature Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698533/
50481,Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189474/
50482,"Knowledge and practice toward seasonal influenza vaccine and its barriers at the community level in Riyadh, Saudi Arabia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266234/
50483,Characterizing intentions to receive the COVID-19 vaccine among the general population in British Columbia based on their future intentions towards the seasonal influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387116/
50484,Intratumoral Influenza Vaccine Administration Attenuates Breast Cancer Growth and Restructures the Tumor Microenvironment through Sialic Acid Binding of Vaccine Hemagglutinin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10779129/
50485,Predictors of self and parental vaccination decisions in England during the 2009 H1N1 pandemic: Analysis of the Flu Watch pandemic cohort data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593150/
50486,Publishing interim early or mid-season influenza vaccine effectiveness – US Flu VE Network,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204739/
50487,Influenza virus vaccination in pediatric nephrotic syndrome significantly reduces rate of relapse and influenza virus infection as assessed in a nationwide survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640023/
50488,Microneedle patch delivery of influenza vaccine during pregnancy enhances maternal immune responses promoting survival and long-lasting passive immunity to offspring,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515933/
50489,Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine‐mediated immune protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863573/
50490,Influenza vaccination: protecting the most vulnerable,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488965/
50491,Vaccinees against the 1976 “swine flu” have enhanced neutralization responses to the 2009 novel H1N1 influenza virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946351/
50492,Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002966/
50493,Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510854/
50494,Understanding and Increasing Influenza Vaccination Acceptance: Insights from a 2016 National Survey of U.S. Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923753/
50495,Effectiveness of trivalent inactivated influenza vaccines in children during 2017–2018 season in Korea: Comparison of test-negative analysis by rapid and RT-PCR influenza tests,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381399/
50496,Distinguishing Causation from Correlation in the Use of Correlates of Protection to Evaluate and Develop Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217279/
50497,"Determinants of Influenza Vaccination among High-Risk Black and White
Adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712242/
50498,Efficacy of an Adenoviral Vectored Multivalent Centralized Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668234/
50499,"Understanding COVID-19 vaccine uptake during pregnancy: ‘Hesitance’, knowledge, and evidence-based decision-making",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947956/
50500,Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396888/
50501,Adjuvanted (AS03) A/H1N1 2009 Pandemic Influenza Vaccines and Solid Organ Transplant Rejection: Systematic Signal Evaluation and Lessons Learnt,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519647/
50502,Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360116/
50503,"Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832587/
50504,Refining the approach to vaccines against influenza A viruses with pandemic potential,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648374/
50505,Multi-Epitope Peptide-Based and Vaccinia-Based Universal Influenza Vaccine Candidates Subjected to Clinical Trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409566/
50506,Public health impact and economic benefits of quadrivalent influenza vaccine in Latin America,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404619/
50507,Underserved population acceptance of combination influenza-COVID-19 booster vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650809/
50508,"Influenza vaccines and vaccinations in Poland – past, present and future",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560607/
50509,The Role of Nucleoprotein in Immunity to Human Negative-Stranded RNA Viruses—Not Just Another Brick in the Viral Nucleocapsid,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955406/
50510,Development of a Pan-H1 Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206494/
50511,Cytokine Profile in Human Peripheral Blood Mononuclear Leukocytes Exposed to Immunoadjuvant and Adjuvant-Free Vaccines Against Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339108/
50512,"Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803382/
50513,Flu and Pneumococcal Vaccine Coverage in Scleroderma Patients Still Need to Be Prompted: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617735/
50514,Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590113/
50515,Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463610/
50516,Bringing influenza vaccines into the 21st century,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130286/
50517,Differential Recognition of Computationally Optimized H3 Hemagglutinin Influenza Vaccine Candidates by Human Antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400492/
50518,"Effectiveness of the MF59‐adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta‐analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542957/
50519,"MF59-adjuvanted influenza vaccine (FLUAD®) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone®): A randomized, multicenter, Phase III pediatric trial in Mexico",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806633/
50520,Evaluating the case for trivalent or quadrivalent influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085006/
50521,A Single Oral Immunization with a Replication-Competent Adenovirus-Vectored Vaccine Protects Mice from Influenza Respiratory Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373536/
50522,Viral vector-based influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137548/
50523,Egg-Independent Influenza Vaccines and Vaccine Candidates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620549/
50524,Vaccines That Reduce Viral Shedding Do Not Prevent Transmission of H1N1 Pandemic 2009 Swine Influenza A Virus Infection to Unvaccinated Pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851569/
50525,Age- and risk-related appropriateness of the use of available influenza vaccines in the Italian elderly population is advantageous: results from a budget impact analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912787/
50526,Early influenza vaccination rates decline in children during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756823/
50527,"Patient Portal Reminders for Pediatric Influenza Vaccinations: A Randomized
Clinical Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669575/
50528,"Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban Bangladesh",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695509/
50529,"Immunogenicity and safety assessment of a trivalent, inactivated split influenza vaccine in Korean children: Double-blind, randomized, active-controlled multicenter phase III clinical trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514431/
50530,Insurance Status Predicts Self-Reported Influenza Vaccine Coverage Among Pregnant Women in the United States: A Cross-Sectional Analysis of the National Health Interview Study Data from 2012 to 2018,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117778/
50531,Pneumococcal colonization impairs mucosal immune responses to live attenuated influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934923/
50532,Reasons for nonadherence to vaccination for influenza among older people in Brazil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575254/
50533,PLoS One. 2022; 17(6): e0270443. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212160/
50534,"Antibodies against SARS-CoV-2 Alpha, Beta, and Gamma Variants in Pregnant Women and Their Neonates under Antenatal Vaccination with Moderna (mRNA-1273) Vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505142/
50535,A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478518/
50536,Factors associated with COVID-19 vaccination intentions among adults in the deep South,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744449/
50537,"Ethnic inequalities in COVID-19 vaccine uptake and comparison to seasonal influenza vaccine uptake in Greater Manchester, UK: A cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893324/
50538,PLoS Med. 2022 Apr; 19(4): e1003982. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033280/
50539,"Knowledge, attitudes and practices on influenza vaccination during pregnancy in Quito, Ecuador",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791889/
50540,A gene-based avian influenza vaccine in poultry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194532/
50541,Is disgust proneness prospectively associated with influenza vaccine hesitancy and uptake?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066988/
50542,Effects of influenza immunization on pneumonia in the elderly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861791/
50543,"Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482712/
50544,R848 Adjuvant Laden With Self-Assembled Nanoparticle-Based mRNA Vaccine Elicits Protective Immunity Against H5N1 in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197463/
50545,The Next Generation of Influenza Vaccines: Towards a Universal Solution,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825669/
50546,Differential Gene Expression Elicited by Children in Response to the 2015–16 Live Attenuated versus Inactivated Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711596/
50547,Clinical and Economic Outcomes Associated with Cell-Based Quadrivalent Influenza Vaccine vs. Standard-Dose Egg-Based Quadrivalent Influenza Vaccines during the 2018–19 Influenza Season in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911861/
50548,"Available influenza vaccines: immunization strategies, history and new tools for fighting the disease",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910442/
50549,Vaccine safety in HIV-infected adults within the Vaccine Safety Datalink Project,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538462/
50550,Comparison of the Hemagglutination Inhibition Titers against Influenza Vaccine Strains in Japan from the 2017/2018 to 2021/2022 Seasons Using a Single Set of Serum Samples,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323423/
50551,Evaluation of Next-Generation H3 Influenza Vaccines in Ferrets Pre-Immune to Historical H3N2 Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406686/
50552,Motivating Seasonal Influenza Vaccination and Cross-Promoting COVID-19 Vaccination: An Audience Segmentation Study among University Students,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705827/
50553,Recombinant Protein Vaccines Formulated with Enantio-Specific Cationic Lipid R-DOTAP Induce Protective Cellular and Antibody-Mediated Immune Responses in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965888/
50554,Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841615/
50555,Influenza vaccine effectiveness by test-negative design – Comparison of inpatient and outpatient settings,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826670/
50556,MF59®‐adjuvanted vaccines for seasonal and pandemic influenza prophylaxis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634121/
50557,Knowledge and Attitudes of Healthcare Professionals Regarding Perinatal Influenza Vaccination during the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863632/
50558,"Public awareness, attitudes, beliefs, and behaviors regarding the role of pharmacists as immunizers",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381788/
50559,"Influenza vaccination hesitancy in large urban centers in South America. Qualitative analysis of confidence, complacency and convenience across risk groups",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360613/
50560,Microneedle and mucosal delivery of influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555223/
50561,Influenza immunization policies: Which could be the main reasons for differences among countries?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861803/
50562,Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703309/
50563,Options and Obstacles for Designing a Universal Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147691/
50564,"The convergent evolution of influenza A virus: Implications, therapeutic strategies and what we need to know",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493511/
50565,An oil-in-water nanoemulsion enhances immunogenicity of H5N1 vaccine in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240149/
50566,Seasonal Influenza Vaccine Effectiveness in Persons Aged 15–64 Years: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459161/
50567,"Burden of medically attended influenza infection and cases averted by vaccination – United States, 2016/17 through 2018/19 influenza seasons",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732931/
50568,"Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013−May 31, 2015",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916262/
50569,Trivalent inactivated influenza vaccines induce broad immunological reactivity to both internal virion components and influenza surface proteins,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3690927/
50570,“World in motion” – emulsion adjuvants rising to meet the pandemic challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692316/
50571,NPJ Vaccines. 2023; 8: 7. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894945/
50572,Influenza virus vaccine compliance among pregnant women during the COVID-19 pandemic (pre-vaccine era) in Israel and future intention to uptake BNT162b2 mRNA COVID-19 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843331/
50573,"Parents' attitude, awareness and behaviour towards influenza vaccination in Pakistan",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893193/
50574,"Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young Children",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156924/
50575,mRNA vaccines encoding computationally optimized hemagglutinin elicit protective antibodies against future antigenically drifted H1N1 and H3N2 influenza viruses isolated between 2018-2020,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10963417/
50576,"New-age vaccine adjuvants, their development, and future perspective",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998920/
50577,Inactivated and live-attenuated seasonal influenza vaccines boost broadly neutralizing antibodies in children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861809/
50578,Asthma exacerbations among asthmatic children receiving live attenuated versus inactivated influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636629/
50579,Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060936/
50580,Effects of Influenza Vaccine on the Immune Responses to SARS-CoV-2 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11054385/
50581,The disease burden of influenza beyond respiratory illness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545338/
50582,In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813682/
50583,Comparison of Heterosubtypic Protection in Ferrets and Pigs Induced by a Single-Cycle Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985365/
50584,Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894995/
50585,Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate—Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550445/
50586,"Intentions to Seek Information About the Influenza Vaccine: The Role of Informational Subjective Norms, Anticipated and Experienced Affect, and Information Insufficiency Among Vaccinated and Unvaccinated People",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434697/
50587,Modification of a vaccine hesitancy scale for use in adult vaccinations in the United States and China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475604/
50588,Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772109/
50589,Associations between pharmacy choice and influenza vaccination: Mail order vs community pharmacy users,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373029/
50590,Co-administration of SARS-CoV-2 and influenza vaccines in healthcare workers: Results of two vaccination campaigns in a large teaching hospital in Rome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10732597/
50591,Traditional and New Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719499/
50592,"Seasonal and pandemic influenza: 100 years of progress, still much to learn",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223327/
50593,Factors associated with death due to severe acute respiratory syndrome caused by influenza: Brazilian population study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605860/
50594,A Review on Equine Influenza from a Human Influenza Perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229935/
50595,Harnessing the non-specific immunogenic effects of available vaccines to combat COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678415/
50596,Willingness to Vaccinate Children against Influenza after the Coronavirus Disease 2019 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410815/
50597,"Influenza Vaccine Effectiveness Among Patients with High-Risk Medical Conditions in the United States, 2012—2016",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282182/
50598,"Examining Public Messaging on Influenza Vaccine over Social Media: Unsupervised Deep Learning of 235,261 Twitter Posts from 2017 to 2023",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610639/
50599,Mouse Models of Influenza Infection with Circulating Strains to Test Seasonal Vaccine Efficacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797846/
50600,"Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in pregnant women: a randomized, observer-blind trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227680/
50601,Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650573/
50602,Efficacy of inactivated trivalent influenza vaccine in rural India: a 3-year cluster-randomised controlled trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347003/
50603,Consistency of self‐reported and documented historical influenza vaccination status of US healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343323/
50604,The Future of Influenza Vaccines: A Historical and Clinical Perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160951/
50605,Inactivated influenza virus vaccines: the future of TIV and QIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502789/
50606,Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530046/
50607,"Efficacy of a Russian-backbone live attenuated influenza vaccine among children in Senegal: a randomised, double-blind, placebo-controlled trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118222/
50608,"History and evolution of influenza control
through vaccination: from the first monovalent vaccine
to universal vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139605/
50609,"Safety, Immunogenicity, and Protective Efficacy of an H5N1 Chimeric Cold-Adapted Attenuated Virus Vaccine in a Mouse Model",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709164/
50610,Recombinant Influenza Vaccines: Saviors to Overcome Immunodominance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966699/
50611,Identification of groups at high risk for under-coverage of seasonal influenza vaccination: A national study to inform vaccination priorities during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677422/
50612,cGAMP/Saponin Adjuvant Combination Improves Protective Response to Influenza Vaccination by Microneedle Patch in an Aged Mouse Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884748/
50613,Quadrivalent Formulation of Intranasal Influenza Vaccine M2SR (M2-Deficient Single Replication) Protects against Drifted Influenza A and B Virus Challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142185/
50614,Modular vaccine platform based on the norovirus-like particle,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815183/
50615,Declining influenza vaccination rates in an underserved pediatric primary care center during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464574/
50616,The rationale for quadrivalent influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350141/
50617,"Heterologous Humoral Response against H5N1, H7N3, and H9N2 Avian Influenza Viruses after Seasonal Vaccination in a European Elderly Population",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620548/
50618,Development of a universal CTL-based vaccine for influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937198/
50619,Acceptance of Flu Vaccine among Parents of Diabetic Children in Jordan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976120/
50620,Cross-Protective Immunity against Multiple Influenza Virus Subtypes by a Novel Modified Vaccinia Ankara (MVA) Vectored Vaccine in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224110/
50621,Pandemic Preparedness Against Influenza: DNA Vaccine for Rapid Relief,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531196/
50622,Bioengineering Strategies for Developing Vaccines against Respiratory Viral Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597982/
50623,Microarray Gene Expression Dataset Re-analysis Reveals Variability in Influenza Infection and Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854009/
50624,High-Dose Seasonal Influenza Vaccine in Patients Undergoing Dialysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237058/
50625,Towards universal influenza vaccines?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146782/
50626,"Knowledge, attitude and practice of influenza vaccination among Lebanese parents: A cross-sectional survey from a developing country",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516244/
50627,Efficacy and clinical effectiveness of influenza vaccines in HIV-infected individuals: a meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574329/
50628,Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201308/
50629,Safety of COVID-19 vaccines during pregnancy: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040368/
50630,Comparison of attitudes toward routine maternal vaccines and COVID-19 vaccines among pregnant patients in an urban safety-net setting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194813/
50631,"Healthcare professionals’ knowledge, attitude and acceptance of influenza vaccination in Saudi Arabia: a multicenter cross-sectional study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469139/
50632,From Variation of Influenza Viral Proteins to Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536042/
50633,Is It Possible to Develop a “Universal” Influenza Virus Vaccine?: Potential Target Antigens and Critical Aspects for a Universal Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028071/
50634,Improving Medical Student Clinical Knowledge and Skills Through Influenza Education,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446123/
50635,Investigating the effect of AS03 adjuvant on the plasma cell repertoire following pH1N1 influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110968/
50636,Flagellin-expressing virus-like particles exhibit adjuvant effects on promoting IgG isotype-switched long-lasting antibody induction and protection of influenza vaccines in CD4-deficient mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274143/
50637,Trends in effectiveness of inactivated influenza vaccine in children by age groups in seven seasons immediately before the COVID-19 era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995322/
50638,Maternal vaccination: a review of current evidence and recommendations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582099/
50639,Association of dual COVID-19 and seasonal influenza vaccination with COVID-19 infection and disease severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786535/
50640,Childhood Influenza Vaccination and Its Determinants during 2020–2021 Flu Seasons in China: A Cross-Sectional Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783337/
50641,Enablers and barriers to COVID-19 vaccine uptake: An international study of perceptions and intentions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299222/
50642,Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099848/
50643,"Evaluation of a city-wide school-located influenza vaccination program in Oakland, California, with respect to vaccination coverage, school absences, and laboratory-confirmed influenza: A matched cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433855/
50644,Structural Biology of Influenza Hemagglutinin: An Amaranthine Adventure,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551194/
50645,African American adults and seasonal influenza vaccination: Changing our approach can move the needle,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861789/
50646,Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436086/
50647,"Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067463/
50648,PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022981/
50649,A systematic review and meta-analysis of cross-reactivity of antibodies induced by H7 influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062429/
50650,The development trend of influenza in China from 2010 to 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359369/
50651,Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640007/
50652,The long road of pandemic vaccine development to rollout: A systematic review on the lessons learnt from the 2009 H1N1 influenza pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815192/
50653,Trends in Excess Winter Mortality (EWM) from 1900/01 to 2019/20—Evidence for a Complex System of Multiple Long-Term Trends,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953800/
50654,Influenza vaccination in children primed with MF59®-adjuvanted or non-adjuvanted seasonal influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962648/
50655,Immunodominance hierarchy after seasonal influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639523/
50656,Preventing an Antigenically Disruptive Mutation in Egg-Based H3N2 Seasonal Influenza Vaccines by Mutational Incompatibility,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579542/
50657,"Canadian vaccine safety surveillance reports following immunization with seasonal influenza vaccines, 2021–2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11037881/
50658,The Doctrine of Original Antigenic Sin: Separating Good From Evil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853211/
50659,Intranasal Flu Vaccine Protective against Seasonal and H5N1 Avian Influenza Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671162/
50660,Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027237/
50661,Effect of Adjuvants on Responses to Skin Immunization by Microneedles Coated with Influenza Subunit Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405087/
50662,"Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251022/
50663,Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664442/
50664,"Determinants of vaccination uptake, and influenza vaccine effectiveness in preventing deaths and hospital admissions in the elderly population; Treviso, Italy, 2014/2015-2016/2017 seasons",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062427/
50665,Universal Live-Attenuated Influenza Vaccine Candidates Expressing Multiple M2e Epitopes Protect Ferrets against a High-Dose Heterologous Virus Challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310119/
50666,Preparing for the 2020—2021 influenza season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237025/
50667,Nutritional status of infants at six months of age following maternal influenza immunization: A randomized placebo-controlled trial in rural Nepal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714610/
50668,Safety and effectiveness of dose-sparing strategies for intramuscular seasonal influenza vaccine: a rapid scoping review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450963/
50669,Both hemispheric influenza vaccine recommendations would have missed near half of the circulating viruses in Madagascar,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705694/
50670,An evaluation of the emerging vaccines against influenza in children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847180/
50671,Evaluation of a Clinical Decision Support Strategy to Increase Seasonal Influenza Vaccination Among Hospitalized Children Before Inpatient Discharge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299313/
50672,The Role of Needle Fear in Pediatric Flu Vaccine Hesitancy: A Cross-Sectional Study in Bologna Metropolitan Area,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506010/
50673,Balanced Cellular and Humoral Immune Responses Targeting Multiple Antigens in Adults Receiving a Quadrivalent Inactivated Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146362/
50674,"Early signal detection of adverse events following influenza vaccination using proportional reporting ratio, Victoria, Australia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824574/
50675,Epitope analysis for influenza vaccine design,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482133/
50676,DNA and protein-generated chimeric molecules for delivery of influenza viral epitopes in mouse and humanized NSG transfer models,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793685/
50677,"International meeting on influenza vaccine effectiveness, 3–4 December 2012, Geneva, Switzerland",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733129/
50678,Factors that influence vaccination decision-making among pregnant women: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347125/
50679,Value of influenza vaccines in cancer patients during the coronavirus (COVID-19) pandemic: a cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035604/
50680,From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241783/
50681,"Roles for Pathogen Interference in Influenza Vaccination, with Implications to Vaccine Effectiveness (VE) and Attribution of Influenza Deaths",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602062/
50682,How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313962/
50683,Selecting and Using the Appropriate Influenza Vaccine for Each Individual,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225103/
50684,Development of a Universal Epitope-Based Influenza Vaccine and Evaluation of Its Effectiveness in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026828/
50685,"Research on Knowledge, Attitudes, and Practices of Influenza Vaccination Among Healthcare Workers in Chongqing, China—Based on Structural Equation Model",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160795/
50686,"Influenza: the virus and prophylaxis with inactivated influenza vaccine in “at risk” groups, including COPD patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695195/
50687,Immune interference in effectiveness of influenza and COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154574/
50688,Effectiveness of Influenza Vaccines in the HIVE Household Cohort Over 8 Years: Is There Evidence of Indirect Protection?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492146/
50689,"Vaccines Induce Homeostatic Immunity, Generating Several Secondary Benefits",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11053716/
50690,Relative Effectiveness of Cell-based Versus Egg-based Quadrivalent Influenza Vaccines in Children and Adolescents in the United States During the 2019–2020 Influenza Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359763/
50691,Increasing vaccine uptake among employees within the non-health related critical infrastructure sectors: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980543/
50692,"The adjuvant GLA-AF enhances human intradermal vaccine
responses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136895/
50693,What do pregnant women think about influenza disease and vaccination practices in selected countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189050/
50694,Comparative safety of mRNA COVID‐19 vaccines to influenza vaccines: A pharmacovigilance analysis using WHO international database,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662238/
50695,"How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777640/
50696,Potential health and economic impact of paediatric vaccination using next-generation influenza vaccines in Kenya: a modelling study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032252/
50697,Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027718/
50698,A Systematic Review and Meta-Analysis of the Relationship between Receiving the Flu Vaccine with Acute Cerebrovascular Accident and Its Hospitalization in the Elderly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940958/
50699,Mitigating co-circulation of seasonal influenza and COVID-19 pandemic in the presence of vaccination: A mathematical modeling approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845909/
50700,"Vaccination in pregnancy: Attitudes of nurses, midwives and health visitors in England",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791587/
50701,Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801892/
50702,Phase 2 Assessment of the Safety and Immunogenicity of Two Inactivated Pandemic Monovalent H1N1 Vaccines in Adults as a Component of the U.S. Pandemic Preparedness Plan in 2009,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490194/
50703,"The role of vaccination in COPD: influenza, SARS-CoV-2, pneumococcus, pertussis, RSV and varicella zoster virus",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481333/
50704,Understanding the Global Burden of Influenza in Adults Aged 18–64 years: A Systematic Literature Review from 2012 to 2022,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499696/
50705,Introduction of a quadrivalent influenza vaccine in Italy: a budget impact analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910441/
50706,"Quadrivalent influenza vaccine: a new opportunity to reduce the influenza burden
",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910440/
50707,Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499326/
50708,Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248945/
50709,The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767530/
50710,Impact of age and pre-existing immunity on the induction of human antibody responses against influenza B viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773397/
50711,Estimating Influenza Vaccine Effectiveness With the Test-Negative Design Using Alternative Control Groups: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860156/
50712,Production of adenovirus vectors and their use as a delivery system for influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951029/
50713,The burden of influenza and the role of influenza vaccination in adults aged 50-64 years: A summary of available evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10760501/
50714,Protection of young children from influenza through universal vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635866/
50715,Impact of hemagglutination activity and M2e immunity on conferring protection against influenza viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978532/
50716,Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874655/
50717,Influence of the H1N1 influenza pandemic on the humoral immune response to seasonal flu vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535392/
50718,Induction of influenza-specific local CD8 T-cells in the respiratory tract after aerosol delivery of vaccine antigen or virus in the Babraham inbred pig,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5957346/
50719,"Uptake and effectiveness of influenza vaccine in those aged 65 years and older in the United Kingdom, influenza seasons 2010/11 to 2016/17",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169201/
50720,Factors affecting immune responses to the influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861809/
50721,Human Innate Lymphoid Cells in Influenza Infection and Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185163/
50722,"Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: A critical review and re-analysis of 15 meta-analyses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495721/
50723,"Seasonal influenza vaccination among older adults in Jordan: prevalence, knowledge, and attitudes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553699/
50724,Partnering for enhanced digital surveillance of influenza‐like disease and the effect of antivirals and vaccines (PEDSIDEA),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586183/
50725,Seasonal influenza: Modelling approaches to capture immunity propagation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837557/
50726,Next generation methodology for updating HA vaccines against emerging human seasonal influenza A(H3N2) viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925519/
50727,Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009–2010 season in the active component U.S. military and civilians aged 17–44 years reported to the Vaccine Adverse Event Reporting System,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463880/
50728,Genetic and antigenic characterization of influenza A(H3N2) in Cameroon during the 2014-2016 influenza seasons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587321/
50729,Effectiveness of a pay-it-forward intervention compared with user-paid vaccination to improve influenza vaccine uptake and community engagement among children and older adults in China: a quasi-experimental pragmatic trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492551/
50730,Influenza vaccination rates among healthcare workers: a systematic review and meta-analysis investigating influencing factors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657874/
50731,A Cross-Sectional Factor Analysis of COVID-19 and Influenza Vaccination Decisions in a Racially Diverse Western Pennsylvania Community,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668581/
50732,Attitudes of Nursing Home Staff towards Influenza Vaccination: Opinions and Factors Influencing Hesitancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143910/
50733,Distinct immunological and molecular signatures underpinning influenza vaccine responsiveness in the elderly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653450/
50734,Influenza vaccination among U.S. pediatric patients receiving care from federally funded health centers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378489/
50735,Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158729/
50736,New Points of Departure for More Global Influenza Vaccine Use,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563509/
50737,Decline in Seasonal Influenza Vaccine Effectiveness With Vaccination Program Maturation: A Systematic Review and Meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953658/
50738,A universal long-term flu vaccine may not prevent severe epidemics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003272/
50739,Clinician-parent discussions about influenza vaccination of children and their association with vaccine acceptance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572763/
50740,Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910541/
50741,Impact of pharmacist administration of influenza vaccines on uptake in Canada,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266568/
50742,Predicting COVID-19 and Influenza Vaccination Confidence and Uptake in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611394/
50743,Summary of the NACI Statement on Seasonal Influenza Vaccine for 2017–2018,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764726/
50744,Titer on Chip: New Analytical Tool for Influenza Vaccine Potency Determination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203742/
50745,Seasonal influenza vaccination in Kenya: an economic evaluation using dynamic transmission modelling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438179/
50746,Young Adult Human Papillomavirus and Influenza Vaccine Coverage: A Comparison Across College Enrollment Status,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666656/
50747,Effect of inactivated influenza vaccination on human coronavirus infection: Secondary analysis of a randomized trial in Hutterite colonies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520850/
50748,Yeast Surface-Displayed H5N1 Avian Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204078/
50749,Successes and Failures of the Live-attenuated Influenza Vaccine: Can We Do Better?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319054/
50750,Strategic Planning of a Joint SARS-CoV-2 and Influenza Vaccination Campaign in the UK,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10891881/
50751,Neutralization and hemagglutination-inhibition antibodies following influenza vaccination of HIV-infected and HIV-uninfected pregnant women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312282/
50752,Influenza vaccine and cardiac protection: a study from a tertiary care center,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227676/
50753,Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006891/
50754,A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922371/
50755,A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865568/
50756,A Nanoparticle-Poly(I:C) Combination Adjuvant Enhances the Breadth of the Immune Response to Inactivated Influenza Virus Vaccine in Pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349929/
50757,Vaccine Safety,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173515/
50758,Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967648/
50759,Estimating the Potential Effects of a Vaccine Program Against an Emerging Influenza Pandemic—United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610126/
50760,Replicating Single-Cycle Adenovirus Vectors Generate Amplified Influenza Vaccine Responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215357/
50761,"The Unmet Need in the Elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345132/
50762,COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459551/
50763,Age-Related Changes in Durability and Function of Vaccine-Elicited Influenza-Specific CD4+ T-Cell Responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224983/
50764,Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551669/
50765,The establishment of surrogates and correlates of protection: Useful tools for the licensure of effective influenza vaccines?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861778/
50766,Influenza vaccine for chronic obstructive pulmonary disease (COPD),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513384/
50767,"Comparison of the Immunogenicity and Safety of a Split-virion, Inactivated, Trivalent Influenza Vaccine (Fluzone®) Administered by Intradermal or Intramuscular Route in Healthy Adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150501/
50768,Heterogeneity of Circulating Influenza Viruses and Their Impact on Influenza Virus Vaccine Effectiveness During the Influenza Seasons 2016/17 to 2018/19 in Austria,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092378/
50769,"Conserved Influenza Hemagglutinin, Neuraminidase and Matrix Peptides Adjuvanted with ALFQ Induce Broadly Neutralizing Antibodies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310080/
50770,Assessment of the Knowledge and Opinions of Undergraduate Health Care Students Concerning Influenza Vaccination in Saudi Arabia: A Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503518/
50771,The Effect of Monovalent Influenza Vaccine on the Risk of Hospitalization and All-Cause Mortality According to the Results of Randomized Clinical Trials: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362208/
50772,Impact of General Practitioner Education on Acceptance of an Adjuvanted Seasonal Influenza Vaccine among Older Adults in England,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952828/
50773,Nonreplicating Influenza A Virus Vaccines Confer Broad Protection against Lethal Challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620468/
50774,Host immune response–inspired development of the influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327511/
50775,Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203918/
50776,Influenza in temperate and tropical Asia: a review of epidemiology and vaccinology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482764/
50777,Influenza and pneumococcal vaccination and COVID-19 in kidney transplant patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365519/
50778,Dried Ginger Extract Restores the T Helper Type 1/T Helper Type 2 Balance and Antibody Production in Cyclophosphamide-Induced Immunocompromised Mice after Flu Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102251/
50779,A literature review of severity scores for adults with influenza or community-acquired pneumonia – implications for influenza vaccines and therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903905/
50780,Advances in the development of universal influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781207/
50781,Changes in Attitudes and Beliefs Concerning Vaccination and Influenza Vaccines between the First and Second COVID-19 Pandemic Waves: A Longitudinal Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470379/
50782,Influenza vaccine hesitancy and influencing factors among university students in China: a multicenter cross-sectional survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142317/
50783,"Safety and Immunogenicity of Inactivated, Vero Cell Culture-Derived Whole Virus Influenza A/H5N1 Vaccine Given Alone or with Aluminum Hydroxide Adjuvant in Healthy Adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022490/
50784,Influenza and Antibody-Dependent Cellular Cytotoxicity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611398/
50785,"Flu and pertussis vaccination during pregnancy in Geneva during the COVID-19 pandemic: A multicentric, prospective, survey-based study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076028/
50786,Systemic and mucosal humoral immune responses induced by the JY-adjuvanted nasal spray H7N9 vaccine in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076272/
50787,Technologies to Improve Immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152424/
50788,Pre-existing immunity and vaccine history determine hemagglutinin-specific CD4 T cell and IgG response following seasonal influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602312/
50789,Trivalent inactivated influenza vaccine (IIV3) during pregnancy and six-month infant development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309563/
50790,Vaccine Effectiveness Against Acute Respiratory Illness Hospitalizations for Influenza-Associated Pneumonia During the 2015–2016 to 2017–2018 Seasons: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049268/
50791,"Trends in Childhood Influenza Vaccination Coverage, United States, 2012-2019",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485062/
50792,Clinical Advances in Viral-Vectored Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027524/
50793,Genetic diversity of influenza A viruses circulating in Bulgaria during the 2018–2019 winter season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481746/
50794,Expression of Toll-like Receptors on the Immune Cells in Patients with Common Variable Immune Deficiency after Different Schemes of Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611272/
50795,"Antenatal influenza vaccination in urban Pune, India: clinician and community stakeholders’ awareness, priorities, and practices",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018408/
50796,The Future of Flu: A Review of the Human Challenge Model and Systems Biology for Advancement of Influenza Vaccinology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489464/
50797,Factors influencing refusing of flu vaccination among pregnant women in Italy: Healthcare workers’ role,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379633/
50798,Effect of the 2020/21 season influenza vaccine on SARS-CoV-2 infection in a cohort of Italian healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829680/
50799,Socio‐demographic differences in opinions about 2009 pandemic influenza A (H1N1) and seasonal influenza vaccination and disease among adults during the 2009–2010 influenza season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779826/
50800,The influenza vaccines roadmap – A better future through improved influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499092/
50801,Enhanced Immune Responses Conferring Cross-Protection by Skin Vaccination With a Tri-Component Influenza Vaccine Using a Microneedle Patch,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077188/
50802,Antenatal influenza and pertussis vaccination in Western Australia: a cross-sectional survey of vaccine uptake and influencing factors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201540/
50803,Safety of Inactivated Influenza Vaccine in Cancer Patients Receiving Immune Checkpoint Inhibitors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938975/
50804,Optimal timing of influenza vaccine during pregnancy: A systematic review and meta‐analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692549/
50805,"Trends in Childhood Influenza Vaccination Coverage—U.S., 2004–2012",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116369/
50806,Heterotypic Neuraminidase Antibodies Against Different A(H1N1) Strains are Elicited after Seasonal Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466453/
50807,Towards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731596/
50808,Immunogenicity and Safety of Trivalent Split Influenza Vaccine in Healthy Korean Adults with Low Pre-Existing Antibody Levels: An Open Phase I Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011266/
50809,Cost–effectiveness analysis of quadrivalent influenza vaccine in Spain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027707/
50810,Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657512/
50811,Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880815/
50812,"Influenza Vaccination in Massachusetts Jails: A Mixed-Methods
Analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379841/
50813,Understanding why healthcare workers refuse the flu vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238696/
50814,"Barriers and facilitators to vaccination uptake against COVID-19, influenza, and pneumococcal pneumonia in immunosuppressed adults with immune-mediated inflammatory diseases: A qualitative interview study during the COVID-19 pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462800/
50815,Vaccination during pregnancy: Canadian maternity care providers' opinions and practices,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733901/
50816,Multigenic DNA vaccine induces protective cross-reactive T cell responses against heterologous influenza virus in nonhuman primates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739435/
50817,Characterization of cross protection of Swine-Origin Influenza Virus (S-OIV) H1N1 and reassortant H5N1 influenza vaccine in BALB/c mice given a single-dose vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615951/
50818,Influenza vaccination in the time of COVID-19: A national U.S. survey of adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931729/
50819,"Longitudinal Evaluation of Clinical Decision Support to Improve Influenza Vaccine Uptake in an Integrated Pediatric Health Care Delivery System, Houston, Texas",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924327/
50820,Immunogenicity of Split Inactivated Quadrivalent Influenza Vaccine in Adults with Obesity in the 2017/2018 Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139133/
50821,Concurrent Administration of COVID-19 and Influenza Vaccines Enhances Spike-Specific Antibody Responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10986856/
50822,"Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014–2015",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812259/
50823,J Infect Dis. 2017 Jun 1; 215(11): 1774. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692644/
50824,How the COVID 19 pandemic will shape influenza public health initiatives: The UK experience,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255027/
50825,Hum Vaccin Immunother. 2022; 18(5): 2071083. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359364/
50826,Influenza vaccine uptake among at-risk adults (aged 16–64 years) in the UK: a retrospective database analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460844/
50827,Does Choice of Influenza Vaccine Type Change Disease Burden and Cost-Effectiveness in the United States? An Agent-Based Modeling Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411677/
50828,"Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 Influenza Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779578/
50829,The immune correlates of protection for an avian influenza H5N1 vaccine in the ferret model using oil-in-water adjuvants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381113/
50830,"Development
of Self-Assembled Protein Nanocage Spatially
Functionalized with HA Stalk as a Broadly Cross-Reactive Influenza
Vaccine Platform",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10753887/
50831,Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009–2010,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708558/
50832,Reducing Antibiotic Use in Ambulatory Care Through Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778345/
50833,High Rates of COVID-19 Vaccine Hesitancy and Its Association with Conspiracy Beliefs: A Study in Jordan and Kuwait among Other Arab Countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826844/
50834,Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854614/
50835,Influenza vaccines for preventing cardiovascular disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511741/
50836,Healthcare professional and professional stakeholders’ perspectives on vaccine mandates in Switzerland: A mixed-methods study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832463/
50837,Metformin-induced suppression of IFN-α via mTORC1 signalling following seasonal vaccination is associated with impaired antibody responses in type 2 diabetes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039947/
50838,Live Attenuated Influenza Vaccine in Children Induces B-Cell Responses in Tonsils,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978372/
50839,J Infect Dis. 2016 Nov 15; 214(10): 1613. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144659/
50840,"What Demographic, Social, and Contextual Factors Influence the Intention to Use COVID-19 Vaccines: A Scoping Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431323/
50841,Influenza vaccine effectiveness against influenza A in children based on the results of various rapid influenza tests in the 2018/19 season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997015/
50842,Modulation of Immune Responses to Influenza A Virus Vaccines by Natural Killer T Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606973/
50843,Role of Multivalency and Antigenic Threshold in Generating Protective Antibody Responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504826/
50844,Evolutionary conservation and positive selection of influenza A nucleoprotein CTL epitopes for universal vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052727/
50845,YouTube as a Source of Influenza Vaccine Information in Spanish,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830572/
50846,Antibodies to a Conserved Influenza Head-interface Epitope Protect by an IgG Subtype Dependent Mechanism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825805/
50847,Advancements in the development of subunit influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336774/
50848,An assessment of healthcare professionals’ knowledge about and attitude towards influenza vaccination in Freetown Sierra Leone: a cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584505/
50849,Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2888842/
50850,Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712959/
50851,Convergent antibody evolution and clonotype expansion following influenza virus vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899375/
50852,Factors associated with uptake of influenza and pertussis vaccines among pregnant women in South Australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002099/
50853,A Cohort Study on Influenza Vaccine and All-Cause Mortality in Older Adults: Methodological Concerns and Public Health Implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305032/
50854,A multi-site feasibility study to assess fever and wheezing in children after influenza vaccines using text messaging,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693331/
50855,Effectiveness of influenza vaccination in the elderly: a population-based case-crossover study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860060/
50856,Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10879490/
50857,The New Quadrivalent Adjuvanted Influenza Vaccine for the Italian Elderly: A Health Technology Assessment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998177/
50858,Understanding the Impact of Approved but Unfunded Vaccine Status on Parental Acceptance of an Adjuvanted Seasonal Influenza Vaccine for Infants: Results from the Pediatric Influenza Vaccination Optimization Trial (PIVOT)–III,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606895/
50859,"Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206469/
50860,"Phase 1 Randomized, Placebo-Controlled, Dose-Escalating Study to Evaluate OVX836, a Nucleoprotein-Based Influenza Vaccine: Intramuscular Results",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373130/
50861,Better Pandemic Influenza Preparedness through Adjuvant Technology Transfer: Challenges and Lessons Learned,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148163/
50862,Transient Humoral Protection against H5N1 Challenge after Seasonal Influenza Vaccination of Humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116209/
50863,"Passive enhanced safety surveillance of GSK’s quadrivalent seasonal influenza vaccine in Belgium, Germany and Spain, an observational study: protocol for the 2018/2019 influenza season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701642/
50864,A systematic review of communication interventions for countering vaccine misinformation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829031/
50865,Immunogenicity and safety of MF59-adjuvanted and full-dose unadjuvanted trivalent inactivated influenza vaccines among vaccine-naïve children in a randomized clinical trial in rural Senegal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327321/
50866,"Influenza vaccination uptake and its determinants during the 2019-2020 and early 2020-2021 flu seasons among migrants in Shanghai, China: a cross-sectional survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973321/
50867,"Knowledge, attitude, and practice regarding infection and vaccination in patients with rheumatic diseases in China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605817/
50868,Immunogenicity and safety of an egg-based inactivated quadrivalent influenza vaccine (GC3110A) versus two inactivated trivalent influenza vaccines with alternate B strains: A phase Ⅲ randomized clinical trial in adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605850/
50869,Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863932/
50870,Knowledge attitudes and practices toward seasonal influenza vaccine among pregnant women during the 2018/2019 influenza season in Tunisia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939791/
50871,Estimating Influenza Vaccine Efficacy From Challenge and Community-based Study Data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2638553/
50872,Adverse Events of Interest Following Influenza Vaccination in the First Season of Adjuvanted Trivalent Immunization: Retrospective Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002594/
50873,Influenza vaccine failure in the tropics: a retrospective cohort study of waning effectiveness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801929/
50874,Factors associated with seasonal influenza and HPV vaccination uptake among different ethnic groups in Arab and Jewish society in Israel,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423338/
50875,Adjuvanted-influenza vaccination in patients infected with HIV: a systematic review and meta-analysis of immunogenicity and safety,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227622/
50876,Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340030/
50877,Impact of early life exposure to ionizing radiation on influenza vaccine response in an elderly Japanese cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172087/
50878,Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944288/
50879,Targeting Hemagglutinin: Approaches for Broad Protection against the Influenza A Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563292/
50880,Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2200794/
50881,"Adherence, Perception of, and Attitude toward Influenza and Flu Vaccination: A Cross-Sectional Study among a Population of Future Healthcare Workers",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701137/
50882,Update: Influenza Activity in the United States During the 2017–18 Season and Composition of the 2018–19 Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991814/
50883,"Surveillance of adverse events after seasonal influenza vaccination in pregnant women and their infants in the Vaccine Adverse Event Reporting System, July, 2010 – May, 2016",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602065/
50884,The impact of human vaccines on bacterial antimicrobial resistance. A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479502/
50885,Waning of Measured Influenza Vaccine Effectiveness Over Time: The Potential Contribution of Leaky Vaccine Effect,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422999/
50886,The impact of mental distress on influenza vaccine coverage,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989344/
50887,"Development of Lentiviral Vectors Pseudotyped With Influenza B Hemagglutinins: Application in Vaccine Immunogenicity, mAb Potency, and Sero-Surveillance Studies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182064/
50888,Effectiveness of Seasonal Influenza Vaccines in the United States During a Season With Circulation of All Three Vaccine Strains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657521/
50889,Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900784/
50890,Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625511/
50891,Immunogenicity of High-Dose Versus MF59-Adjuvanted Versus Standard Influenza Vaccine in Solid Organ Transplant Recipients: The Swiss/Spanish Trial in Solid Organ Transplantation on Prevention of Influenza (STOP-FLU Trial),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10810716/
50892,"Knowledge, attitudes and practices related to influenza and influenza vaccine among healthcare workers in Chongqing, China—a cross-sectional study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903929/
50893,A review of the changes to the licensing of influenza vaccines in Europe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687503/
50894,Associations between vaccination and quality of life among Taiwan general population: A comparison between COVID-19 vaccines and flu vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621022/
50895,Influenza Vaccine Effectiveness Against Pediatric Deaths: 2010–2014,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728382/
50896,Increasing the breadth and potency of response to the seasonal influenza virus vaccine by immune complex immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617290/
50897,Social determinants of health and adult influenza vaccination: a nationwide claims analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372982/
50898,Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903946/
50899,"Prospective cohort studies to evaluate the safety and immunogenicity
of the 2013, 2014, and 2015 seasonal influenza vaccines produced by Instituto
Butantan",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069271/
50900,How has the flu virus infected the Web? 2010 influenza and vaccine information available on the Internet,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608255/
50901,A PBMC-Based System to Assess Human T Cell Responses to Influenza Vaccine Candidates In Vitro,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963913/
50902,The Intersection of Age and Influenza Severity: Utility of Ferrets for Dissecting the Age-Dependent Immune Responses and Relevance to Age-Specific Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071347/
50903,"Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494343/
50904,System Vaccinology for the Evaluation of Influenza Vaccine Safety by Multiplex Gene Detection of Novel Biomarkers in a Preclinical Study and Batch Release Test,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092028/
50905,Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241597/
50906,Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324956/
50907,"Influenza Vaccine Effectiveness Against All-Cause Mortality Following Laboratory-Confirmed Influenza in Older Adults, 2010–2011 to 2015–2016 Seasons in Ontario, Canada",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423473/
50908,The Impact of the COVID-19 Pandemic on the Uptake of Influenza Vaccine: UK-Wide Observational Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048709/
50909,Novel synthetic plasmid and Doggybone™ DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635705/
50910,Assessment of temporally-related acute respiratory illness following influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115556/
50911,Cell culture-based influenza vaccines: A necessary and indispensable investment for the future,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514150/
50912,Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552029/
50913,Parents’ Willingness to Vaccinate Their Children Against Seasonal Influenza After the COVID-19 Pandemic in Saudi Arabia: A Retrospective Cross-Sectional Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687681/
50914,Immunization with M2e-Displaying T7 Bacteriophage Nanoparticles Protects against Influenza A Virus Challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3454340/
50915,B cell Responses to H5 influenza HA in Human Subjects Vaccinated with a Drifted Variant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814950/
50916,Novel vaccines against influenza viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401575/
50917,A review of epidemic preparedness for influenza through local vaccine production: national security for Thailand,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816430/
50918,Maternal Vaccination and Vaccine Hesitancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9956150/
50919,Association between Adult Vaccine Hesitancy and Parental Acceptance of Childhood COVID-19 Vaccines: A Web-Based Survey in a Northwestern Region in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539638/
50920,Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta‐Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174205/
50921,Predictors of influenza vaccine uptake during the 2009/10 influenza A H1N1v (‘swine flu’) pandemic: Results from five national surveys in the United Kingdom,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766366/
50922,Predictors of seasonal influenza and COVID-19 vaccination coverage among adults in Tennessee during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10945017/
50923,A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517730/
50924,Hemagglutinin (HA) Proteins from H1 and H3 Serotypes of Influenza A Viruses Require Different Antigen Designs for the Induction of Optimal Protective Antibody Responses as Studied by Codon-Optimized HA DNA Vaccines ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1642598/
50925,A comprehensive review of the epidemiology and disease burden of Influenza B in 9 European countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962970/
50926,Functional Immune Response to Influenza H1N1 in Children and Adults after Live Attenuated Influenza Virus Vaccination.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746580/
50927,Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070775/
50928,Combining COVID-19 and seasonal influenza vaccines together to increase the acceptance of newly developed vaccines in the Eastern Mediterranean Region: a cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10836265/
50929,Influenza Vaccination During COVID-19 in a Rural Community: A Cross-sectional Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514004/
50930,"Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015–2018",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326549/
50931,"Healthy Bodies, Toxic Medicines: College Students and the Rhetorics of Flu Vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257030/
50932,Analysis on the intention and influencing factors of free influenza vaccination among the elderly people aged 70 and above in Hangzhou in 2022,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853049/
50933,Trivalent mRNA vaccine-candidate against seasonal flu with cross-specific humoral immune response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11058219/
50934,A Mutated PB1 Residue 319 Synergizes with the PB2 N265S Mutation of the Live Attenuated Influenza Vaccine to Convey Temperature Sensitivity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693792/
50935,New Pre-pandemic Influenza Vaccines: An Egg-and Adjuvant-independent Human Adenoviral Vector Strategy Induces Long-lasting Protective Immune Responses in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2793094/
50936,Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443807/
50937,Evaluation of a ‘serious game’ on nursing student knowledge and uptake of influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808644/
50938,Excessive daytime sleepiness is associated with impaired antibody response to influenza vaccination in older male adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10749933/
50939,Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915537/
50940,Selenium supplementation has beneficial and detrimental effects on immunity to influenza vaccine in older adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381341/
50941,Do People Taking Flu Vaccines Need Them the Most?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229476/
50942,COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10810638/
50943,Cureus. 2024 Feb; 16(2): r137. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10897748/
50944,Induction of trained immunity by influenza vaccination - impact on COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568262/
50945,Vaccine Hesitancy: Contemporary Issues and Historical Background,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612044/
50946,Challenges and Adaptation of a European Influenza Vaccine Effectiveness Study Platform in Response to the COVID-19 Emergence: Experience from the DRIVE Project,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908420/
50947,Prevention of influenza virus shedding and protection from lethal H1N1 challenge using a consensus 2009 H1N1 HA and NA adenovirus vector vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578229/
50948,OVX836 Heptameric Nucleoprotein Vaccine Generates Lung Tissue-Resident Memory CD8+ T-Cells for Cross-Protection Against Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223747/
50949,Preclinical Evaluation of TB/FLU-04L—An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138401/
50950,Antiviral Approaches against Influenza Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035319/
50951,"H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149781/
50952,Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823897/
50953,Investigating the Interaction between Negative Strand RNA Viruses and Their Hosts for Enhanced Vaccine Development and Production,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830660/
50954,Influenza Vaccines: Unmet Needs and Recent Developments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902815/
50955,Cost Effectiveness of Influenza Vaccine Choices in Children Aged 2–8 Years in the U.S.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841730/
50956,Visualization of Alternative Functional Configurations of Influenza Virus Hemagglutinin Facilitates Rapid Selection of Complementing Vaccines in Emergency Situations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412350/
50957,"Influenza Vaccine Acceptance and Hesitancy Among Adults Hospitalized with Severe Acute Respiratory Illnesses, United States 2019–2020",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588478/
50958,Investigation of Tunable Acetalated Dextran Microparticle Platform to Optimize M2e-Based Influenza Vaccine Efficacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365168/
50959,Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190794/
50960,"Pregnant women’s attitudes and behaviours towards antenatal vaccination against Influenza and COVID-19 in the Liverpool City Region, United Kingdom: Cross-sectional survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518603/
50961,Human immune responses elicited by an intranasal inactivated H5 influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216874/
50962,"Analysis of factors influencing parents’ willingness to accept the quadrivalent influenza vaccine for school-aged children in the Nanhai District, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227682/
50963,Within-subject associations between inflammation and features of depression: Using the flu vaccine as a mild inflammatory stimulus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857469/
50964,Baseline Levels of Influenza-Specific CD4 Memory T-Cells Affect T-Cell Responses to Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440350/
50965,Calcium Phosphate Nanoparticle (CaPNP) for Dose-Sparing of Inactivated Whole Virus Pandemic Influenza A (H1N1) 2009 Vaccine in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562532/
50966,Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920214/
50967,Attitudes of school teachers toward influenza and COVID-19 vaccine in Greece during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437491/
50968,CD40-mediated enhancement of immune responses against three forms of influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265986/
50969,"Safety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in Adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707871/
50970,"Evaluation of a city-wide school-located influenza vaccination program in Oakland, California with respect to race and ethnicity: A matched cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881996/
50971,Views and experiences of maternal healthcare providers regarding influenza vaccine during pregnancy globally: A systematic review and qualitative evidence synthesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830613/
50972,Suppression by Thimerosal of Ex-Vivo CD4+ T Cell Response to Influenza Vaccine and Induction of Apoptosis in Primary Memory T Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972181/
50973,Effectiveness of influenza vaccination on influenza-associated hospitalisations over time among children in Hong Kong: a test-negative case-control study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637165/
50974,Immunosignatures can predict vaccine efficacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831987/
50975,The Impact of Vaccine Concerns on Racial/Ethnic Disparities in Influenza Vaccine Uptake Among Health Care Workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539840/
50976,Improving Rates of Outpatient Influenza Vaccination Through EHR Portal Messages and Interactive Automated Calls: A Randomized Controlled Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910339/
50977,"Age-Specific Etiology of Severe Acute Respiratory Infections and Influenza Vaccine Effectivity in Prevention of Hospitalization in Russia, 2018–2019 Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552611/
50978,A Vaccine Displaying a Trimeric Influenza-A HA Stem Protein on Capsid-Like Particles Elicits Potent and Long-Lasting Protection in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564254/
50979,Examining Perceptions about Mandatory Influenza Vaccination of Healthcare Workers through Online Comments on News Stories,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473076/
50980,"Effectiveness of the 2013 and 2014 Southern Hemisphere Influenza Vaccines Against Laboratory-Confirmed Influenza in Young Children Using a Test-Negative Design, Bangkok, Thailand",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021558/
50981,Searching the Web for Influenza Vaccines: HealthMap Vaccine Finder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503243/
50982,The post-2009 influenza pandemic era: time to revisit antibody immunodominance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205375/
50983,"Safety and Immunogenicity of Cell Culture-Derived A/H3N2 Variant Influenza Vaccines: A Phase I Randomized, Observer-Blind, Dose-Ranging Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542591/
50984,The Vaccine Hesitancy Profiles and Determinants of Seasonal Influenza among Chinese Community Healthcare Workers: A Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505772/
50985,A Primer on Strategies for Prevention and Control of Seasonal and Pandemic Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504386/
50986,"Knowledge, attitudes, and practices associated with frequent influenza vaccination among healthcare personnel in Peru, 2016─2018",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205539/
50987,Social Media Engagement and Influenza Vaccination During the COVID-19 Pandemic: Cross-sectional Survey Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968480/
50988,Effect of influenza vaccines against mismatched strains: a systematic review protocol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488466/
50989,Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800680/
50990,"Factors and considerations for establishing and improving seasonal influenza vaccination of health workers: Report from a WHO meeting, January 16–17, Berlin, Germany",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868506/
50991,Influenza vaccine coverage and factors associated with non-vaccination among adults at high risk for severe outcomes: An analysis of the Canadian Longitudinal Study on Aging,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524702/
50992,The Economic and Fiscal Impact of Influenza Vaccination for Health Care Workers in Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609125/
50993,Novel Lipidated Imidazoquinoline TLR7/8 Adjuvants Elicit Influenza-Specific Th1 Immune Responses and Protect Against Heterologous H3N2 Influenza Challenge in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075946/
50994,"Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: a randomized, double-blind, controlled phase III clinical trial in children aged 6–35 months in China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482894/
50995,A Bayesian Network to Predict the Risk of Post Influenza Vaccination Guillain-Barré Syndrome: Development and Validation Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994148/
50996,Phase IV: Randomized controlled trial to evaluate lot consistency of trivalent split influenza vaccines in healthy adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443091/
50997,Vaccines for an influenza pandemic: scientific and political challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634554/
50998,Intradermal Immunization of Soluble Influenza HA Derived from a Lethal Virus Induces High Magnitude and Breadth of Antibody Responses and Provides Complete Protection In Vivo,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141624/
50999,Respiratory Viruses and Virus-like Particle Vaccine Development: How Far Have We Advanced?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965150/
51000,Seasonal quadrivalent mRNA vaccine prevents and mitigates influenza infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570305/
51001,How has COVID-19 pandemic changed flu vaccination attitudes among an Italian cancer center healthcare workers?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903766/
51002,Strategies Targeting Hemagglutinin as a Universal Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998911/
51003,"Inactivated influenza vaccine effectiveness among department of defense beneficiaries aged 6 months-17 years, 2016–2017 through 2019–2020 influenza seasons",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397503/
51004,"Optimization of Elderly Influenza and Pneumococcal Immunization Programs in Beijing, China Using Health Economic Evaluations: A Modeling Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863432/
51005,From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272596/
51006,Effects of Confounding Bias in Coronavirus Disease 2019 (COVID-19) and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129127/
51007,"The Effect of Pneumococcal, Influenza, and COVID-19 Vaccinations on COVID-19 Hospitalization and Progression in People over 65 Years Old Living in Nursing Homes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222139/
51008,"Provider Communication and Mothers’ Willingness to Vaccinate
Against HPV and Influenza: A Randomized Health Messaging Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785569/
51009,Cellular Immune Responses in Children and Adults Receiving Inactivated or Live Attenuated Influenza Vaccines ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1642596/
51010,"Knowledge, attitudes, and practices regarding seasonal influenza vaccination during pregnancy in Costa Rica: A mixed-methods study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656696/
51011,Statewide evaluation of COVID-19 vaccine hesitancy in Rhode Island,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159551/
51012,Post-authorisation passive enhanced safety surveillance of seasonal influenza vaccines: protocol of a pilot study in England,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541341/
51013,Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10767121/
51014,A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014–2015 Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901864/
51015,Influenza–Host Interplay and Strategies for Universal Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564814/
51016,The evolutionary footprint of influenza A subtype H3N2 strains in Bangladesh: implication of vaccine strain selection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519982/
51017,Seasonal Variability and Shared Molecular Signatures of Inactivated Influenza Vaccination in Young and Older Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755271/
51018,Factors influencing the decision to receive seasonal influenza vaccination among US corporate non-healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746537/
51019,A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18–50 Years of Age,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564144/
51020,Influenza Vaccine Effectiveness in the Tropics: Moderate Protection in a Case Test-Negative Analysis of a Hospital-Based Surveillance Population in Bangkok between August 2009 and January 2013,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534293/
51021,Production of Inactivated Influenza H5N1 Vaccines from MDCK Cells in Serum-Free Medium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025921/
51022,Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382595/
51023,"COVID-19 and seasonal flu vaccination hesitancy: Links to personality and general intelligence in a large, UK cohort",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135693/
51024,Pseudotyped Influenza A Virus as a Vaccine for the Induction of Heterotypic Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503098/
51025,Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985159/
51026,The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828088/
51027,Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893060/
51028,Development of an Intranasal Gel for Delivery of a Broadly Acting Subunit Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627116/
51029,Knowledge of influenza vaccination recommendation and early vaccination uptake during the 2015–16 season among adults aged ≥18 years – United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794206/
51030,Imprinting of Repeated Influenza A/H3 Exposures on Antibody Quantity and Antibody Quality: Implications for Seasonal Vaccine Strain Selection and Vaccine Performance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206119/
51031,Making Universal Influenza Vaccines: Lessons From the 1918 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452324/
51032,Influence of Digital Intervention Messaging on Influenza Vaccination Rates Among Adults With Cardiovascular Disease in the United States: Decentralized Randomized Controlled Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587491/
51033,Quantitative review of antibody response to inactivated seasonal influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175249/
51034,Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785652/
51035,Comparing factors influencing seasonal influenza vaccine acceptance and intentions among Chinese university students residing in China and UK: A cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10760351/
51036,A polyvalent virosomal influenza vaccine induces broad cellular and humoral immunity in pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428566/
51037,Self-amplifying mRNA bicistronic influenza vaccines raise cross-reactive immune responses in mice and prevent infection in ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589142/
51038,Mol Ther Methods Clin Dev. 2023 Mar 9; 28: 11. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747525/
51039,"Influenza vaccine effectiveness among healthcare workers in comparison to hospitalized patients: A 2004-2009 case-test, negative-control, prospective study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049739/
51040,Retrospective immunogenicity analysis of seasonal flu H3N2 vaccines recommended in the past ten years using immunized animal sera,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678686/
51041,Is a universal influenza vaccine feasible?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842179/
51042,Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788307/
51043,Effective influenza vaccines for children: A critical unmet medical need and a public health priority,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426083/
51044,"Flagellin/Virus-like
Particle Hybrid Platform with
High Immunogenicity, Safety, and Versatility for Vaccine Development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121874/
51045,Influenza vaccination: key facts for general practitioners in Europe—a synthesis by European experts based on national guidelines and best practices in the United Kingdom and the Netherlands,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974050/
51046,Vinyl Sulfone-functionalized Acetalated Dextran Microparticles as a Subunit Broadly Acting Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350900/
51047,A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965144/
51048,Development of American-Lineage Influenza H5N2 Reassortant Vaccine Viruses for Pandemic Preparedness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631248/
51049,"Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060263/
51050,Human B cell lineages associated with germinal centers following influenza vaccination are measurably evolving,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741214/
51051,Vaccines against Major Poultry Viral Diseases: Strategies to Improve the Breadth and Protective Efficacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230070/
51052,Repeated influenza vaccination induces similar immune protection as first‐time vaccination but with differing immune responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835420/
51053,Retrospective public health impact of a quadrivalent influenza vaccine in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549101/
51054,Pandemic Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121491/
51055,Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581668/
51056,DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185472/
51057,Disparities in parental awareness of children’s seasonal influenza vaccination recommendations and influencers of vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145195/
51058,Evaluation of novel disposable bioreactors on pandemic influenza virus production,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690526/
51059,Bacterially Produced Recombinant Influenza Vaccines Based on Virus-Like Particles,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832520/
51060,Human influenza virus challenge identifies cellular correlates of protection for oral vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665113/
51061,The Highly Productive Thermothelomyces heterothallica C1 Expression System as a Host for Rapid Development of Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877961/
51062,The impact of pharmacist involvement on immunization uptake and other outcomes: An updated systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448680/
51063,"DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8+ T Cell Responses, Enabling Faster Resolution of Influenza Disease",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993793/
51064,What attributes influence rural household’s willingness to get vaccinated for COVID-19? Perspectives from six Chinese townships,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705199/
51065,Influence function methods to assess the effectiveness of influenza vaccine with survey data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763297/
51066,Strategies in recommending influenza vaccination in Europe and US,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861797/
51067,Comparison of the post-marketing safety profile between influenza and COVID-19 vaccines: An analysis of the vaccine adverse event reporting system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232269/
51068,Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709590/
51069,Vaccine hesitancy in COVID-19 times. An update from Italy before flu season starts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716975/
51070,Health Systems Determinants of Delivery and Uptake of Maternal Vaccines in Low- and Middle-Income Countries: A Qualitative Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144938/
51071,Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389592/
51072,"Incorporation of membrane-bound, mammalian-derived immunomodulatory proteins into influenza whole virus vaccines boosts immunogenicity and protection against lethal challenge",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2679740/
51073,Vaccination of poultry against highly pathogenic avian influenza – part 1. Available vaccines and vaccination strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563699/
51074,Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562812/
51075,Impact of seasonal influenza vaccination in the presence of vaccine interference,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825190/
51076,Influenza diagnosis and vaccination in Poland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105210/
51077,High Preexisting Serological Antibody Levels Correlate with Diversification of the Influenza Vaccine Response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337521/
51078,Associations between 5-year Influenza Vaccination and Sociodemographic Factors and Healthcare Access among Arkansans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810239/
51079,Collaborative studies on the development of national reference standards for potency determination of H7N9 influenza vaccine ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514420/
51080,Spillover effects of the COVID-19 pandemic on attitudes to influenza and childhood vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126550/
51081,Perceptions of COVID-19 vaccines in a predominantly Hispanic patient population from the Texas–Mexico border,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570390/
51082,Dynamic Propagation and Impact of Pandemic Influenza A (2009 H1N1) in Children: A Detailed Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505219/
51083,"Bandwagoning, free‐riding and heterogeneity in influenza vaccine decisions: An online experiment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305895/
51084,Understanding Antibody Responses in Early Life: Baby Steps towards Developing an Effective Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310046/
51085,"Awareness, Attitude, and Current Practices Toward Influenza Vaccination Among Physicians in India: A Multicenter, Cross-Sectional Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419342/
51086,"Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920144/
51087,Cost effectiveness of quadrivalent influenza vaccines in the elderly population of Malaysia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618214/
51088,Women's views and experiences of accessing pertussis vaccination in pregnancy and infant vaccinations during the COVID-19 pandemic: A multi-methods study in the UK,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247266/
51089,Facilitators and Barriers of Parental Attitudes and Beliefs toward School-Located Influenza Vaccination in the United States: Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401629/
51090,Respiratory Vaccination with Hemagglutinin Nanoliposomes Protects Mice from Homologous and Heterologous Strains of Influenza Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555155/
51091,"The impact of repeated vaccination using 10-year vaccination history on protection against influenza in older adults: a test-negative design study across the 2010/11 to 2015/16 influenza seasons in Ontario, Canada",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961264/
51092,Low prevalence of influenza viruses and predominance of A(H3N2) virus with respect to SARS‐CoV‐2 during the 2021–2022 season in Bulgaria,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107854/
51093,Characterising antibody kinetics from multiple influenza infection and vaccination events in ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715255/
51094,"Uptake rates, knowledge, attitudes, and practices toward seasonal influenza vaccination among healthcare workers in Lebanon",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827638/
51095,Negotiating Equitable Access to Influenza Vaccines: Global Health Diplomacy and the Controversies Surrounding Avian Influenza H5N1 and Pandemic Influenza H1N1,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864298/
51096,Hemagglutinin head-specific responses dominate over stem-specific responses following prime boost with mismatched vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948858/
51097,Comparative effectiveness of H7N9 vaccines in healthy individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363152/
51098,Acceptance of a Vaccine Against Novel Influenza A (H1N1) Virus Among Health Care Workers in Two Major Cities in Mexico,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854164/
51099,Influenza vaccines based on virus-like particles,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753524/
51100,Associations of Guillain‐Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350095/
51101,Type I and Type III Interferons Differ in Their Adjuvant Activities for Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854507/
51102,Hemagglutinin Quantitative ELISA-based Potency Assay for Trivalent Seasonal Influenza Vaccine Using Group-Specific Universal Monoclonal Antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927952/
51103,"Influenza vaccination for elderly, vulnerable and high-risk subjects: a narrative review and expert opinion",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11039544/
51104,Safety and immunogenicity of 3 seasonal trivalent influenza vaccines in the Chinese military,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084975/
51105,Parental perceptions and predictors of consent for school-located influenza vaccination in urban elementary school children in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548995/
51106,"Knowledge, attitudes, and practices of seasonal influenza vaccination in healthcare workers, Honduras",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861374/
51107,Media Exposure and Media Credibility Influencing Public Intentions for Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024633/
51108,Predictors of COVID-19 vaccine acceptability among health professions students in Vietnam,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047623/
51109,"Knowledge, attitudes, concern, behaviors, and barriers associated with the readiness to receive seasonal influenza vaccine among healthcare workers in oncology setting during the COVID-19 pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464533/
51110,Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V® and Fluad®) in preventing hospitalization for influenza and pneumonia in the elderly: A matched case-control study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667930/
51111,2015/16 I‐MOVE/I‐MOVE+ multicentre case‐control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage‐mismatched influenza B among children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005601/
51112,Effectiveness of Trivalent Inactivated Influenza Vaccine in Children Estimated by a Test-Negative Case-Control Design Study Based on Influenza Rapid Diagnostic Test Results,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552891/
51113,Correlates of 2009 H1N1 influenza vaccine acceptability among parents and their adolescent children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202907/
51114,Surveillance systems and methods for monitoring the post-marketing safety of influenza vaccines at the Centers for Disease Control and Prevention,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500454/
51115,Single-cycle influenza virus vaccine generates lung CD8+ Trm that cross-react against viral variants and subvert virus escape mutants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491285/
51116,An Egg-Derived Sulfated N-Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263001/
51117,Impact of the influenza vaccine on COVID-19 infection rates and severity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899024/
51118,Organisational factors affecting performance in delivering influenza vaccination to staff in NHS Acute Hospital Trusts in England: A qualitative study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090903/
51119,High-Dose Influenza Vaccine to Reduce Clinical Outcomes in High Risk Cardiovascular Patients: Rationale and Design of the INVESTED Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067954/
51120,"Knowledge, Perceptions, Attitudes and Practices of Midwives Regarding Maternal Influenza and Pertussis Vaccination: A Qualitative Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322479/
51121,"The effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong, 2009–2013",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165553/
51122,A Novel Recombinant Influenza Virus Neuraminidase Vaccine Candidate Stabilized by a Measles Virus Phosphoprotein Tetramerization Domain Provides Robust Protection from Virus Challenge in the Mouse Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609353/
51123,"Comparison of the epidemiology of laboratory-confirmed influenza A and influenza B cases in Manitoba, Canada",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331145/
51124,"Influenza Vaccination Among Pregnant Women: Self-report Compared With Vaccination Data From Electronic Health Records, 2018-2020 Influenza Seasons",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240889/
51125,Engineering Temperature Sensitive Live Attenuated Influenza Vaccines from Emerging Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595159/
51126,Vaccine Preparedness for the Next Influenza Pandemic: A Regulatory Perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784935/
51127,A Novel M2e Based Flu Vaccine Formulation for Dogs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788766/
51128,Regulatory T cell frequencies and phenotypes following anti-viral vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489208/
51129,Antibody responses to influenza A(H1N1)pdm infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707244/
51130,Hesitance and Misconceptions about the Annual Influenza Vaccine among the Saudi Population Post-COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610791/
51131,"Delta Inulin Adjuvant Enhances Plasmablast Generation, Expression of Activation-Induced Cytidine Deaminase and B-Cell Affinity Maturation in Human Subjects Receiving Seasonal Influenza Vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503308/
51132,COVID-19 vaccine hesitancy and acceptance among the public in the Gulf Cooperation Council countries: A review of the literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746509/
51133,Challenges for the Newborn Following Influenza Virus Infection and Prospects for an Effective Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524958/
51134,"Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693284/
51135,"Factors driving choices between types and brands of influenza vaccines in general practice in Austria, Italy, Spain and the UK",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205138/
51136,Influenza vaccine coverage in 6months-64 years-old patients affected by chronic diseases: A retrospective cohort study in Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012954/
51137,Caregivers’ understanding of childhood influenza vaccination during the epidemic in China. A mixed-methods study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447896/
51138,CAF01 Potentiates Immune Responses and Efficacy of an Inactivated Influenza Vaccine in Ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151275/
51139,Vaccination has minimal impact on the intrahost diversity of H3N2 influenza viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302840/
51140,"Incidence of medically attended influenza infection and cases averted by vaccination, 2011/12 and 2012/13 influenza seasons",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843472/
51141,Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242973/
51142,Effective and lesion-free cutaneous influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413338/
51143,Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine over Three Consecutive Influenza Seasons in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504704/
51144,Development of an mRNA vaccine against a panel of heterologous H1N1 seasonal influenza viruses using a consensus hemagglutinin sequence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155637/
51145,Willingness to Receive the COVID-19 and Seasonal Influenza Vaccines among the Saudi Population and Vaccine Uptake during the Initial Stage of the National Vaccination Campaign: A Cross-Sectional Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310157/
51146,Enhanced growth of seed viruses for H5N1 influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827194/
51147,Novel universal influenza virus vaccine approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902764/
51148,"Live, Attenuated Influenza A H5N1 Candidate Vaccines Provide Broad Cross-Protection in Mice and Ferrets",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564176/
51149,"Burden of medically attended influenza infection and cases averted by vaccination — United States, 2013/14 through 2015/16 influenza seasons",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843364/
51150,Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871858/
51151,"MAIVeSS: streamlined selection of antigenically matched, high-yield viruses for seasonal influenza vaccine production",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10847134/
51152,Unconjugated Multi-Epitope Peptides Adjuvanted with ALFQ Induce Durable and Broadly Reactive Antibodies to Human and Avian Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537791/
51153,Increased risk of influenza among vaccinated adults who are obese,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585026/
51154,Social determinants of health and seasonal influenza vaccination in adults ≥65 years: a systematic review of qualitative and quantitative data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667118/
51155,Enhanced passive safety surveillance of a quadrivalent inactivated split virion influenza vaccine in Finland during the influenza season 2020/21,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358077/
51156,Risk perceptions regarding inclusion of seasonal influenza vaccinations in the school immunization program in Israel: Arab vs. Jewish mothers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015128/
51157,Identification of Rare Adverse Events with Year-varying Reporting Rates for FLU4 Vaccine in VAERS,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371315/
51158,Predicting intention to receive COVID-19 vaccine among the general population using the health belief model and the theory of planned behavior model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075011/
51159,Influenza Vaccination Assessment according to a Value-Based Health Care Approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612276/
51160,"Pilot Study on Evaluating the Impact of Tetanus, Diphtheria, and Pertussis (Tdap), Influenza, and COVID-19 Vaccinations on Antibody Responses in Pregnant Women",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10974830/
51161,Characterization of Inactivated Influenza Vaccines Used in the Russian National Immunization Program,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564049/
51162,Monitoring influenza vaccination coverage and acceptance among health-care workers in German hospitals – results from three seasons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993141/
51163,Selective induction of antibody effector functional responses using MF59-adjuvanted vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994146/
51164,Factors Impacting Vaccine Uptake during Pregnancy: A Retrospective Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551120/
51165,A Live Attenuated Influenza Vaccine Elicits Enhanced Heterologous Protection When the Internal Genes of the Vaccine Are Matched to Those of the Challenge Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997774/
51166,Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485662/
51167,"Examining Influenza Vaccination Patterns Among Young Adults with Asthma: Insights into Knowledge, Attitudes, and Practices",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644889/
51168,"Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522535/
51169,Association between seasonal flu vaccination and COVID-19 among healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798744/
51170,"New Influenza Vaccines: Promises, Perils, and Pitfalls",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641969/
51171,Influenza vaccine effectiveness among high-risk groups: A systematic literature review and meta-analysis of case-control and cohort studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890832/
51172,Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza in 2015–2016: a hospital-based test-negative case–control study in Lithuania,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652622/
51173,Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806665/
51174,"Transcriptional and Immunologic Correlates of Response to Pandemic Influenza Vaccine in Aviremic, HIV-Infected Children ",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044856/
51175,Timeliness of signal detection for adverse events following influenza vaccination in young children: a simulation case study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050305/
51176,Circulation of influenza A and B in the Czech Republic from 2000-2001 to 2015-2016,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376715/
51177,Effect of Personalized Messages Sent by a Health System’s Patient Portal on Influenza Vaccination Rates: a Randomized Clinical Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858355/
51178,College Students’ Perceptions of H1N1 Flu Risk and Attitudes toward Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3190084/
51179,"Serial Passaging of Seasonal H3N2 Influenza A/Singapore/G2-31.1/2014 Virus in MDCK-SIAT1 Cells and Primary Chick Embryo Cells Generates HA D457G Mutation and Other Variants in HA, NA, PB1, PB1-F2, and NS1",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604028/
51180,"Seasonal influenza vaccine uptake among healthcare workers in tertiary care hospitals, Bangladesh: Study protocol for influenza vaccine supply and awareness intervention",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509585/
51181,A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906365/
51182,Understanding Influenza and SARS-CoV-2 Vaccine Hesitancy in Racial and Ethnic Minority Caregivers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697963/
51183,Examining the barriers of influenza vaccine hesitancy in persons with dementia: a literature review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316106/
51184,"Knowledge, attitude, and practices about the seasonal influenza vaccination among healthcare workers in Srinagar, India",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781001/
51185,Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063076/
51186,"Association of vaccine awareness and confidence on the influenza vaccination status of Al Ahsa, Saudi Arabia residents",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189070/
51187,HLA-A*11:01-restricted CD8+ T cell immunity against influenza A and influenza B viruses in Indigenous and non-Indigenous people,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929706/
51188,"Enhanced humoral response to influenza vaccine in aged mice with a novel adjuvant, rOv-ASP-1",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731280/
51189,"Clinical and serologic responses following a two dose series of high-dose influenza vaccine in plasma cell disorders: a prospective, single-arm trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413398/
51190,"Knowledge, attitudes, and practices for the use of seasonal influenza vaccination, healthcare workers, Costa Rica",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131022/
51191,"Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824126/
51192,The National Vaccine Advisory Committee at 30: Impact and opportunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115546/
51193,An Economic Evaluation of the Adjuvanted Quadrivalent Influenza Vaccine Compared with Standard-Dose Quadrivalent Influenza Vaccine in the Spanish Older Adult Population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412909/
51194,"Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013–2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799665/
51195,Influenza Vaccination for the Prevention of Cardiovascular Disease in the Americas: Consensus document of the Inter-American Society of Cardiology and the Word Heart Federation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344961/
51196,Clinical and laboratory predictors of influenza infection among individuals with influenza-like illness presenting to an urban Thai hospital over a five-year period,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841736/
51197,Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592394/
51198,Clade 2.3.4.4 H5 chimeric cold-adapted attenuated influenza vaccines induced cross-reactive protection in mice and ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688331/
51199,Clinical Effectiveness of Split-Virion Versus Subunit Trivalent Influenza Vaccines in Older Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447778/
51200,Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines – Multi-country assessment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404226/
51201,Pathway towards an ideal and sustainable framework agreement for the public procurement of vaccines in Spain: a multi-criteria decision analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733903/
51202,Virus Aggregating Peptide Enhances the Cell-Mediated Response to Influenza Virus Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3190079/
51203,Coronavirus disease 2019 (COVID-19) vaccination uptake among healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503070/
51204,Swine Influenza Virus: Current Status and Challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587018/
51205,"Knowledge, Perceptions, and Self-Reported Rates of Influenza Immunization among Canadians at High Risk from Influenza: A Cross-Sectional Survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459598/
51206,Influenza epidemiology and influenza vaccine effectiveness during the 2015–2016 season: results from the Global Influenza Hospital Surveillance Network,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518734/
51207,"Virus-induced pathogenesis, vaccine development, and diagnosis of
novel H7N9 avian influenza A virus in humans: a systemic literature
review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140199/
51208,"Low Influenza Vaccination Rates Among Child Care Workers in the United States: Assessing Knowledge, Attitudes, and Behaviors",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532262/
51209,Impact of quadrivalent influenza vaccines in Brazil: a cost-effectiveness analysis using an influenza transmission model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487874/
51210,Vaccines and vaccination: history and emerging issues,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903967/
51211,Comparison of VAERS fetal-loss reports during three consecutive influenza seasons: Was there a synergistic fetal toxicity associated with the two-vaccine 2009/2010 season?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888271/
51212,Construction and identification of influenza plasmid pool imparting high yields to candidate vaccine viruses in Vero cell at low temperature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576294/
51213,"The Spanish Flu, Epidemics, and the Turn to Biomedical Responses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187783/
51214,Effectiveness of pneumococcal and influenza vaccines to prevent serious health complications in adults with chronic liver disease: a protocol for a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857657/
51215,Protection against Multiple Influenza A Virus Strains Induced by Candidate Recombinant Vaccine Based on Heterologous M2e Peptides Linked to Flagellin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370815/
51216,"Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502079/
51217,Adv Drug Deliv Rev. 2022 Oct; 189: 114501. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413842/
51218,"Targeting dendritic cells in humanized mice receiving adoptive T cells via monoclonal antibodies fused to Flu
epitopes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598757/
51219,"Social Attitude to COVID-19 and Influenza Vaccinations after the Influenza Vaccination Season and between the Second and Third COVID-19 Wave in Poland, Lithuania, and Ukraine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871771/
51220,Australian hospital paediatricians and nurses’ perspectives and practices for influenza vaccine delivery in children with medical comorbidities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744269/
51221,Influenza vaccine effect on risk of stroke occurrence: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10806129/
51222,Retrospective study of the use of an influenza disease two-tiered classification system to characterize clinical severity in US children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482751/
51223,Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149987/
51224,Attitudes and intentions towards COVID-19 vaccines and associated factors among Egyptian adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253692/
51225,Universal stabilization of the influenza hemagglutinin by structure-based redesign of the pH switch regions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833195/
51226,The influence of a community intervention on influenza vaccination knowledge and behavior among diabetic patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935125/
51227,Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15–64-year-olds in Europe: exploration by birth cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891946/
51228,From Original Antigenic Sin to the Universal Influenza Virus Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748348/
51229,Reasons for non-vaccination against influenza among older adults with hypertension in Brazil: a cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673836/
51230,Vaccine-elicited antibody that neutralizes H5N1 influenza and variants binds the receptor site and polymorphic sites,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522792/
51231,Vaccines for the prevention of infections in adults: an opinion paper on the situation in Spain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719651/
51232,Efficacy of commercial vaccines against newly emerging avian influenza H5N8 virus in Egypt,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018731/
51233,Effects of MF59 Adjuvant on Induction of Isotype-Switched IgG Antibodies and Protection after Immunization with T-Dependent Influenza Virus Vaccine in the Absence of CD4+ T Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944285/
51234,Effect of receptor binding specificity on the immunogenicity and protective efficacy of influenza virus A H1 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788005/
51235,"Trivalent inactivated influenza vaccine effective against influenza A(H3N2) variant viruses in children during the 2014/15 season, Japan",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291153/
51236,Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672496/
51237,Longevity and Mechanism of Heterosubtypic Protection Induced by M2SR (M2-Deficient Single-Replication) Live Influenza Virus Vaccine in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781428/
51238,Identifying reasons for non-acceptance of influenza vaccine in healthcare workers: an observational study using declination form data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604813/
51239,Epidemiology and prevention of influenza in children in Argentina and Brazil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6645205/
51240,Virus-like particles as universal influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513402/
51241,Quantifying the Persistence of Vaccine-Related T Cell Epitopes in Circulating Swine Influenza A Strains from 2013–2017,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148565/
51242,Potential probiotics for regulation of the gut-lung axis to prevent or alleviate influenza in vulnerable populations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037066/
51243,Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463277/
51244,"Acceptability of live attenuated influenza vaccine by vaccine providers in Quebec, Canada",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514394/
51245,Moderately Low Effectiveness of the Influenza Quadrivalent Vaccine: Potential Mismatch between Circulating Strains and Vaccine Strains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304586/
51246,Effectiveness of Cell-Based Quadrivalent Seasonal Influenza Vaccine: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610589/
51247,Flu vaccination among older persons: study of knowledge and practices,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318864/
51248,Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130260/
51249,Influenza Chimeric Protein (3M2e-3HA2-NP) Adjuvanted with PGA/Alum Confers Cross-Protection against Heterologous Influenza A Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705887/
51250,"Randomized, Double-Blind, Reference-Controlled, Phase 2a Study Evaluating the Immunogenicity and Safety of OVX836, A Nucleoprotein-Based Influenza Vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022189/
51251,Immune History and Influenza Vaccine Effectiveness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027411/
51252,"Safety, Immunogenicity, and Protective Efficacy of a Chimeric A/B Live Attenuated Influenza Vaccine in a Mouse Model",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910998/
51253,"Knowledge, Perception, Attitudes and Behavior on Influenza Immunization and the Determinants of Vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958282/
51254,Knowledge and Perceptions of Influenza Vaccinations Among College Students in Vietnam and the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541278/
51255,Development of Cross-Protective Influenza A Vaccines Based on Cellular Responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432795/
51256,A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941884/
51257,"Centralized Consensus Hemagglutinin Genes Induce Protective Immunity against H1, H3 and H5 Influenza Viruses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607479/
51258,Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709581/
51259,The pre-existing human antibody repertoire to computationally optimized influenza H1 hemagglutinin vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246865/
51260,"Reciprocal relationships among influenza experiences, perceptions, and behavior: Results from a national, longitudinal survey of United States adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936068/
51261,A cost-effectiveness analysis of South Africa’s seasonal influenza vaccination programme,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804372/
51262,"Genetic evolution of influenza viruses among selected countries in Latin America, 2017–2018",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064222/
51263,A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485063/
51264,A typology of beliefs and misperceptions about the influenza disease and vaccine among older adults in Singapore,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202625/
51265,A rapid global review of strategies to improve influenza vaccination uptake in Australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904008/
51266,"Development of vaccine formulations: past, present, and future",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889058/
51267,COVID-19 Vaccine Hesitancy in South Africa: Lessons for Future Pandemics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180246/
51268,Review of the status and challenges associated with increasing influenza vaccination coverage among pregnant women in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227693/
51269,A Pilot Study Showing a Stronger H1N1 Influenza Vaccination Response during Pregnancy in Women Who Subsequently Deliver Preterm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456418/
51270,Differences between Frequentist and Bayesian inference in routine surveillance for influenza vaccine effectiveness: a test-negative case-control study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968177/
51271,"Alkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489292/
51272,Maternal antibodies protect offspring from severe influenza infection and do not lead to detectable interference with subsequent offspring immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485558/
51273,Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632244/
51274,Fifty Years of Influenza A(H3N2) Following the Pandemic of 1968,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144439/
51275,Evolution and Vaccination of Influenza Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563926/
51276,Influenza A and B in a cohort of outpatient children and adolescent with influenza like-illness during two consecutive influenza seasons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110568/
51277,Clinical and Immune Responses to Inactivated Influenza A(H1N1)pdm09 Vaccine in Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166548/
51278,The influence of social norms on flu vaccination among African American and White adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914409/
51279,Causes of Vaccine Hesitancy in Adults for the Influenza and COVID-19 Vaccines: A Systematic Literature Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503596/
51280,The influence of prebiotic or probiotic supplementation on antibody titers after influenza vaccination: a systematic review and meta-analysis of randomized controlled trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790137/
51281,Factors Influencing the Implementation of Flu Vaccination in Healthcare Professionals: Pros and Cons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879438/
51282,Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2925114/
51283,PEG modified liposomes containing CRX-601 adjuvant in combination with methylglycol chitosan enhance the murine sublingual immune response to influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729458/
51284,Longevity of B-Cell and T-Cell Responses After Live Attenuated Influenza Vaccination in Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407761/
51285,"Vaccine Hesitancy in Israel: Exploring the Relationships with Vaccination History, Knowledge, and Attitudes towards Influenza Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10814916/
51286,Metal-Organic Coordination Polymer for Delivery of a Subunit Broadly Acting Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495290/
51287,City-wide school-located influenza vaccination: A retrospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881995/
51288,Development of an Alternative Modified Live Influenza B Virus Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446642/
51289,Vaccinations and Autoimmune Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402446/
51290,Swine influenza A virus: challenges and novel vaccine strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11021629/
51291,Progress Toward the Development of Universal Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179460/
51292,Understanding national trends in COVID-19 vaccine hesitancy in Canada: results from five sequential cross-sectional representative surveys spanning April 2020–March 2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983402/
51293,Comparative Safety and Efficacy Profile of a Novel Oil in Water Vaccine Adjuvant Comprising Vitamins A and E and a Catechin in Protective Anti-Influenza Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452246/
51294,Universal influenza vaccines: Shifting to better vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899887/
51295,"Influenza surveillance in Middle East, North, East and South Africa: Report of the 8th MENA Influenza Stakeholders Network",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468068/
51296,Influenza epidemiology and influenza vaccine effectiveness during the 2014–2015 season: annual report from the Global Influenza Hospital Surveillance Network,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001209/
51297,Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109939/
51298,FLU‐LISA (fluorescence‐linked immunosorbent assay): high‐throughput antibody profiling using antigen microarrays,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275175/
51299,Assessing influenza vaccination success to inform COVID‐19 vaccination campaign,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662223/
51300,A Novel Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice from Pandemic H1N1 and Highly Pathogenic H5N1 Virus Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3700221/
51301,Improved Specificity and False Discovery Rates for Multiplex Analysis of Changes in Strain-Specific Anti-Influenza IgG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501432/
51302,"Factors associated with COVID-19 vaccine confidence among primary care providers in Kazakhstan, March–April 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517263/
51303,Front Public Health. 2023; 11: 1308374. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660272/
51304,Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230705/
51305,Influence of sources of information about influenza vaccine on parental attitudes and adolescent vaccine receipt,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514164/
51306,Effectiveness of Non-Adjuvanted Pandemic Influenza A Vaccines for Preventing Pandemic Influenza Acute Respiratory Illness Visits in 4 U.S. Communities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155536/
51307,Influenza-Related Hospitalization and ED Visits in Children Less Than 5 Years: 2000–2011,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279064/
51308,Multiple Neuraminidase Containing Influenza Virus-like Particle Vaccines Protect Mice from Avian and Human Influenza Virus Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875606/
51309,Do parents prefer inactivated or live attenuated influenza vaccine for their children?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369922/
51310,Does Influenza Vaccination Reduce the Risk of Contracting COVID-19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504696/
51311,The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162512/
51312,Predicting Egg Passage Adaptations to Design Better Vaccines for the H3N2 Influenza Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501976/
51313,Development of Live-Attenuated Influenza Vaccines against Outbreaks of H5N1 Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528281/
51314,Puzzling inefficiency of H5N1 influenza vaccines in Egyptian poultry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890765/
51315,The critical factors for COVID-19 vaccination uptake are perceived ‎vaccine effectiveness and the desire to protect others,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583610/
51316,Effects of Different Adjuvants in the Context of Intramuscular and Intranasal Routes on Humoral and Cellular Immune Responses Induced by Detergent-Split A/H3N2 Influenza Vaccines in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272927/
51317,COVID-19 Vaccine intent in appalachian patients with multiple sclerosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645289/
51318,Materials‐based vaccines for infectious diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541041/
51319,Risk of peripheral facial palsy following parenteral inactivated influenza vaccination in the elderly Chinese population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902766/
51320,"Flu vaccination among patients with diabetes: motives, perceptions, trust, and risk culture - a qualitative survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930433/
51321,Evaluating the safety of influenza vaccine using a claims-based health system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688603/
51322,"Immunopotentiators Improve the Efficacy of Oil-Emulsion-Inactivated Avian Influenza Vaccine in Chickens, Ducks and Geese",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883754/
51323,Influenza Vaccination among Underserved African-American Older Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671800/
51324,Epidemiology of influenza over a ten-year period in Belgium: overview of the historical and current evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664657/
51325,M2e-immobilized gold nanoparticles as influenza A vaccine: role of soluble M2e and longevity of protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418433/
51326,Facial Paralysis Following Influenza Vaccination: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System Database,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371962/
51327,COVID-19 vaccine perceptions and hesitancy amongst parents of school-aged children during the pediatric vaccine rollout,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533673/
51328,Reduced Influenza B–Specific Postvaccination Antibody Cross-reactivity in the B/Victoria Lineage–Predominant 2019/20 Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315234/
51329,Factors Influencing Childhood Influenza Vaccination: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10975121/
51330,"The Integrated Consideration of Vaccine Platforms, Adjuvants, and Delivery Routes for Successful Vaccine Development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055765/
51331,Engineered Nanoparticulate Vaccines to Combat Recurring and Pandemic Influenza Threats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231845/
51332,Knowledge and beliefs about vaccination in pregnant women before and during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386522/
51333,Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904949/
51334,Influenza Vaccine Response in Adults Exposed to Perfluorooctanoate and Perfluorooctanesulfonate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724206/
51335,The Human Antibody Response to the Influenza Virus Neuraminidase Following Infection or Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402431/
51336,Reply letter to “Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018–2019 and 2019–2020 calculated using a retrospective test-negative design”,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288927/
51337,Investigation of Avian Influenza H5N6 Virus-like Particles as a Broad-Spectrum Vaccine Candidate against H5Nx Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143382/
51338,Single HA2 Mutation Increases the Infectivity and Immunogenicity of a Live Attenuated H5N1 Intranasal Influenza Vaccine Candidate Lacking NS1,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072404/
51339,Respiratory and Intramuscular Immunization With ChAdOx2-NPM1-NA Induces Distinct Immune Responses in H1N1pdm09 Pre-Exposed Pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595216/
51340,"What motivates adults to accept influenza vaccine? An assessment of incentives, ease of access, messaging, and sources of information using a discrete choice experiment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060740/
51341,"Knowledge, Attitudes, and Practices of Influenza Vaccination among Parents of Children with Asthma: A Cross-Sectional Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301876/
51342,Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736859/
51343,"The importance of confidence, complacency, and convenience for influenza vaccination among key risk groups in large urban areas of Peru",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899688/
51344,In silico design of recombinant multi-epitope vaccine against influenza A virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808469/
51345,"Seasonal influenza vaccine effectiveness against medically attended influenza illness among children aged 6–59 months, October 2011–September 2012: A matched test-negative case–control study in Suzhou, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855226/
51346,Factors influencing Covid-19 vaccine acceptance across subgroups in the United States: Evidence from a conjoint experiment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064867/
51347,Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383554/
51348,Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457525/
51349,Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic wave: a cross-sectional survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699157/
51350,Innate signalling molecules as genetic adjuvants do not alter the efficacy of a DNA-based influenza A vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122823/
51351,Vaccine-related Anaphylaxis Cases Confirmed by KCDC from 2001–2016,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521962/
51352,"Knowledge, attitudes and practices about influenza vaccination among pregnant women and healthcare providers serving pregnant women in Managua, Nicaragua",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008783/
51353,Peritoneal Cells Mediate Immune Responses and Cross-Protection Against Influenza A Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546726/
51354,Influenza Vaccination and Mortality: Differentiating Vaccine Effects From Bias,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728831/
51355,"Public Perception towards Vaccines as Preventive Measures against a Twindemic (Seasonal Influenza and COVID-19): A Cross-Sectional Study from the Aseer Region, Saudi Arabia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051924/
51356,A Hemagglutinin Stem Vaccine Designed Rationally by AlphaFold2 Confers Broad Protection against Influenza B Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229588/
51357,The Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccination: A Study of Maternal-Cord Blood Pairs in Taiwan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675132/
51358,Parental Vaccine Hesitancy and Childhood Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097955/
51359,New Vaccine Technologies to Combat Outbreak Situations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156540/
51360,Influenza vaccine community outreach: leveraging an interprofessional healthcare student workforce to immunize marginalized populations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096696/
51361,Pleiotropic Effects of Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536538/
51362,Does Vaccinating against Influenza in a Given Epidemic Season Have an Impact on Vaccination in the Next Season: A Follow-Up Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265947/
51363,Parents' perceptions on COVID-19 vaccination as the new routine for their children ≤ 11 years old,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250244/
51364,Highly Conserved Protective Epitopes on Influenza B Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538841/
51365,Perceptions of pandemic influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367708/
51366,Characteristics associated with influenza vaccination uptake in pregnancy: a retrospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888578/
51367,A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642189/
51368,Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Children: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610859/
51369,"Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12–13 February 2020",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595925/
51370,Cross-lineage protection by human antibodies binding the influenza B hemagglutinin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338745/
51371,Towards the knowledge-based design of universal influenza epitope ensemble vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079473/
51372,Comparative Immunological Study in Mice of Inactivated Influenza Vaccines Used in the Russian Immunization Program,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768547/
51373,Evaluation of the field-protective effectiveness of seasonal influenza vaccine among Korean children aged < 5 years during the 2014–2015 and 2015–2016 influenza seasons: a cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422443/
51374,A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667890/
51375,Enhanced Immunogenicity of an Influenza Ectodomain Matrix-2 Protein Virus-like Particle (M2e VLP) Using Polymeric Microparticles for Vaccine Delivery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506217/
51376,Three seasons of enhanced safety surveillance of a cell culture-based quadrivalent influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10549188/
51377,Annual influenza vaccination: coverage and attitudes of primary care staff in Australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942009/
51378,Response of BALB/c mice to a monovalent influenza A (H1N1) 2009 split vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076736/
51379,Influenza virus vaccination elicits poorly adapted B cell responses in elderly individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452894/
51380,The Hurdles From Bench to Bedside in the Realization and Implementation of a Universal Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036122/
51381,Molecular Signature of High Yield (Growth) Influenza A Virus Reassortants Prepared as Candidate Vaccine Seeds,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679156/
51382,"Interventions to increase vaccination against COVID-19, influenza and pertussis during pregnancy: a systematic review and meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10755181/
51383,Identifying Potential Candidate Hub Genes and Functionally Enriched Pathways in the Immune Responses to Quadrivalent Inactivated Influenza Vaccines in the Elderly Through Co-Expression Network Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746648/
51384,Designing a multi-epitope vaccine to provoke the robust immune response against influenza A H7N9,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716528/
51385,"Flu Vaccination among Healthcare Professionals in Times of COVID-19: Knowledge, Attitudes, and Behavior",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414714/
51386,Comparative Immunogenicity of Enhanced Seasonal Influenza Vaccines in Older Adults: A Systematic Review and Meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775043/
51387,Vaccine discussions in pregnancy: interviews with midwives to inform design of an intervention to promote uptake of maternal and childhood vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930050/
51388,Influenza vaccination during pregnancy and influencing factors in Korea: A multicenter questionnaire study of pregnant women and obstetrics and gynecology doctors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285826/
51389,The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165819/
51390,Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine: Phase IIb study protocol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369918/
51391,The impact of physical frailty on the response to inactivated influenza vaccine in older adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803506/
51392,The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819610/
51393,Influenza Vaccine Induces Intracellular Immune Memory of Human NK Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363902/
51394,Patient’s behaviors and missed opportunities for vaccination against seasonal epidemic influenza and evaluation of their impact on patient’s influenza vaccine uptake,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863940/
51395,The impact of personal coaching on influenza vaccination among healthcare workers before and during COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233998/
51396,Investigating the procurement system for understanding seasonal influenza vaccine brand availability in Europe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031425/
51397,T-cell-mediated cross-strain protective immunity elicited by prime–boost vaccination with a live attenuated influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197066/
51398,"Pooled influenza vaccine effectiveness estimates for Australia, 2012–2014",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150515/
51399,Single dose vaccination of the ASO3-adjuvanted A(H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514283/
51400,Estimated Effectiveness of Coadministration of the BNT162b2 BA.4/5 COVID-19 Vaccine With Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632958/
51401,One “misunderstood” health issue: demonstrating and communicating the safety of influenza a vaccination in pregnancy: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034177/
51402,Next-generation T cell–activating vaccination increases influenza virus mutation prevalence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986104/
51403,Design and initiation of a study to assess the direct and indirect effects of influenza vaccine given to children in rural India,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769473/
51404,"Enhancing the yield of seasonal influenza viruses through
manipulation of microRNAs in Madin–Darby canine kidney cells",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442458/
51405,Depletion of Human NK and CD8 Cells prior to In Vitro H1N1 Flu Vaccine Stimulation Increases the Number of Gamma Interferon-Secreting Cells Compared to the Initial Undepleted Population in an ELISPOT Assay,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC119957/
51406,Supplementation of Influenza Split Vaccines with Conserved M2 Ectodomains Overcomes Strain Specificity and Provides Long-term Cross Protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089011/
51407,Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971476/
51408,Deep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794676/
51409,J Virol. 2016 Sep 1; 90(17): 8029. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988149/
51410,Enhanced Growth of Influenza Vaccine Seed Viruses in Vero Cells Mediated by Broadening the Optimal pH Range for Virus Membrane Fusion,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264368/
51411,Sudden-Onset Sensorineural Hearing Loss after Immunization: A Case-Centered Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708600/
51412,"Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005–2011",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686813/
51413,Impact of population aging on the burden of vaccine-preventable diseases among older adults in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899694/
51414,"Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) — United States, 2014–15 Influenza Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584910/
51415,Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161894/
51416,PLoS One. 2018; 13(12): e0210043. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307928/
51417,PLoS One. 2024; 19(1): e0297253. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10781065/
51418,"Reasons given for not receiving an influenza vaccination, 2011–12 influenza season, United States",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751433/
51419,"Knowledge, attitudes, and practices of seasonal influenza vaccination among older adults in nursing homes and daycare centers, Honduras",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877760/
51420,"An evaluation and update of methods for estimating the number of influenza cases averted by vaccination in the United
States",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6666399/
51421,"Influenza Activity and Composition of the 2022–23 Influenza Vaccine — United States, 2021–22 Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310632/
51422,Broad-spectrum pan-genus and pan-family virus vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265776/
51423,Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789596/
51424,Impact of ageing and a synbiotic on the immune response to seasonal influenza vaccination; a randomised controlled trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851674/
51425,Biopolymer encapsulated live influenza virus as a universal CD8+ T cell vaccine against influenza virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004745/
51426,"Knowledge, attitudes and uptake related to influenza vaccine among healthcare workers during the 2018–2019 influenza season in Tunisia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116062/
51427,Evaluating Potential Impacts of a Preferential Vaccine Recommendation for Adults 65 Years of Age and Older on US Influenza Burden,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069750/
51428,Impact of aging and HIV infection on serologic response to seasonal influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6574117/
51429,Nanoparticle-Based Bivalent Swine Influenza Virus Vaccine Induces Enhanced Immunity and Effective Protection against Drifted H1N1 and H3N2 Viruses in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693272/
51430,Seasonal and 2009 Pandemic H1N1 Vaccine Acceptance as a Predictor for COVID-19 Vaccine Acceptance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888253/
51431,Is Systemic Lupus Erythematosus Associated With a Declined Immunogenicity and Poor Safety of Influenza Vaccination?: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902520/
51432,"The impact of a vaccine scare on parental views, trust and information needs: a qualitative study in Sydney, Australia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259986/
51433,"Prevaccination
Glycan Markers of Response to an Influenza
Vaccine Implicate the Complement Pathway",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361353/
51434,Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473191/
51435,Rapid determination of influenza vaccine potency by an SPR-based method using subtype or lineage-specific monoclonal antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344355/
51436,Differential immune imprinting by influenza virus vaccination and infection in nonhuman primates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201799/
51437,Immunogenicity and Safety of High-Dose Trivalent Inactivated Influenza Vaccine Compared to Standard-Dose Vaccine in Children and Young Adults with Cancer or HIV Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899146/
51438,"Influenza vaccine coverage, awareness, and beliefs regarding seasonal influenza vaccination among people aged 65 years and older in Central Saudi Arabia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887878/
51439,Saudi Med J. 2020 Jan; 41(1): 105. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001064/
51440,Risk for Shoulder Conditions After Vaccination: A Population-Based Study Using Real-World Data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117507/
51441,"Clinical Effectiveness of Influenza Vaccination After Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-sectional, Prospective, Observational Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108095/
51442,Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735770/
51443,Optimizing spatial allocation of seasonal influenza vaccine under temporal constraints,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6762205/
51444,Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017–2018 and 2018–2019 Influenza Seasons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423477/
51445,"Molecular characterization of influenza viruses from women and
infants in Sarlahi, Nepal",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566802/
51446,Pandemic non-adjuvanted influenza A H1N1 vaccine in a cohort of patients with systemic sclerosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313820/
51447,Live Attenuated Influenza Vaccines engineered to express the nucleoprotein of a recent isolate stimulate human influenza CD8+ T cells more relevant to current infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893192/
51448,Novel Viral Vectored Vaccines for the Prevention of Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510293/
51449,Immunologic consequences of chemotherapy for ovarian cancer: Impaired responses to the influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826173/
51450,Nanovaccine Delivery Approaches and Advanced Delivery Systems for the Prevention of Viral Infections: From Development to Clinical Application,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707864/
51451,Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248865/
51452,Prime-Boost Vaccination With a Novel Hemagglutinin Protein Produced in Bacteria Induces Neutralizing Antibody Responses Against H5-Subtype Influenza Viruses in Commercial Chickens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736996/
51453,"Beliefs, attitudes, and activities of healthcare personnel about influenza and pneumococcal vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791560/
51454,Rapid-response vaccines—does DNA offer a solution?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097425/
51455,Early vaccine availability represents an important public health advance for the control of pandemic influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427977/
51456,"Roles of antibodies to Influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636684/
51457,"Population attributable fraction of non-vaccination of child and adolescent vaccines attributed to parental vaccine hesitancy, 2018-2019",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444805/
51458,"Knowledge, attitudes, and practices of seasonal influenza vaccination in postpartum women, Honduras",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877664/
51459,Cross-protective immunity of the haemagglutinin stalk domain presented on the surface of Lactococcus lactis against divergent influenza viruses in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781637/
51460,Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246941/
51461,"Continuous Readout versus Titer-Based Assays of Influenza Vaccine Trials: Sensitivity, Specificity, and False Discovery Rates",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530215/
51462,Costs of seasonal influenza vaccination in South Africa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343325/
51463,Metformin Use before Influenza Vaccination May Lower the Risks of Influenza and Related Complications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609450/
51464,Update: Influenza Activity in the United States During the 2018–19 Season and Composition of the 2019–20 Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586370/
51465,Establishment of a New Quality Control and Vaccine Safety Test for Influenza Vaccines and Adjuvants Using Gene Expression Profiling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409070/
51466,Exploring determinants of community pharmacist-led influenza vaccination in a Middle Eastern country: a national web-based cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450692/
51467,The Way Forward: Potentiating Protective Immunity to Novel and Pandemic Influenza Through Engagement of Memory CD4 T Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452298/
51468,Cloned cDNA of A/swine/Iowa/15/1930 internal genes as a candidate backbone for reverse genetics vaccine against influenza A viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3274597/
51469,Food Additives as Novel Influenza Vaccine Adjuvants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963695/
51470,Optimizing Benefits of Influenza Virus Vaccination during Pregnancy: Potential Behavioral Risk Factors and Interventions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043397/
51471,Attractive Flu Shot: A Behavioral Approach to Increasing Influenza Vaccination Uptake Rates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457453/
51472,Causality Assessment of Serious Neurologic Adverse Events Following 2009 H1N1 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860884/
51473,Individual antibody and T cell responses to vaccination and infection with the 2009 pandemic swine-origin H1N1 influenza virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197711/
51474,Immunogenicity of trivalent influenza vaccines in patients with chronic kidney disease undergoing hemodialysis: MF59-adjuvanted versus non-adjuvanted vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137514/
51475,Patterns of Influenza Vaccination and Vaccine Effectiveness Among Young US Children Who Receive Outpatient Care for Acute Respiratory Tract Illness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199168/
51476,Simultaneous Aerosol and Intramuscular Immunization with Influenza Vaccine Induces Powerful Protective Local T Cell and Systemic Antibody Immune Responses in Pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812058/
51477,"Knowledge, attitudes, and practices toward seasonal influenza vaccination among healthcare workers and pregnant women in Pakistan: A mixed methods approach",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10760499/
51478,"Immunogenicity and Safety of Trivalent Inactivated Influenza Vaccine: A Randomized, Double-Blind, Multi-Center, Phase 3 Clinical Trial in a Vaccine-Limited Country",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031001/
51479,Imprinted Anti-Hemagglutinin and Anti-Neuraminidase Antibody Responses after Childhood Infections of A(H1N1) and A(H1N1)pdm09 Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294682/
51480,Characterization of Immune Response towards Generation of Universal Anti-HA-Stalk Antibodies after Immunization of Broiler Hens with Triple H5N1/NA-HA-M1 VLPs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029564/
51481,Investigation of barriers to county-level seasonal influenza vaccine uptake among Medicare beneficiaries in the United States – 2018–2019 seasonal influenza season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422654/
51482,Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350142/
51483,Universal Protection against Influenza Infection by a Multi-Domain Antibody to Influenza Hemagglutinin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241527/
51484,Heterosubtypic Antibody Response Elicited with Seasonal Influenza Vaccine Correlates Partial Protection against Highly Pathogenic H5N1 Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064567/
51485,Racial/Ethnic Differences in Influenza and Pneumococcal Vaccination Rates Among Older Adults in New York City and Los Angeles and Orange Counties,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307839/
51486,"Vaccine effectiveness against influenza A(H3N2) and B among laboratory‐confirmed, hospitalised older adults, Europe, 2017‐18: A season of B lineage mismatched to the trivalent vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182608/
51487,Factors influencing H1N1 vaccine behavior among Manitoba Metis in Canada: a qualitative study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334920/
51488,Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482569/
51489,Subcutaneous vaccine administration – an outmoded practice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086591/
51490,An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851053/
51491,Influenza vaccination coverage among health-care workers during the COVID-19 epidemic in 2020/2021 influenza season: Evidence from a web-based survey in northwestern China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746390/
51492,Influenza vaccine effectiveness: potential of the test-negative design. A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277796/
51493,Longitudinal assessment of COVID-19 vaccine uptake: A two-wave survey of a nationally representative U.S. sample,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553259/
51494,"Real-life experience on COVID-19 and seasonal influenza vaccines co-administration in the vaccination hub of the University Hospital of Palermo, Italy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10950263/
51495,"Despite Small Improvement, Black Nursing Home Residents Remain Less Likely Than Whites To Receive Flu Vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833696/
51496,Potency determination of inactivated H7 influenza vaccines using monoclonal antibody‐based ELISA and biolayer interferometry assays,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820428/
51497,Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489286/
51498,Characteristics associated with the willingness to receive a COVID-19 vaccine and an exploration of the general public's perceptions: A mixed-methods approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068660/
51499,A Survey of Parental Perception and Pattern of Action in Response to Influenza-like Illness in Their Children: Including Healthcare Use and Vaccination in Korea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219985/
51500,A Dynamic Model for Evaluation of the Bias of Influenza Vaccine Effectiveness Estimates From Observational Studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357810/
51501,Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655918/
51502,Flu and Tdap Maternal Immunization Hesitancy in Times of COVID-19: An Italian Survey on Multiethnic Sample,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537858/
51503,Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432999/
51504,"Agreement between state registry, health record, and self-report of influenza vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452147/
51505,Uptake of vaccination in pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021457/
51506,Influenza virus vaccination in children with nephrotic syndrome: insignificant risk of relapse,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383070/
51507,Rapid changes in serum cytokines and chemokines in response to inactivated influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820426/
51508,"Characterizing genetic and antigenic divergence from vaccine strain of influenza A and B viruses circulating in Thailand, 2017–2020",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803983/
51509,A novel household‐based patient outreach pilot program to boost late‐season influenza vaccination rates during the COVID‐19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530505/
51510,"Construction, characterization, and immunization of nanoparticles that display a diverse array of influenza HA trimers",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932532/
51511,Influenza-Specific Lung-Resident Memory CD8+ T Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849341/
51512,Passive inhalation of dry powder influenza vaccine formulations completely protects chickens against H5N1 lethal viral challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126314/
51513,Whole-Genome Analysis of Influenza A(H3N2) and B/Victoria Viruses Detected in Myanmar during the COVID-19 Pandemic in 2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964416/
51514,Profiling vaccine believers and skeptics in nurses: A latent profile analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8676577/
51515,"Vaccine conspiracy association with higher COVID-19 vaccination side effects and negative attitude towards booster COVID-19, influenza and monkeypox vaccines: A pilot study in Saudi Universities",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653693/
51516,Serum Samples From Middle-aged Adults Vaccinated Annually with Seasonal Influenza Vaccines Cross-neutralize Some Potential Pandemic Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313900/
51517,Prospective Cohort Study on the Effectiveness of Influenza and Pneumococcal Vaccines in Preventing Pneumonia Development and Hospitalization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308868/
51518,Oral Adverse Events Following COVID-19 Vaccination: Analysis of VAERS Reports,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309565/
51519,Rational Design of Vaccines for AIDS and Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540641/
51520,Time-Course Gene Set Analysis for Longitudinal Gene Expression Data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482329/
51521,PLoS Comput Biol. 2015 Aug; 11(8): e1004446. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546690/
51522,Decreased antibody response to influenza vaccine with an enhanced antibody response to subsequent SARS‐CoV‐2 vaccination in patients with chronic hepatitis B virus infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803931/
51523,COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295053/
51524,Post-marketing surveillance study on influenza vaccine in South Korea using a nationwide spontaneous reporting database with multiple data mining methods,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691710/
51525,"Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330673/
51526,Virus-Vectored Influenza Virus Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147686/
51527,Vaccine Confidence and Hesitancy at the Start of COVID-19 Vaccine Deployment in the UK: An Embedded Mixed-Methods Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632016/
51528,Rationally Designed Influenza Virus Vaccines That Are Antigenically Stable during Growth in Eggs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461409/
51529,Sublingual Immunization with M2-Based Vaccine Induces Broad Protective Immunity against Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227615/
51530,Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958762/
51531,Annual flu shot: Does it help patients with COVID‐19?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646810/
51532,Evaluating the importance of policy amenable factors in explaining influenza vaccination: a cross-sectional multinational study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734251/
51533,A naturally protective epitope of limited variability as an influenza vaccine target,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155085/
51534,Vaccination against Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152391/
51535,"Update: Influenza Activity — United States and Worldwide, May 19–September 28, 2019, and Composition of the 2020 Southern Hemisphere Influenza Vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788403/
51536,The responses of Aboriginal Canadians to adjuvanted pandemic (H1N1) 2009 influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176866/
51537,Immunogenicity and clinical protection against equine influenza by gene-based DNA vaccination of ponies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474358/
51538,Retrospective Assessment of the Antigenic Similarity of Egg-Propagated and Cell Culture-Propagated Reference Influenza Viruses as Compared with Circulating Viruses across Influenza Seasons 2002–2003 to 2017–2018,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432082/
51539,Antibodies Against Egg- and Cell-Grown Influenza A(H3N2) Viruses in Adults Hospitalized During the 2017–2018 Influenza Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534188/
51540,"Assessment of human milk samples obtained pre and post-influenza vaccination reveals a poor boosting of seasonally-relevant, hemagglutinin-specific antibodies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264617/
51541,Universal flu vaccines: a shot at lifelong cardioprotection?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757624/
51542,A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518248/
51543,Heterologous HA DNA vaccine prime - inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802517/
51544,Bidirectional and persistent immunomodulation of Astragalus polysaccharide as an adjuvant of influenza and recombinant SARS-CoV-2 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932796/
51545,"Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: Results of a randomized, controlled comparison",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981857/
51546,"Impact of a community-based health education intervention on awareness of influenza, pneumonia, and vaccination intention in chronic patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920218/
51547,Influenza vaccination strategies targeting the hemagglutinin stem region,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323124/
51548,Immunity to Influenza Infection in Humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919402/
51549,"EXamining the knowledge, Attitudes and experiences of Canadian seniors Towards influenza (the EXACT survey)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595620/
51550,Field Effectiveness of Pandemic and 2009-2010 Seasonal Vaccines against 2009-2010 A(H1N1) Influenza: Estimations from Surveillance Data in France,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091864/
51551,"Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746468/
51552,"Epidemiological and virological surveillance of Severe Acute Respiratory Infections in the 2019/2020 season in Siena, Tuscany, Italy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639125/
51553,The Importance of Vaccinating Children and Pregnant Women against Influenza Virus Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963306/
51554,Optimizing the Dose of Pre-Pandemic Influenza Vaccines to Reduce the Infection Attack Rate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1892041/
51555,"Expression and Characterization of Recombinant, Tetrameric and Enzymatically Active Influenza Neuraminidase for the Setup of an Enzyme-Linked Lectin-Based Assay",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539205/
51556,Influenza: Can we cope better with the unpredictable?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964641/
51557,Phase 4 clinical trials in the era of the Coronavirus Disease (COVID-19) pandemic and their importance to optimize the COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351445/
51558,Influenza vaccination in the Americas: Progress and challenges after the 2009 A(H1N1) influenza pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994725/
51559,Hum Vaccin Immunother. 2016 Jul; 12(7): 1948. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964802/
51560,Influenza vaccination uptake and attitudes among adult cancer patients in Japan: a web-based questionnaire survey before the 2020/2021 season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903950/
51561,Vaccinology in the third millennium: scientific and social challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902778/
51562,Adjuvanted nanoliposomes displaying six hemagglutinins and neuraminidases as an influenza virus vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10982964/
51563,Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013887/
51564,Influenza Vaccine Effectiveness: Analysis of the Impact of Repeated Vaccinations in Military Health System Beneficiaries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578161/
51565,"Immunogenicity Is Not Improved by Increased Antigen Dose or Booster
Dosing of Seasonal Influenza Vaccine in a Randomized Trial of HIV Infected
Adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064575/
51566,Association between Influenza Vaccine Administration and Primary Care Consultations for Respiratory Infections: Sentinel Network Study of Five Seasons (2014/2015–2018/2019) in the UK,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827078/
51567,Direct Comparison of an Inactivated Subvirion Influenza A Virus Subtype H5N1 Vaccine Administered by the Intradermal and Intramuscular Routes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501693/
51568,Live-attenuated H1N1 influenza vaccine candidate displays potent efficacy in mice and ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791556/
51569,Antigenicity prediction and vaccine recommendation of human influenza virus A (H3N2) using convolutional neural networks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734114/
51570,Seasonal Influenza Vaccination Does Not Effectively Expand H2 Cross-Reactive Antibodies in Humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067019/
51571,Antigenic Variability a Potential Factor in Assessing Relationship Between Guillain Barré Syndrome and Influenza Vaccine – Up to Date Literature Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532881/
51572,"Combatting a ""Twin-demic"": A quantitative assessment of COVID-19 and influenza vaccine hesitancy in primary care patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233667/
51573,Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409530/
51574,Antigenicity of the 2015–2016 seasonal H1N1 human influenza virus HA and NA proteins,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690631/
51575,Cost effectiveness analysis of elementary school-located vaccination against influenza – Results from a randomized controlled trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583066/
51576,The Operational Feasibility of Vaccination Programs Targeting Influenza Risk Groups in the World Health Organization (WHO) African and South-East Asian Regions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800189/
51577,"The 1918 Influenza Pandemic: Looking Back, Looking Forward",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454441/
51578,Poly-γ-glutamic acid/Alum adjuvanted pH1N1 vaccine-immunized aged mice exhibit a significant increase in vaccine efficacy with a decrease in age-associated CD8+ T cell proportion in splenocytes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124744/
51579,Distribution of Droplets and Immune Responses After Aerosol and Intra-Nasal Delivery of Influenza Virus to the Respiratory Tract of Pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653178/
51580,Alternating 3 different influenza vaccines for swine in Europe for a broader antibody response and protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202218/
51581,"Cost-consequence analysis of influenza vaccination among the staff of a large teaching hospital in Rome, Italy: A pilot study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855652/
51582,Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776812/
51583,IRF7-deficient MDCK cell based on CRISPR/Cas9 technology for enhancing influenza virus replication and improving vaccine production,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508885/
51584,Achieving Influenza Vaccine Uptake Target in Canada via a Pharmacy-Led Telephone Discussion during the 2019–2020 Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065524/
51585,A scoping review of the reasons for and approaches to non-uptake of pertussis and influenza vaccinations in pregnant women in the United Kingdom and Ireland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10717507/
51586,"High Public-Health Impact in an Influenza-B-Mismatch Season in Southern Italy, 2017-2018",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720359/
51587,Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783479/
51588,PLoS One. 2013; 8(11): 10.1371/annotation/c2c0b5cc-ce3e-4c1f-a821-caed5697d72d. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832677/
51589,Anamnestic broadly reactive antibodies induced by H7N9 virus more efficiently bind to seasonal H3N2 strains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746487/
51590,"Reduction in self-reported influenza-like-illness in school children and household members following influenza vaccine administration – a cohort study, Israel, 2016–7",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256775/
51591,Coverage and factors associated with influenza vaccination among kindergarten children 2-7 years old in a low-income city of north-western China (2014-2016),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531459/
51592,Vaccines to prevent pneumonia in children – a developing country perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995362/
51593,Chemically Modified Bovine β-Lactoglobulin as a Broad-Spectrum Influenza Virus Entry Inhibitor with the Potential to Combat Influenza Outbreaks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506557/
51594,Geographic Prioritization of Distributing Pandemic Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295509/
51595,"Parental Seasonal Influenza Vaccine Hesitancy and Associated Factors in Shanghai, China, during the COVID-19 Pandemic: A Cross-Sectional Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788477/
51596,Influenza vaccination in HIV-positive subjects: latest evidence and future perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718365/
51597,"Seasonal influenza: Knowledge, attitude and vaccine uptake among adults with chronic conditions in Italy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493755/
51598,In the Shadow of Hemagglutinin: A Growing Interest in Influenza Viral Neuraminidase and Its Role as a Vaccine Antigen,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074938/
51599,International Consensus (ICON): allergic reactions to vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026780/
51600,Assessing the impact of educational methods on influenza vaccine uptake and patient knowledge and attitudes: a randomised controlled trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071845/
51601,Kinetics of Hemagglutination-Inhibiting Antibodies Following Maternal Influenza Vaccination Among Mothers With and Those Without HIV Infection and Their Infants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655859/
51602,J Infect Dis. 2019 Oct 15; 220(8): 1392. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325324/
51603,Live Attenuated Influenza Vaccine contains Substantial and Unexpected Amounts of Defective Viral Genomic RNA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691621/
51604,Injectable Excipients as Novel Influenza Vaccine Adjuvants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353828/
51605,"Prolonged Codelivery of Hemagglutinin and a TLR7/8
Agonist in a Supramolecular Polymer–Nanoparticle Hydrogel Enhances
Potency and Breadth of Influenza Vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153386/
51606,Vaccines for Pandemic Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291408/
51607,Influenza Gain-of-Function Experiments: Their Role in Vaccine Virus Recommendation and Pandemic Preparedness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278542/
51608,Past and Future Influenza Vaccine Uptake Motivation: A Cross-Sectional Analysis among Italian Health Sciences Students,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143571/
51609,IL-33 Is Essential for Adjuvant Effect of Hydroxypropyl-β-Cyclodexrin on the Protective Intranasal Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069475/
51610,Seasonal influenza self-vaccination behaviours and attitudes among nurses in Southeastern France,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816369/
51611,Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440689/
51612,Determinants of change in intention to receive influenza vaccination among health-care workers in Singapore,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227634/
51613,Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099545/
51614,"Trait reactance and trust in doctors as predictors of vaccination behavior, vaccine attitudes, and use of complementary and alternative medicine in parents of young children",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384640/
51615,Effective inactivated influenza vaccine for the elderly using a single-stranded RNA-based adjuvant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184738/
51616,Use of Biolayer Interferometry to Identify Dominant Binding Epitopes of Influenza Hemagglutinin Protein of A(H1N1)pdm09 in the Antibody Response to 2010–2011 Influenza Seasonal Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458479/
51617,Influenza Seasonality in the Tropics and Subtropics – When to Vaccinate?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847850/
51618,Promising Adjuvants and Platforms for Influenza Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825707/
51619,4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099094/
51620,Influenza vaccination situation in Middle-East and North Africa countries: Report of the 7th MENA Influenza Stakeholders Network (MENA-ISN),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102733/
51621,"Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046143/
51622,A Comparison of the Level of Acceptance and Hesitancy towards the Influenza Vaccine and the Forthcoming COVID-19 Vaccine in the Medical Community,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150871/
51623,Web-Based Video Education to Improve Uptake of Influenza Vaccination and Other Preventive Health Recommendations in Adults With Inflammatory Bowel Disease: Randomized Controlled Trial of Project PREVENT,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483303/
51624,Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658110/
51625,"Alteration of humoral, cellular and cytokine immune response to inactivated influenza vaccine in patients with Sickle Cell Disease",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786629/
51626,"Patient characteristics of Medicare beneficiaries who report not getting influenza and pneumococcal vaccinations, 2001–2013",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227672/
51627,Induction of Virus-Specific Cytotoxic T Lymphocytes as a Basis for the Development of Broadly Protective Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189652/
51628,BTLA expression declines on B cells of the aged and is associated with low responsiveness to the trivalent influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637297/
51629,The Epidemiological and Economic Impact of a Cell-Based Quadrivalent Influenza Vaccine in Adults in the US: A Dynamic Modeling Approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538069/
51630,Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687931/
51631,Impact of video-led educational intervention on uptake of influenza vaccine among the elderly in western China: a community-based randomized controlled trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169441/
51632,Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease‐modifying therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488907/
51633,A pan-influenza antibody inhibiting neuraminidase via receptor mimicry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266979/
51634,Nature. 2023; 619(7970): E50. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356599/
51635,A Live Attenuated H7N3 Influenza Virus Vaccine is Well-tolerated and Immunogenic in a Phase I Trial in Healthy Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771405/
51636,Vaccination and Antiviral Treatment against Avian Influenza H5Nx Viruses: A Harbinger of Virus Control or Evolution,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675773/
51637,A Dose-finding Study of a Wild-type Influenza A(H3N2) Virus in a Healthy Volunteer Human Challenge Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880340/
51638,High-Dose Influenza Vaccine Is Associated With Reduced Mortality Among Older Adults With Breakthrough Influenza Even When There Is Poor Vaccine-Strain Match,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552589/
51639,Modeling the Impacts of Clinical Influenza Testing on Influenza Vaccine Effectiveness Estimates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967445/
51640,Focus group study on perceptions and information needs regarding vaccines targeting the older population: a cross-country comparison in four European countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684753/
51641,Genome-Wide Analysis of Evolutionary Markers of Human Influenza A(H1N1)pdm09 and A(H3N2) Viruses May Guide Selection of Vaccine Strain Candidates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700966/
51642,Intranasal Delivery of Inactivated Influenza Virus and Poly(I:C) Adsorbed Corn-Based Nanoparticle Vaccine Elicited Robust Antigen-Specific Cell-Mediated Immune Responses in Maternal Antibody Positive Nursery Pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772411/
51643,Factors associated with COVID-19 vaccine intent among Latino SNAP participants in Southern California,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981200/
51644,Technical guidelines for the application of seasonal influenza vaccine in China (2014–2015),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635867/
51645,Predictors of Influenza Vaccination among Chinese Middle School Students Based on the Health Belief Model: A Mixed-Methods Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697411/
51646,Immunogenicity of H5N1 influenza vaccines in elderly adults: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899698/
51647,"Safety Profile of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543775/
51648,An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884525/
51649,A randomized trial of maternal influenza immunization decision-making: A test of persuasive messaging models,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994759/
51650,"Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793388/
51651,Construction and Immunogenicity of a Novel Multivalent Vaccine Prototype Based on Conserved Influenza Virus Antigens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349063/
51652,Improving uptake of vaccines in pregnancy: A service evaluation of an antenatal vaccination clinic at a tertiary hospital in the UK,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639287/
51653,BECC Adjuvanted Vaccine Provides Cross-Protection from Both Homologous and Heterologous Influenza A Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744187/
51654,Flu vaccine administration in the period before SARS-CoV-2 infection and its outcomes: An umbrella review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10820254/
51655,Generation of an Attenuated Chimeric Bat Influenza A Virus Live-Vaccine Prototype,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769755/
51656,Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395492/
51657,Influenza virus specific human antibody repertoire studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327975/
51658,Strategies to improve vaccination rates in people who are homeless: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040475/
51659,Predictive modeling of influenza shows the promise of applied evolutionary biology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830126/
51660,"COVID-19 and Seasonal Influenza Vaccination: Cross-Protection, Co-Administration, Combination Vaccines, and Hesitancy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952219/
51661,Effect of Probiotics and Prebiotics on Immune Response to Influenza Vaccination in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707647/
51662,Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2500171/
51663,"Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019108/
51664,A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60–85 years old) and very elderly (>85 years old) institutionalized subjects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703374/
51665,Use of adjuvanted trivalent influenza vaccine in older-age adults: a systematic review of economic evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605847/
51666,Carboxymethyl chitosan bounded iron oxide nanoparticles and gamma‐irradiated avian influenza subtype H9N2 vaccine to development of immunity on mouse and chicken,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959295/
51667,"Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446406/
51668,Distinct and complementary roles of CD4 T cells in protective immunity to influenza virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141328/
51669,Stalking influenza by vaccination with pre-fusion headless HA mini-stem,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780079/
51670,Do Thai Physicians Recommend Seasonal Influenza Vaccines to Pregnant Women? A Cross-Sectional Survey of Physicians’ Perspectives and Practices in Thailand,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242501/
51671,Development and Evaluation of Vero Cell-Derived Master Donor Viruses for Influenza Pandemic Preparedness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712210/
51672,Antibody-mediated NK cell activation as a correlate of immunity against influenza infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449820/
51673,"Influenza vaccination in the elderly:
why are the overall benefits still hotly debated?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718343/
51674,"Influenza vaccination coverage of professionals working in nursing homes in France and related determinants, 2018–2019 season: a cross-sectional survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134603/
51675,Making Better Influenza Virus Vaccines?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291403/
51676,Pre‐existing influenza‐specific nasal IgA or nasal viral infection does not affect live attenuated influenza vaccine immunogenicity in children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944357/
51677,A Human Multi-Epitope Recombinant Vaccinia Virus as a Universal T Cell Vaccine Candidate against Influenza Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3187825/
51678,Clinical development and approval of COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935460/
51679,Facial paralysis and vaccinations: a vaccine adverse event reporting system review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344709/
51680,Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354223/
51681,An infodemiological investigation of the so-called “Fluad effect” during the 2014/2015 influenza vaccination campaign in Italy: Ethical and historical implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861810/
51682,Seasonal Influenza Vaccination Among Saudi Children: Parental Barriers and Willingness to Vaccinate Their Children in the Makkah Region,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257357/
51683,Attitudes towards COVID-19 vaccine and reasons for adherence or not among nursing students,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285215/
51684,A Bivalent Live-Attenuated Vaccine for the Prevention of Equine Influenza Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832603/
51685,Changes in Sialic Acid Binding Associated with Egg Adaptation Decrease Live Attenuated Influenza Virus Replication in Human Nasal Epithelial Cell Cultures,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184632/
51686,Protection against homo and hetero-subtypic inﬂuenza A virus by optimized M2e DNA vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455129/
51687,The Potential of Neuraminidase as an Antigen for Nasal Vaccines To Increase Cross-Protection against Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475506/
51688,Proteomic Signatures of the Serological Response to Influenza Vaccination in a Large Human Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696600/
51689,Response to influenza vaccination in immunocompromised children with rheumatic disease: a prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953767/
51690,Workshop report: Immunoassay standardisation for “universal” influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410724/
51691,How influenza vaccination and virus interference may impact combined influenza-coronavirus disease burden,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285194/
51692,Prior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714852/
51693,Cell Rep Med. 2022 Feb 15; 3(2): 100516. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861827/
51694,Annual public health and economic benefits of seasonal influenza vaccination: a European estimate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141103/
51695,Systematic Review of Equine Influenza A Virus Vaccine Studies and Meta-Analysis of Vaccine Efficacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10747572/
51696,"Heterogeneity in influenza seasonality and vaccine effectiveness in Australia, Chile, New Zealand and South Africa: early estimates of the 2019 influenza season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852316/
51697,Effectiveness of Pandemic and Seasonal Influenza Vaccines in Preventing Laboratory-Confirmed Influenza in Adults: A Clinical Cohort Study during Epidemic Seasons 2009–2010 and 2010–2011 in Finland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180439/
51698,"Change in Threads on Twitter Regarding Influenza, Vaccines, and Vaccination During the COVID-19 Pandemic: Artificial Intelligence–Based Infodemiology Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521455/
51699,Correlates of influenza vaccination among underserved Latinx middle-aged and older adults: a cross-sectional survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077953/
51700,Seasonal Influenza Split Vaccines Confer Partial Cross-Protection against Heterologous Influenza Virus in Ferrets When Combined with the CAF01 Adjuvant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766649/
51701,Exploring provider and parental perceptions to influenza vaccination in the inpatient setting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907817/
51702,"Paid sick leave benefits, influenza vaccination, and taking sick days due to influenza-like illness among U.S. workers",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433122/
51703,"Effect of State Immunization Information System Based Reminder/Recall for Influenza Vaccinations: A Randomized Trial of Autodialer, Text, and Mailed Messages",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518461/
51704,Cross-Neutralizing Antibodies to Pandemic 2009 H1N1 and Recent Seasonal H1N1 Influenza A Strains Influenced by a Mutation in Hemagglutinin Subunit 2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111540/
51705,Tetravalent Influenza Vaccine Is Not Associated With Neuroaxonal Damage in Multiple Sclerosis Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428149/
51706,Hemagglutination Inhibition (HAI) antibody landscapes after vaccination with H7Nx virus like particles,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971484/
51707,The FLU-FOBT Program in community clinics: durable benefits of a randomized controlled trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442378/
51708,Solid Bioneedle-Delivered Influenza Vaccines Are Highly Thermostable and Induce Both Humoral and Cellular Immune Responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966824/
51709,A Map of Racial and Ethnic Disparities in Influenza Vaccine Uptake in the Medicare Fee-for-Service Program,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467464/
51710,N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158744/
51711,Influenza A surface glycosylation and vaccine design,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240703/
51712,Factors associated with uptake of influenza vaccine in people aged 50 to 64 years in Hong Kong: a case–control study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491862/
51713,"Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470701/
51714,Protective Efficacy of a Mucosal Influenza Vaccine Formulation Based on the Recombinant Nucleoprotein Co-Administered with a TLR2/6 Agonist BPPcysMPEG,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057018/
51715,TLR7 Recognition Is Dispensable for Influenza Virus A Infection but Important for the Induction of Hemagglutinin-Specific Antibodies in Response to the 2009 Pandemic Split Vaccine in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457183/
51716,"Barriers and facilitators of vaccine hesitancy for COVID-19, influenza, and pertussis during pregnancy and in mothers of infants under two years: An umbrella review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980804/
51717,Microbial Composition of the Human Nasopharynx Varies According to Influenza Virus Type and Vaccination Status,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606809/
51718,The impact of a vaccine mandate and the COVID-19 pandemic on influenza vaccination uptake in Western Australian health care students,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393169/
51719,Quadrivalent influenza nanoparticle vaccines induce broad protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269962/
51720,"An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179046/
51721,"Evolution of Therapeutic Antibodies, Influenza Virus Biology, Influenza, and Influenza Immunotherapy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994580/
51722,Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778197/
51723,Improved capacity for influenza surveillance in the WHO Eastern Mediterranean Region: Progress in a challenging setting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102713/
51724,Prolonging the delivery of influenza virus vaccine improves the quantity and quality of the induced immune responses in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585035/
51725,Determinants of Vaccination and Willingness to Vaccinate against COVID-19 among Pregnant and Postpartum Women during the Third Wave of the Pandemic: A European Multinational Cross-Sectional Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220755/
51726,A Comparison between the Predictors of Vaccine Uptake Intentions for Influenza and Dengue,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313676/
51727,"Interim estimates of the effectiveness of influenza vaccination against influenza‐associated hospitalization in children in Hong Kong, 2015–16",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155726/
51728,"SIMON, an Automated Machine Learning System, Reveals Immune Signatures of Influenza Vaccine Responses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643048/
51729,Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on Estimates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007111/
51730,Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888232/
51731,"Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011–2017",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495015/
51732,Gene Constellation of Influenza A Virus Reassortants with High Growth Phenotype Prepared as Seed Candidates for Vaccine Production,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113853/
51733,Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10819631/
51734,Characterization of pandemic influenza immune memory signature after vaccination or infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071387/
51735,Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711626/
51736,Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/
51737,Designing vaccines for pandemic influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133292/
51738,Exploring strategies to promote influenza vaccination of children with medical comorbidities: the perceptions and practices of hospital healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883556/
51739,Longitudinal Assessment of Immune Responses to Repeated Annual Influenza Vaccination in a Human Cohort of Adults and Teenagers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7965973/
51740,Universal influenza virus vaccines and therapeutics: Where do we stand with influenza B virus?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141316/
51741,"Intranasal Immunization of Ferrets with Commercial Trivalent Influenza Vaccines Formulated in a Nanoemulsion-Based Adjuvant

",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3147313/
51742,"Immunogenicity, safety and tolerability of intradermal influenza vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861844/
51743,Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107133/
51744,Evaluation of the Sublingual Route for Administration of Influenza H5N1 Virosomes in Combination with the Bacterial Second Messenger c-di-GMP,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206068/
51745,Narrowing the policy gap: lessons from years 2 and 3 of the British Columbia influenza prevention policy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482846/
51746,A randomized controlled trial to evaluate the effect of influenza vaccination and probiotic supplementation on immune response and incidence of influenza-like illness in an elderly population in Indonesia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675694/
51747,"An Alphavirus-Based Adjuvant Enhances Serum and Mucosal Antibodies, T Cells, and Protective Immunity to Influenza Virus in Neonatal Mice",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136293/
51748,Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899102/
51749,Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113517/
51750,Association of Post-vaccination Adverse Reactions After Influenza Vaccine with Mortality and Cardiopulmonary Outcomes in Patients with High-risk Cardiovascular Disease: The INVESTED Trial.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292027/
51751,Reasons for Failure to Receive Pneumococcal and Influenza Vaccinations Among Immunosuppressed Patients with Systemic Lupus Erythematosus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464934/
51752,Short and Long-Term Safety of the 2009 AS03-Adjuvanted Pandemic Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389012/
51753,Cost-Effectiveness Analysis of Cell Versus Egg-Based Seasonal Influenza Vaccination in Children and Adults in Argentina,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612026/
51754,Models for predicting the evolution of influenza to inform vaccine strain selection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861780/
51755,How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692539/
51756,"Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy adults ≥ 18 years of age: A randomized, multicenter, phase II / III clinical trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037459/
51757,Influenza A virus vaccine research conducted in swine from 1990 to May 2018: A scoping review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365442/
51758,"Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086271/
51759,A Live Attenuated Influenza A(H5N1) Vaccine Induces Long-Term Immunity in the Absence of a Primary Antibody Response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047295/
51760,J Infect Dis. 2014 Dec 15; 210(12): 2021. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342688/
51761,Protection against Divergent Influenza H1N1 Virus by a Centralized Influenza Hemagglutinin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065472/
51762,Influenza A virus vaccines for swine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609643/
51763,Bioprocess development for universal influenza vaccines based on inactivated split chimeric and mosaic hemagglutinin viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277804/
51764,Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762105/
51765,Influenza and Memory T Cells: How to Awake the Force,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192353/
51766,Identification of Low- and High-Impact Hemagglutinin Amino Acid Substitutions That Drive Antigenic Drift of Influenza A(H1N1) Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825936/
51767,"The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620982/
51768,I-MOVE Multi-Centre Case Control Study 2010-11: Overall and Stratified Estimates of Influenza Vaccine Effectiveness in Europe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216983/
51769,"Attitudes, beliefs and practice of Egyptian healthcare workers towards seasonal influenza vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542955/
51770,Intention of nurses to receiving influenza vaccination before the 2013–14 season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514435/
51771,Intranasal Vaccination Promotes Detrimental Th17-Mediated Immunity against Influenza Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900655/
51772,SARS-CoV-2 and Influenza Vaccines in People with Excessive Body Mass—A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605570/
51773,A consensus–hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533225/
51774,Quantifying Influenza Vaccine Efficacy and Antigenic Distance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474378/
51775,HIV infection Worsens Age-Associated Defects in Antibody Responses to Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836723/
51776,Influenza vaccines in immunosuppressed adults with cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457732/
51777,Cochrane Database Syst Rev. 2018; 2018(2): CD008983. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491273/
51778,Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959521/
51779,A Computationally Optimized Hemagglutinin Virus-Like Particle Vaccine Elicits Broadly Reactive Antibodies that Protect Nonhuman Primates from H5N1 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415819/
51780,Cross-Protective Peptide Vaccine against Influenza A Viruses Developed in HLA-A*2402 Human Immunity Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176274/
51781,Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type Nucleoprotein,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056296/
51782,Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646626/
51783,Thermal Stabilization of Viral Vaccines in Low-Cost Sugar Films,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529427/
51784,"The genetic match between vaccine strains and circulating seasonal influenza A viruses in Vietnam, 2001–2009",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634303/
51785,"Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139892/
51786,Influenza Vaccine Effectiveness in Mainland China: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912587/
51787,Combined use of live-attenuated and inactivated influenza vaccines to enhance heterosubtypic protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275109/
51788,Does having a seasonal influenza program facilitate pandemic preparedness? An analysis of vaccine deployment during the 2009 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992512/
51789,New Vaccine Design and Delivery Technologies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452296/
51790,Displaying and delivering viral membrane antigens via WW domain–activated extracellular vesicles,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882979/
51791,Projected Population Benefit of Increased Effectiveness and Coverage of Influenza Vaccination on Influenza Burden — United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6980871/
51792,COVID-19 Vaccine Hesitancy among the Public in Kuwait: A Cross-Sectional Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394561/
51793,Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115642/
51794,"A 680,000-person megastudy of nudges to encourage vaccination in pharmacies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833156/
51795,The potential of a universal influenza virus-like particle vaccine expressing a chimeric cytokine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644419/
51796,Barriers and Facilitators Associated With Vaccine Acceptance and Uptake Among Pregnant Women in High Income Countries: A Mini-Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107947/
51797,Estimating the Effect of Influenza Vaccination on Nursing Home Residents’ Morbidity and Mortality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762025/
51798,Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318028/
51799,Convergent Evolution in Breadth of Two VH6-1-Encoded Influenza Antibody Clonotypes from a Single Donor,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486241/
51800,Influenza vaccination among adults living with persons at high-risk for complications from influenza during early 2016-17 influenza season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478164/
51801,Clinical vaccine development for H5N1 influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101019/
51802,Surveillance of the current situation regarding influenza vaccination according to medical oncologists in Japan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780033/
51803,Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344733/
51804,Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross‐reactive immunity in ferrets against infection with viruses drifted for decades,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941650/
51805,Nano-carriers of COVID-19 vaccines: the main pillars of efficacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544481/
51806,Influenza vaccination in coronavirus times: Primary Care professionals’ intention to get vaccinated in Central Catalonia (VAGCOVID). A cross sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302504/
51807,Determinants of Receiving the Pandemic (H1N1) 2009 Vaccine and Intention to Receive the Seasonal Influenza Vaccine in Taiwan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074160/
51808,SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906421/
51809,Difference in immune response in vaccinated and unvaccinated Swedish individuals after the 2009 influenza pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067073/
51810,Vaccine Strategies to Elicit Mucosal Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10892965/
51811,B Cell Response and Hemagglutinin Stalk-Reactive Antibody Production in Different Age Cohorts following 2009 H1N1 Influenza Virus Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675965/
51812,Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2572794/
51813,Influenza Vaccination among Pregnant Women: Patient Beliefs and Medical Provider Practices,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983379/
51814,Sequential Immunizations with heterosubtypic virus-like particles elicit cross protection against divergent influenza A viruses in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854580/
51815,Impact of pharmacy intervention on influenza vaccination acceptance: a systematic literature review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161720/
51816,Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702536/
51817,Multiplexed electrospray enables high throughput production of cGAMP microparticles to serve as an adjuvant for a broadly acting influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484837/
51818,Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890838/
51819,Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474494/
51820,"Parents' Hesitancy to Vaccinate Their Children Against COVID-19, a Country-Wide Survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095949/
51821,Use of vaccines as probes to define disease burden,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682543/
51822,"DNA Vaccination Elicits Protective Immune Responses against Pandemic and Classic Swine Influenza Viruses in Pigs

",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3209026/
51823,H1N1 viral proteome peptide microarray predicts individuals at risk for H1N1 infection and segregates infection versus Pandemrix® vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479535/
51824,"Safety and immunogenicity of a paediatric presentation of an
influenza vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1718589/
51825,Natural STING agonist as an “ideal” adjuvant for cutaneous vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091668/
51826,Effect of vaccination on the use of antimicrobial agents: a systematic literature review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880080/
51827,Is Insomnia a Risk Factor for Decreased Influenza Vaccine Response?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554442/
51828,Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864978/
51829,Improving Influenza Vaccination Coverage in Patients with Cancer: A Position Paper from a Multidisciplinary Expert Group,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11053698/
51830,Noninvasive vaccination against infectious diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067898/
51831,Antibody Responses to Trivalent Inactivated Influenza Vaccine in Health Care Personnel Previously Vaccinated and Vaccinated for The First Time,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241813/
51832,Determinants of Refusal of A/H1N1 Pandemic Vaccination in a High Risk Population: A Qualitative Approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323624/
51833,Adjuvants for COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222622/
51834,Influenza Vaccine Effectiveness Among Children: 2011–2020,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071433/
51835,H5N1 Vaccine-Specific B Cell Responses in Ferrets Primed with Live Attenuated Seasonal Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635969/
51836,Antibody responses against heterologous H5N1 strains for an MF59-adjuvanted cell culture–derived H5N1 (aH5n1c) influenza vaccine in adults and older adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114991/
51837,"Effectiveness of the 2012/13 Trivalent Live and Inactivated Influenza Vaccines in Children and Adolescents in Saxony-Anhalt, Germany: A Test-Negative Case-Control Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401761/
51838,"Influenza and Pneumococcal Vaccination in Hematological Malignancies: a Systematic Review of Efficacy, Effectiveness, and Safety",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016013/
51839,Interplay between cost and effectiveness in influenza vaccine uptake: a vaccination game approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936611/
51840,US Public Support for Vaccine Donation to Poorer Countries in the 2009 H1N1 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295778/
51841,The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736984/
51842,Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498426/
51843,Effects of Ownership Text Message Wording and Reminders on Receipt of an Influenza Vaccination: A Randomized Clinical Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855238/
51844,"Update: Influenza Activity — United States, September 30, 2018–February 2, 2019",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375659/
51845,NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885027/
51846,Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277076/
51847,The Importance of COVID-19/Influenza Vaccines Co-Administration: An Essential Public Health Tool,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778301/
51848,Broad Protection against Avian Influenza Virus by Using a Modified Vaccinia Ankara Virus Expressing a Mosaic Hemagglutinin Gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249068/
51849,Influenza Vaccination Coverage among Multiple Sclerosis Patients: Evolution over Time and Associated Factors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322179/
51850,"Seasonal influenza vaccine effectiveness among health-care workers in Prince Sultan Military Medical City, Riyadh, KSA, 2018–2019",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872086/
51851,Epitope-targeting platform for broadly protective influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158873/
51852,Influenza Vaccinations for All Pregnant Women? Better Evidence Is Needed,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164291/
51853,Broadly neutralizing DNA vaccine with specific mutation alters the antigenicity and sugar-binding activities of influenza hemagglutinin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048126/
51854,DNA vaccine based on conserved HA-peptides induces strong immune response and rapidly clears influenza virus infection from vaccinated pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760788/
51855,Multiple-Clade H5N1 Influenza Split Vaccine Elicits Broad Cross Protection against Lethal Influenza Virus Challenge in Mice by Intranasal Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261182/
51856,A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342948/
51857,Influenza vaccination among children with idiopathic nephrotic syndrome: an investigation of practices,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388483/
51858,A Multiyear Model of Influenza Vaccination in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580553/
51859,Beliefs and attitudes towards the influenza vaccine in high-risk individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203300/
51860,Varying Viral Replication and Disease Profiles of H2N2 Influenza in Ferrets Is Associated with Virus Isolate and Inoculation Route,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327684/
51861,Galvanizing medical students in the administration of influenza vaccines: the Stanford Flu Crew,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492543/
51862,Seasonal Influenza Vaccination among Saudi Children: Parental Barriers and Willingness to Vaccinate Their Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862221/
51863,Influenza Vaccine Uptake and Missed Opportunities Among the Medicare-Covered Population With High-Risk Conditions During the 2018 to 2019 Influenza Season: A Retrospective Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109634/
51864,Cost Effectiveness of Influenza Vaccine For U.S. Children Live Attenuated and Inactivated Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384696/
51865,Does Loneliness Predict Subsequent Use of Flu Vaccination? Findings from a Nationally Representative Study of Older Adults in Germany,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950003/
51866,"Influenza vaccination hesitancy in five countries of South America. Confidence, complacency and convenience as determinants of immunization rates",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732123/
51867,Update: Influenza Activity in the United States During the 2016–17 Season and Composition of the 2017–18 Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687497/
51868,Organizational factors associated with Health Care Provider (HCP) influenza campaigns in the Veterans health care system: a qualitative study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932695/
51869,Clinical practice guidelines 2019: Indian consensus-based recommendations on influenza vaccination in adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703812/
51870,Targeting Xcr1 on Dendritic Cells Rapidly Induce Th1-Associated Immune Responses That Contribute to Protection Against Influenza Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918470/
51871,Development of vaccines at the time of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798935/
51872,"Agreement among Sources of Adult Influenza Vaccination in the Age of
Immunization Information Systems",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653902/
51873,Potency of an inactivated influenza vaccine prepared from A/duck/Hokkaido/162/2013 (H2N1) against a challenge with A/swine/Missouri/2124514/2006 (H2N3) in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709558/
51874,Divergent Attitudes Toward COVID-19 Vaccine vs Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10739094/
51875,‘What have you HEARD about the HERD?’ Does education about local influenza vaccination coverage and herd immunity affect willingness to vaccinate?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008254/
51876,Comparison of the Influenza Virus-Specific Effector and Memory B-Cell Responses to Immunization of Children and Adults with Live Attenuated or Inactivated Influenza Virus Vaccines ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797237/
51877,Influenza Virus Vaccines: Lessons from the 2009 H1N1 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224079/
51878,Fractional dose of intradermal compared to intramuscular and subcutaneous vaccination - A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474844/
51879,Induction of broadly reactive influenza antibodies increases susceptibility to autoimmunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036619/
51880,Economics of Influenza Vaccine Administration Timing for Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763213/
51881,TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996078/
51882,Development of NP-Based Universal Vaccine for Influenza A Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10892571/
51883,"Influence of Vaccination Characteristics on COVID-19 Vaccine Acceptance Among Working-Age People in Hong Kong, China: A Discrete Choice Experiment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702724/
51884,"A Knowledge, Attitude, and Perception Study on Flu and COVID-19 Vaccination during the COVID-19 Pandemic: Multicentric Italian Survey Insights",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875897/
51885,Do Vaccines Need a Gender Perspective? Influenza Says Yes!,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287332/
51886,Reports of social circles’ and own vaccination behavior: A national longitudinal survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038818/
51887,On the Bias of Estimates of Influenza Vaccine Effectiveness from Test–negative Studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712239/
51888,The emerging influenza virus threat: status and new prospects for its therapy and control,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087104/
51889,Microneedle Patches: Usability and Acceptability for Self-Vaccination against Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979961/
51890,Potential cross-species transmission of highly pathogenic avian influenza H5 subtype (HPAI H5) viruses to humans calls for the development of H5-specific and universal influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275984/
51891,"Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901381/
51892,Association between hospitalization with community acquired laboratory-confirmed influenza pneumonia and prior receipt of influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688454/
51893,"A Comparison of the Attitudes to Influenza Vaccination Held by Nursing, Midwifery, Pharmacy, and Public Health Students and Their Knowledge of Viral Infections",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565400/
51894,Influenza vaccination of school teachers: A scoping review and an impact estimation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371289/
51895,"The intentions to get vaccinated against influenza and actual vaccine uptake among diabetic patients in Ningbo, China: identifying motivators and barriers",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877400/
51896,Seasonal influenza vaccines differentially activate and modulate toll-like receptor expression within the tumor microenvironment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10928891/
51897,"Seasonal Influenza A H1N1pdm09 Virus and Severe Outcomes: A Reason for Broader Vaccination in Non-Elderly, At-Risk People",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104455/
51898,"Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2015",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584793/
51899,Exploring the acceptance of COVID‐19 vaccine among healthcare workers and general population using health belief model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242385/
51900,Effects of maternal influenza vaccination on adverse birth outcomes: A systematic review and Bayesian meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693758/
51901,Mass Cytometry Defines Virus-Specific CD4+ T Cells in Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891553/
51902,The “Fluad Case” in Italy: Could it have been dealt differently?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328213/
51903,Perceptions of influenza vaccination during pregnancy in Korean women of childbearing age,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994757/
51904,The intersection of gender and race in older adults’ decision to receive COVID-19 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485425/
51905,Immunogenicity and Safety of the Quadrivalent Adjuvant Subunit Influenza Vaccine in Seropositive and Seronegative Healthy People and Patients with Common Variable Immunodeficiency,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712402/
51906,Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450434/
51907,"Comparison of the Immunogenicity and Safety of the Conventional Subunit, MF59-Adjuvanted, and Intradermal Influenza Vaccines in the Elderly",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097439/
51908,Cost-effectiveness of seasonal influenza vaccination of children in China: a modeling analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566174/
51909,mRNA vaccines encoding influenza virus hemagglutinin (HA) elicits immunity in mice from influenza A virus challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11025922/
51910,Assessing Fever Frequency After Pediatric Live Attenuated Versus Inactivated Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675416/
51911,Immunogenicity of Trivalent Inactivated Influenza Vaccination Received During Pregnancy or Postpartum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3327739/
51912,H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514355/
51913,Black-white disparities in 2009 H1N1 vaccination among adults in the United States: A cautionary tale for the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800135/
51914,"Impact of the coronavirus disease 2019 epidemic and a free influenza vaccine strategy on the willingness of residents to receive influenza vaccines in Shanghai, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189049/
51915,"Enhanced passive surveillance of influenza vaccination in England, 2016−2017– an observational study using an adverse events reporting card",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605873/
51916,Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406166/
51917,"Knowledge, attitudes, and practices (KAP) toward seasonal influenza vaccine among college students under the COVID‐19 pandemic in South China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10720255/
51918,The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316438/
51919,"Immunogenicity and safety of the quadrivalent inactivated split-virion influenza vaccine in populations aged ≥ 3 years: A phase 3, randomized, double-blind, non-inferiority clinical trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438852/
51920,"Healthcare Providers’ Vaccine Perceptions, Hesitancy, and Recommendation to Patients: A Systematic Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310254/
51921,N-Glycosylation of Seasonal Influenza Vaccine Hemagglutinins: Implication for Potency Testing and Immune Processing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321900/
51922,Influenza Vaccine Effectiveness in Children at the Emergency Department during the 2018-2019 Season: the First Season School-aged Children Were Included in the Korean Influenza National Immunization Program,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961871/
51923,Epistasis reduces fitness costs of influenza A virus escape from stem-binding antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151473/
51924,Viral Shedding in Recipients of Live Attenuated Influenza Vaccine in the 2016–2017 and 2017–2018 Influenza Seasons in the United Kingdom,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286380/
51925,Evaluation of influenza vaccination coverage in Shanghai city during the 2016/17 to 2020/21 influenza seasons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481150/
51926,Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315843/
51927,Exploring patients' awareness and healthcare professionals' knowledge and attitude to pertussis and influenza vaccination during the antenatal periods in Cavan Monaghan general hospital,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893215/
51928,Focusing on flu: Adolescents’ perspectives on school-located immunization programs for influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181009/
51929,Monitoring vaccine safety during an influenza pandemic.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259166/
51930,Vaccines for COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597597/
51931,Immunogenicity and safety of quadrivalent inactivated influenza vaccine in children aged 6 to 35 months: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557567/
51932,Induction of IL-21 in Peripheral T Follicular Helper cells is Indicator of Influenza Vaccine Response in Previously Vaccinated HIV-Infected Pediatric Cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322168/
51933,Using Point of Care Testing to estimate influenza vaccine effectiveness in the English primary care sentinel surveillance network,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951853/
51934,Increased reactions to pediatric influenza vaccination following concomitant pneumococcal vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780760/
51935,"Next-Generation TB Vaccines: Progress, Challenges, and Prospects",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457792/
51936,Low hemagglutinin antigen dose influenza vaccines adjuvanted with AS03 alter the long-term immune responses in BALB/c mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360139/
51937,Key Differences in B cell Activation Patterns and Immune Correlates among Treated HIV-Infected Patients Versus Healthy Controls Following Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803607/
51938,A Matched Influenza Vaccine Strain Was Effective in Reducing the Risk of Acute Myocardial Infarction in Elderly Persons: A Population-Based Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998863/
51939,A Randomized Trial of Candidate Inactivated Quadrivalent Influenza Vaccine versus Trivalent Influenza Vaccines in Children Aged 3–17 Years,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654742/
51940,2014–2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146719/
51941,What do adolescents think about vaccines? Systematic review of qualitative studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022047/
51942,A split influenza vaccine formulated with a combination adjuvant composed of alpha-d-glucan nanoparticles and a STING agonist elicits cross-protective immunity in pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652892/
51943,J Nanobiotechnology. 2022; 20: 539. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783397/
51944,"Prenatal influenza vaccination and allergic and autoimmune diseases in childhood: A longitudinal, population-based linked cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017895/
51945,The immunogenicity of the intradermal injection of seasonal trivalent influenza vaccine containing influenza A(H1N1)pdm09 in COPD patients soon after a pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964808/
51946,"Administration Time Between Seasonal Live-Attenuated Influenza Vaccine and Trivalent Influenza Vaccine During the “Stop Flu at School” Campaign— Hawaii, 2009",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982552/
51947,"Impact of an influenza information pamphlet on vaccination uptake among Polish pupils in Edinburgh, Scotland and the role of social media in parental decision making",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488143/
51948,Implications for COVID-19 vaccine uptake: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884645/
51949,Factors Influencing COVID-19 Vaccine Uptake among Nepali People in the UK: A Qualitative Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143668/
51950,An inactivated multivalent influenza A virus vaccine is broadly protective in mice and ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11022527/
51951,Functional and structural modifications of influenza antibodies during pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991102/
51952,"Influenza-associated hospitalisation, vaccine uptake and socioeconomic deprivation in an English city region: an ecological study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303586/
51953,Effect of influenza vaccine on COVID-19 mortality: a retrospective study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980752/
51954,Predictors of Seasonal Influenza Vaccination Willingness among High-Risk Populations Three Years after the Onset of the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963446/
51955,The Potential Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in Elderly People and Clinical Risk Groups in the UK: A Lifetime Multi-Cohort Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048201/
51956,Mild and asymptomatic influenza B virus infection among unvaccinated pregnant persons: Implication for effectiveness of non-pharmaceutical intervention and vaccination to prevent influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250188/
51957,Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362424/
51958,Modulation of injectable hydrogel properties for slow co‐delivery of influenza subunit vaccine components enhance the potency of humoral immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518857/
51959,Mechanisms of sex disparities in influenza pathogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046247/
51960,Influenza vaccination during pregnancy for prevention of influenza confirmed illness in the infants: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861794/
51961,Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836330/
51962,A Complex Dance: Measuring the Multidimensional Worlds of Influenza Virus Evolution and Anti-Influenza Immune Responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963821/
51963,Review of 10 years of clinical experience with Chinese domestic trivalent influenza vaccine Anflu®,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181027/
51964,The safety and efficacy of quadrivalent live attenuated influenza vaccine in Japanese children aged 2‐18 years: Results of two phase 3 studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005581/
51965,Investigation of factors affecting COVID-19 vaccine acceptance among communities of universities in the United Arab Emirates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302497/
51966,"Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18–64 Years: A Randomized, Open-Label Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907492/
51967,Induction of ICOS+CXCR3+CXCR5+ TH Cells Correlates with Antibody Responses to Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621097/
51968,Reply letter to “Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial”,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624209/
51969,Risk factors associated with hospitalisation for influenza-associated severe acute respiratory illness in South Africa: A case-population study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714809/
51970,Development of high-yield influenza B virus vaccine viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187690/
51971,Association of Online Search Trends With Vaccination in the United States: June 2020 Through May 2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066639/
51972,Factors impacting influenza vaccination of urban low-income Latino children under nine years requiring two doses in the 2010–2011 season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314518/
51973,Heterologous Antibody Responses Conferred by A(H3N2) Variant and Seasonal Influenza Vaccination Against Newly Emerged 2016–2018 A(H3N2) Variant Viruses in Healthy Persons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974393/
51974,"Vaccines are underused in pregnancy: what about knowledge, attitudes and practices of providers?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7975891/
51975,A Voice-Annotated Digital Decision Aid to Promote Child Influenza Vaccination: A Feasibility Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058950/
51976,Healthcare worker influenza vaccination and sickness absence – an ecological study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297706/
51977,"Impact of influenza vaccination on respiratory illness rates in children attending private boarding schools in England, 2013–2014: a cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150965/
51978,Autoimmune Variant PTPN22 C1858T Is Associated With Impaired Responses to Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918823/
51979,Sex-specific effects of age and body mass index on antibody responses to seasonal influenza vaccines in healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417149/
51980,Influenza vaccination: policy versus evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1626345/
51981,Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488048/
51982,Models of determinants of COVID-19 vaccine hesitancy in non-pregnant and pregnant population: Review of current literature”,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746492/
51983,Rollout of the 2022/2023 Seasonal Influenza Vaccination and Correlates of the Use of Enhanced Vaccines among Italian Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10747154/
51984,"Trimeric, APC-Targeted Subunit Vaccines Protect Mice against Seasonal and Pandemic Influenza",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972960/
51985,A Novel Dynamic Model for Health Economic Analysis of Influenza Vaccination in the Elderly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675767/
51986,Infect Dis Ther. 2015 Dec; 4(4): 489–490. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675764/
51987,Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538208/
51988,TLR7 and RIG-I dual-adjuvant loaded nanoparticles drive broadened and synergistic responses in dendritic cells in vitro and generate unique cellular immune responses in influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906919/
51989,Influenza Vaccine Hesitancy and Its Determinants Among Rheumatology Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992470/
51990,Confronting Potential Influenza A (H5N1) Pandemic with Better Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851514/
51991,Influenza Vaccination and Guillain–Barré Syndrome: Reality or Fear,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985921/
51992,Innate sensors of influenza virus: clues to developing better intranasal vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724183/
51993,Combined local and systemic immunization is essential for durable T-cell mediated heterosubtypic immunity against influenza A virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735591/
51994,"A 2013/2014 northern hemisphere season surface antigen inactivated trivalent influenza vaccine - Assessing the immunogenicity and safety in an open label, uncontrolled study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635855/
51995,The priming effect of previous natural pandemic H1N1 infection on the immunogenicity to subsequent 2010-2011 influenza vaccination in children: a prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994212/
51996,Human Influenza Epidemiology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634793/
51997,Proinflammatory cytokine responses correspond with subjective side effects after influenza virus vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467994/
51998,Recombinant single-cycle influenza virus with exchangeable pseudotypes allows repeated immunization to augment anti-tumour immunity with immune checkpoint inhibitors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831609/
51999,Prospects of HA-Based Universal Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345066/
52000,On the Centenary of the Spanish Flu: Being Prepared for the Next Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335225/
52001,College students’ influenza vaccine hesitation: a reasoned action investigation with quantitative and qualitative data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005020/
52002,"Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831770/
52003,Alpha-C-Galactosylceramide as an Adjuvant for a Live Attenuated Influenza Virus Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818010/
52004,Electronically Delivered Nudges to Increase Influenza Vaccination Uptake in Older Adults With Diabetes: A Secondary Analysis of the NUDGE-FLU Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10733794/
52005,OVX836 a recombinant nucleoprotein vaccine inducing cellular responses and protective efficacy against multiple influenza A subtypes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344521/
52006,Cost-Effectiveness of the Use of Adjuvanted Quadrivalent Seasonal Influenza Vaccine in Older Adults in Ireland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221880/
52007,"Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824129/
52008,Analysis of Attitudes and Practices towards the Influenza Vaccine in High-Risk Adults in Poland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10975961/
52009,Simulating influenza epidemics with waning vaccine immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428734/
52010,"Influenza A Virus in Swine: Epidemiology, Challenges and Vaccination Strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536279/
52011,Acceptance of COVID-19 and Influenza Vaccine Co-Administration: Insights from a Representative Italian Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878648/
52012,Relative Effectiveness of MF59 Adjuvanted Trivalent Influenza Vaccine vs Nonadjuvanted Vaccines During the 2019–2020 Influenza Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045943/
52013,Combating Human Viral Diseases: Will Plant-Based Vaccines Be the Answer?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310141/
52014,"The impact of clinical risk conditions on influenza and pneumonia diagnoses in England: a nationally representative retrospective cohort study, 2010–2019",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171903/
52015,Reasons for the low influenza vaccination rate among nurses in Slovenia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576542/
52016,Parents’ Intentions to Vaccinate Their Children Against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245313/
52017,Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807328/
52018,Adjuvant solution for pandemic influenza vaccine production,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491477/
52019,African Green Monkeys Recapitulate the Clinical Experience with Replication of Live Attenuated Pandemic Influenza Virus Vaccine Candidates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097805/
52020,Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012–2013,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725387/
52021,Structural basis of influenza virus neutralization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062959/
52022,“PErCEIVE in Umbria”: evaluation of anti-influenza vaccination’s perception among Umbrian pharmacists,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009065/
52023,"Heterologous Prime-Boost Vaccination Using an AS03B-Adjuvanted
Influenza A(H5N1) Vaccine in Infants and Children <3 Years of Age",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224137/
52024,100 Years of Medical Countermeasures and Pandemic Influenza Preparedness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187768/
52025,Immunogenicity of Novel Consensus-based DNA Vaccines Against Avian Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477802/
52026,Examining the direct and indirect effects of trust in motivating COVID-19 vaccine uptake,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840822/
52027,Parental vaccine hesitancy and acceptance of seasonal influenza vaccine in the pediatric emergency department,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864559/
52028,Development of an Enhanced High-Yield Influenza Vaccine Backbone in Embryonated Chicken Eggs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459923/
52029,"Comparative Study of the Temperature Sensitive, Cold Adapted and Attenuated Mutations Present in the Master Donor Viruses of the Two Commercial Human Live Attenuated Influenza Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832241/
52030,Assessing the Immunomodulatory Effect of Size on the Uptake and Immunogenicity of Influenza- and Hepatitis B Subunit Vaccines In Vitro,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321264/
52031,Attitudes and Knowledge of European Medical Students and Early Graduates about Vaccination and Self-Reported Vaccination Coverage—Multinational Cross-Sectional Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036942/
52032,Hemagglutination inhibiting antibody persistence 1 year after influenza vaccination in Korean children and adolescents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404370/
52033,The Adenylyl Cyclase Activator Forskolin Increases Influenza Virus Propagation in MDCK Cells by Regulating ERK1/2 Activity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10772552/
52034,"Interim Estimates of 2016–17 Seasonal Influenza Vaccine Effectiveness — United States, February 2017",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657861/
52035,Influenza A Virus Infection in Pigs Attracts Multifunctional and Cross-Reactive T Cells to the Lung,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044846/
52036,"Vaccinating in the Emergency Department, a Novel Approach to Improve Influenza Vaccination Rates via a Quality Improvement Initiative",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351463/
52037,Immunological persistence of a seasonal influenza vaccine in people more than 3 years old,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514239/
52038,"Influenza Activity — United States, 2014–15 Season and Composition of the 2015–16 Influenza Vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584770/
52039,COVID-19 Vaccines in Older Adults: Challenges in Vaccine Development and Policy Making,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934735/
52040,“You need to be an advocate for yourself”: Factors associated with decision-making regarding influenza and pneumococcal vaccine use among US older adults from within a large metropolitan health system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287320/
52041,"Cost-Effectiveness of Influenza Vaccination Strategies in Adults: Older Adults Aged ≥65 Years, Adults Aged 50–64 Years, and At-Risk Adults Aged 19–64 Years",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955502/
52042,"Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012–2013",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051447/
52043,Use of High-Dose Influenza and Live Attenuated Influenza Vaccines by US Primary Care Physicians,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298749/
52044,Surveillance of Vaccination Coverage of Inactivated Influenza Vaccines and Allergic Rash Adverse Events Following Immunization for Children From 6 Manufacturers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293511/
52045,Induction of Cross-Reactive and Protective Antibody Responses After DNA Vaccination With MHCII-Targeted Stem Domain From Influenza Hemagglutinin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112135/
52046,Capacity Building for Vaccine Manufacturing Across Developing Countries: The Way Forward,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986212/
52047,"Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215410/
52048,"Influenza Vaccination Coverage Among School Employees: Assessing Knowledge, Attitudes, and Behaviors",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532263/
52049,Exposure to quadrivalent influenza vaccine during pregnancy: Results from a global pregnancy registry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692812/
52050,Influenza Vaccine Uptake in Italy—The 2022–2023 Seasonal Influenza Vaccination Campaign in Italy: An Update from the OBVIOUS Project,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10974551/
52051,Immunogenicity and Safety of the Influenza A/H1N1 2009 Inactivated Split-Virus Vaccine in Young and Older Adults: MF59-Adjuvanted Vaccine versus Nonadjuvanted Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3147346/
52052,"Acceptability, cost-effectiveness, and capacity of a facility-based seasonal influenza vaccination among high-risk groups: a study protocol in selected tertiary care hospitals of Bangladesh",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10800039/
52053,Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504432/
52054,Optimizing the Live Attenuated Influenza A Vaccine Backbone for High-Risk Patient Groups,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599596/
52055,Increasing influenza vaccination coverage in healthcare workers: analysis of an intensified on-site vaccination campaign during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972307/
52056,Influenza Vaccine Effectiveness and Disease Burden in Children and Adolescents with Sickle Cell Disease: 2012–2017,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221251/
52057,Talking about colds and flu: The lay diagnosis of two common illnesses among older British people,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116948/
52058,Acute disseminated encephalomyelitis with severe neurological outcomes following virosomal seasonal influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186031/
52059,TLR5-Mediated Sensing of Gut Microbiota Is Necessary for Antibody Responses to Seasonal Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169736/
52060,Factors associated with influenza vaccination failure and severe disease in a French region in 2015,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903663/
52061,Influenza A Virus Antibodies with Antibody-Dependent Cellular Cytotoxicity Function,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150983/
52062,Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001348/
52063,Feasibility of Text Message Influenza Vaccine Safety Monitoring During Pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675451/
52064,Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595494/
52065,Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427213/
52066,Antibody Responsiveness to Influenza: What Drives It?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310379/
52067,"Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711822/
52068,PLoS One. 2016; 11(6): e0157211. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900605/
52069,Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018–2019 Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325528/
52070,All-in-One Bacmids: an Efficient Reverse Genetics Strategy for Influenza A Virus Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136356/
52071,"Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712942/
52072,"Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778105/
52073,A shortened interval between vaccinations with the trivalent inactivated influenza vaccine increases responsiveness in the aged,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712333/
52074,Aluminum salts as an adjuvant for pre-pandemic influenza vaccines: a meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065440/
52075,Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466292/
52076,Recent Advances in the Use of Plant Virus-Like Particles as Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150928/
52077,Immunogenicity of Enhanced Influenza Vaccines Against Mismatched Influenza Strains in Older Adults: A Review of Randomized Controlled Trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11004266/
52078,Estimating the impact of influenza vaccination of low-risk 50–64-year-olds on acute and ICU hospital bed usage in an influenza season under endemic COVID-19 in the UK,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054290/
52079,Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people living with HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696686/
52080,Factors associated with vaccine intention in adults living in England who either did not want or had not yet decided to be vaccinated against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903974/
52081,Influenza virus hemagglutinin stalk-based antibodies and vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804342/
52082,Comparative Study of Influenza Virus Replication in MDCK Cells and in Primary Cells Derived from Adenoids and Airway Epithelium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486302/
52083,2011–12 Seasonal Influenza Vaccines Effectiveness against Confirmed A(H3N2) Influenza Hospitalisation: Pooled Analysis from a European Network of Hospitals. A Pilot Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614550/
52084,Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665503/
52085,"Comparative Immunogenicity of Several Enhanced Influenza Vaccine Options for Older Adults: A Randomized, Controlled Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289658/
52086,Social Media as an Effective Provider of Quality-Assured and Accurate Information to Increase Vaccine Rates: Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10777282/
52087,A Retrospective Test-Negative Case-Control Study to Evaluate Influenza Vaccine Effectiveness in Preventing Hospitalizations in Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599178/
52088,Parental Perception Towards Flu Vaccination for Asthmatic Children in Saudi Arabia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979311/
52089,Application of Traditional Vaccine Development Strategies to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134813/
52090,Influenza and pertussis vaccination in pregnancy: Portrayal in online media articles and perceptions of pregnant women and healthcare professionals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263273/
52091,Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta‐analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986623/
52092,Immunogenicity and Safety of Reduced-Dose Intradermal vs Intramuscular Influenza Vaccines: A Systematic Review and Meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873776/
52093,Determinants of influenza vaccination among a large adult population in Quebec,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314416/
52094,"Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893548/
52095,A Functional Food Mixture “Protector” Reinforces the Protective Immune Parameters against Viral Flu Infection in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024812/
52096,Zoonotic Potential of Influenza A Viruses: A Comprehensive Overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165440/
52097,"Socialization, Indifference, and Convenience: Exploring the Uptake of Influenza Vaccine Among Medical Students and Early Career Doctors",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669255/
52098,Should the vaccine injury compensation program be expanded to cover adults?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1308674/
52099,Summary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1308674/
52100,Prostaglandin D2 Receptor DP1 Antibodies Predict Vaccine-induced and Spontaneous Narcolepsy Type 1: Large-scale Study of Antibody Profiling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925455/
52101,"Attitudes toward COVID-19 and Other Vaccines: Comparing Parents to Other Adults, September 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10748314/
52102,A meta-analysis of influenza vaccination following correspondence: Considerations for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592234/
52103,A Perfect Storm: Increased Colonization and Failure of Vaccination Leads to Severe Secondary Bacterial Infection in Influenza Virus-Infected Obese Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605935/
52104,Emerging Role of Mucosal Vaccine in Preventing Infection with Avian Influenza A Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472103/
52105,Influenza infection and heart failure—vaccination may change heart failure prognosis?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438419/
52106,Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607041/
52107,Exploring determinants of acceptance of the pandemic influenza A (H1N1) 2009 vaccination in nurses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115264/
52108,A comparative analysis on serious adverse events reported for COVID-19 vaccines in adolescents and young adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291619/
52109,The Effects of Imprinting and Repeated Seasonal Influenza Vaccination on Adaptive Immunity after Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712189/
52110,"Fever After Influenza, Diphtheria-Tetanus-Acellular Pertussis, and
Pneumococcal Vaccinations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055925/
52111,Acceptability of the COVID-19 Vaccine and Its Determinants among University Students in Saudi Arabia: A Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473185/
52112,Moderate Vaccine Effectiveness against Severe Acute Respiratory Infection Caused by A(H1N1)pdm09 Influenza Virus and No Effectiveness against A(H3N2) Influenza Virus in the 2018/2019 Season in Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564262/
52113,Molecular signatures of antibody responses derived from a systems biological study of 5 human vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946932/
52114,"How Media Literacy, Trust of Experts and Flu Vaccine Behaviors
Associated with COVID-19 Vaccine Intentions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551663/
52115,"Trends in Nonparenteral Delivery of Biologics, Vaccines and Cancer Therapies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150203/
52116,Relative Vaccine Effectiveness of Cell- vs Egg-Based Quadrivalent Influenza Vaccine Against Test-Confirmed Influenza Over 3 Seasons Between 2017 and 2020 in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11064727/
52117,Vaccination mitigates influenza-induced muscular declines in aged mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732952/
52118,Vital Signs: Burden and Prevention of Influenza and Pertussis Among Pregnant Women and Infants — United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788399/
52119,"A Reassortment-Incompetent Live Attenuated Influenza Virus Vaccine for Protection against Pandemic Virus Strains
",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126605/
52120,Frequency and Associations of Adverse Reactions of COVID-19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850379/
52121,Virus-Like Particle Vaccine Containing Hemagglutinin Confers Protection against 2009 H1N1 Pandemic Influenza ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232700/
52122,Distinct Cross-reactive B-Cell Responses to Live Attenuated and Inactivated Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200073/
52123,Influenza vaccination in children being treated with chemotherapy for cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466690/
52124,Co-Delivery of M2e Virus-Like Particles with Influenza Split Vaccine to the Skin Using Microneedles Enhances the Efficacy of Cross Protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523215/
52125,Influenza vaccine intention after a medically-attended acute respiratory infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389426/
52126,Haemagglutinin displayed on the surface of Lactococcus lactis confers broad cross-clade protection against different H5N1 viruses in chickens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557258/
52127,"Variation in influenza vaccine assessment, receipt, and refusal by the concentration of Medicare Advantage enrollees in U.S. nursing homes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917469/
52128,Incidence and neutralizing antibody seroprevalence of influenza B virus in Egypt: Results of a community-based cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242516/
52129,Intention to Receive COVID-19 Vaccine by U.S. Health Sciences University Employees,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358575/
52130,Immunogenicity and safety of different dosing schedules of trivalent inactivated influenza vaccine in pregnant women with HIV: a randomised controlled trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167514/
52131,A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396251/
52132,What can we learn about influenza infection and vaccination from transcriptomics?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930070/
52133,"Vaccination uptake among Australian early childhood education staff: assessing perceptions, behaviours and workplace practices",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744694/
52134,OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512027/
52135,The Application and Outcome Evaluation of a Social Marketing Intervention to Increase Seasonal Influenza Vaccination among University Students,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607588/
52136,Brand-specific enhanced safety surveillance of GSK’s Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482908/
52137,Substantial effect of phytochemical constituents against the pandemic disease influenza—a review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196934/
52138,Association between provider recommendation and influenza vaccination status among children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6432907/
52139,Computationally optimized broadly reactive vaccine based upon swine H1N1 influenza hemagglutinin sequences protects against both swine and human isolated viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773400/
52140,A vaccine manufacturer’s approach to address medical needs related to seasonal and pandemic influenza viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710798/
52141,"COVID-19 Vaccine Intent Among Health Care Professionals of Queen Elizabeth Hospital, Barbados",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643144/
52142,Comparison of local influenza vaccine effectiveness using two methods,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825890/
52143,"Effects of Vaccination Against Influenza, Pertussis, and COVID-19 on Human Milk Antibodies: Current Evidence and Implications for Health Equity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314549/
52144,"Prevention and Control of Influenza with Vaccines: Interim Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605018/
52145,Vaccine package inserts and prescribing habits of obstetricians-gynecologists for maternal vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437486/
52146,Influenza immunization during pregnancy: Benefits for mother and infant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215408/
52147,2009 H1N1 and Seasonal Influenza Immunization Among Pregnant Women: A Comparison of Different Sources of Immunization Information,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883912/
52148,Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I–II clinical trials),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634119/
52149,"Cost-Effectiveness of Vaccination of Older Adults with an MF59®-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145635/
52150,Relative Effectiveness of the Cell-derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-related Medical Encounters During the 2018–2019 Influenza Season in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326580/
52151,Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126854/
52152,Examples of Outcome Reporting Bias in Vaccine Studies: Illustrating How Perpetuating Medical Consensus Can Impede Progress in Public Health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585808/
52153,Safety and Efficacy of Spray Intranasal Live Attenuated Influenza Vaccine: Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472940/
52154,Healthcare staff perceptions towards influenza and potential COVID-19 vaccination in the 2020 pandemic context,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973053/
52155,Influenza Hemagglutinin Structures and Antibody Recognition,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397844/
52156,An Adjuvanted A(H5N1) Subvirion Vaccine Elicits Virus-Specific Antibody Response and Improves Protection Against Lethal Influenza Viral Challenge in Mouse Model of Protein Energy Malnutrition,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737928/
52157,Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746500/
52158,Inflammatory Reactivity to the Influenza Vaccine is Associated with Changes in Automatic Social Behavior,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041378/
52159,"Comparison of Human H3N2 Antibody Responses Elicited by Egg-Based, Cell-Based, and Recombinant Protein–Based Influenza Vaccines During the 2017–2018 Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486837/
52160,A rapid evidence appraisal of influenza vaccination in health workers: An important policy in an area of imperfect evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668237/
52161,"A Descriptive Study of Maternal Vaccination Uptake, Attitudes, and Beliefs in Pregnancy Among Persons Delivering at an Urban Safety Net Hospital",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285378/
52162,Modelling the impact of universal influenza vaccines on seasonal influenza with different subtypes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697312/
52163,Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine in US Children 6–35 Months of Age During 2013–2014: Results From A Phase II Randomized Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407130/
52164,Divergent evolutionary trajectories of influenza B viruses underlie their contemporaneous epidemic activity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955377/
52165,"Assessing parents’ knowledge and attitudes towards seasonal influenza vaccination of children before and after a seasonal influenza vaccination effectiveness study in low-income urban and rural Kenya, 2010–2011",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639236/
52166,Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527143/
52167,Seasonal influenza vaccine uptake and vaccine refusal among pregnant women in France: results from a national survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227616/
52168,Antigenic Distance between North American Swine and Human Seasonal H3N2 Influenza A Viruses as an Indication of Zoonotic Risk to Humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791259/
52169,Drop the Needle; A Temperature Stable Oral Tablet Vaccine Is Protective against Respiratory Viral Pathogens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031097/
52170,"Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401346/
52171,The metabolic hormone leptin promotes the function of TFH cells and supports vaccine responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144586/
52172,Converting the maybes: Crucial for a successful COVID-19 vaccination strategy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817004/
52173,Multi-Dimensional Measurement of Antibody-Mediated Heterosubtypic Immunity to Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478018/
52174,SARS-CoV-2 and influenza co-infection: A cross-sectional study in central Missouri during the 2021–2022 influenza season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523501/
52175,Optimal Dosing and Dynamic Distribution of Vaccines in an Influenza Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691801/
52176,"Knowledge, attitudes and anxiety towards influenza A/H1N1 vaccination of healthcare workers in Turkey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161359/
52177,Measurement of Vaccine Direct Effects Under the Test-Negative Design,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269249/
52178,Is flu vaccination opt-out feasible? Evidence from vaccination programme implementers and managers in the English National Health Service,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254052/
52179,"Delays and declines in seasonal influenza vaccinations due to Hurricane Harvey narrow annual gaps in vaccination by race, income and rurality",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753087/
52180,Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574595/
52181,Influenza Vaccination for Immunocompromised Patients: Systematic Review and Meta-Analysis from a Public Health Policy Perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245259/
52182,Ad Hoc Influenza Vaccination During Years of Significant Antigenic Drift in a Tropical City With 2 Seasonal Peaks: A Cross-Sectional Survey Among Health Care Practitioners,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902475/
52183,Vaccine-induced ICOS+CD38+ circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathways,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149371/
52184,Role of Extracellular Vesicles in Influenza Virus Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396637/
52185,Social media use and influenza vaccine uptake among White and African American adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655625/
52186,Influenza vaccination 2014–2015: Results of a survey conducted among general practitioners in Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037480/
52187,Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864274/
52188,Maternal uptake of pertussis cocooning strategy and other pregnancy related recommended immunizations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514360/
52189,Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829898/
52190,Influenza vaccination and healthcare workers: barriers and predisposing factors. A literature review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138807/
52191,"Analysis of the adverse events following immunization with inactivated quadrivalent influenza vaccine from 2018 to 2020 in Zhejiang province, with a comparison to trivalent influenza vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828122/
52192,Factors Associated With US Adults’ Likelihood of Accepting COVID-19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576409/
52193,JAMA Netw Open. 2020 Nov; 3(11): e2030649. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684447/
52194,Low coverage of influenza vaccination among Chinese children aged 12-23 months: Prevalence and associated factors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179290/
52195,"Trends in seasonal influenza vaccine coverage of target groups in France, 2006/07 to 2015/16: Impact of recommendations and 2009 influenza A(H1N1) pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280418/
52196,Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161866/
52197,Effectiveness of MF59™ Adjuvanted Influenza A(H1N1)pdm09 Vaccine in Risk Groups in the Netherlands,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640023/
52198,"Racial/Ethnic Disparities in Maternal Vaccine Knowledge, Attitudes, and Intentions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579395/
52199,Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677760/
52200,Cross-Neutralization of 1918 and 2009 Influenza Viruses: Role of Glycans in Viral Evolution and Vaccine Design,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182573/
52201,COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922043/
52202,"Frequency and cost of live vaccines administered too soon after prior live vaccine in children aged 12 months through 6 years, 2014–2017",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815661/
52203,Molecular characterization of influenza A(H1N1)pdm09 in Cameroon during the 2014-2016 influenza seasons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331099/
52204,Postmarketing observational study on the safety of 2021/2022 and 2022/2023 influenza vaccination campaigns in Italy: TheShinISS-Vax|Flu study protocol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407352/
52205,Differential Influence of Age on the Relationship between Genetic Mismatch and A(H1N1)pdm09 Vaccine Effectiveness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065480/
52206,The intranasal adjuvant Endocine™ enhances both systemic and mucosal immune responses in aged mice immunized with influenza antigen,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335733/
52207,Structural inequities in seasonal influenza vaccination rates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210739/
52208,"Responses to A(H1N1)pdm09 Influenza Vaccines in Participants Previously Vaccinated With Seasonal Influenza Vaccine: A Randomized, Observer-Blind, Controlled Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195439/
52209,Experimental PCEP-Adjuvanted Swine Influenza H1N1 Vaccine Induced Strong Immune Responses but Did Not Protect Piglets against Heterologous H3N2 Virus Challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349969/
52210,Influenza H5 Hemagglutinin DNA Primes the Antibody Response Elicited by the Live Attenuated Influenza A/Vietnam/1203/2004 Vaccine in Ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132217/
52211,Influenza vaccination and the risk of COVID-19 infection and severe illness in older adults in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155195/
52212,"Identification and Characterization of Swine Influenza Virus H1N1 Variants Generated in Vaccinated and Nonvaccinated, Challenged Pigs",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539973/
52213,"Oral immunization with a novel attenuated Salmonella Typhimurium encoding influenza HA, M2e and NA antigens protects chickens against H7N9 infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796500/
52214,Influenza Vaccination Coverage Among English-Speaking Asian Americans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402803/
52215,Epigraph hemagglutinin vaccine induces broad cross-reactive immunity against swine H3 influenza virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900167/
52216,"Role of Age in the Spread of Influenza, 2011–2019: Data From the US Influenza Vaccine Effectiveness Network",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004732/
52217,Adjuvant is necessary for a robust immune response to a single dose of H1N1 pandemic flu vaccine in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762756/
52218,Yearly licensing studies from 1997 to 2007 of the inactivated whole virus seasonal influenza vaccine fluval – a useful approach to pandemic vaccine development even in less well developed countries?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634116/
52219,"Trajectories of seasonal influenza vaccine uptake among French people with diabetes: a nationwide retrospective cohort study, 2006–2015",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617633/
52220,Structure of an Influenza Group 2-Neutralizing Antibody Targeting the Hemagglutinin Stem Supersite,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271601/
52221,"Dose effect of influenza vaccine on protection against laboratory-confirmed influenza illness among children aged 6 months to 8 years of age in southern China, 2013/14–2015/16 seasons: a matched case–control study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227664/
52222,Influenza vaccine induced human bone marrow plasma cells decline within a year after vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155619/
52223,Microneedle-based vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904604/
52224,Attitudes toward influenza vaccination in healthcare workers in Italy: A systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586073/
52225,Advanced drug delivery systems can assist in managing influenza virus infection: A hypothesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515600/
52226,Intramuscular immunization with a vesicular stomatitis virus recombinant expressing the influenza hemagglutinin provides post-exposure protection against lethal influenza challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787752/
52227,The level and determinants of COVID-19 vaccine acceptance in Ghana,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9269973/
52228,Prophylactic and Therapeutic Efficacy of Avian Antibodies Against Influenza Virus H5N1 and H1N1 in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854139/
52229,"Pandemic influenza preparedness (PIP) framework: Progress challenges in improving influenza preparedness response capacities in the Eastern Mediterranean Region, 2014–2017",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102835/
52230,"Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151402/
52231,In Vivo Imaging of Influenza Virus Infection in Immunized Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449660/
52232,The Influence of the COVID-19 Pandemic on Seasonal Influenza Vaccine Uptake Among Patients Visiting a University Hospital in Saudi Arabia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643639/
52233,Optimizing the impact of low-efficacy influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960327/
52234,Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787645/
52235,Prioritising access to pandemic influenza vaccine: a review of the ethics literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224123/
52236,Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189493/
52237,Targeting B cell responses in universal influenza vaccine design,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212832/
52238,Innovative vaccine platforms against infectious diseases: Under the scope of the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527590/
52239,"Clinical characteristics, risk factors and antiviral treatments of influenza in immunosuppressed inpatients in Beijing during the 2015–2020 influenza seasons",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760682/
52240,Immunosenescence and Influenza Vaccine Efficacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121450/
52241,The Possible Impact of Vaccination for Seasonal Influenza on Emergence of Pandemic Influenza via Reassortment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262424/
52242,Protective Immunity Based on the Conserved Hemagglutinin Stalk Domain and Its Prospects for Universal Influenza Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055638/
52243,The Association Between Previous Influenza Vaccination and COVID-19 Infection Risk and Severity: A Systematic Review and Meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920881/
52244,Am J Prev Med. 2022 Nov; 63(5): 874. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579269/
52245,"Effect of Influenza Vaccination on Rate of Influenza Virus Infection in Chinese Military Personnel, 2015–2016: A Cluster Randomized Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534408/
52246,Why are influenza vaccination coverage rates still too low among health care workers in a tertiary care children’s hospital in Turkey?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726293/
52247,Vaccines’ New Era-RNA Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458896/
52248,Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840921/
52249,COVID-19 vaccine hesitancy among healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098031/
52250,"Factors underlying COVID-19 vaccine and booster hesitancy and refusal, and incentivizing vaccine adoption",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498968/
52251,Addressing Parental Vaccine Hesitancy towards Childhood Vaccines in the United States: A Systematic Literature Review of Communication Interventions and Strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712553/
52252,Progress in the development of virus-like particle vaccines against respiratory viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103727/
52253,Setting up a platform for plant-based influenza virus vaccine production in South Africa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358240/
52254,"Circulation and characterization of seasonal influenza viruses in Cambodia, 2012‐2015",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692578/
52255,Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292388/
52256,Chronic psychosocial stress: does it modulate immunity to the influenza vaccine in Hong Kong Chinese elderly caregivers?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705094/
52257,Feasibility of a cluster-randomized influenza vaccination trial in U.S. nursing homes: Lessons learned,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861801/
52258,Mitigating effects of vaccination on influenza outbreaks given constraints in stockpile size and daily administration capacity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162903/
52259,Neuraminidase-Inhibiting Antibody Is a Correlate of Cross-Protection against Lethal H5N1 Influenza Virus in Ferrets Immunized with Seasonal Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3592172/
52260,Strategies for Pandemic and Seasonal Influenza Vaccination of Schoolchildren in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737588/
52261,Evaluation of Pre-Pandemic Trivalent COBRA HA Vaccine in Mice Pre-Immune to Historical H1N1 and H3N2 Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861495/
52262,An mRNA-based broad-spectrum vaccine candidate confers cross-protection against heterosubtypic influenza A viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512870/
52263,Stakeholders’ perceptions of 10 years of the Global Action Plan for Influenza Vaccines (GAP) – Results from a survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357767/
52264,Persistence of vaccine-induced antibodies to A/H5N1 at 30 months and 36 months after vaccination in Vietnam,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854785/
52265,Results of Influenza Vaccination: Short Follow-Up Study of a Turkish Population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491554/
52266,A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179143/
52267,Vaccine Coverage against Influenza and SARS-CoV-2 in Health Sciences Students during COVID-19 Pandemic in Spain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875301/
52268,What Affected Primary Care Patients’ Decisions to Receive the Seasonal Influenza Vaccine in the 2020 to 2021 Season?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841909/
52269,Nebulized Live-Attenuated Influenza Vaccine Provides Protection in Ferrets at a Reduced Dose,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292676/
52270,"Adverse events of interest following influenza vaccination, a comparison of cell culture-based with egg-based alternatives: English sentinel network annual report paper 2019/20",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454842/
52271,Immunobiology of Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619640/
52272,Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800816/
52273,Influenza vaccination in north Indian patients with heart failure,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319129/
52274,Preparing for the availability of a partially effective HIV vaccine: Some lessons from other licensed vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578794/
52275,"Immunogenicity and safety of Southern Hemisphere inactivated quadrivalent influenza vaccine: a Phase III, open-label study of adults in Brazil",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425532/
52276,Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021235/
52277,Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: A cross-sectional survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834255/
52278,Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486343/
52279,Influenza vaccination in the elderly boosts antibodies against conserved viral proteins and egg-produced glycans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245176/
52280,Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488283/
52281,"Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845585/
52282,Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623926/
52283,Decreased vaccine protection of egg-based influenza vaccine in the elderly and nonhemagglutinin-focused immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321562/
52284,Interventions to Increase the Rate of Influenza and Pneumococcal Vaccination in Patients with Chronic Obstructive Pulmonary Disease: A Scoping Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631363/
52285,"Influenza Vaccination during Pregnancy: A Descriptive Study of the Knowledge, Beliefs, and Practices of Mexican Gynecologists and Family Physicians",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459716/
52286,Baseline Serum Vitamin A and D Levels Determine Benefit of Oral Vitamin A&D Supplements to Humoral Immune Responses Following Pediatric Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832482/
52287,Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768360/
52288,Perspectives in the Development of Tools to Assess Vaccine Literacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11054371/
52289,Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming Effect,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699006/
52290,Sustained low influenza vaccination in health care workers after H1N1 pandemic: a cross sectional study in an Italian health care setting for at-risk patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533948/
52291,"Vaccinating healthcare workers: Level of implementation, barriers and proposal for evidence-based policies in Turkey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443379/
52292,A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430863/
52293,Sci Rep. 2019; 9: 14730. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783480/
52294,Mucosal immunization in perspective: Pediatric influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370357/
52295,"A phase II study of an investigational tetravalent influenza vaccine formulation combining MF59®: Adjuvanted, pre-pandemic, A/H5N1 vaccine and trivalent seasonal influenza vaccine in healthy adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181038/
52296,"Recommendations for Mandatory Influenza Vaccinations for Health Care Personnel from Infection Advisory Subcommittee of AMDA, the Society for Post-Acute Long-Term Care Medicine.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996022/
52297,"Knowledge, attitude, and barriers of seasonal influenza vaccination among pregnant women visiting primary healthcare centers in Al-Ahsa, Saudi Arabia. 2019/2020",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138387/
52298,Modelling the Economic Impact of lnfluenza Vaccine Programs with the Cell-Based Quadrivalent Influenza Vaccine and Adjuvanted Trivalent Influenza Vaccine in Canada,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412987/
52299,Activated CD4+ T cells and CD14hiCD16+ monocytes correlate with antibody response following influenza virus infection in humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080109/
52300,"Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433505/
52301,Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439264/
52302,CD4 T cell epitope abundance in ferritin core potentiates responses to hemagglutinin nanoparticle vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605951/
52303,"Influenza vaccination of healthcare personnel by work setting and occupation--United States, 2014",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831180/
52304,"Knowledge, Attitude, and Practice towards Influenza Vaccination among Older Adults in Southern China during the COVID-19 Pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384555/
52305,Prevalence and correlates of COVID-19 vaccine hesitancy among the elderly in Qatar: A cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239589/
52306,Low immunogenicity of seasonal trivalent influenza vaccine among patients receiving docetaxel for a solid tumour: results of a prospective pilot study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111157/
52307,Seasonal influenza vaccination coverage and its determinants among nursing homes personnel in western France,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501011/
52308,"Flu Shots Unveiled: A Global Systematic Review of Healthcare Providers’ Uptake of, Perceptions, and Attitudes toward Influenza Vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10747442/
52309,The immune response to influenza in older humans: beyond immune senescence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204009/
52310,Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847555/
52311,Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096819/
52312,Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031700/
52313,A Predictive Model of the Economic Effects of an Influenza Vaccine Adjuvant for the Older Adult (Age 65 and Over) Population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954894/
52314,Vaccine confidence among people who use drugs: A cross-sectional survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746418/
52315,"Recombinant protein vaccines, a proven approach against coronavirus pandemics",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788321/
52316,"Knowledge, utilization and barriers of pregnant women to influenza vaccine in primary health care centers in Dammam and Al Khobar, Saudi Arabia, 2017–2018",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440453/
52317,Lessons learned from 2 years of influenza vaccinations in the UK and USA during the COVID-19 pandemic as respiratory viruses return,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746353/
52318,Seasonal and Pandemic A (H1N1) 2009 influenza vaccination coverage and attitudes among health-care workers in a Spanish University Hospital,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115598/
52319,Trends in influenza coverage rates in five consecutive immunisation seasons in the Local Health Unit of Ferrara (North Italy),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639119/
52320,"Trends in influenza and pneumococcal vaccination among U.S. nursing home residents, 2006–2014",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751715/
52321,Exploring barriers to influenza vaccine uptake and recommendation among healthcare providers in the community in China: A qualitative study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11095569/
52322,Randomized Comparative Study of the Serum Antihemagglutinin and Antineuraminidase Antibody Responses to Six Licensed Trivalent Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520601/
52323,"Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911998/
52324,Assessment of trivalent live influenza vaccines in MDCK cell line,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374651/
52325,MethodsX. 2021; 8: 101526. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563684/
52326,Mannan adjuvants intranasally administered inactivated influenza virus in mice rendering low doses inductive of strong serum IgG and IgA in the lung,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350615/
52327,"Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India - A phase III, active-controlled, randomized clinical study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920161/
52328,Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449847/
52329,Centralized Reminder/Recall to Increase Influenza Vaccination Rates: A Two-State Pragmatic Randomized Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477488/
52330,"mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166207/
52331,Attitudes and barriers associated with seasonal influenza vaccination uptake among public health students; a cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148773/
52332,Association between influenza vaccination and SARS-CoV-2 infection and its outcomes: systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771237/
52333,Both haemagglutinin-specific antibody and T cell responses induced by a chimpanzee adenoviral vaccine confer protection against influenza H7N9 viral challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431854/
52334,Distinct Patterns of B-Cell Activation and Priming by Natural Influenza Virus Infection Versus Inactivated Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366605/
52335,Protecting pregnant people & infants against influenza: A landscape review of influenza vaccine hesitancy during pregnancy and strategies for vaccine promotion,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019833/
52336,Investigation of CD4 and CD8 T cell-mediated protection against influenza A virus in a cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301821/
52337,Comparison of the Seasonal Influenza Vaccination amidst the 2020 COVID-19 Pandemic within Six Regional Community Pharmacies of a Large Pharmacy Chain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815869/
52338,"Knowledge, Attitudes and Perception toward COVID-19 Vaccines among Adults in Jazan Province, Saudi Arabia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618661/
52339,"A Comprehensive Review of the Global Efforts on COVID-19 Vaccine
Development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029445/
52340,Enhancing vaccine effectiveness in the elderly to counter antibiotic resistance: The potential of adjuvants via pattern recognition receptors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10913723/
52341,Predicting Antigenic Variants of Influenza A/H3N2 Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320420/
52342,T-cell responses following Natural Influenza Infection or Vaccination in Solid Organ Transplant Recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308384/
52343,Efficacy of the Influenza Vaccine in Patients with Malignant Lymphoma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1288406/
52344,Comparison of a Live Attenuated 2009 H1N1 Vaccine with Seasonal Influenza Vaccines against 2009 Pandemic H1N1 Virus Infection in Mice and Ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068036/
52345,Epidemiological Studies to Support the Development of Next Generation Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027373/
52346,The potency of newly development H5N8 and H9N2 avian influenza vaccines against the isolated strains in laying hens from Egypt during 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381005/
52347,Seasonal Influenza Vaccine Intention among Nurses Who Have Been Fully Vaccinated against COVID-19: Evidence from Greece,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867012/
52348,"Vaccine Hesitancy: COVID-19 and Influenza Vaccine Willingness among Parents in Wuxi, China—A Cross-Sectional Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066309/
52349,2009 H1N1 Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800287/
52350,Natural Killer Cells Dampen the Pathogenic Features of Recall Responses to Influenza Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019041/
52351,Influenza vaccines may protect against cardiovascular diseases: The evidence is mounting and should be known by the Canadian public health community,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10936748/
52352,Evaluation of a vectored equine herpesvirus type 1 (EHV-1) vaccine expressing H3 haemagglutinin in the protection of dogs against canine influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430215/
52353,"Individual, cultural and structural predictors of vaccine safety confidence and influenza vaccination among Hispanic female subgroups",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5097889/
52354,"Nanoparticles Carrying Conserved Regions of Influenza A Hemagglutinin, Nucleoprotein, and M2 Protein Elicit a Strong Humoral and T Cell Immune Response and Protect Animals from Infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537994/
52355,An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100302/
52356,"Immunogenicity of influenza vaccine in elderly people: a systematic review and meta-analysis of randomized controlled trials, and its association with real-world effectiveness",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746244/
52357,Response of Sport Horses to Different Formulations of Equine Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563521/
52358,"Safety and Immunogenicity of a Monovalent 2009 Influenza A/H1N1v Vaccine Adjuvanted With AS03A or Unadjuvanted in HIV-Infected Adults: A Randomized, Controlled Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307156/
52359,Ginsenoside Rb1 enhanced immunity and altered the gut microflora in mice immunized by H1N1 influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588687/
52360,Opposing Effects of Prior Infection versus Prior Vaccination on Vaccine Immunogenicity against Influenza A(H3N2) Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949461/
52361,Immunizing the Immune: Can We Overcome Influenza’s Most Formidable Challenge?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313899/
52362,Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840263/
52363,Evolutionary Dynamics of Whole-Genome Influenza A/H3N2 Viruses Isolated in Myanmar from 2015 to 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699102/
52364,Neutralizing immune responses induced by oligomeric H5N1-hemagglutinins from plants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607582/
52365,A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033969/
52366,Determinants of vaccine hesitancy in Quebec: a large population-based survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930046/
52367,Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848947/
52368,"Molecular influenza surveillance at a tertiary university hospital during four consecutive seasons (2012–2016) in Catalonia, Spain",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173002/
52369,Influenza and Pneumococcal Vaccinations for Patients With Chronic Obstructive Pulmonary Disease (COPD): An Evidence-Based Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384373/
52370,1976 and 2009 H1N1 Influenza Virus Vaccines Boost Anti-Hemagglutinin Stalk Antibodies in Humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523798/
52371,Partial protection against 2009 pandemic influenza A (H1N1) of seasonal influenza vaccination and related regional factors: Updated systematic review and meta-analyses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514212/
52372,Determinants of Willingness of Patients with Type 2 Diabetes Mellitus to Receive the Seasonal Influenza Vaccine in Southeast China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617503/
52373,"H5N2 vaccine viruses on Russian and US live attenuated influenza virus backbones demonstrate similar infectivity, immunogenicity and protection in ferrets",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854182/
52374,Generation of Live Attenuated Influenza Virus by Using Codon Usage Bias,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621104/
52375,Association of COVID-19 Vaccination With Influenza Vaccine History and Changes in Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664264/
52376,Missed Opportunities of Flu Vaccination in Italian Target Categories: Insights from the Online EPICOVID 19 Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712748/
52377,Knowledge and decisions about maternal immunisation by pregnant women in Aotearoa New Zealand,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192336/
52378,"Cooperativity Between CD8+ T Cells, Non-Neutralizing Antibodies, and Alveolar Macrophages Is Important for Heterosubtypic Influenza Virus Immunity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597515/
52379,Topics in Antivax and Provax Discourse: Yearlong Synoptic Study of COVID-19 Vaccine Tweets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411425/
52380,In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10805787/
52381,Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632720/
52382,Interventions to increase influenza vaccination rates of those 60 years and older in the community,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464876/
52383,Cochrane Database Syst Rev. 2018; 2018(5): CD005188. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494593/
52384,"Aging, cytomegalovirus (CMV) and influenza vaccine responses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964725/
52385,M2e-Based Universal Influenza A Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494237/
52386,Development of a novel oil-in-water emulsion and evaluation of its potential adjuvant function in a swine influenza vaccine in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303909/
52387,Cumulative Risk of Guillain–Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025712/
52388,"Influenza vaccination coverage of Vaccine for Children (VFC)-entitled versus privately insured children, United States, 2011–2013",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847713/
52389,"Randomized, Controlled Trial of High-Dose Influenza Vaccine Among Frail Residents of Long-Term Care Facilities",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539906/
52390,Comparative Glycomics Analysis of Influenza Hemagglutinin (H5N1) Produced in Vaccine Relevant Cell Platforms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800089/
52391,A consensus-hemagglutinin-based vaccine delivered by an attenuated Salmonella mutant protects chickens against heterologous H7N1 influenza virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503571/
52392,On field vaccine effectiveness in three periods of 2018/2019 influenza season in Emilia-Romagna Region,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233652/
52393,Influenza surveillance in Western Turkey in the era of quadrivalent vaccines: A 2003–2016 retrospective analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149844/
52394,A novel vaccine strategy to overcome poor immunogenicity of avian influenza vaccines through mobilization of memory CD4 T cells established by seasonal influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737897/
52395,Animal Models for Influenza Research: Strengths and Weaknesses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228315/
52396,"Prevention and Treatment of Influenza, Influenza-Like Illness, and Common Cold by Herbal, Complementary, and Natural Therapies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871211/
52397,Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499175/
52398,Is there any effect of flu vaccine on the SARS-CoV-2 infected patients?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374318/
52399,Next Generation of Computationally Optimized Broadly Reactive HA Vaccines Elicited Cross-Reactive Immune Responses and Provided Protection against H1N1 Virus Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310220/
52400,Racial and Ethnic Disparities in Uptake and Location of Vaccination for 2009-H1N1 and Seasonal Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110237/
52401,"Clinicians Are Not Able to Infer Parental Intentions to Vaccinate Infants with a Seasonal Influenza Vaccine, and Perhaps They Should Not Try: Findings from the Pediatric Influenza Vaccination Optimization Trial (PIVOT)–IV",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697433/
52402,Changes of urine metabolite profiles are induced by inactivated influenza vaccine inoculations in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838172/
52403,Review of prescribing information for influenza vaccines for pregnant and lactating women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218337/
52404,Household Transmission of Influenza A Viruses in 2021-2022,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880862/
52405,Impaired HA-specific T follicular helper cell and antibody responses to influenza vaccination are linked to inflammation in humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562996/
52406,Influenza virus immune imprinting dictates the clinical outcomes in ferrets challenged with highly pathogenic avian influenza virus H5N1,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10759238/
52407,"Seasonal influenza vaccine effectiveness at primary care level, Hong Kong SAR, 2017/2018 winter",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363165/
52408,"Emotional Distress, Targeted Rejection, and Antibody Production Following Influenza Vaccination in Adolescence",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064924/
52409,Influenza vaccines and influenza antiviral drugs in Africa: are they available and do guidelines for their use exist?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898391/
52410,Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432993/
52411,Diversity in the Circulation of Influenza A(H3N2) Viruses in the Northern Hemisphere in the 2018–19 Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069444/
52412,"Changing risk awareness and personal protection measures for low to high pathogenic avian influenza in live-poultry markets in Taiwan, 2007 to 2012",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478710/
52413,Impact of Hospitalization in an Endocrinology Department on Vaccination Coverage in People Living with Diabetes: A Real-Life Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879927/
52414,Vaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109906/
52415,Ethical and policy implications of vaccinomics in the United States: community members’ perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189107/
52416,A Universal Influenza A Vaccine Based on Adenovirus Expressing Matrix-2 Ectodomain and Nucleoprotein Protects Mice From Lethal Challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997593/
52417,Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906390/
52418,A proteomics-based method for identifying antigens within immune complexes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757895/
52419,Functional antibody-dependent cell mediated cytotoxicity (ADCC) responses to vaccine and circulating influenza strains following vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013517/
52420,COVID-19 Vaccination Hesitancy among Healthcare Workers—A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227837/
52421,"Knowledge, attitudes, beliefs and behaviors of general practitioners/family physicians toward their own vaccination: A systematic review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963063/
52422,Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072113/
52423,A prospective cohort study comparing the reactogenicity of trivalent influenza vaccine in pregnant and non-pregnant women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379607/
52424,Protection by universal influenza vaccine is mediated by memory CD4 T cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127355/
52425,Is there any effect of flu vaccine on the SARS-CoV-2 infected patients?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566373/
52426,Attitude for vaccination prophylaxis among pregnant women: a cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067467/
52427,Patients’ Perception and Knowledge about Influenza and Pneumococcal Vaccination during the COVID-19 Pandemic: An Online Survey in Patients at Risk of Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623007/
52428,Induction of Cross-Reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-Cell Responses by a Recombinant Matrix-M–Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664440/
52429,Vaccine attitudes among young adults in Asia: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018491/
52430,Factors Influencing the Knowledge Gap regarding Influenza and Influenza Vaccination in the Context of COVID-19 Pandemic: A Cross-Sectional Survey in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228307/
52431,Flu and COVID-19 Vaccination: What Happens to the Flu Shot When the Campaigns Overlap? Experience from a Large Italian Research Hospital,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228127/
52432,Behavior of nurses and nurse aides toward influenza vaccine: the impact of the perception of occupational working conditions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227720/
52433,"A Comprehensive Review on Equine Influenza Virus: Etiology, Epidemiology, Pathobiology, Advances in Developing Diagnostics, Vaccines, and Control Strategies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135912/
52434,Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544921/
52435,"Update: Influenza Activity — United States and Worldwide, May 20–October 13, 2018",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290813/
52436,A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516373/
52437,Inclusion of Safety-Related Issues in Economic Evaluations for Seasonal Influenza Vaccines: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913116/
52438,"SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054865/
52439,Factors associated with differential uptake of seasonal influenza immunizations among underserved communities during the 2009–2010 influenza season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369692/
52440,Assessing the State of Knowledge Regarding the Effectiveness of Interventions to Contain Pandemic Influenza Transmission: A Systematic Review and Narrative Synthesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5158032/
52441,"Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512784/
52442,Augmented CD4+ T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092382/
52443,NPJ Vaccines. 2018; 3: 45. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134085/
52444,Estimating the Influenza Vaccine Effectiveness against Medically Attended Influenza in Clinical Settings: A Hospital-Based Case-Control Study with a Rapid Diagnostic Test in Japan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543401/
52445,Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012143/
52446,Short Message Service Reminder Nudge for Parents and Influenza Vaccination Uptake in Children and Adolescents With Special Risk Medical Conditions: The Flutext-4U Randomized Clinical Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941970/
52447,Underlying cardiopulmonary conditions as a risk factor for influenza and respiratory syncytial virus infection among community‐dwelling adults aged ≥ 65 years in Thailand: Findings from a two‐year prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404046/
52448,Protective effect of single‐dose adjuvanted pandemic influenza vaccine in children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964543/
52449,Influenza vaccination: from epidemiological aspects and advances in research to dissent and vaccination policies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910436/
52450,The adverse reactions to vaccines practice parameter 10 years on—what have we learned?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801260/
52451,A year of terror and a century of reflection: perspectives on the great influenza pandemic of 1918–1919,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364422/
52452,Immune Protection Induced on Day 10 Following Administration of the 2009 A/H1N1 Pandemic Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000335/
52453,PLoS One. 2012; 7(5): e39314. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368519/
52454,A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310163/
52455,A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210727/
52456,The expected emotional benefits of influenza vaccination strongly affect pre-season intentions and subsequent vaccination among healthcare personnel,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901693/
52457,"Immunogenicity and Safety of MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared with a Nonadjuvanted, Quadrivalent Influenza Vaccine in Adults 50–64 Years of Age",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611124/
52458,"Evolutionarily Conserved Protein Sequences of Influenza A Viruses, Avian and Human, as Vaccine Targets",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2065905/
52459,Preventing the Risk of Hospitalization for Respiratory Complications of Influenza among the Elderly: Is There a Better Influenza Vaccination Strategy? A Retrospective Population Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564213/
52460,Repurposing Infectious Diseases Vaccines Against Cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155725/
52461,Vaccination of influenza a virus decreases transmission rates in pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258204/
52462,Misinformation about vaccine safety and uptake of COVID-19 vaccines among adults and 5–11-year-olds in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492517/
52463,"The Association Between Receiving the Flu and COVID-19 Vaccines and Related Factors, Data from the StopFlu Campaign in Eight States and the District of Columbia, 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066005/
52464,"Burden of Influenza-Associated Respiratory Hospitalizations, Vietnam, 2014–2016",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462305/
52465,Host Protective Immune Responses against Influenza A Virus Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291249/
52466,Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177469/
52467,"Awareness of Vaccination against Respiratory Tract Diseases, Including Pneumonia, Influenza, and COVID-19 in Patients with Diabetes Mellitus",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366267/
52468,Continuing challenges in influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159436/
52469,Guillain-Barré syndrome and influenza vaccines: current evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719653/
52470,Superior In Vitro Stimulation of Human CD8+ T-Cells by Whole Virus versus Split Virus Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114834/
52471,The role of non–COVID-specific and COVID-specific factors in predicting a shift in willingness to vaccinate: A panel study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719857/
52472,"Dual influenza and pneumococcal vaccination was associated with lower short-term risks of all-cause and acute respiratory hospitalizations among the elderly in Shenzhen, China: a retrospective cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734018/
52473,A chimeric influenza hemagglutinin delivered by parainfluenza virus 5 vector induces broadly protective immunity against genetically divergent influenza a H1 viruses in swine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500346/
52474,The Cost of Seasonal Influenza: A Systematic Literature Review on the Humanistic and Economic Burden of Influenza in Older (≥ 65 Years Old) Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10879238/
52475,Understanding the Impact of General Vaccine Attitudes on the Intent for Early COVID-19 Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966616/
52476,Using population-wide administrative and laboratory data to estimate type- and subtype-specific influenza vaccine effectiveness: a surveillance protocol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773297/
52477,Potency of a vaccine prepared from A/swine/Hokkaido/2/1981 (H1N1) against A/Narita/1/2009 (H1N1) pandemic influenza virus strain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571931/
52478,The business of making vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097449/
52479,Effect of latent cytomegalovirus infection on the antibody response to influenza vaccination: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647367/
52480,Immunogenicity and safety of subunit influenza vaccines in pregnant women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890026/
52481,Vaccines in pregnancy: The dual benefit for pregnant women and infants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962964/
52482,Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60+,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048840/
52483,Mucosal CD8+ T cell responses induced by an MCMV based vaccine vector confer protection against influenza challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763260/
52484,Influenza Vaccination Documentation Rates During the First Year After Diagnosis of Diffuse Large B Cell Lymphoma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513688/
52485,Combination of the immunization with the sequence close to the consensus sequence and two DNA prime plus one VLP boost generate H5 hemagglutinin specific broad neutralizing antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443486/
52486,"Attitudes, motivators, and barriers toward influenza vaccination for children: a study from a conflict-ridden country",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10988905/
52487,"Haemagglutinin substitutions N125D, D127E, D222G and R223Q improve replicative fitness and vaccine effectiveness of an A/H1N1pdm09 live attenuated influenza vaccine virus by enhancing α-2,6 receptor binding",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182293/
52488,Intradermal delivery of a fractional dose of influenza H7N9 split vaccine elicits protective immunity in mice and rats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861799/
52489,"Influenza vaccination of pregnant women in Paris, France: Knowledge, attitudes and practices among midwives",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483190/
52490,Postpandemic Sentinel Surveillance of Respiratory Diseases in the Context of the World Health Organization Mosaic Framework: Protocol for a Development and Evaluation Study Involving the English Primary Care Network 2023-2024,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11024753/
52491,“Figuring stuff out myself” – a qualitative study on maternal vaccination in socially and ethnically diverse areas in England,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362695/
52492,Single PA mutation as a high yield determinant of avian influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5233958/
52493,"Vaccine Effectiveness Against Influenza A(H3N2)–Associated Hospitalized Illness: United States, 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226741/
52494,Towards a sane and rational approach to management of Influenza H1N1 2009,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691743/
52495,Avian Orthoavulavirus Type-1 as Vaccine Vector against Respiratory Viral Pathogens in Animal and Human,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876055/
52496,Whole virus influenza vaccine activates dendritic cells (DC) and stimulates cytokine production by peripheral blood mononuclear cells (PBMC) while subunit vaccines support T cell proliferation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1905106/
52497,"Outbreak of influenza A in a boarding school in South Africa, 2016",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658148/
52498,"Co-Administration of Influenza and COVID-19 Vaccines: A Cross-Sectional Survey of Canadian Adults’ Knowledge, Attitudes, and Beliefs",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11054434/
52499,Influenza A H1N1 2009 (Swine Flu) and Pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295877/
52500,A mixed methods study of health care professionals’ attitudes towards vaccination in 15 countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526144/
52501,"Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127729/
52502,Production of a novel influenza vaccine using insect cells: protection against drifted strains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634664/
52503,Incidence of medically attended influenza and influenza virus infections confirmed by serology in Ningbo City from 2017–2018 to 2019–2020,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983918/
52504,Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC122937/
52505,"Low response in eliciting neuraminidase inhibition activity of sera among recipients of a split, monovalent pandemic influenza vaccine during the 2009 pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219752/
52506,When good messages go wrong: Perspectives on COVID-19 vaccines and vaccine communication from generally vaccine accepting individuals in Canada,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762838/
52507,"Influenza Activity — United States, 2013–14 Season and Composition of the 2014–15 Influenza Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779357/
52508,Dual-linker gold nanoparticles as adjuvanting carriers for multivalent display of recombinant influenza hemagglutinin trimers and flagellin improve the immunological responses in vivo and in vitro,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503497/
52509,"Examining the Negative Sentiments Related to Influenza Vaccination from 2017 to 2022: An Unsupervised Deep Learning Analysis of 261,613 Twitter Posts",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305179/
52510,Pilot Study for Immunogenicity of SARS-CoV-2 Vaccine with Seasonal Influenza and Pertussis Vaccines in Pregnant Women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860598/
52511,"Barriers and beliefs among health-care workers regarding seasonal influenza vaccine in Al-Qassim region, Saudi Arabia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062449/
52512,"Global Influenza Hospital-based Surveillance Network (GIHSN): results of surveillance of influenza and other respiratory viruses in hospitalised patients in Brazil, 2015",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829850/
52513,The challenges of vaccine strain selection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553772/
52514,Healthcare worker compliance with seasonal and pandemic influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909401/
52515,End of 2022/23 Season Influenza Vaccine Effectiveness in Primary Care in Great Britain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11093773/
52516,Factors associated with influenza vaccine uptake in older adults living in the community in Singapore,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9507716/
52517,"Public Knowledge, Attitudes, and Practices toward Seasonal Influenza Vaccine in Saudi Arabia: A Cross-Sectional Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827581/
52518,The Contribution of Systemic and Pulmonary Immune Effectors to Vaccine-Induced Protection from H5N1 Influenza Virus Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347357/
52519,The missing season: The impacts of the COVID-19 pandemic on influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376231/
52520,Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401307/
52521,Heterosubtypic T‐cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634225/
52522,Psychometric validation of a chinese version of COVID-19 vaccine hesitancy scale: a cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526461/
52523,"Influenza Vaccine Effectiveness against Hospitalization, Season 2021/22: A Test-Negative Design Study in Barcelona",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534370/
52524,Profiles of influenza A/H1N1 vaccine response using hemagglutination-inhibition titers ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514374/
52525,Universal influenza virus vaccines and therapeutic antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389886/
52526,High Vaccination Coverage among Children during Influenza A(H1N1)pdm09 as a Potential Factor of Herd Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086756/
52527,Randomized Controlled Trial of Text Message Reminders for Increasing Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683861/
52528,Understanding the gap between guidelines and influenza vaccination coverage in people with diabetes: a scoping review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11066301/
52529,Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112395/
52530,A Host-Restricted Self-Attenuated Influenza Virus Provides Broad Pan-Influenza A Protection in a Mouse Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674563/
52531,Trends in Influenza Vaccination Rates among a Medicaid Population from 2016 to 2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675465/
52532,Emerging concepts in the science of vaccine adjuvants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023785/
52533,Quantitative multiplexed imaging analysis reveals a strong association between immunogen-specific B cell responses and tonsillar germinal center immune dynamics in children after influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760299/
52534,Protective Immunity to H7N9 Influenza viruses elicited by synthetic DNA Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221260/
52535,"Prime-boost, double-dose influenza vaccine immunity in COPD: a pilot observational study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986756/
52536,Assessment of Influenza Vaccine Uptake According to the Presence of a Chronic Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223139/
52537,"Impact of pharmacists as immunizers on influenza vaccination coverage in Nova Scotia, Canada",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963057/
52538,Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940123/
52539,"A Glycolipid Adjuvant, 7DW8-5, Enhances the Protective Immune Response to the Current Split Influenza Vaccine in Mice",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759631/
52540,Enhancing neutralizing activity against influenza H1N1/PR8 by engineering a single-domain VL-M2 specific into a bivalent form,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9432714/
52541,Intranasal Immunization with the Influenza A Virus Encoding Truncated NS1 Protein Protects Mice from Heterologous Challenge by Restraining the Inflammatory Response in the Lungs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067201/
52542,Changes in childhood immunization decisions in the United States: Results from 2012 & 2014 National Parental Surveys,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026855/
52543,Respiratory viruses: New frontiers—a Keystone Symposia report,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580159/
52544,"Infant Pneumococcal Carriage During Influenza, RSV, and hMPV Respiratory Illness Within a Maternal Influenza Immunization Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688054/
52545,Neoadjuvant intratumoral influenza vaccine treatment in patients with proficient mismatch repair colorectal cancer leads to increased tumor infiltration of CD8+ T cells and upregulation of PD-L1: a phase 1/2 clinical trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186478/
52546,"GLA-AF, an Emulsion-Free Vaccine Adjuvant for Pandemic Influenza",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925208/
52547,"Relation of study quality, concordance, take home message, funding, and impact in studies of influenza vaccines: systematic review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643439/
52548,MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501657/
52549,"Much ado about flu: A mixed methods study of parental perceptions, trust and information seeking in a pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005583/
52550,Influenza Vaccine Effectiveness in the United States during the 2015–2016 Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727917/
52551,"Can online self-reports assist in real-time identification of influenza vaccination uptake? A cross-sectional study of influenza vaccine-related tweets in the USA, 2013–2017",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340631/
52552,"Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019–2020: A Test-Negative Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8682606/
52553,Switching from trivalent to quadrivalent inactivated influenza vaccines in Uruguay: a cost-effectiveness analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225211/
52554,Deriving effective vaccine allocation strategies for pandemic influenza: Comparison of an agent-based simulation and a compartmental model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319753/
52555,Efficacy of inactivated vaccines in patients treated with immunosuppressive drug therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088666/
52556,"Costs and benefits of influenza vaccination: more evidence, same challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139610/
52557,"Factors associated with uptake of pandemic influenza vaccine among general practitioners and practice nurses in Shropshire, UK",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547956/
52558,Viral Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830773/
52559,Inactivated pandemic 2009 H1N1 influenza A virus human vaccines have different efficacy after homologous challenge in the ferret model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767958/
52560,Enhanced Passive Safety Surveillance (EPSS) confirms an optimal safety profile of the use of MF59®‐adjuvanted influenza vaccine in older adults: Results from three consecutive seasons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928029/
52561,"Plant-Based COVID-19 Vaccines: Current Status, Design, and Development Strategies of Candidate Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473425/
52562,"Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010–13, United States",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889456/
52563,Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487019/
52564,Flagellin-Fused Protein Targeting M2e and HA2 Induces Innate and T-Cell Responses in Mice of Different Genetic Lines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786633/
52565,Immunogenicity and safety of high-dose quadrivalent influenza vaccine in Japanese adults ≥65 years of age: a randomized controlled clinical trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227668/
52566,Supplementation of H7N9 Virus-Like Particle Vaccine With Recombinant Epitope Antigen Confers Full Protection Against Antigenically Divergent H7N9 Virus in Chickens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898936/
52567,A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2658634/
52568,Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932897/
52569,Patient experiences with influenza immunizations administered by pharmacists,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861777/
52570,"Knowledge, attitudes, beliefs and practices
of Occupational Physicians towards seasonal influenza
vaccination: a cross-sectional study
from North-Eastern Italy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584083/
52571,"The gap in use of bronchodilators, inhaled corticosteroids and influenza vaccine among 23 high and low income sites",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531306/
52572,Acceptance and rejection of influenza vaccination by pregnant women in southern Iran:  Physicians' role and barriers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656077/
52573,"Influenza Vaccination: A Cross-Sectional Survey of Knowledge, Attitude and Practices among the Lebanese Adult Population",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690936/
52574,Detection of live attenuated influenza vaccine virus and evidence of reassortment in the U.S. swine population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081507/
52575,Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223911/
52576,Cluster Randomized Trial of a Toolkit and Early Vaccine Delivery to Improve Childhood Influenza Vaccination Rates in Primary Care,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070849/
52577,A comprehensive insight on the challenges for COVID-19 vaccine: A lesson learnt from other viral vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245239/
52578,The Social Ecological Model as a Framework for Determinants of 2009 H1N1 Influenza Vaccine Uptake in the US,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916095/
52579,Modifications in the Polymerase Genes of a Swine-Like Triple-Reassortant Influenza Virus To Generate Live Attenuated Vaccines against 2009 Pandemic H1N1 Viruses  ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014183/
52580,Adverse Events following Administration to Pregnant Women of Influenza A (H1N1) 2009 Monovalent Vaccine reported to the Vaccine Adverse Event Reporting System (VAERS).,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602056/
52581,A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405556/
52582,Vaccination Confidence and Parental Refusal/Delay of Early Childhood Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938536/
52583,"Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141346/
52584,Racial and geographic disparities in influenza vaccination in the U.S. among individuals with atherosclerotic cardiovascular disease: Renewed importance in the setting of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826080/
52585,Prediction of post‐vaccination Guillain‐Barré syndrome using data from a passive surveillance system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014460/
52586,Cutaneous immunization: an evolving paradigm in influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009492/
52587,Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara–Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047453/
52588,Quadrivalent Influenza Vaccine-Induced Antibody Response and Influencing Determinants in Patients ≥ 55 Years of Age in the 2018/2019 Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887788/
52589,Hemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284014/
52590,FluKB: A Knowledge-Based System for Influenza Vaccine Target Discovery and Analysis of the Immunological Properties of Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609449/
52591,Tissue resident memory T cells- A new benchmark for the induction of vaccine-induced mucosal immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581298/
52592,Disparities in Influenza Vaccination Coverage Among Women with Live-Born Infants: PRAMS Surveillance During the 2009–2010 Influenza Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116368/
52593,An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147349/
52594,Factors affecting the willingness of mental health staff to get vaccinated against COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349556/
52595,Impact of COVID-19 Outbreak on Influenza and Pneumococcal Vaccination Uptake: A Multi-Center Retrospective Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223787/
52596,Risk of influenza infection with low vaccine effectiveness: the role of avoidance behaviour,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518843/
52597,Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318684/
52598,"Influenza virus intracellular replication dynamics, release kinetics, and particle morphology during propagation in MDCK cells",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947482/
52599,Proteomic contributions to our understanding of vaccine and immune responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713355/
52600,Determinants of adults' intention to vaccinate against pandemic swine flu,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024930/
52601,Targeted Vaccine Selection in Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859908/
52602,New vaccines against influenza virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890446/
52603,"Comparison of the Use of H1N1 and seasonal influenza vaccinations between veterans and non-veterans in the United States, 2010",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225574/
52604,A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579574/
52605,Factors effecting influenza vaccination uptake among health care workers: a multi-center cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855819/
52606,"Influenza Vaccination Coverage, Motivators for, and Barriers to Influenza Vaccination among Healthcare Workers in Wroclaw, Poland",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835710/
52607,"Interim Estimates of 2013–14 Seasonal Influenza Vaccine Effectiveness — United States, February 2014",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584757/
52608,Effects of Lactobacillus coryniformis K8 CECT5711 on the immune response to influenza vaccination and the assessment of common respiratory symptoms in elderly subjects: a randomized controlled trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424921/
52609,Influenza vaccination: in the UK and across Europe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198692/
52610,Coverage and determinants of influenza vaccine among pregnant women: a cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612156/
52611,An Orf-Virus (ORFV)-Based Vector Expressing a Consensus H1 Hemagglutinin Provides Protection against Diverse Swine Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147081/
52612,Association between Interferon Response and Protective Efficacy of NS1-Truncated Mutants as Influenza Vaccine Candidates in Chickens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892592/
52613,"Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043386/
52614,MMWR Morb Mortal Wkly Rep. 2020 Mar 27; 69(12): 358. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725518/
52615,Public health and budget impacts of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Paraguay,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302507/
52616,Intranasal Vaccination with 1918 Influenza Virus-Like Particles Protects Mice and Ferrets from Lethal 1918 and H5N1 Influenza Virus Challenge ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2681940/
52617,"Effect of a Russian-backbone live-attenuated influenza vaccine with an updated pandemic H1N1 strain on shedding and immunogenicity among children in The Gambia: an open-label, observational, phase 4 study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650545/
52618,Factors Affecting Influenza Vaccination Uptake and Attitudes among Lebanese University Students: The Impact of Vaccination Promotional Programs and COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222101/
52619,What Is the Willingness to Receive Vaccination Against COVID-19 Among the Elderly in Italy? Data From the PASSI d'Argento Surveillance System,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602068/
52620,"The Immunogenicity of the Influenza, Pneumococcal, and Hepatitis B Vaccines in Patients With Inflammatory Bowel Disease Treated With Vedolizumab",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802260/
52621,"Neonatal Outcomes After Antenatal Influenza Immunization During the 2009 H1N1 Influenza Pandemic: Impact on Preterm Birth, Birth Weight, and Small for Gestational Age Birth",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357807/
52622,Immunogenicity of third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: An open question,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746376/
52623,Influenza viral vectors expressing two kinds of HA proteins for bivalent vaccines against clade 2.3.4.4 and clade 2.3.2.1 H5 HPAIVs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008415/
52624,Technological Approaches for Improving Vaccination Compliance and Coverage,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350210/
52625,Association between patient reminders and influenza vaccination status among children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419731/
52626,"Interim Adjusted Estimates of Seasonal Influenza Vaccine Effectiveness — United States, February 2013",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604884/
52627,Immunization with a Hemagglutinin-Derived Synthetic Peptide Formulated with a CpG-DNA-Liposome Complex Induced Protection against Lethal Influenza Virus Infection in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492448/
52628,Characterization and Immunogenicity of Influenza H7N9 Vaccine Antigens Produced Using a Serum-Free Suspension MDCK Cell-Based Platform,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502495/
52629,Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181805/
52630,Cost Effectiveness of Quadrivalent Versus Trivalent Inactivated Influenza Vaccines for the Portuguese Elderly Population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416623/
52631,The beginning and ending of a respiratory viral pandemic‐lessons from the Spanish flu,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049621/
52632,Cross-Protective Immune Responses Elicited by Live Attenuated Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575970/
52633,Understanding reasons for participating in a school-based influenza vaccination program and decision-making dynamics among adolescents and parents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708138/
52634,Influenza in long‐term care facilities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596516/
52635,Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878135/
52636,Original Antigenic Sin: How Original? How Sinful?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091961/
52637,"A Call for Greater Consideration for the Role of Vaccines in National Strategies to Combat Antibiotic-Resistant Bacteria: Recommendations from the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on June 10, 2015",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716466/
52638,Healthcare workers and H1N1 vaccination: Does having a chronic disease make a difference?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127734/
52639,A Global Perspective on Vaccine Safety and Public Health: The Global Advisory Committee on Vaccine Safety,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1448561/
52640,Survey of Adult Influenza Vaccination Practices and Perspectives Among US Primary Care Providers (2016–2017 Influenza Season),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816593/
52641,Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030213/
52642,Influenza activity and regional mortality for non-small cell lung cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10709588/
52643,A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940207/
52644,Acceptance of the COVID-19 vaccine based on the health belief model: a multicenter national survey among medical care workers in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481094/
52645,"Influenza Vaccines: Good, but We Can Do Better",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787547/
52646,Pandemic Influenza Vaccines – The Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185517/
52647,Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11004685/
52648,Multivalent HA DNA Vaccination Protects against Highly Pathogenic H5N1 Avian Influenza Infection in Chickens and Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657001/
52649,PLoS One. 2008; 3(9): 10.1371/annotation/5fbbf39a-fb47-4ce1-8069-acd830b3d41f. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651666/
52650,PLoS One. 2008; 3(9): 10.1371/annotation/b8b66a84-4919-4a3e-ba3e-bb11f3853755. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651664/
52651,Mini-HA Is Superior to Full Length Hemagglutinin Immunization in Inducing Stem-Specific Antibodies and Protection Against Group 1 Influenza Virus Challenges in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194913/
52652,Cost-effectiveness of inactivated seasonal influenza vaccination in a cohort of Thai children ≤60 months of age,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570265/
52653,Report from enhanced safety surveillance of two influenza vaccines (Vaxigrip and Intanza 15 μg) in two European countries during influenza season 2016/17 and comparison with 2015/16 season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806654/
52654,Lower influenza-specific cell-mediated immune responses in individuals with atopic dermatitis compared with healthy controls,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734037/
52655,Case-Control Study of the Effectiveness of the 2010-2011 Seasonal Influenza Vaccine for Prevention of Laboratory-Confirmed Influenza Virus Infection in the Korean Adult Population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675970/
52656,"Incidence of medically attended influenza during pandemic and post-pandemic seasons through the Influenza Incidence Surveillance Project, 2009–13",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749913/
52657,Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2980851/
52658,"Exploring Perceptions and Practices Regarding Adult Vaccination against Seasonal Influenza, Tetanus, Pneumococcal Disease, Herpes Zoster and COVID-19: A Mixed-Methods Study in Greece",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10818817/
52659,Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764605/
52660,"A phase 2/3 double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a seasonal trivalent inactivated split-virion influenza vaccine (IVACFLU-S) in healthy adults in Vietnam",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930107/
52661,A Phase I Evaluation of Inactivated Influenza A/H5N1 Vaccine Administered by the Intradermal or the Intramuscular Route,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913582/
52662,Coverage and predictors of influenza vaccination in patients with cystic fibrosis in a campaign with a mobile phone text messaging intervention,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363150/
52663,Who uses pharmacy for flu vaccinations? Population profiling through a UK pharmacy chain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828468/
52664,Efforts to Improve Immunization Coverage during Pregnancy among Ob-Gyns,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746379/
52665,Humoral and cell-mediated immune responses to H5N1 plant-made virus-like particle vaccine are differentially impacted by alum and GLA-SE adjuvants in a Phase 2 clinical trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780465/
52666,"Rare cases of Guillain-Barré syndrome after COVID-19 vaccination, Germany, December 2020 to August 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318936/
52667,Peptides to combat viral infectious diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462603/
52668,H3N2 influenza hemagglutination inhibition method qualification with data driven statistical methods for human clinical trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117676/
52669,Attitudes amongst Australian hospital healthcare workers towards seasonal influenza and vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941952/
52670,"The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand in 2013: provisional results",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627593/
52671,Influenza A/H1N1 Vaccine in Patients Treated by Kidney Transplant or Dialysis: A Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359578/
52672,Structural characterisation of hemagglutinin from seven Influenza A H1N1 strains reveal diversity in the C05 antibody recognition site,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140725/
52673,Immunogenicity and Protective Efficacy of a Vero Cell Culture-Derived Whole-Virus H7N9 Vaccine in Mice and Guinea Pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342221/
52674,Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910872/
52675,Spread of Influenza Viruses in Poland and Neighboring Countries in Seasonal Terms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000516/
52676,Vaccinating to Protect a Vulnerable Subpopulation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1872043/
52677,Age groups and spread of influenza: implications for vaccination strategy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876165/
52678,Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407759/
52679,Immune response to influenza vaccination in children with cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183334/
52680,A(H1N1) pandemic influenza and its prevention by vaccination: Paediatricians' opinions before and after the beginning of the vaccination campaign,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050752/
52681,Tolerability of 2 doses of pandemic influenza vaccine (Focetria®) and of a prior dose of seasonal 2009-2010 influenza vaccination in the Netherlands,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962940/
52682,Global Ethical Considerations Regarding Mandatory Vaccination in Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817402/
52683,Intranasal Single-Replication Influenza Vector Induces Cross-Reactive Serum and Mucosal Antibodies against SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302585/
52684,"Knowledge, Attitude, Awareness, and Barriers Toward Influenza Vaccination Among Medical Doctors at Tertiary Care Health Settings in Peshawar, Pakistan–A Cross-Sectional Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030373/
52685,An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886961/
52686,Clinical and molecular epidemiology of influenza viruses from Romanian patients hospitalized during the 2019/20 season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589178/
52687,Pulmonary delivery of influenza vaccine formulations in cotton rats: site of deposition plays a minor role in the protective efficacy against clinical isolate of H1N1pdm virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058687/
52688,Recent Advances in Inhaled Nanoformulations of Vaccines and Therapeutics Targeting Respiratory Viral Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129308/
52689,Can a new flu vaccine cure efficacy woes?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646745/
52690,"High-dose influenza vaccination and mortality among predominantly male, white, senior veterans, United States, 2012/13 to 2014/15",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238741/
52691,Review: interventions to increase influenza vaccination among healthcare workers in hospitals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781006/
52692,Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352374/
52693,Public preferences for vaccination and antiviral medicines under different pandemic flu outbreak scenarios,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350649/
52694,"Age Differences in Comorbidities, Presenting Symptoms, and Outcomes of Influenza Illness Requiring Hospitalization: A Worldwide Perspective From the Global Influenza Hospital Surveillance Network",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296081/
52695,Introducing seasonal influenza vaccine in low-income countries: an adverse events following immunization survey in the Lao People's Democratic Republic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353322/
52696,"COVID-19 Healthcare Inequity: Lessons Learned from Annual Influenza
Vaccination Rates to Mitigate COVID-19 Vaccine Disparities",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461587/
52697,A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686743/
52698,Population implications of the deployment of novel universal vaccines against epidemic and pandemic influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115234/
52699,Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/
52700,A statistical analysis of vaccine-adverse event data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540382/
52701,Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489561/
52702,A Prospective Cohort Study on Pregnancy Outcomes of Persons Immunized with a Seasonal Quadrivalent Inactivated Influenza Vaccine during Pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611467/
52703,"GLA-SE, a Synthetic Toll-like Receptor 4 Agonist, Enhances T-Cell Responses to Influenza Vaccine in Older Adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256953/
52704,A VLP Vaccine Induces Broad-Spectrum Cross-Protective Antibody Immunity against H5N1 and H1N1 Subtypes of Influenza A Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413679/
52705,"SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291226/
52706,Effectiveness of Influenza Vaccines in Asthma: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850022/
52707,"Spotlight influenza: Laboratory-confirmed seasonal influenza in people with acute respiratory illness: a literature review and meta-analysis, WHO European Region, 2004 to 2017",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485580/
52708,MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739032/
52709,Antibiotics-driven gut microbiome perturbation alters immunity to vaccines in humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750738/
52710,Association of Influenza Vaccination With Cardiovascular Risk: A Meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055450/
52711,Ocular Inflammation Post-Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611055/
52712,Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355240/
52713,Optimized clade 2.3.2.1c H5N1 recombinant-vaccine strains against highly pathogenic avian influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583417/
52714,Prevention of influenza among travellers attending at a UK travel clinic: beliefs and perceptions. A cross‐sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781004/
52715,Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223387/
52716,Application of volumetric absorptive microsampling (VAMS) to measure multidimensional anti-influenza IgG antibodies by the mPlex-Flu assay,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885997/
52717,Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733714/
52718,A megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor’s appointment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157982/
52719,Addressing Unmet Needs in Vaccination for Older Adults in the Asia Pacific: Insights from the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239646/
52720,Safety of influenza vaccination during pregnancy: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496691/
52721,Role of γδ T cells in controlling viral infections with a focus on influenza virus: implications for designing novel therapeutic approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659406/
52722,Vaccine adjuvants: mechanisms and platforms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356842/
52723,Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821650/
52724,Development of a Novel Live Attenuated Influenza A Virus Vaccine Encoding the IgA-Inducing Protein,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310050/
52725,Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836704/
52726,Factors predicting influenza vaccination adherence among patients in dialysis: an Italian survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816406/
52727,"The epitope regions of H1-subtype influenza A, with application to vaccine efficacy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307478/
52728,"Influenza A non-H1N1 associated with acute respiratory failure and
acute renal failure in a previously vaccinated cystic fibrosis
patient",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885241/
52729,Integrating influenza antigenic dynamics with molecular evolution,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909918/
52730,Development of PREDAC-H1pdm to model the antigenic evolution of influenza A/(H1N1) pdm09 viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436056/
52731,The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742362/
52732,Uptake of influenza vaccination in pregnancy amongst Australian Aboriginal and Torres Strait Islander women: a mixed-methods pilot study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423150/
52733,"Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717082/
52734,Seasonal Trivalent Inactivated Influenza Vaccine Protects against 1918 Spanish Influenza Virus Infection in Ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416326/
52735,Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509669/
52736,Bioinformatics design and experimental validation of influenza A virus multi-epitopes that induce neutralizing antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222995/
52737,Effectiveness of seasonal influenza vaccines in children – a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662362/
52738,A review of policies and coverage of seasonal influenza vaccination programs in the WHO Eastern Mediterranean Region,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030358/
52739,Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834448/
52740,"Co-circulation of the two influenza B lineages during 13 consecutive influenza surveillance seasons in Italy, 2004–2017",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873537/
52741,Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941877/
52742,"Attitudes, knowledge, and willingness to be vaccinated against seasonal influenza among patients hospitalized with influenza-like-illness: impact of diagnostic testing",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227674/
52743,Cost-Effectiveness Analysis of Switching from Trivalent to Quadrivalent Seasonal Influenza Vaccine in Argentina,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067173/
52744,Improving older adults’ vaccination uptake: Are existing measures of vaccine hesitancy valid and reliable for older people?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720707/
52745,Adjuvanticity of Processed Aloe vera gel for Influenza Vaccination in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458799/
52746,"AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167326/
52747,Vaccinating Health Care Workers Against Influenza: The Ethical and Legal Rationale for a Mandate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020194/
52748,Maximizing influenza vaccination uptake among healthcare personnel in Israel: lessons learned from mandatory vaccination policy in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745778/
52749,The Adjuvanticity of an O. volvulus-Derived rOv-ASP-1 Protein in Mice Using Sequential Vaccinations and in Non-Human Primates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355165/
52750,COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536649/
52751,"Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2013",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604840/
52752,Burden of Seasonal Influenza A and B in Panama from 2011 to 2017: An Observational Retrospective Database Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381717/
52753,Skin Immunization Obviates Alcohol-Related Immune Dysfunction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693267/
52754,Teach ‘em young: Influenza vaccines induce broadly neutralizing antibodies in children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861966/
52755,Estimates of Inactivated Influenza Vaccine Effectiveness Among Children in Senegal: Results From 2 Consecutive Cluster-Randomized Controlled Trials in 2010 and 2011,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204774/
52756,"Improving the selection and development of influenza vaccine viruses – Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18–20 November 2015",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357705/
52757,Does Influenza Vaccination of Older Adult Medicare Beneficiaries Lower Treatment Costs for Acute and Chronic Respiratory Disease?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771651/
52758,Vaccination of pregnant women in the Valencian Community during the 2014-15 influenza season: a multicentre study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172683/
52759,The Coming of Age of Nucleic Acid Vaccines during COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134841/
52760,Improving rates of maternal immunization: Challenges and opportunities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962946/
52761,Lessons From Influenza Pandemics of the Last 100 Years,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314237/
52762,Pre-existing immunity to influenza virus hemagglutinin stalk might drive selection for antibody-escape mutant viruses in a human challenge model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450362/
52763,Physicians’ recommendations to their patients concerning a novel pandemic vaccine: a cross-sectional survey of the 2009 influenza A/H1N1 pandemic in Japan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156842/
52764,Mitigating the effects of climate change on human health with vaccines and vaccinations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602790/
52765,From the Patient Perspective: the Economic Value of Seasonal and H1N1 Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046420/
52766,"The re-emergence of influenza following the COVID-19 pandemic in Victoria, Australia, 2021 to 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687983/
52767,Conserved HA-peptide NG34 formulated in pCMV-CTLA4-Ig reduces viral shedding in pigs after a heterosubtypic influenza virus SwH3N2 challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396909/
52768,Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case series,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735133/
52769,"Safety of COVID-19 vaccines, their components or their platforms for pregnant women: A rapid review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202435/
52770,Vaccine. 2021 Sep 24; 39(40): 5891–5908. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360993/
52771,Potential Strategies to Achieve Universal Influenza Vaccination for Children: Provider Attitudes in Two States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477487/
52772,Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons: A Randomized Clinical Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004464/
52773,"Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573632/
52774,Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2973924/
52775,Preclinical Toxicology of Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161388/
52776,End of season 2022/2023 quadrivalent influenza vaccine effectiveness in preventing influenza in primary care in Portugal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653732/
52777,Determinants of parental self-reported uptake of influenza vaccination in preschool children during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653755/
52778,The Pandemic Influenza A (H1N1) 2009 Vaccine Does Not Increase the Mortality Rate of Idiopathic Interstitial Pneumonia: A Matched Case-Control Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934868/
52779,Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612214/
52780,Altered Influenza Vaccination Coverage and Related Factors in Pregnant Women in Korea from 2007 to 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850865/
52781,Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514388/
52782,Influenza Vaccination of Pregnant Women and Serious Adverse Events in the Offspring,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887964/
52783,Antibody Responses with Fc-Mediated Functions after Vaccination of HIV-Infected Subjects with Trivalent Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886795/
52784,"Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1–3, 2010",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634548/
52785,Immunogenicity and Cross-Reactivity of 2009–2010 Inactivated Seasonal Influenza Vaccine in US Adults and Elderly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031605/
52786,Does Influenza Vaccination Modify Influenza Severity? Data on Older Adults Hospitalized With Influenza During the 2012−2013 Season in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683374/
52787,"Usage of quadrivalent influenza vaccine among children in the United States, 2013–14",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746024/
52788,Broadly Protective CD8+ T Cell Immunity to Highly Conserved Epitopes Elicited by Heat Shock Protein gp96-Adjuvanted Influenza Monovalent Split Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315956/
52789,J Virol. 2021 Dec; 95(24): e01750-21. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610597/
52790,"Predominance of a Drifted Influenza A (H3N2) Clade and Its Association with Age-Specific Influenza Vaccine Effectiveness Variations, Influenza Season 2018–2019",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157661/
52791,Predicting Antigenicity of Influenza A Viruses Using biophysical ideas,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629677/
52792,Efficacy and Safety of a Modified Vaccinia Ankara-NP+M1 Vaccine Combined with QIV in People Aged 65 and Older: A Randomised Controlled Clinical Trial (INVICTUS),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402379/
52793,Nanocarrier vaccines for SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794055/
52794,Burden of severe illness associated with laboratory confirmed influenza in adults aged 50–64 years: A rapid review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178069/
52795,"Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815489/
52796,Recurring and Adaptable Binding Motifs in Broadly Neutralizing Antibodies to Influenza Virus Are Encoded on the D3-9 Segment of the Ig Gene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327842/
52797,Scientific barriers to developing vaccines against avian influenza viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097526/
52798,Influenza vaccines licensed in the United States in healthy children: a systematic review and network meta-analysis (Protocol),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537683/
52799,Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8+ Lung-Resident Memory T Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832804/
52800,Month of Influenza Virus Vaccination Influences Antibody Responses in Children and Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909259/
52801,Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early time,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919024/
52802,The role of epidemiology in informing United States childhood immunization policy and practice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553935/
52803,"Update: Influenza Activity — United States, September 28, 2014–February 21, 2015",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584716/
52804,Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza A/H3N2 evolution,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553778/
52805,Antibody Landscape Analysis following Influenza Vaccination and Natural Infection in Humans with a High-Throughput Multiplex Influenza Antibody Detection Assay,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858056/
52806,Responses to Quadrivalent Influenza Vaccine Reveal Distinct Circulating CD4+CXCR5+ T Cell Subsets in Men Living with HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821795/
52807,Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796333/
52808,"Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907359/
52809,Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013–14: Results from the InNHOVE network,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036960/
52810,Severe and moderate seasonal influenza epidemics among Italian healthcare workers: A comparison of the excess of absenteeism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767959/
52811,Text messaging reminders for influenza vaccine in primary care: protocol for a cluster randomised controlled trial (TXT4FLUJAB),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025454/
52812,Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151880/
52813,Immunogenicity of Three Different Influenza Vaccines against Homologous and Heterologous Strains in Nursing Home Elderly Residents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847378/
52814,Different Repeat Annual Influenza Vaccinations Improve the Antibody Response to Drifted Influenza Strains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507920/
52815,Influenza vaccines: an Asia–Pacific perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492652/
52816,Newcastle disease virus-based H5 influenza vaccine protects chickens from lethal challenge with a highly pathogenic H5N2 avian influenza virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714955/
52817,NPJ Vaccines. 2018; 3: 19. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958092/
52818,Plasmodium falciparum Malaria Vaccines and Vaccine Adjuvants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541031/
52819,Live Attenuated and Inactivated Influenza Vaccine Effectiveness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361354/
52820,The coverage of influenza and pneumococcal vaccinations among people living with HIV in Denmark: A single-center cross-sectional survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475619/
52821,"Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2547490/
52822,Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111335/
52823,The Effects of Influenza Vaccination of Health Care Workers in Nursing Homes: Insights from a Mathematical Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2573905/
52824,Outcomes of COVID-19 Infection in People Previously Vaccinated Against Influenza: Population-Based Cohort Study Using Primary Health Care Electronic Records,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662290/
52825,"A Multicenter, Prospective, Randomized, Parallel‐Group Trial on the Effects of Temporary Methotrexate Discontinuation for One Week Versus Two Weeks on Seasonal Influenza Vaccination in Patients With Rheumatoid Arthritis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107245/
52826,Inflammatory responses to influenza vaccination at the extremes of age,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506419/
52827,Investigate Non-EPI Vaccination Recommendation Practice from a Socio-Ecological Perspective: A Mixed-Methods Study in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788484/
52828,Protective effect of a polyvalent influenza DNA vaccine in pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764121/
52829,"Evaluation of the impact of immunization policies, including the addition of pharmacists as immunizers, on influenza vaccination coverage in Nova Scotia, Canada: 2006 to 2016",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019522/
52830,Influenza Vaccines Delivered in Early Childhood Could Turn Antigenic Sin into Antigenic Blessings,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371515/
52831,Influenza in Infants Born to Women Vaccinated During Pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894254/
52832,Nanoparticle-Based Delivery Systems for Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694785/
52833,Age is not only criterion for flu vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1113993/
52834,Prior Population Immunity Reduces the Expected Impact of CTL-Inducing Vaccines for Pandemic Influenza Control,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374977/
52835,Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385383/
52836,Influenza Vaccine Effectiveness in the Elderly Based on Administrative Databases: Change in Immunization Habit as a Marker for Bias,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144220/
52837,Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047834/
52838,Factors affecting influenza vaccination in adults aged 50-64 years with high-risk chronic diseases in South Korea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605866/
52839,Influenza Vaccines Have a Short but Illustrious History of Dedicated Science Enabling the Rapid Global Production of A/Swine (H1N1) Vaccine in the Current Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123788/
52840,Protective effect of influenza vaccination on cardiovascular diseases: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692477/
52841,Conservation and Diversity of Influenza A H1N1 HLA-Restricted T Cell Epitope Candidates for Epitope-Based Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2807450/
52842,“Gnothi Seauton”: Leveraging the Host Response to Improve Influenza Virus Vaccine Efficacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027147/
52843,"Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy children (6 months to 17 years of age): a randomized, multicenter, phase III clinical trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993130/
52844,Oral immunization of a non-recombinant Lactococcus lactis surface displaying influenza hemagglutinin 1 (HA1) induces mucosal immunity in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673223/
52845,Timing of seasonal influenza epidemics for 25 countries in Africa during 2010–19: a retrospective analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126228/
52846,"Determinants of seasonal influenza vaccination in pregnant women in Valencia, Spain",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117491/
52847,Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2748222/
52848,The burden of severe cases of Influenza disease: the Friuli Venezia Giulia Region experience,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797893/
52849,"A Retrospective observational cohort study of the effect of antenatal influenza vaccination on birth outcomes in Cape Town, South Africa, 2015‐2016",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189187/
52850,Prioritization of risk groups for influenza vaccination in resource limited settings – A case study from South Africa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470296/
52851,Impact of Individual Viral Gene Segments from Influenza A/H5N8 Virus on the Protective Efficacy of Inactivated Subtype-Specific Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003407/
52852,"Vaccines, inspiring innovation in health",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238075/
52853,"Designing a chimeric subunit vaccine for influenza virus, based on HA2, M2e and CTxB: a bioinformatics study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716444/
52854,Immunogenicity of a Monovalent 2009 Influenza A (H1N1) Vaccine in an Immunocompromised Population: A Prospective Study Comparing HIV-Infected Adults with HIV-Uninfected Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060889/
52855,Does Vaccine-Induced Maternally-Derived Immunity Protect Swine Offspring against Influenza a Viruses? A Systematic Review and Meta-Analysis of Challenge Trials from 1990 to May 2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571953/
52856,Immunologic Characterization of a Rhesus Macaque H1N1 Challenge Model for Candidate Influenza Virus Vaccine Assessment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248778/
52857,An exploration of midwives’ role in the promotion and provision of antenatal influenza immunisation: A mixed methods inquiry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211614/
52858,Validation of the Vaccination Trust Indicator (VTI) in a multi-country survey of adult vaccination attitudes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096184/
52859,Risk of Guillain-Barré Syndrome Among Older Adults Receiving Influenza Vaccine in Taiwan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494192/
52860,Examining the role of a decision aid in reducing decisional conflict amongst hospital healthcare workers towards receiving the influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785629/
52861,"Librator: a platform for the optimized analysis, design, and expression of mutable influenza viral antigens",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921739/
52862,T Cell Epitope Discovery in the Context of Distinct and Unique Indigenous HLA Profiles,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121770/
52863,Association Between Influenza Vaccine Uptake and Health Awareness: A Cross-Sectional Questionnaire-Based Study Among Medical Students and Healthcare Workers in Northern Vietnam,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10771011/
52864,Additive preventive effect of influenza and pneumococcal vaccines in the elderly: Results of a large cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667927/
52865,A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611209/
52866,Matrix-M Adjuvated Seasonal Virosomal Influenza Vaccine Induces Partial Protection in Mice and Ferrets against Avian H5 and H7 Challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581625/
52867,Hemagglutinin and Neuraminidase Antibodies Are Induced in an Age- and Subtype-Dependent Manner after Influenza Virus Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081922/
52868,The effect of influenza vaccine on severity of COVID-19 infection: An original study from Iran,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683836/
52869,Tfh cell response in influenza vaccines in humans: What is visible and what is invisible,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761038/
52870,Self-Assembly M2e-Based Peptide Nanovaccine Confers Broad Protection Against Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457018/
52871,Identification of specific neutralizing antibodies for highly pathogenic avian influenza H5 2.3.4.4b clades to facilitate vaccine design and therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10810642/
52872,Intranasal Immunization with Influenza VLPs Incorporating Membrane-Anchored Flagellin Induces Strong Heterosubtypic Protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993933/
52873,Is influenza-like illness a useful concept and an appropriate test of influenza vaccine effectiveness?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127078/
52874,"Vaccination into the Dermal Compartment: Techniques, Challenges, and Prospects",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564253/
52875,Seasonal influenza vaccination among cancer patients during the COVID-19 pandemic in Poland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547183/
52876,A novel vaccination strategy mediating the induction of lung-resident memory CD8 T cells confers heterosubtypic immunity against future pandemic influenza virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779729/
52877,"Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza
      virus",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964451/
52878,Long-term influenza antibodies profiles in previously vaccinated and non-vaccinated adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399472/
52879,Usefulness of Vaccine Adverse Event Reporting System for Machine-Learning Based Vaccine Research: A Case Study for COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368306/
52880,"Why, when and for what diseases pregnant and new mothers “should” be vaccinated",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328236/
52881,Genotyping assay for differentiation of wild-type and vaccine viruses in subjects immunized with live attenuated influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501548/
52882,Factors Associated with Attitudes towards Seasonal Influenza Vaccination in Poland: A Nationwide Cross-Sectional Survey in 2020,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620474/
52883,"Waning Vaccine Protection against Influenza among Department of Defense Adult Beneficiaries in the United States, 2016–2017 through 2019–2020 Influenza Seasons",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229659/
52884,Adjuvant Effects of a New Saponin Analog VSA-1 on Enhancing Homologous and Heterosubtypic Protection by Influenza Virus Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501088/
52885,"Influenza-like illness in Norway: clinical course, attitudes towards vaccination and preventive measures during the 2009 pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314038/
52886,Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818346/
52887,Advancements in Vaccine Adjuvants: The Journey from Alum to Nano Formulations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674458/
52888,"Health and economic burden of influenza‐associated illness in South Africa, 2013‐2015",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692552/
52889,Efficacy and synergy of live-attenuated and inactivated influenza vaccines in young chickens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889186/
52890,"Measuring Cellular Immunity to Influenza: Methods of Detection, Applications and Challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494351/
52891,COVID-19 and the flu: data simulations and computational modelling to guide public health strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499780/
52892,Fam Pract. 2022 Jun 3 : cmac061. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384232/
52893,"The influence of social network on COVID-19 vaccine hesitancy among healthcare workers: a cross-sectional survey in Chongqing, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903998/
52894,A Single Electroporation Delivery of a DNA Vaccine Containing the Hemagglutinin Gene of Asian H5N1 Avian Influenza Virus Generated a Protective Antibody Response in Chickens against a North American Virus Strain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623422/
52895,Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301914/
52896,Pneumonia immunization in older adults: review of vaccine effectiveness and strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496196/
52897,Cross-clade protective immunity of H5N1 influenza vaccines in a mouse model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626625/
52898,The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014–2015 Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850544/
52899,Comparison of a novel microcrystalline tyrosine adjuvant with aluminium hydroxide for enhancing vaccination against seasonal influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369220/
52900,Characterization of a Neuraminidase-Deficient Influenza A Virus as a Potential Gene Delivery Vector and a Live Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC353727/
52901,A Combination in-ovo Vaccine for Avian Influenza Virus and Newcastle Disease Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394284/
52902,"Defective Interfering Particles of Influenza Virus and Their Characteristics, Impacts, and Use in Vaccines and Antiviral Strategies: A Systematic Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781619/
52903,Technical Transformation of Biodefense Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729025/
52904,Influenza vaccine coverage among children under the age of 5 years in Poland during 2004-2008,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360261/
52905,Influenza NP core and HA or M2e shell double-layered protein nanoparticles induce broad protection against divergent influenza A viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897236/
52906,Membrane Chromatography-Based Downstream Processing for Cell-Culture Produced Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414887/
52907,Impact of quadrivalent influenza vaccine on public health and influenza-related costs in Australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957923/
52908,Understanding barriers and predictors of maternal immunization: Identifying gaps through an exploratory literature review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431095/
52909,A DNA Vaccine-Encoded Nucleoprotein of Influenza Virus Fails To Induce Cellular Immune Responses in a Diabetic Mouse Model ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2849332/
52910,"Place of influenza vaccination among children—United States, 2010–11 through 2013–14 influenza seasons",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751425/
52911,Workplace Vaccination and Other Factors Impacting Influenza Vaccination Decision among Employees in Israel,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872324/
52912,"Recommendations and offers for adult influenza vaccination, 2011–2012 season, United States",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689412/
52913,Antibody Response to Influenza A(H1N1)pdm09 Among Healthcare Personnel Receiving Trivalent Inactivated Vaccine: Effect of Prior Monovalent Inactivated Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313942/
52914,Inactivated Seasonal Influenza Vaccines Increase Serum Antibodies to the Neuraminidase of Pandemic Influenza A(H1N1) 2009 Virus in an Age-Dependent Manner,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2974032/
52915,Linking time use data to explore health outcomes: Choosing to vaccinate against Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976524/
52916,Masking terminal neo-epitopes of linear peptides through glycosylation favours immune responses towards core epitopes producing parental protein bound antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595224/
52917,2012-2013 Seasonal Influenza Vaccine Effectiveness against Influenza Hospitalizations: Results from the Global Influenza Hospital Surveillance Network,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063939/
52918,PLoS One. 2014; 9(9): e107849. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157882/
52919,Factors associated with Humoral Immune Response in Older Adults who Received Egg-free Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850444/
52920,Associated virus-bacterial vaccine based on seasonal LAIV and S. pneumoniae chimeric peptide provide protection against post-influenza pneumococcal infection in mouse model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920162/
52921,Development of an ELISA-Based Potency Assay for Inactivated Influenza Vaccines Using Cross-Reactive Nanobodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503116/
52922,"Determinants of policy and uptake of national vaccine programs for pregnant women: results of mixed method study from Spain, Italy, and India",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078648/
52923,"Immunogenicity and safety of an inactivated 2012/2013 trivalent influenza vaccine produced in mammalian cell culture (Optaflu®): An open label, uncontrolled study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185887/
52924,"Molecular characterization of influenza viruses collected from young children in Uberlandia, Brazil - from 2001 to 2010",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336712/
52925,Resurgence of Influenza Circulation in the Russian Federation during the Delta and Omicron COVID-19 Era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506591/
52926,Influenza in Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778215/
52927,Obesity Is Associated with an Impaired Baseline Repertoire of Anti-Influenza Virus Antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269616/
52928,Influenza and tuberculosis co‐infection: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928059/
52929,Perfluoroalkyl Substance Serum Concentrations and Immune Response to FluMist Vaccination among Healthy Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907856/
52930,Comparative Immunogenicity of the 2014–2015 Northern Hemisphere Trivalent IIV and LAIV against Influenza A Viruses in Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789519/
52931,COVID-19 vaccine platforms: Delivering on a promise?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381795/
52932,A novel approach for preparation of the antisera reagent for potency determination of inactivated H7N9 influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746557/
52933,Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891888/
52934,Vaccination coverage of patients with type 2 diabetes mellitus: Challenging issues from an outpatient secondary care setting in Greece,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376377/
52935,Front Public Health. 2022; 10: 1034544. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687085/
52936,Front Public Health. 2022; 10: 1114452. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881408/
52937,Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021406/
52938,Seasonal Influenza Vaccination of Children Induces Humoral and Cell-Mediated Immunity Beyond the Current Season: Cross-reactivity With Past and Future Strains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731644/
52939,Influenza Vaccine Utilization: A Comparison between Urban and Rural Counties in Florida,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145088/
52940,Protective Antibodies Against Influenza Proteins,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657620/
52941,Effects of Prior Influenza Exposure on Immunogenicity of Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423295/
52942,Variation in COVID-19 booster uptake in England: An ecological study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242486/
52943,Novel H7N9 influenza immunogen design enhances mobilization of seasonal influenza T cell memory in H3N2 pre-immune mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721412/
52944,Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688359/
52945,Influenza Vaccine: An Engineering Vision from Virological Importance to Production,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589582/
52946,School‐Based Influenza Vaccination: Health and Economic Impact of Maine's 2009 Influenza Vaccination Program,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682124/
52947,Impact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332092/
52948,The Screening and Mechanism of Influenza-Virus Sensitive MDCK Cell Lines for Influenza Vaccine Production,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10814076/
52949,Agent-based model of the impact of higher influenza vaccine efficacy on seasonal influenza burden,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753457/
52950,Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547759/
52951,Determinants of influenza vaccination uptake in pregnancy: a large single-Centre cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924067/
52952,"Statin Use and Influenza Vaccine Effectiveness in Persons >65 Years of Age, Taiwan",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258485/
52953,Virus-like particles as antigenic nanomaterials for inducing protective immune responses in the lung,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415509/
52954,"Influenza evolution and H3N2 vaccine effectiveness, with application to the 2014/2015 season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955871/
52955,Sex-specific differences of humoral immunity and transcriptome diversification in older adults vaccinated with inactivated quadrivalent influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064175/
52956,Recombinant vaccines in 2022: a perspective from the cell factory,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532831/
52957,Influenza Vaccination Experiences of Pregnant Women as a Predictor of the Intention to Become Vaccinated in Future Pregnancies in Spain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350003/
52958,Estimating the Impact of Influenza Vaccination on Acute and ICU Hospital Bed Usage in an Influenza Season under Endemic COVID-19 in the US,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693626/
52959,Development and characterization of standard reagents for cell-based prepandemic influenza vaccine products,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553690/
52960,ARE LONG-TERM INFLUENZA VACCINES POSSIBLE AND HOW DO WE DISCOVER THEM?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904565/
52961,"Likely Correlation between Sources of Information and Acceptability of A/H1N1 Swine-Origin Influenza Virus Vaccine in Marseille, France",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892508/
52962,The challenge of vaccinating adults: attitudes and beliefs of the Canadian public and healthcare providers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593142/
52963,Vaccine Attitudes and COVID-19 Vaccine Intention Among Parents of Children With Kidney Disease or Primary Hypertension,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212850/
52964,"Preparation and evaluation of a novel, live, attenuated influenza H1N1 vaccine strain produced by a modified classical reassortment method",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861788/
52965,"Influenza Vaccine Effectiveness: Mysteries, Enigmas, and a Few Clues",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837904/
52966,Intanza® 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667924/
52967,Vaccine Adjuvants: from 1920 to 2015 and Beyond,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494348/
52968,"Influenza Vaccination: Effectiveness, Indications, and Limits in the Pediatric Population",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682587/
52969,Data resource profile: Household Influenza Vaccine Evaluation (HIVE) Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693804/
52970,Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births: A Retrospective Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104979/
52971,Protective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteins,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5375616/
52972,Infectious disease mRNA vaccines and a review on epitope prediction for vaccine design,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194884/
52973,Evaluation of the immuno-stimulatory effect of aqueous neem (Azadirachta indica) leaf extract against highly pathogenic avian influenza (H5N8) in experimental chickens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520533/
52974,"Knowledge, Attitude, Perceptions, and Concerns of Pregnant Women Regarding the Influenza Vaccination in Kocaeli, Turkey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064710/
52975,"Determinants of pregnant women’s knowledge about influenza and the influenza vaccine: A large, single-centre cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394385/
52976,Estimated health and economic impact of using high-dose influenza vaccine on respiratory and circulatory plus respiratory hospitalizations of older adults in Australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440578/
52977,"Matrix Protein 2 Vaccination and Protection against Influenza Viruses, Including Subtype H5N1",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725899/
52978,Estimation of Influenza Vaccine Effectiveness from Routine Surveillance Data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2658741/
52979,Two novel HLA-A*0201 T-cell epitopes in avian H5N1 viral nucleoprotein induced specific immune responses in HHD mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2820229/
52980,A global perspective of maternal influenza immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243657/
52981,Application of Traditional Vaccine Development Strategies to SARS-CoV-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413721/
52982,mSystems. 2023 Mar-Apr; 8(2): e00927-22. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134813/
52983,Broadly Protective Adenovirus-Based Multivalent Vaccines against Highly Pathogenic Avian Influenza Viruses for Pandemic Preparedness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640067/
52984,"A study of acceptance and hesitation factors towards tetanus, diphtheria, and acellular pertussis (Tdap) and influenza vaccines during pregnancy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372311/
52985,Understanding parental vaccine refusal: Implicit and explicit associations about vaccines as potential building blocks of vaccine beliefs and behavior,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374490/
52986,Influenza Vaccination Strategies in Healthcare Workers: A Cohort Study (2018–2021) in an Italian University Hospital,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473239/
52987,Is seasonal vaccination a contributing factor to the selection of influenza epidemic variants?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861807/
52988,Characterization of the Efficacy of a Split Swine Influenza A Virus Nasal Vaccine Formulated with a Nanoparticle/STING Agonist Combination Adjuvant in Conventional Pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675483/
52989,Vaccine effect of recombinant single-chain hemagglutinin protein as an antigen,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327749/
52990,Association between the 2008–09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring–Summer 2009: Four Observational Studies from Canada,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850386/
52991,"Willingness, refusal and influential factors of parents to vaccinate their children against the COVID-19: A systematic review and meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861629/
52992,"Interim Estimates of 2018–19 Seasonal Influenza Vaccine Effectiveness — United States, February 2019",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375657/
52993,A Prospective Study of the Factors Shaping Antibody Responses to the AS03-Adjuvanted Influenza A/H1N1 Vaccine in Cancer Outpatients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316930/
52994,Factors Associated with COVID-19 Vaccine Hesitancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004673/
52995,A dual purpose universal influenza vaccine candidate confers protective immunity against anthrax,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290250/
52996,Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659679/
52997,Vaccine-Induced Immunity Elicited by Microneedle Delivery of Influenza Ectodomain Matrix Protein 2 Virus-like Particle (M2e VLP)-Loaded PLGA Nanoparticles,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341628/
52998,Do People Who Intend to Get a Flu Shot Actually Get One?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787941/
52999,Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321569/
53000,Risk Factors and Attack Rates of Seasonal Influenza Infection: Results of the Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance (SHIVERS) Seroepidemiologic Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006182/
53001,NS-based Live Attenuated H1N1 Pandemic Vaccines Protect Mice and Ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991506/
53002,Mark Mulligan leads Emory swine flu vaccine trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735905/
53003,Practice and Child Characteristics Associated with Influenza Vaccine Uptake in Young Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673003/
53004,Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357706/
53005,"Establishment of a TaqMan-based real-time quantitative PCR method for detection of exogenous fowl adenovirus type Ⅰ, type Ⅲ and avian leukosis virus in human cold adapted live attenuated influenza vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10703828/
53006,Safety and Immunogenicity of Multimeric-001 (M-001) Followed by Seasonal Quadrivalent Inactivated Influenza Vaccine in Young Adults – A Randomized Clinical Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396309/
53007,Intranasal Immunization of Mice to Avoid Interference of Maternal Antibody against H5N1 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900595/
53008,Advances in gene-based vaccine platforms to address the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789827/
53009,Structural insights into the broad protection against H1 influenza viruses by a computationally optimized hemagglutinin vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126545/
53010,"Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20–64 years, 2007–2011",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781205/
53011,Challenges of influenza A viruses in humans and animals and current animal vaccines as an effective control measure,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795040/
53012,MicroRNA-Based Attenuation of Influenza Virus across Susceptible Hosts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752925/
53013,Imprinting and Editing of the Human CD4 T Cell Response to Influenza Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514101/
53014,"Genetic Structure of Human A/H1N1 and A/H3N2 Influenza Virus on Corsica Island: Phylogenetic Analysis and Vaccine Strain Match, 2006–2010",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173375/
53015,"Seroprevalence of pandemic (H1N1) 2009 influenza and effectiveness of 2010/2011 influenza vaccine during 2010/2011 season in Beijing, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941694/
53016,"Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638338/
53017,"Genetic and Antigenic Characterization of an Influenza A(H3N2) Outbreak in Cambodia and the Greater Mekong Subregion during the COVID-19 Pandemic, 2020",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610588/
53018,Eliciting B cell immunity against infectious diseases using nanovaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855692/
53019,Probiotics for preventing acute upper respiratory tract infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400717/
53020,Current prospects and future challenges for nasal vaccine delivery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287317/
53021,Subdominance in Antibody Responses: Implications for Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709521/
53022,"Laypersons’ perception of common cold and influenza prevention—a qualitative study in Austria, Belgium and Croatia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853228/
53023,Vaccine strain affects seroconversion after influenza vaccination in COPD patients and healthy older people,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786852/
53024,Lung Homing CTLs and Their Proliferation Ability are Important Correlates of Vaccine Protection against Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269910/
53025,"Factors associated with influenza vaccination coverage and willingness in the elderly with chronic diseases in Shenzhen, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746395/
53026,"Beliefs, attitudes and barriers associated with the uptake of the seasonal influenza vaccine among patients visiting primary healthcare clinics",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146252/
53027,Protein and modified vaccinia virus Ankara‐based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588771/
53028,Antibody-dependent NK cell degranulation as a marker for assessing antibody-dependent cytotoxicity against pandemic 2009 influenza A(H1N1) infection in human plasma and influenza-vaccinated transchromosomic bovine intravenous immunoglobulin therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113754/
53029,Survey of State Practices During the 2004–2005 Influenza Vaccine Shortage,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1847493/
53030,"Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653685/
53031,Influenza Vaccination Campaign during the COVID-19 Pandemic: The Experience of a Research and Teaching Hospital in Milan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198860/
53032,Strategies for fighting pandemic virus infections: Integration of virology and drug delivery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810279/
53033,"Relative Efficacy of AS03-Adjuvanted Pandemic Influenza A(H1N1) Vaccine in Children: Results of a Controlled, Randomized Efficacy Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111912/
53034,Boosting Heterosubtypic Neutralization Antibodies in Recipients of 2009 Pandemic H1N1 Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243653/
53035,"Effectiveness of seasonal influenza vaccine against clinically diagnosed influenza over 2 consecutive seasons in children in Guangzhou, China: A matched case-control study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906272/
53036,"Influenza and morbidity and mortality risk in patients in Mexico with systemic arterial hypertension alone or with comorbidities: a retrospective, observational, cross-sectional study from 2014 to 2020",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685964/
53037,Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177275/
53038,A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847613/
53039,Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040413/
53040,Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965371/
53041,Potential recombinant vaccine against influenza A virus based on M2e displayed on nodaviral capsid nanoparticles,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396508/
53042,"Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283457/
53043,Suboptimal Effectiveness of the 2011–2012 Seasonal Influenza Vaccine in Adult Korean Populations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376859/
53044,Evaluation of Vaccine Immunogenicity—Correlates to Real-World Protection: Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10975834/
53045,Granzyme B ELISPOT assay to measure influenza-specific cellular immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840047/
53046,Investing in Immunity: Prepandemic Immunization to Combat Future Influenza Pandemics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314213/
53047,Co-immunization with tandem repeat heterologous M2 extracellular proteins overcomes strain-specific protection of split vaccine against influenza A virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560976/
53048,Strong influenza-induced TFH generation requires CD4 effectors to recognize antigen locally and receive signals from continuing infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872786/
53049,Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458178/
53050,New Vaccine Platforms—Novel Dimensions of Economic and Societal Value and Their Measurement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10974797/
53051,Effectiveness of influenza vaccination for preventing influenza-related complications in people with asthma: a systematic review protocol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823396/
53052,Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965360/
53053,COVID-19 Vaccine Hesitancy in a Representative Education Sector Population in Qatar,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235273/
53054,The effect of influenza vaccine in reducing the severity of clinical outcomes in patients with COVID-19: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395333/
53055,"The State of Science, Microbiology, and Vaccines Circa 1918",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2862332/
53056,Influenza hemagglutinin head domain mimicry by rational design,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704708/
53057,"Influenza and pneumococcal vaccine uptake among nursing home residents in Nottingham, England: a postal questionnaire survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2413222/
53058,Review on the effects of influenza vaccination during pregnancy on preterm births,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685674/
53059,Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2346510/
53060,Artificial Intelligence Applied to in vitro Gene Expression Testing (IVIGET) to Predict Trivalent Inactivated Influenza Vaccine Immunogenicity in HIV Infected Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569088/
53061,Cost effectiveness of school-located influenza vaccination programs for elementary and secondary school children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591987/
53062,Vaccination Confidence among Healthcare Workers: Results from Two Anamnestic Questionnaires Adopted in the COVID-19 and Influenza Campaign,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697632/
53063,Does influenza vaccination help reduce incidence of COVID-19 infection among hospital employees?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757937/
53064,Influenza Anti-Stalk Antibodies: Development of a New Method for the Evaluation of the Immune Responses to Universal Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158664/
53065,"Low awareness of influenza vaccination among pregnant women and their obstetricians: a population-based survey in Beijing, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930072/
53066,Determinants of COVID-19 vaccine acceptance in healthcare workers in Iran: National Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395894/
53067,A/H1N1 hemagglutinin antibodies show comparable affinity in vaccine-related Narcolepsy type 1 and control and are unlikely to contribute to pathogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893011/
53068,The Impact and Vaccination Coverage of Seasonal Influenza among Children Aged 6–59 Months in China in 2017–2018: An Internet Panel Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031834/
53069,Spontaneous glycan reattachment following N-glycanase treatment of influenza and HIV vaccine antigens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241686/
53070,Persistent Antibody Clonotypes Dominate the Serum Response to Influenza Over Multiple Years and Repeated Vaccinations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417944/
53071,Safety and immunogenicity of a novel quadrivalent subunit influenza vaccine in animal models,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734080/
53072,Mucosal poly IC improves protection elicited by replicating influenza vaccines via enhanced dendritic cell function and T cell immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111144/
53073,The US Military Commitment to Vaccine Development: A Century of Successes and Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021486/
53074,An influenza virus vector candidate vaccine stably expressing SARS-CoV-2 receptor-binding domain produces high and long-lasting neutralizing antibodies in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181763/
53075,"Influenza vaccination effectiveness for people aged under 65 years in Japan, 2013/2014 season: application of a doubly robust method to a large-scale, real-world dataset",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612174/
53076,BMC Infect Dis. 2019; 19: 709. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691521/
53077,Predicting the short-term success of human influenza virus variants with machine learning,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209065/
53078,Improving Influenza Vaccination Coverage in the Pediatric Asthma Population: The Case for Combined Methodologies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257031/
53079,Hemagglutinin inhibition antibody responses to commercial equine influenza vaccines in vaccinated horses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877680/
53080,The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685526/
53081,Potential impact of influenza vaccine roll-out on antibiotic use in Africa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054263/
53082,B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224597/
53083,Vaccine-Preventable Hospitalisations from Seasonal Respiratory Diseases: What Is Their True Value?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220863/
53084,"Willingness to accept a future influenza A(H7N9) vaccine in Beijing, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115431/
53085,"COVID-19 vaccine intentions in the United States, a social-ecological framework",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7945864/
53086,"Safety, Reactogenicity, and Health-Related Quality of Life After Trivalent Adjuvanted vs Trivalent High-Dose Inactivated Influenza Vaccines in Older Adults: A Randomized Clinical Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809592/
53087,Nasal spray live attenuated influenza vaccine: the first experience in Italy in children and adolescents during the 2020–21 season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590342/
53088,Exploring Prime-Boost Vaccination Regimens with Different H1N1 Swine Influenza A Virus Strains and Vaccine Platforms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699596/
53089,Febrile seizures after 2009 influenza A (H1N1) vaccination and infection: a nationwide registry-based study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640112/
53090,Does the availability of influenza vaccine at prenatal care visits and of immediate vaccination improve vaccination coverage of pregnant women?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675112/
53091,A signal detection method for temporal variation of adverse effect with vaccine adverse event reporting system data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506615/
53092,"Assessing the Relationship Between Seasonal and H1N1 Influenza Vaccination Status in Michigan Children, 2009–2010",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113432/
53093,Progression and Trends in Virus from Influenza A to COVID-19: An Overview of Recent Studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232279/
53094,"Waning Vaccine Effectiveness Against Influenza-Associated
Hospitalizations Among Adults, 2015–2016 to 2018–2019, United States
Hospitalized Adult Influenza Vaccine Effectiveness Network",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499703/
53095,Cost-Effectiveness of 2009 Pandemic Influenza A(H1N1) Vaccination in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146485/
53096,Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115023/
53097,Medical students’ attitude towards influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419496/
53098,Concurrent administration of COVID-19 and influenza vaccines enhances Spike-specific antibody responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515870/
53099,Open Forum Infect Dis. 2024 Apr; 11(4): ofae144. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10986856/
53100,Adherence to Vaccines in Adult Patients with Immune-Mediated Inflammatory Diseases: A Two-Year Prospective Portuguese Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056318/
53101,Broad Humoral and Cellular Immunity Elicited by a Bivalent DNA Vaccine Encoding HA and NP Genes from an H5N1 Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034638/
53102,Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473581/
53103,A Single-Dose Influenza A (H5N1) Vaccine Safe and Immunogenic in Adult and Elderly Patients: an Approach to Pandemic Vaccine Development ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812344/
53104,Increasing influenza vaccination rates via low cost messaging interventions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812620/
53105,Expanding global and national influenza vaccine systems to match the COVID-19 pandemic response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577667/
53106,Adjuvant Formulations for Virus-Like Particle (VLP) Based Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673579/
53107,"WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061925/
53108,"Influenza-Like-Illness and Clinically Diagnosed Flu: Disease Burden, Costs and Quality of Life for Patients Seeking Ambulatory Care or No Professional Care at All",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102549/
53109,Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173218/
53110,The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427073/
53111,Influenza vaccination in Western Australian children: Exploring the health benefits and cost savings of increased vaccine coverage in children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613898/
53112,Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287261/
53113,Antibody responses induced by trivalent inactivated influenza vaccine among pregnant and non-pregnant women in Thailand: A matched cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189519/
53114,Magnitude and breadth of antibody cross-reactivity induced by recombinant influenza hemagglutinin trimer vaccine is enhanced by combination adjuvants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163070/
53115,Preferential Amplification of CD8 Effector-T Cells after Transcutaneous Application of an Inactivated Influenza Vaccine: A Randomized Phase I Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877091/
53116,Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the “von Magnus effect”,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830746/
53117,Understanding the barriers to uptake of antenatal vaccination by women from culturally and linguistically diverse backgrounds: A cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067853/
53118,Tailored Vaccines Targeting the Elderly Using Whole Inactivated Influenza Vaccines Bearing Cytokine Immunomodulators,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924801/
53119,Assessing Optimal Target Populations for Influenza Vaccination Programmes: An Evidence Synthesis and Modelling Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793005/
53120,"Influenza vaccine effectiveness against laboratory-confirmed influenza in hospitalised adults aged 60 years or older, Valencia Region, Spain, 2017/18 influenza season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685101/
53121,A micro-sterile inflammation array as an adjuvant for influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391636/
53122,Immunogenicity Measures of Influenza Vaccines: A Study of 1164 Registered Clinical Trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350243/
53123,Reinfection With SARS-CoV-2: Implications for Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799323/
53124,Identifying Missed Opportunities for Routine Vaccination among People Who Use Drugs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913920/
53125,Cellular Interferon Gamma and Granzyme B Responses to Cytomegalovirus-pp65 and Influenza N1 Are Positively Associated in Elderly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827302/
53126,COVID-19 vaccines: The status and perspectives in delivery points of view,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759095/
53127,Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134565/
53128,"Emerging trends of edible vaccine therapy for combating human diseases especially COVID‐19: Pros, cons, and future challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347755/
53129,Recombinant Vectors as Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115000/
53130,Vaccines and cardiovascular outcomes: lessons learned from influenza epidemics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021491/
53131,Flublok Quadrivalent Vaccine Adjuvanted with R-DOTAP Elicits a Robust and Multifunctional CD4 T Cell Response That Is of Greater Magnitude and Functional Diversity Than Conventional Adjuvant Systems,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10975948/
53132,"Safety, equity and monitoring: a review of the gaps in maternal vaccination strategies for Aboriginal and Torres Strait Islander women",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062431/
53133,"A phase IIb study to determine the safety and efficacy of candidate
INfluenza
Vaccine MVA-NP+M1 in combination with licensed
Ina
CTivated infl
Uenza vaccine in adult
S aged 65 years and above (INVICTUS): a study protocol",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014788/
53134,Assessing direct and indirect effects of pediatric influenza vaccination in Germany by individual-based simulations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227695/
53135,The impact of COVID‐19 on hospital‐based workers influenza vaccination uptake: A two‐year retrospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748491/
53136,J Occup Health. 2023 Jan-Dec; 65(1): e12394. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158767/
53137,Targeting the HA2 subunit of influenza A virus hemagglutinin via CD40L provides universal protection against diverse subtypes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269809/
53138,Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686712/
53139,An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619166/
53140,Modified Vaccinia Virus Ankara Encoding Influenza Virus Hemagglutinin Induces Heterosubtypic Immunity in Macaques,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249095/
53141,T resident helper cells promote humoral responses in the lung,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063390/
53142,Association of Influenza Vaccination Coverage in Younger Adults With Influenza-Related Illness in the Elderly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614413/
53143,"Comparison of influenza and COVID-19 hospitalisations in British Columbia, Canada: a population-based study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895913/
53144,"The Safety of mRNA-1273, BNT162b2 and JNJ-78436735 COVID-19 Vaccines: Safety Monitoring for Adverse Events Using Real-World Data",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879025/
53145,Socioeconomic privilege and political ideology are associated with racial disparity in COVID-19 vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379950/
53146,Body height and immune efficacy: testing body stature as a signal of biological quality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543236/
53147,"Severity of influenza illness by seasonal influenza vaccination status among hospitalised patients in four South American countries, 2013–19: a surveillance-based cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876808/
53148,Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550859/
53149,"Changes of influenza vaccination rate and associated influencing factors after the COVID-19 pandemic in Shanghai, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10841022/
53150,The Effect of Income Disparities on Influenza Vaccination Coverage in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730181/
53151,"Impact of a multi-component antenatal vaccine promotion package on improving knowledge, attitudes and beliefs about influenza and Tdap vaccination during pregnancy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994750/
53152,An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175216/
53153,Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319039/
53154,Vaccine Hesitancy among Master’s Degree Students in Nursing and Midwifery: Attitude and Knowledge about Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579204/
53155,Influenza Vaccines: A Moving Interdisciplinary Field,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213563/
53156,Multi-COBRA hemagglutinin formulated with cGAMP microparticles elicit protective immune responses against influenza viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10925245/
53157,Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514405/
53158,Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773654/
53159,Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017–2018 influenza season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126676/
53160,Structural basis of protection against H7N9 influenza virus by human anti-N9 neuraminidase antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908751/
53161,Obesity Outweighs Protection Conferred by Adjuvanted Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981723/
53162,"Protein-Based Adjuvants for Vaccines as Immunomodulators of the Innate and Adaptive Immune Response: Current Knowledge, Challenges, and Future Opportunities",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414397/
53163,Influenza Vaccine Effectiveness in Households With Children During the 2012–2013 Season: Assessments of Prior Vaccination and Serologic Susceptibility,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462665/
53164,Has the COVID-19 Pandemic Changed Parental Attitudes and Beliefs Regarding Vaccinating Their Children against the Flu?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611412/
53165,Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803737/
53166,"Vaccine hesitancy among communities in ten countries in Asia, Africa, and South America during the COVID-19 pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132408/
53167,A choice experiment assessment of stated early response to COVID-19 vaccines in the USA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968243/
53168,Acquired immune responses to the seasonal trivalent influenza vaccination in COPD,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718283/
53169,"Nasal delivery of H5N1 avian influenza vaccine formulated with GenJet™ or in vivo-jetPEI® induces enhanced serological, cellular and protective immune responses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058713/
53170,A Synthetic Micro-Consensus DNA Vaccine Generates Comprehensive Influenza A H3N2 Immunity and Protects Mice Against Lethal Challenge by Multiple H3N2 Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152850/
53171,Cell-free production of trimeric influenza hemagglutinin head domain proteins as vaccine antigens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542462/
53172,"Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza
Vaccine, MVA-NP+M1, in Humans",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369564/
53173,Clin Infect Dis. 2019 Jul 1; 69(1): 195. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579951/
53174,The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151550/
53175,"Coverage and Timing of Influenza Vaccination Among Privately Insured Pregnant Women in the United States, 2010-2018",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257513/
53176,Plant-Derived Recombinant Vaccines against Zoonotic Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878793/
53177,Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216430/
53178,Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287747/
53179,Socio-Psychological Factors Driving Adult Vaccination: A Qualitative Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260791/
53180,PLoS One. 2015; 10(3): e0119893. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367984/
53181,"A matter of trust: a qualitative comparison of the determinants of COVID-19 vaccine hesitancy in Taiwan, the United States, the Netherlands, and Haiti",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225662/
53182,Maintenance of Increased Childhood Influenza Vaccination Rates 1 Year After an Intervention in Primary Care Practices,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311666/
53183,Immunogenicity and Toxicity of Different Adjuvants Can Be Characterized by Profiling Lung Biomarker Genes After Nasal Immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516075/
53184,Optimising age coverage of seasonal influenza vaccination in England: A mathematical and health economic evaluation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567368/
53185,Trends in racial/ethnic disparities in influenza vaccination coverage among adults during the 2007-08 through 2011-12 seasons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822446/
53186,Alternative Live-Attenuated Influenza Vaccines Based on Modifications in the Polymerase Genes Protect against Epidemic and Pandemic Flu ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2863734/
53187,"The Immune Signatures data resource, a compendium of systems vaccinology datasets",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584267/
53188,The mucosal and systemic immune responses elicited by a chitosan‐adjuvanted intranasal influenza H5N1 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942079/
53189,The Expected Number of Background Disease Events during Mass Immunization in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748117/
53190,Promotion of flu vaccination among healthcare workers in an Italian academic hospital: An experience with tailored web tools,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085013/
53191,Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312188/
53192,An Economic Comparison of Influenza Vaccines Recommended for Use in Eligible Adults under 65 Years in the United Kingdom,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025244/
53193,Investigation of non-National Immunization Program vaccination intentions in rural areas of China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401748/
53194,COVID-19 vaccination hesitancy and associated factors among solid organ transplant recipients in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903951/
53195,Essential Oils and Their Compounds as Potential Anti-Influenza Agents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693178/
53196,Influenza B Viruses Exhibit Lower Within-Host Diversity than Influenza A Viruses in Human Hosts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7022338/
53197,"Protein Nanoparticle-Mediated Delivery of Recombinant
Influenza Hemagglutinin Enhances Immunogenicity and Breadth of the
Antibody Response",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926493/
53198,Cross-Reactive Neuraminidase Antibodies Afford Partial Protection against H5N1 in Mice and Are Present in Unexposed Humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1796909/
53199,Cellular and Humoral Immune Responses to Pandemic Influenza Vaccine in Healthy and in Highly Active Antiretroviral Therapy-Treated HIV Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505053/
53200,Improving seasonal and pandemic influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634120/
53201,Vaccination take-up and health: Evidence from a flu vaccination program for the elderly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524524/
53202,"Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110975/
53203,Structural insights into key sites of vulnerability on HIV-1 Env and Influenza HA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479221/
53204,Label‐free mass spectrometry‐based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781000/
53205,Low influenza vaccine uptake by healthcare workers caring for the elderly in South African old age homes and primary healthcare facilities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834679/
53206,Industry steps up efforts to develop avian flu vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1285131/
53207,Acceptance of coronavirus disease 2019 (COVID-19) vaccines among healthcare workers: A meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525162/
53208,mRNA vaccines: A novel weapon to control infectious diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576954/
53209,Impact of video-led educational intervention on the uptake of influenza vaccine among adults aged 60 years and above in China: a study protocol for a randomized controlled trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839176/
53210,"Increased genetic variation of A(H3N2) virus from influenza surveillance at the end of the 2016/2017 season for Shanghai port, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556717/
53211,"Global respiratory virus surveillance: strengths, gaps, and way forward",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107382/
53212,"Knowledge, attitudes, and practices regarding vaccination among community pharmacists",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309755/
53213,Viruses to fight other viruses: the influenza vaccine case,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207152/
53214,PB1 as a potential target for increasing the breadth of T-cell mediated immunity to Influenza A,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054373/
53215,In Vivo Assessment of NS1-Truncated Influenza Virus with a Novel SLSYSINWRH Motif as a Self-Adjuvanting Live Attenuated Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366013/
53216,Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274347/
53217,The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452325/
53218,"Reverse genetics for influenza B viruses and recent advances in
vaccine development",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693393/
53219,"Influenza B virus infections in Western Saxony, Germany in three consecutive seasons between 2015 and 2018: Analysis of molecular and clinical features",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115636/
53220,Sublingual vaccination with influenza virus protects mice against lethal viral infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2234198/
53221,Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case series,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343247/
53222,Modified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian ‘avian-like’ H1N1 swine viruses in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181486/
53223,Kinetic of the Antibody Response Following AddaVax-Adjuvanted Immunization with Recombinant Influenza Antigens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415944/
53224,A global agenda for older adult immunization in the COVID-19 era: A roadmap for action,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332930/
53225,2009 H1N1 Influenza: A Twenty-First Century Pandemic With Roots in the Early Twentieth Century,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119454/
53226,A Competitive Hemagglutination Inhibition Assay for Dissecting Functional Antibody Activity against Influenza Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577348/
53227,"Progress in Vaccine-Preventable and Respiratory Infectious Diseases—First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006–2015",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038744/
53228,"Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334936/
53229,"Tetanus, Diphtheria, and Acellular Pertussis and Influenza
Vaccinations among Women With a Live Birth, Internet Panel Survey,
2017-2018",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011328/
53230,"A randomized controlled trial of antibody response to 2019–20
cell-based inactivated and egg-based live attenuated influenza vaccines in
children and young adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803136/
53231,Optimizing Vaccine Allocation at Different Points in Time during an Epidemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978681/
53232,Inactivated vaccines. 1. Volunteer studies with very high doses of influenza vaccine purified by zonal ultracentrifugation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2495385/
53233,Summary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2495385/
53234,Advances in the design and development of SARS-CoV-2 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674100/
53235,"Will they, or Won't they? Examining patients' vaccine intention for flu and COVID-19 using the Health Belief Model",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833824/
53236,Influenza vaccination in cancer patients receiving immune checkpoint inhibitors: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365730/
53237,The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385234/
53238,Strategies to Achieve the Healthy People 2020 Annual Influenza Vaccine Coverage Goal for Health-Care Personnel: Recommendations from the National Vaccine Advisory Committee,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514716/
53239,"Influenza illness averted by influenza vaccination among school year children in Beijing, 2013‐2016",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6185895/
53240,mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877136/
53241,"COVID-19 Vaccine Acceptance in a Sample From the United Arab Emirates General Adult Population: A Cross-Sectional Survey, 2020",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350048/
53242,Molecular and cellular signatures of human vaccine adjuvants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483233/
53243,Recent Developments in Vaccine Design: From Live Vaccines to Recombinant Toxin Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536331/
53244,Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115484/
53245,Current Vaccine Platforms in Enhancing T-Cell Response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413345/
53246,Long-Lasting Mucosal and Systemic Immunity against Influenza A Virus Is Significantly Prolonged and Protective by Nasal Whole Influenza Immunization with Mucosal Adjuvant N3 and DNA-Plasmid Expressing Flagellin in Aging In- and Outbred Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789645/
53247,Influenza B virus infection and Stevens–Johnson syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628912/
53248,Intention to get vaccinated against COVID-19 among the general population in France: Associated factors and gender disparities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437523/
53249,The safety of inactivated influenza vaccines in pregnancy for birth outcomes: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605784/
53250,"Nursing knowledge, attitude, and practice to influenza vaccination at suburban hospital in West Java, Indonesia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225651/
53251,Limits of the social-benefit motive among high-risk patients: a field experiment on influenza vaccination behaviour,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027065/
53252,Broadly neutralizing antibodies suggest new prospects to counter highly antigenically diverse viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600854/
53253,CD154 expression is associated with neutralizing antibody titer levels post- Influenza vaccination in stem cell transplant patients and healthy adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933414/
53254,"Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126971/
53255,Effectiveness of Seasonal Influenza Vaccination in Children in Senegal During a Year of Vaccine Mismatch: A Cluster-randomized Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821165/
53256,Effects of MS disease-modifying therapies on responses to vaccinations: A review.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395588/
53257,Coalition Shaping the Vaccination Landscape,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783736/
53258,Impact of the COVID-19 pandemic on routine vaccine landscape: A global perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294763/
53259,Influenza vaccination motivators among healthcare personnel in a large acute care hospital in Israel,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080682/
53260,"United States Centers for Disease Control and Prevention support for influenza surveillance, 2013–2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178423/
53261,"A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134758/
53262,Broadly Inhibiting Antineuraminidase Monoclonal Antibodies Induced by Trivalent Influenza Vaccine and H7N9 Infection in Humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997757/
53263,"Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576519/
53264,Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged ≥ 65 Years in the US during the 2019–20 Influenza Season—A Retrospective Cohort Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540032/
53265,Moving the Needle on Atherosclerotic Cardiovascular Disease and Heart Failure with Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528654/
53266,The new generation of messenger RNA (mRNA) vaccines against influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315338/
53267,"Protecting the Offspring, the Gift of Maternal Immunization: Current Status and Future Perspectives",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692240/
53268,Is this the end of the line for flu vaccine as we know it?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1119870/
53269,Langerhans cells and cDC1s play redundant roles in mRNA-LNP induced protective anti-influenza and anti-SARS-CoV-2 immune responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812972/
53270,Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2021–2022,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448463/
53271,Supplementation of inactivated influenza vaccine with norovirus P particle-M2e chimeric vaccine enhances protection against heterologous virus challenge in chickens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289506/
53272,Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151135/
53273,"Out-of-Season Influenza during a COVID-19 Void in the State of Rio de Janeiro, Brazil: Temperature Matters",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143486/
53274,30-Year Development of Inactivated Virus Vaccine in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10748258/
53275,Superior antigen-specific CD4+T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138369/
53276,Transmission dynamics of seasonal influenza in a remote island population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068240/
53277,"Preference of influenza vaccination among the elderly population in Shaanxi province, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381797/
53278,Matrix M Adjuvanted H5N1 Vaccine Elicits Broadly Neutralizing Antibodies and Neuraminidase Inhibiting Antibodies in Humans That Correlate With In Vivo Protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650010/
53279,Development and characterization of influenza M2 ectodomain and/or hemagglutinin stalk-based dendritic cell-targeting vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393625/
53280,Antigenic Fingerprinting of H5N1 Avian Influenza Using Convalescent Sera and Monoclonal Antibodies Reveals Potential Vaccine and Diagnostic Targets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2661249/
53281,"Uptake and impact of vaccinating primary school children against influenza: Experiences in the fourth season of the live attenuated influenza vaccination programme, England, 2016/2017",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692804/
53282,"Influenza and Influenza-Like Respiratory Virus Infections in Children During the 2019/20 Influenza Season and the COVID-19 Pandemic in Poland: Data from the National Influenza Centre, the Department of Influenza Research at the National Institute of Public Health, and 16 Voivodeship Sanitary and Epidemiological Stations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675239/
53283,Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659201/
53284,B cell responses to the 2011/12-influenza vaccine in the aged,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629292/
53285,Knowledge and Willingness toward Vaccination among Pregnant Women: Comparison between Pertussis and Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658401/
53286,Flu Vaccine—Too Much of a Good Thing?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853256/
53287,Mass Spectrometric Characterization of Narcolepsy-Associated Pandemic 2009 Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712488/
53288,Did the H1N1 Vaccine Reduce the Risk of Admission with Influenza and Pneumonia during the Pandemic?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658136/
53289,"Influenza Epidemiology and Vaccine Effectiveness among Patients with Influenza-Like Illness, Viral Watch Sentinel Sites, South Africa, 2005–2009",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988097/
53290,To Be or Not to Be Vaccinated? The Ethical Aspects of Influenza Vaccination among Healthcare Workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844122/
53291,An In Vitro Microneutralization Assay for Influenza Virus Serology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298957/
53292,Curr Protoc. 2022 Sep; 2(9): e567. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117922/
53293,Patient reported outcome data following influenza A (H1N1p) vaccination in the 2009–2010 season: web-based and telephone evaluation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208407/
53294,Peptides for Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384901/
53295,Virus-like particle (VLP)-based vaccines for pandemic influenza: Performance of a VLP vaccine during the 2009 influenza pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426084/
53296,Influenza and Pregnancy: A Review of the Literature from India,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355110/
53297,Efficacy in Pigs of Inactivated and Live Attenuated Influenza Virus Vaccines against Infection and Transmission of an Emerging H3N2 Similar to the 2011-2012 H3N2v,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754103/
53298,Factory's loss of licence halves supply of flu vaccine to US,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC523142/
53299,"New Immunoinformatics Tools for Swine: Designing Epitope-Driven Vaccines, Predicting Vaccine Efficacy, and Making Vaccines on Demand",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571332/
53300,"Prospective cohort study of influenza vaccine effectiveness among healthcare personnel in Lima, Peru: Estudio Vacuna de Influenza Peru, 2016‐2018",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298283/
53301,Associations between Influenza Vaccination and Health Care Access among Adults in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958667/
53302,Immunogenicity of influenza H1N1 vaccination in mixed connective tissue disease: effect of disease and therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584286/
53303,Influenza and Pertussis Maternal Vaccination Coverage and Influencing Factors in Spain: A Study Based on Primary Care Records Registry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998305/
53304,Adjuvanted influenza vaccine dynamics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329778/
53305,Taming influenza viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223391/
53306,Differences in the influenza-specific CD4 T cell immunodominance hierarchy and functional potential between children and young adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349841/
53307,Trivalent and quadrivalent influenza vaccination effectiveness in Australia and South Africa: results from a modelling study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910176/
53308,High Influenza Vaccine Effectiveness and Absence of Increased Influenza-like-Illness Epidemic Activity in the 2021–2022 Influenza Season in Catalonia (Spain) Based on Surveillance Data Collected by Sentinel Pharmacies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783856/
53309,Immunogenicity and safety of influenza vaccination in patients with juvenile idiopathic arthritis on biological therapy using the microneutralization assay,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547451/
53310,Patterns of influenza B circulation in Brazil and its relevance to seasonal vaccine composition,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110561/
53311,Clinician perspectives on strategies to improve patient maternal immunization acceptability in obstetrics and gynecology practice settings,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067872/
53312,Evaluation of the Efficacy and Cross-Protectivity of Recent Human and Swine Vaccines against the Pandemic (H1N1) 2009 Virus Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2793524/
53313,Vaccines from the Spanish Influenza as a firm foundation for new developments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553681/
53314,"Whole-genome sequencing reveals origin and evolution of influenza A(H1N1)pdm09 viruses in Lincang, China, from 2014 to 2018",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314029/
53315,Long-Term Immunogenicity of an Inactivated Split-Virion 2009 Pandemic Influenza A H1N1 Virus Vaccine with or without Aluminum Adjuvant in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340896/
53316,"Influenza vaccination rates, knowledge, attitudes and behaviours of healthcare workers in Turkey: A multicentre study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435504/
53317,Fear of Influenza Resurgence amid COVID-19 Pandemic: Need for Effective Flu Vaccine Still Exists,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538357/
53318,Influenza and Other Prophylactic Vaccination Coverage in Polish Adult Patients Undergoing Allergen Immunotherapy—A Survey Study among Patients and Physicians,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027432/
53319,Vaccination of health‐care workers against influenza: our obligation to protect patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780654/
53320,Effectiveness of influenza vaccines in adults with chronic liver disease: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731888/
53321,Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769292/
53322,Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine in Individuals at High Risk of Influenza Complications in the 2018–2019 United States Influenza Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314952/
53323,Prevalence of influenza and pneumococcal vaccine uptake in Saudi type 2 diabetic individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618205/
53324,Maternal vaccines during the Covid-19 pandemic:A qualitative interview study with UK pregnant women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192261/
53325,Current clinical status of new COVID-19 vaccines and immunotherapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442597/
53326,Measurement of Cellular Immune Response to Viral Infection and Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604353/
53327,Independent Protection and Influence of the Spike-Specific Antibody Response of SARS-CoV-2 Nucleocapsid Protein (N) in Whole-Virion Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675215/
53328,Reference antigen-free and antibody-free LTD-IDMS assay for influenza H7N9 vaccine in vitro potency determination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413694/
53329,"Fourth meeting of the Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) network and first scientific conference on acute respiratory infections in the Eastern Mediterranean Region, 11-14 December, 2017, Amman, Jordan",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102791/
53330,Using Influenza Vaccination Location Data from the 2018 Behavioral Risk Factor Surveillance System (BRFSS) to Expand COVID-19 Vaccination Coverage,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345551/
53331,Recombinant Vesicular Stomatitis Virus Expressing Influenza Nucleoprotein Induces CD8 T-Cell Responses That Enhance Antibody-Mediated Protection after Lethal Challenge with Influenza Virus ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668267/
53332,"A Mixed-Methods Study to Evaluate Elementary School Staff’s Acceptability, Delivery Challenges, and Communication Regarding the Implementation of School-Located Influenza Vaccination Program in Hong Kong",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540161/
53333,"Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668902/
53334,Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853904/
53335,Assessing the Presence of IgG Antibodies against Influenza Viruses in Neonates after Maternal Vaccination and Factors That May Affect the Transplacental Transfer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660699/
53336,Vaccine efficacy and immune interference: co-administering COVID-19 and influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598211/
53337,Influenza Reverse Genetics—Historical Perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015701/
53338,Higher PIK3C2B gene expression of H1N1+ specific B-cells is associated with lower H1N1 immunogenicity after trivalent influenza vaccination in HIV infected children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714025/
53339,Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092830/
53340,J Virol. 2022 Oct; 96(19): e01358-22. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555160/
53341,Principles underlying rational design of live attenuated influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623510/
53342,Reverse genetics approaches for the development of new vaccines against influenza A virus infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755736/
53343,A Nationwide Survey on the Hospital Vaccination Policies in Korea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105507/
53344,Meeting report narcolepsy and pandemic influenza vaccination: What we know and what we need to know before the next pandemic? A report from the 2nd IABS meeting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668612/
53345,Effects of influenza vaccination on the risk of cardiovascular and respiratory diseases and all-cause mortality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365105/
53346,Association between vaccination coverage decline and influenza incidence rise among Italian elderly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051463/
53347,"Influenza risk groups in Norway by education and employment
status",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361423/
53348,Uptake of Influenza Vaccine and Factors Associated with Influenza Vaccination among Healthcare Workers in Tertiary Care Hospitals in Bangladesh: A Multicenter Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966774/
53349,Self-report compared to electronic medical record across eight adult vaccines: Do results vary by demographic factors?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689428/
53350,Chimeric Virus-like Particles Co-Displaying Hemagglutinin Stem and the C-Terminal Fragment of DnaK Confer Heterologous Influenza Protection in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610613/
53351,Economic Analysis of Pandemic Influenza Vaccination Strategies in Singapore,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743808/
53352,"Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3, Derived from the Bonobo Pan paniscus",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594242/
53353,Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411004/
53354,"COVID-19 Vaccine Hesitancy in Israel Immediately Before the Vaccine
Operation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235256/
53355,RNA Vaccines against Infectious Diseases: Vital Progress with Room for Improvement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622374/
53356,Serologically-Based Evaluation of Cross-Protection Antibody Responses among Different A(H1N1) Influenza Strains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712556/
53357,Further Studies of the Neuraminidase Content of Inactivated Influenza Vaccines and the Neuraminidase Antibody Responses After Vaccination of Immunologically Primed and Unprimed Populations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC551225/
53358,Summary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC551225/
53359,Vaccination Strategies Based on Bacterial Self-Assembling Proteins as Antigen Delivery Nanoscaffolds,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696568/
53360,Cognizance of posttranslational modifications in vaccines: A way to enhanced immunogenicity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427110/
53361,The effect of H1N1 vaccination on serum miRNA expression in children: A tale of caution for microRNA microarray studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701777/
53362,Vaccinating the German Population Aged 60 Years and Over with a Quadrivalent High-Dose Inactivated Influenza Vaccine Compared to Standard-Dose Vaccines: A Transmission and Budget Impact Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570167/
53363,Investigating confounding in network‐based test‐negative design influenza vaccine effectiveness studies—Experience from the DRIVE project,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835455/
53364,Antibody Responses to Influenza A/H1N1pdm09 Virus After Pandemic and Seasonal Influenza Vaccination in Healthcare Workers: A 5-Year Follow-up Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336911/
53365,Predicting antigenic variants of H1N1 influenza virus based on epidemics and pandemics using a stacking model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303045/
53366,Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967455/
53367,Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287697/
53368,Sci Rep. 2022; 12: 16540. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530115/
53369,Direct-to-adolescent text messaging for vaccine reminders: What will parents permit?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347477/
53370,Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330385/
53371,Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007555/
53372,"Seasonal Influenza Vaccine: Uptake, Attitude, and Knowledge Among Patients Receiving Immunoglobulin Replacement Therapy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846511/
53373,"COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment – Meeting report from an isirv-WHO virtual conference",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684224/
53374,Influenza H3 hemagglutinin vaccine with scrambled immunodominant epitopes elicits antibodies directed toward immunosubdominant head epitopes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470489/
53375,"Have Diagnostics, Therapies, and Vaccines Made the Difference in the Pandemic Evolution of COVID-19 in Comparison with “Spanish Flu”?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384375/
53376,Provider Knowledge of Trivalent Inactivated and High-Dose Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194210/
53377,"Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626850/
53378,Efficacy Studies of Influenza Vaccines: Effect of End Points Used and Characteristics of Vaccine Failures,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069734/
53379,A review of the safety of vaccines used in routine immunization in Africa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750064/
53380,The use of RNA-based treatments in the field of cancer immunotherapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401791/
53381,"Seasonal influenza vaccine coverage among high-risk populations in Thailand, 2010–2012",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610807/
53382,Original Antigenic Sin Responses to Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460008/
53383,Comparison of a frailty short interview to a validated frailty index in adults hospitalized for acute respiratory illness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564875/
53384,Protection against Multiple Subtypes of Influenza Viruses by Virus-Like Particle Vaccines Based on a Hemagglutinin Conserved Epitope,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4341857/
53385,A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707880/
53386,Chronic obstructive pulmonary disease and influenza vaccination effect in preventing outpatient and inpatient influenza cases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940916/
53387,"Vaccination: Adherence and Hesitancy among Pregnant Women for COVID-19, Pertussis, and Influenza Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11054588/
53388,Seasonal influenza vaccination in patients with COPD: a systematic literature review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415833/
53389,“Intention to receive COVID-19 vaccine among healthcare workers: a comparison between two surveys”,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342594/
53390,Disparities in influenza vaccination: Arab Americans in California,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932900/
53391,Distribution anomalies hinder access to flu vaccine in the US,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1283226/
53392,Burden of seasonal influenza in the Swiss adult population during the 2016/2017–2018/2019 influenza seasons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667819/
53393,Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493492/
53394,Memory CD4 T cells in Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339101/
53395,"SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143972/
53396,Living with HIV and Getting Vaccinated: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220625/
53397,"Countering vaccine hesitancy through immunization information systems, a narrative review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930057/
53398,"Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801641/
53399,Euro Surveill. 2018 Jul 26; 23(30): 1807261. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153430/
53400,"Determinants of low uptake of vaccination against influenza, measles, and hepatitis B among healthcare professionals in Greece: a multicenter cross-sectional study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733957/
53401,Absence of cross‐reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months–9 years: a prospective study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941649/
53402,Identification of the properties of H5 influenza vaccine viruses with high hemagglutinin yields,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858889/
53403,Development and characterization of a panel of cross-reactive monoclonal antibodies generated using H1N1 influenza virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124281/
53404,Tailored Interventions to Increase Influenza Vaccination in Neighborhood Health Centers Serving the Disadvantaged,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1448037/
53405,Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676311/
53406,Commentary—Anatomy of Racial Disparity in Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1361155/
53407,Vaccination coverage during pregnancy and factors associated with refusal of recommended vaccinations: An Italian cross sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11016930/
53408,"Losing ground at the wrong time: trends in self-reported influenza vaccination uptake in Switzerland, Swiss Health Survey 2007–2017",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875279/
53409,Inactivated Influenza Vaccine Efficacy: Diminished Antigenicity of Split-Product Vaccines in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC423107/
53410,Summary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC423107/
53411,Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48/80 adjuvant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514371/
53412,Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326941/
53413,System Complexity in Influenza Infection and Vaccination: Effects upon Excess Winter Mortality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149983/
53414,Covid-19 vaccination in pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363819/
53415,Market implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550479/
53416,Influenza vaccine response in community-dwelling German prefrail and frail individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501346/
53417,Depletion-of-susceptibles bias in influenza vaccine waning studies: how to ensure robust results,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003633/
53418,"The 2017–2018 influenza season in Bucharest, Romania: epidemiology and characteristics of hospital admissions for influenza-like illness",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852761/
53419,Contributing factors to influenza vaccine uptake in general hospitals: an explorative management questionnaire study from the Netherlands,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545720/
53420,VLPs containing stalk domain and ectodomain of matrix protein 2 of influenza induce protection in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972598/
53421,mRNA vaccines in disease prevention and treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509165/
53422,Considerations of strategies to provide influenza vaccine year round,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218336/
53423,Enhancing Immune Response and Heterosubtypic Protection Ability of Inactivated H7N9 Vaccine by Using STING Agonist as a Mucosal Adjuvant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777483/
53424,Molecular Characterization of In Vivo Adjuvant Activity in Ferrets Vaccinated against Influenza Virus  ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919000/
53425,Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712758/
53426,"LTA1 is a safe, intranasal enterotoxin-based adjuvant that improves vaccine protection against influenza in young, old and B-cell-depleted (μMT) mice",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805908/
53427,Digital Media Exposure and Health Beliefs Influencing Influenza Vaccination Intentions: An Empirical Research in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695165/
53428,Sex-based Biology and the Rational Design of Influenza Vaccination Strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157517/
53429,Parents’ Experience and Views of Vaccinating Their Child against Influenza at Primary School and at the General Practice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923664/
53430,Combined Administration of MF59-Adjuvanted A/H5N1 Prepandemic and Seasonal Influenza Vaccines: Long-Term Antibody Persistence and Robust Booster Responses 1 Year after a One-Dose Priming Schedule,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647761/
53431,Structural and genetic basis for development of broadly neutralizing influenza antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095019/
53432,The Association between Levels of Trust in the Healthcare System and Influenza Vaccine Hesitancy among College Students in Israel,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674655/
53433,Patient reminder and recall interventions to improve immunization rates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491344/
53434,A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364787/
53435,A mixed methods study of seasonal influenza vaccine hesitancy in adults with chronic respiratory conditions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404050/
53436,Development of high-yield influenza A virus vaccine viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569720/
53437,The Race for Global Equitable Access to COVID-19 Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412387/
53438,"Association between COVID-19 and Seasonal Influenza Vaccines to Vaccine Hesitancy, Intolerance of Uncertainty and Mental Health",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959542/
53439,Influenza vaccination coverage in pediatric population in Italy: an analysis of recent trends,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109451/
53440,Influenza-associated thrombotic microangiopathies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153504/
53441,Preventing Influenza: Vaccine Systems and Practices in the Southeast,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781910/
53442,"Determinants of compliance to influenza and COVID-19 vaccination in a cohort of solid organ transplant patients in Puglia, Southern Italy (2017–2022)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580794/
53443,Beliefs and Attitudes about Influenza Immunization among Parents of Children with Chronic Medical Conditions over a Two-Year Period,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2438592/
53444,Identification of Barriers Limiting the Use of Preventive Vaccinations against Influenza among the Elderly Population: A Cross-Sectional Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143662/
53445,Overcoming Aging-Associated Poor Influenza Vaccine Responses with CpG 1018 Adjuvant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695697/
53446,Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905419/
53447,Assessment of the Variability in Influenza A(H1N1) Vaccine Effectiveness Estimates Dependent on Outcome and Methodological Approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244414/
53448,A global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357765/
53449,"Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784929/
53450,Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcγR-dependent protection in vivo,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622865/
53451,Awareness of influenza and pneumococcal vaccines in diabetic patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104465/
53452,"Impact of Immune Priming, Vaccination, and Infection on Influenza A(H3N2) Antibody Landscapes in Children",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145779/
53453,Two years of on-site influenza vaccination strategy in an Italian university hospital: main results and lessons learned,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973379/
53454,Influenza and the Vocal Performer: Update on Prevention and Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135439/
53455,Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for ‘Universal’ Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914524/
53456,Encephalitis after influenza and vaccination: a nationwide population-based registry study from Norway,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313985/
53457,"Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750613/
53458,Gamma-Irradiated Influenza A Virus Provides Adjuvant Activity to a Co-Administered Poorly Immunogenic SFV Vaccine in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050334/
53459,Attitudes of influenza‐vaccinated health care workers toward masks to prevent nosocomial transmission of influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941655/
53460,Broadly neutralizing antibodies against influenza viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987986/
53461,"Immunization with matrix-, nucleoprotein and neuraminidase protects against H3N2 influenza challenge in pH1N1 pre-exposed pigs",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930017/
53462,Self-reported vaccination-related behavior patterns among healthcare workers and the association with self-directed learning frequency: A nationwide cross-sectional survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634157/
53463,Is the impact of childhood influenza vaccination less than expected: a transmission modelling study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387286/
53464,Association of Host Factors With Antibody Response to Seasonal Influenza Vaccination in Allogeneic Hematopoietic Stem Cell Transplant Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016469/
53465,Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511278/
53466,Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760593/
53467,Discussions about preventive services: a qualitative study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2551594/
53468,Development and Regulation of Novel Influenza Virus Vaccines: A United States Young Scientist Perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027304/
53469,Improving influenza vaccination uptake among healthcare workers by on-site influenza vaccination campaign in a tertiary children hospital,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605858/
53470,Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168719/
53471,"Decreased ratio of influenza-specific IgG versus IgM in response to influenza vaccination in antiretroviral-treated HIV-infected African Americans compared to Caucasians, and its direct correlation with the percentages of peripheral Tfh cells",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333243/
53472,Immune-engineered H7N9 influenza hemagglutinin improves protection against viral influenza virus challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553694/
53473,Hexon-modified Recombinant E1-deleted Adenovirus Vectors as Dual Specificity Vaccine Carriers for Influenza Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589160/
53474,Variability is its specialty,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1299234/
53475,Site-specific glycosylation profile of influenza A (H1N1) hemagglutinin through tandem mass spectrometry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861804/
53476,Long Term Persistence of IgE Anti-Influenza Virus Antibodies in Pediatric and Adult Serum Post Vaccination with Influenza Virus Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065793/
53477,Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097467/
53478,Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729430/
53479,Decreased influenza vaccination coverage among Chinese healthcare workers during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547087/
53480,Experience and attitudes on vaccinations recommended during pregnancy: survey on an Italian sample of women and consultant gynecologists,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920149/
53481,Intranasal Immunization Using Mannatide as a Novel Adjuvant for an Inactivated Influenza Vaccine and Its Adjuvant Effect Compared with MF59,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215226/
53482,"Influenza Vaccination Coverage Among Pregnant Women — United States, 2012–13 Influenza Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585537/
53483,Influenza Vaccination Coverage among Adults in Korea: 2008–2009 to 2011–2012 Seasons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276607/
53484,Sustained Low Influenza Vaccination Rates in US Healthcare Workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2839028/
53485,Influenza vaccination among cancer survivors: disparities in prevalence between blacks and whites,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545640/
53486,Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762609/
53487,M2e-Displaying Virus-Like Particles with Associated RNA Promote T Helper 1 Type Adaptive Immunity against Influenza A,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601086/
53488,Program cost analysis of influenza vaccination of health care workers in Albania,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621071/
53489,Association between Influenza Vaccination and the Risk of Bell’s Palsy in the Korean Elderly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310133/
53490,"Impact of Communicative and Informative Strategies on Influenza Vaccination Adherence and Absenteeism from Work of Health Care Professionals Working at the University Hospital of Palermo, Italy: A Quasi-Experimental Field Trial on Twelve Influenza Seasons",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158659/
53491,Influenza vaccination in patients affected by diabetes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021494/
53492,Earliest infections predict the age distribution of seasonal influenza A cases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367686/
53493,Gulllain-Barre Syndrome After Trivalent Influenza Vaccination in Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667925/
53494,Influenza and Workplace Productivity Loss in Working Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982836/
53495,"Frequent Genetic Mismatch between Vaccine Strains and Circulating Seasonal Influenza Viruses, Hong Kong, China, 1996–2012",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154132/
53496,"Current and next-generation formulation strategies for inactivated polio vaccines to lower costs, increase coverage, and facilitate polio eradication",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891683/
53497,Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554235/
53498,Sex-based differences in immune function and responses to vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447843/
53499,Vaccines in a hurry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172988/
53500,Do Vaccines Have a Role as a Cause of Autoimmune Neurological Syndromes?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399175/
53501,Factors Influencing the Intention and Uptake of COVID-19 Vaccines on the African Continent: A Scoping Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146577/
53502,Forecasting demand for maternal influenza immunization in low- and lower-middle-income countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014664/
53503,Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105652/
53504,Maternal influenza vaccine strategies in Kenya: Which approach would have the greatest impact on disease burden in pregnant women and young infants?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746219/
53505,Recommended vaccinations for asplenic and hyposplenic adult patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328222/
53506,"Fighting Flu: Military Pathology, Vaccines, and the Conflicted Identity of the 1918–19 Pandemic in Britain",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574600/
53507,Effectiveness of Seasonal Influenza Vaccines against Influenza-Associated Illnesses among US Military Personnel in 2010–11: A Case-Control Approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409214/
53508,Inactivated Whole Virus Particle Influenza Vaccine Induces Anti-Neuraminidase Antibodies That May Contribute to Cross-Protection against Heterologous Virus Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147865/
53509,"Trends in Influenza Vaccine Coverage in Pregnant Women, 2008 to 2012",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662276/
53510,Acceptability of COVID-19 vaccination in Saudi Arabia: A cross-sectional study using a web-based survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437496/
53511,CpG dinucleotide enrichment in the influenza A virus genome as a live attenuated vaccine development strategy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191365/
53512,A study of Chitosan and c‐di‐GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634239/
53513,Willingness to accept H1N1 pandemic influenza vaccine: A cross-sectional study of Hong Kong community nurses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988052/
53514,Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514375/
53515,Dust or disease? Perceptions of influenza in rural Southern Malawi,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476467/
53516,Influenza During the 2010–2020 Decade in the United States: Seasonal Outbreaks and Vaccine Interventions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619714/
53517,Values for preventing influenza-related morbidity and vaccine adverse events in children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1083419/
53518,Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621378/
53519,A comparison of the intradermal and subcutaneous routes of influenza vaccination with A/New Jersey/76 (swine flu) and A/Victoria/75: report of a study and review of the literature.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1619316/
53520,Summary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1619316/
53521,New theoretical ISM-K2 Bayesian network model for evaluating vaccination effectiveness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253264/
53522,"In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610676/
53523,A Systematic Review of Behaviour Change Techniques within Interventions to Increase Vaccine Uptake among Ethnic Minority Populations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386142/
53524,Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196842/
53525,"Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494249/
53526,Health education and factors influencing acceptance of and willingness to pay for influenza vaccination among older adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620638/
53527,Relationship of influenza virus infection to associated infections in children who present with influenza-like symptoms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912778/
53528,Modelling the population effectiveness of the national seasonal influenza vaccination programme in Scotland: The impact of targeting all individuals aged 65 years and over,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586176/
53529,Estimating Direct and Indirect Protective Effect of Influenza Vaccination in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860220/
53530,Association of recent respiratory illness and influenza with acute myocardial infarction among the Bangladeshi population: A case–control study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10753452/
53531,Effectiveness and Cost-Effectiveness of Expanded Antiviral Prophylaxis and Adjuvanted Vaccination Strategies for the Next Influenza Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428215/
53532,Estimating influenza attack rates in the United States using a participatory cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894435/
53533,Monitoring the safety of influenza A/H1N1 pandemic and seasonal vaccines in Morocco,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968976/
53534,Potential Consequences of Not Using Live Attenuated Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610050/
53535,Can we achieve high uptakes of influenza vaccination of healthcare workers in hospitals? A cross-sectional survey of acute NHS trusts in England,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151164/
53536,"Early season estimate of influenza vaccination effectiveness against influenza hospitalisation in children, Hong Kong, winter influenza season 2018/19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386215/
53537,Prenatal care providers’ perceptions of the SARS-Cov-2 vaccine for themselves and for pregnant women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437278/
53538,Toward a broadly protective influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2542858/
53539,Oseltamivir treatment of influenza A and B infections in infants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404048/
53540,The Influenza Imperative: An Urgent Need to Leverage Lessons from COVID-19 to Prepare for a Global Response to Seasonal and Pandemic Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875850/
53541,The Negative Effect of Preexisting Immunity on Influenza Vaccine Responses Transcends the Impact of Vaccine Formulation Type and Vaccination History,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891420/
53542,Finding a new drug and vaccine for emerging swine flu: What is the concept?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747336/
53543,"Equine Vaccines: How, When and Why? Report of the Vaccinology Session, French Equine Veterinarians Association, 2016, Reims",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748612/
53544,Incorporating Real-time Influenza Detection Into the Test-negative Design for Estimating Influenza Vaccine Effectiveness: The Real-time Test-negative Design (rtTND),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096266/
53545,Influenza vaccination among caregivers and household contacts of children with congenital heart disease before and during COVID‐19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662015/
53546,"The impact of influenza infection on young children, their family and the health care system",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304317/
53547,Immunogenicity and efficacy of replication-competent recombinant influenza virus carrying multimeric M2 extracellular domains in a chimeric hemagglutinin conjugate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5699712/
53548,Female-biased effects of aging on a chimeric hemagglutinin stalk-based universal influenza virus vaccine in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178415/
53549,"Natural History of Influenza B Virus—Current Knowledge on Treatment, Resistance and Therapeutic Options",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10814056/
53550,UK will reserve bird flu vaccine for health workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1388121/
53551,Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2022–2023,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10729780/
53552,Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431709/
53553,Impact of video education on influenza vaccination in pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827704/
53554,Available evidence and potential for vaccines for reduction in antibiotic prescriptions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762846/
53555,"Effectiveness of the quadrivalent inactivated influenza vaccine in Japan during the 2015–2016 season: A test-negative case-control study comparing the results by real time PCR, virus isolation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668230/
53556,Pandemic influenza vaccination during pregnancy: An investigation of vaccine uptake during the 2009/10 pandemic vaccination campaign in Great Britain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903914/
53557,Next Generation Mucosal Vaccine Strategy for Respiratory Pathogens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611113/
53558,Sweep Dynamics (SD) plots: Computational identification of selective sweeps to monitor the adaptation of influenza A viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762865/
53559,Acceptance and attitudes toward COVID-19 vaccines: A cross-sectional study from Jordan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064595/
53560,Antibody Titer Has Positive Predictive Value for Vaccine Protection against Challenge with Natural Antigenic-Drift Variants of H5N1 High-Pathogenicity Avian Influenza Viruses from Indonesia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403412/
53561,Design of the Recombinant Influenza Neuraminidase Antigen Is Crucial for Its Biochemical Properties and Protective Efficacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610580/
53562,"Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325326/
53563,Better Understanding Adult COVID-19 Vaccination Hesitancy and Refusal: The Influence of Broader Beliefs about Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180283/
53564,"Maternal vaccination—current status, challenges, and opportunities",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100318/
53565,Vaccinations against respiratory infections in Arabian Gulf countries: Barriers and motivators,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480069/
53566,"Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135375/
53567,Burden of influenza infection in hospitalised children below 6 months of age and above in Hong Kong from 2005 to 2011,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355210/
53568,Perception and Attitudes of Korean Obstetricians about Maternal Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900997/
53569,A Mathematical Modeling Study: Assessing Impact of Mismatch Between Influenza Vaccine Strains and Circulating Strains in Hajj,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778428/
53570,Bull Math Biol. 2022; 84(8): 83. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486152/
53571,"Knowledge, perception and maternal immunisation practices of obstetricians in Singapore for the Tdap and influenza vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801839/
53572,Pandemic influenza preparedness: The critical role of the syringe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115405/
53573,Influenza Vaccination among Multiple Sclerosis Patients during the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612003/
53574,Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732283/
53575,Benefits and Effectiveness of Administering Pneumococcal Polysaccharide Vaccine With Seasonal Influenza Vaccine: An Approach for Policymakers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489371/
53576,Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706389/
53577,The impact of the COVID-19 pandemic on parents’ perceptions and acceptance of routine childhood vaccination in Canada: A national longitudinal study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684123/
53578,"Estimated Influenza Illnesses and Hospitalizations Averted by Vaccination — United States, 2013–14 Influenza Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584537/
53579,"Assessment of Human Immune Responses to H7 Avian Influenza Virus of Pandemic Potential: Results from a Placebo–Controlled, Randomized Double–Blind Phase I Study of Live Attenuated H7N3 Influenza Vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922724/
53580,Strategies for mitigating an influenza pandemic with pre-pandemic H5N1 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2842780/
53581,Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105657/
53582,Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489290/
53583,Immune Imprinting in the Influenza Ferret Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348859/
53584,"Evaluating Pilot Implementation of ‘PenCS Flu Topbar’ App in Medical Practices to Improve National Immunisation Program–Funded Seasonal Influenza Vaccination in Central Queensland, Australia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11019295/
53585,"Confronting the next pandemic—Workshop on lessons learned from potency testing of pandemic (H1N1) 2009 influenza vaccines and considerations for future potency tests, Ottawa, Canada, July 27–29, 2010",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780660/
53586,Bioprocess Engineering Issues That Would Be Faced in Producing a DNA Vaccine at up to 100 m3 Fermentation Scale for an Influenza Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161863/
53587,Polymeric nanoparticle vaccines to combat emerging and pandemic threats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834201/
53588,Preclinical evaluation of Vaxfectin®-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901827/
53589,Mitochondria-dependent synthetic small-molecule vaccine adjuvants for influenza virus infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201894/
53590,What If the Influenza Vaccine Did Not Offer Such Variable Protection?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459138/
53591,"Anxiety disorders, COVID-19 fear, and vaccine hesitancy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233868/
53592,Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549097/
53593,"Generation and Protective Ability of Influenza Virus–Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996149/
53594,A review of factors influencing vaccination policies and programs for older adults globally,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980618/
53595,Influenza Vaccine Uptake in the United States before and during the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612058/
53596,Influenza Vaccination of Patients With Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270765/
53597,Adenovirus delivery of encoded monoclonal antibody protects against different types of influenza virus infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347565/
53598,Self-Amplifying Pestivirus Replicon RNA Encoding Influenza Virus Nucleoprotein and Hemagglutinin Promote Humoral and Cellular Immune Responses in Pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877248/
53599,Cross-Lineage Influenza B and Heterologous Influenza A Antibody Responses in Vaccinated Mice: Immunologic Interactions and B/Yamagata Dominance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382187/
53600,COVID-19’s Impact on Willingness to Be Vaccinated against Influenza and COVID-19 during the 2020/2021 Season: Results from an Online Survey of Canadian Adults 50 Years and Older,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065823/
53601,"Influenza vaccine supply, 2005–2006: did we come up short?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1871587/
53602,Influenza epidemiology and influenza vaccine effectiveness during the 2016–2017 season in the Global Influenza Hospital Surveillance Network (GIHSN),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498567/
53603,"Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605815/
53604,Integrating pharmacies into public health program planning for pandemic influenza vaccine response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206751/
53605,An epitope-optimized human H3N2 influenza vaccine induces broadly protective immunity in mice and ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226166/
53606,Influenza and pneumococcal vaccinations are not associated to COVID-19 outcomes among patients admitted to a university hospital,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106908/
53607,Impact of Oseltamivir Treatment on Influenza A and B Virus Dynamics in Human Volunteers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957053/
53608,Antigenic evolution of H9N2 chicken influenza viruses isolated in China during 2009–2013 and selection of a candidate vaccine strain with broad cross-reactivity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029119/
53609,Immunogenicity of Influenza Virus Vaccine Is Increased by Anti-Gal-Mediated Targeting to Antigen-Presenting Cells ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1951452/
53610,"Safety and immunogenicity of a quadrivalent, inactivated, split-virion influenza vaccine (IIV4-W) in healthy people aged 3-60 years: a phase III randomized clinical noninferiority trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621009/
53611,Current and Novel Approaches in Influenza Management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630949/
53612,The status of COVID-19 vaccines in India: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126226/
53613,Insurance Reimbursements for Routinely Recommended Adult Vaccines in the Private Sector,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732785/
53614,Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115651/
53615,The Cost of Universal Influenza Vaccination of Children in Pediatric Practices,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936456/
53616,What College Biology Students Know about How Vaccines Work,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727621/
53617,Preventive effects of influenza and pneumococcal vaccination in the elderly – results from a population-based retrospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115600/
53618,Homologous PB1 gene promotes the replication efficiency of avian influenza H7N4 candidate vaccine virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983892/
53619,Protective efficacy of crude virus‐like particle vaccine against HPAI H5N1 in chickens and its application on DIVA strategy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941755/
53620,"The Dutch influenza vaccination policy and medication use, outpatient visits, hospitalization and mortality at age 65",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183360/
53621,Information nudges for influenza vaccination: Evidence from a large-scale cluster-randomized controlled trial in Finland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870595/
53622,The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052681/
53623,The Economic Value of a Quadrivalent versus Trivalent Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696129/
53624,From COVID-19 vaccine candidates to compulsory vaccination: The attitudes of Italian citizens in the key 7-month of vaccination campaign,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981525/
53625,A new approach to estimate vaccine efficacy based on immunogenicity data applied to influenza vaccines administered by the intradermal or intramuscular routes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056065/
53626,"Surveillance for Severe Acute Respiratory Infections among Hospitalized Subjects from 2015/2016 to 2019/2020 Seasons in Tuscany, Italy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067855/
53627,A Comparison of Plasmid DNA and mRNA as Vaccine Technologies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631684/
53628,Gamma-Irradiated Influenza Virus Uniquely Induces IFN-I Mediated Lymphocyte Activation Independent of the TLR7/MyD88 Pathway,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3187801/
53629,Vaccines: Shaping global health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127343/
53630,Who knew? Awareness of being recommended for influenza vaccination among US adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292703/
53631,"A Universal Influenza Vaccine: The Strategic Plan for the National Institute
of Allergy and Infectious Diseases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279170/
53632,Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394856/
53633,Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1613227/
53634,Broadly Protective Neuraminidase-Based Influenza Vaccines and Monoclonal Antibodies: Target Epitopes and Mechanisms of Action,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861061/
53635,Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574046/
53636,Modification of innate immune responses to Bordetella pertussis in babies from pertussis vaccinated pregnancies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517834/
53637,"Regulation of Antinucleoprotein IgG by Systemic Vaccination and Its Effect on Influenza Virus Clearance

",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126167/
53638,Phylogenetic analysis of the human antibody repertoire reveals quantitative signatures of immune senescence and aging,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293037/
53639,Membrane-bound IL-12 and IL-23 serve as potent mucosal adjuvants when co-presented on whole inactivated influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036309/
53640,Evaluation of Vaccines for H5N1 Influenza Virus in Ferrets Reveals the Potential for Protective Single-Shot Immunization ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708649/
53641,Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387531/
53642,Immunogenetics of Seasonal Influenza Vaccine Response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2610683/
53643,"Effect of Broccoli Sprouts and Live Attenuated Influenza Virus on Peripheral Blood Natural Killer Cells: A Randomized, Double-Blind Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731143/
53644,Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466103/
53645,Overview of Tools and Measures Investigating Vaccine Hesitancy in a Ten Year Period: A Scoping Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412526/
53646,Flexible Label-Free Quantitative Assay for Antibodies to Influenza Virus Hemagglutinins  ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944469/
53647,Validation of self‐reported influenza vaccination in the current and prior season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6185882/
53648,Factors contributing to racial disparities in influenza vaccinations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447231/
53649,Influenza Pandemic Vaccines: Spread Them Thin?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1892043/
53650,Influenza Vaccine Hesitancy in Patients with Multiple Sclerosis: A Monocentric Observational Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301852/
53651,Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194875/
53652,Is It Possible to Develop a “Universal” Influenza Virus Vaccine?: Immunogenetic Considerations Underlying B-Cell Biology in the Development of a Pan-Subtype Influenza A Vaccine Targeting the Hemagglutinin Stem,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028068/
53653,"Cell-Based Quadrivalent Inactivated Influenza
Virus Vaccine (Flucelvax® Tetra/Flucelvax
Quadrivalent®): A Review in the Prevention of
Influenza",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874518/
53654,Drugs. 2019; 79(18): 2009. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943396/
53655,Comparative Pathology of Animal Models for Influenza A Virus Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10820042/
53656,The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879794/
53657,Influenza vaccine hesitancy in a low-income community in central New York State,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186041/
53658,Potential business model for a European vaccine R&D infrastructure and its estimated socio-economic impact,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10828550/
53659,Report of the Influenza Vaccination Program in Mexico (2006–2022) and Proposals for Its Improvement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675656/
53660,Antibody and Cell-Mediated Immune Responses Are Correlates of Protection against Influenza Infection in Vaccinated Older Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825602/
53661,"Influenza Vaccination Uptake and Associated Factors Among Adults With and Without Human Immunodeficiency Virus in a Large, Integrated Healthcare System",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320060/
53662,Coronavirus (SARS-CoV-2): a systematic review for potential vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920137/
53663,"Influenza returns with a season dominated by clade 3C.2a1b.2a.2 A(H3N2) viruses, WHO European Region, 2021/22",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012087/
53664,Multiple Vaccines and Strategies for Pandemic Preparedness of Avian Influenza Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459121/
53665,"Influenza vaccination during pregnancy: a qualitative study of the knowledge, attitudes, beliefs, and practices of general practitioners in Central and South-Western Sydney",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038848/
53666,"A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2129324/
53667,Summary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2129324/
53668,Policy perspectives on post pandemic influenza vaccination in Ghana and Malawi,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331702/
53669,Seasonal Influenza Vaccination during Pregnancy and the Risks of Preterm Delivery and Small for Gestational Age Birth,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813306/
53670,Aspects of Phage-Based Vaccines for Protein and Epitope Immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967953/
53671,"Cell-based influenza vaccine: current production, halal status assessment, and recommendations towards Islamic-compliant manufacturing",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189117/
53672,Effect of Vaccines and Antivirals during the Major 2009 A(H1N1) Pandemic Wave in Norway – And the Influence of Vaccination Timing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254636/
53673,Tapping the immunological imprints to design chimeric SARS-CoV-2 vaccine for elderly population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127164/
53674,Cost-effectiveness of adult vaccinations: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545890/
53675,Interpretative immune targets and contemporary position for vaccine development against SARS‐CoV‐2: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753271/
53676,Association of Consecutive Influenza Vaccinations and Pneumonia: A Population-Based Case-Control Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466194/
53677,Paradox of Vaccination: Is Vaccination Really Effective against Avian Flu Epidemics?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657368/
53678,"The national burden of influenza‐associated severe acute respiratory illness hospitalization in Zambia, 2011‐2014",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818337/
53679,The influenza vaccine for nursing and care professionals at emergency services in Flanders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475615/
53680,The estimated age-group specific influenza vaccine coverage rates in Hong Kong and the impact of the school outreach vaccination program,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920126/
53681,Effect of text message communication on patient presentation for an influenza vaccination in a community-based pharmacy setting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281456/
53682,Clinical and immunologic predictors of influenza illness among vaccinated older adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948951/
53683,Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147846/
53684,ADCC: An underappreciated correlate of cross-protection against influenza?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992787/
53685,Incidence of Influenza Virus Infection among Wroclaw’s Healthcare Workers in Pre-COVID-19 2019–2020 Influenza Season Using Novel Flu SensDx Device,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954534/
53686,Live attenuated influenza vaccine use and safety in children and adults with asthma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6674979/
53687,High immunogenicity of plant-produced candidate influenza vaccine based on the M2e peptide fused to flagellin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878292/
53688,Equitable and effective vaccine access considering vaccine hesitancy and capacity constraints,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199497/
53689,"Epidemiology of the 2012 influenza season in Victoria, Australia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854100/
53690,A Lower Level of Post-Vaccinal Antibody Titer against Influenza Virus A H1N1 May Protect Patients with Autoimmune Rheumatic Diseases from Respiratory Viral Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780273/
53691,Vaccine Hesitancy in North Carolina: The Elephant in the Room?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039715/
53692,"‘COVID Is Coming, and I’m Bloody Scared’: How Adults with Co-Morbidities’ Threat Perceptions of COVID-19 Shape Their Vaccination Decisions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957419/
53693,Association of Prior Vaccination With Influenza Vaccine Effectiveness in Children Receiving Live Attenuated or Inactivated Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324442/
53694,Drivers of the Intention to Receive a COVID-19 Booster Vaccine: Insights from the UK and Australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607201/
53695,Impact of Influenza Vaccination on Mortality in the Oldest Old: A Propensity Score-Matched Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564344/
53696,Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510460/
53697,Combining Influenza and COVID-19 Booster Vaccination Strategy to Improve Vaccination Uptake Necessary for Managing the Health Pandemic: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860577/
53698,Seasonal influenza vaccination in the Americas: Progress and challenges during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247885/
53699,"Sufficient Sleep, Time of Vaccination, and Vaccine Efficacy: A
Systematic Review of the Current Evidence and a Proposal for COVID-19
Vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235253/
53700,RSAD2 Is an Effective Target for High-Yield Vaccine Production in MDCK Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695692/
53701,"The use of nonhuman primates in research on seasonal, pandemic and avian influenza, 1893–2014",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462516/
53702,Changes in Immunization Program Managers' Perceptions of Programs' Functional Capabilities During and After Vaccine Shortages and pH1N1,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187306/
53703,A review of the sustainability of vaccine funding across Europe and implications for post-COVID policymaking,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364713/
53704,Cross-sectional survey of older peoples' views related to influenza vaccine uptake,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1621069/
53705,Strengthening the Evidence-Based Approach to Guiding Effective Influenza Vaccination Policies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565028/
53706,Active pharmacovigilance of the seasonal trivalent influenza vaccine produced by Instituto Butantan: A prospective cohort study of five target groups,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877614/
53707,Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against it,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742228/
53708,IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4+ T cells for heterosubtypic protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992686/
53709,Computational Design and Analysis of a Multi-epitope Against Influenza A virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435298/
53710,Parental Attitudes and Perceptions of Support after Brief Clinician Intervention Predict Intentions to Accept the Adjuvanted Seasonal Influenza Vaccination: Findings from the Pediatric Influenza Vaccination Optimization Trial (PIVOT)–I,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698621/
53711,Social determinants of pertussis and influenza vaccine uptake in pregnancy: a national cohort study in England using electronic health records,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217954/
53712,"Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture–Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18–65 Years in 2019–2020",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249269/
53713,"Seasonality, mass vaccination and critical policy evaluation on global exit strategy of COVID-19 crisis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985521/
53714,Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659346/
53715,Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441821/
53716,Assessment of enhanced influenza vaccination finds that FluAd conveys an advantage in mice and older adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997034/
53717,The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in Finland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980401/
53718,Adenoviral-vectored universal influenza vaccines administered intranasally reduce lung inflammatory responses upon viral challenge 15 months post-vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617573/
53719,A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721721/
53720,"Association between maternal influenza vaccination and neurodevelopmental disorders in childhood: a longitudinal, population-based linked cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423464/
53721,COVID-19 Vaccine Hesitancy in Healthcare Personnel: A University Hospital Experience,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625899/
53722,Impact of increased influenza vaccination in 2–3-year-old children on disease burden within the general population: A Bayesian model-based approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731690/
53723,Cell-based influenza vaccines: An effective vaccine option for under 60-year-olds,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11099537/
53724,Cost-effectiveness of seasonal inactivated influenza vaccination among pregnant women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721743/
53725,Pneumococcal and Influenza Vaccination Rates and Pneumococcal Invasive Disease Rates Set Geographical and Ethnic Population Susceptibility to Serious COVID-19 Cases and Deaths,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151685/
53726,A Meta‐analysis of intradermal versus intramuscular influenza vaccines: Immunogenicity and Adverse Events,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781005/
53727,"Inhibition of Influenza Virus Polymerase by Interfering
with Its Protein–Protein Interactions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204303/
53728,Prospective randomized open-label comparative study of immunogenicity after subunit and polymeric subunit influenza vaccines administration among mothers and infants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343619/
53729,The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853583/
53730,Guillain–Barré syndrome following influenza vaccination: A 15‐year nationwide population‐based case–control study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804417/
53731,Impact of disease modifying anti-rheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494475/
53732,Prevention of Symptomatic Seasonal Influenza in 2005–2006 by Inactivated and Live Attenuated Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613648/
53733,Using the Past to Maximize the Success Probability of Future Anti-Viral Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712378/
53734,GENE SIGNATURES ASSOCIATED WITH ADAPTIVE HUMORAL IMMUNITY FOLLOWING SEASONAL INFLUENZA A/H1N1 VACCINATION,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133148/
53735,An Investigation of Severe Influenza Cases in Russia during the 2022–2023 Epidemic Season and an Analysis of HA-D222G/N Polymorphism in Newly Emerged and Dominant Clade 6B.1A.5a.2a A(H1N1)pdm09 Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10819184/
53736,Supplementation of H1N1pdm09 split vaccine with heterologous tandem repeat M2e5x virus-like particles confers improved cross-protection in ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713238/
53737,Prevention of Antigenically Drifted Influenza by Inactivated and Live Attenuated Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614682/
53738,"Influenza Antigens NP and M2 Confer Cross Protection to BALB/c Mice against Lethal Challenge with H1N1, Pandemic H1N1 or H5N1 Influenza A Viruses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473317/
53739,Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810685/
53740,Physicians’ awareness and practice toward influenza and pneumococcal vaccines for high-risk patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691468/
53741,"Impact of funding influenza vaccination on coverage among Australian children: a national study using MedicineInsight, a large general practice database",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227683/
53742,A systematic review and meta-analysis of the direct epidemiological and economic effects of seasonal influenza vaccination on healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991711/
53743,Prevalence of and factors associated with receipt of provider recommendation for influenza vaccination and uptake of influenza vaccination during pregnancy: cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549148/
53744,The Benefits To All Of Ensuring Equal And Timely Access To Influenza Vaccines In Poor Communities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385997/
53745,Effectiveness of Adjuvanted Influenza Vaccination in Elderly Subjects in Northern Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447603/
53746,"Coverage and predictors of vaccination against 2012/13 seasonal influenza in Madrid, Spain: Analysis of population-based computerized immunization registries and clinical records",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185897/
53747,Differential localization and function of antibody-forming cells responsive to inactivated or live-attenuated influenza virus vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579181/
53748,"Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744079/
53749,Targeting Imperfect Vaccines against Drug-Resistance Determinants: A Strategy for Countering the Rise of Drug Resistance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723804/
53750,Local and systemic cytokine and chemokine responses after parenteral influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634537/
53751,"Influenza Activity — United States, 2012–13 Season and Composition of the 2013–14 Influenza Vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604847/
53752,A Cell Culture–Derived Influenza Vaccine Provides Consistent Protection Against Infection and Reduces the Duration and Severity of Disease in Infected Individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297649/
53753,Influenza Vaccination Coverage among Registered Nurses in China during 2017–2018: An Internet Panel Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963313/
53754,"Local-Level Adult Influenza and Pneumococcal Vaccination Disparities: Chicago, Illinois, 2015–2016",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844394/
53755,Microneedle-Based Vaccine Delivery: Review of an Emerging Technology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982652/
53756,Predictors of influenza among older adults in the emergency department,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084347/
53757,Racial/ethnic disparities in influenza risk perception and vaccination intention among Pima County residents in Arizona,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762835/
53758,Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States—2019–2020,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664438/
53759,"Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905985/
53760,Self-amplifying mRNA seasonal influenza vaccines elicit mouse neutralizing antibody and cell-mediated immunity and protect ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550923/
53761,The role of vaccines in combatting antimicrobial resistance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861009/
53762,A pooled genome-wide screening strategy to identify and rank influenza host restriction factors in cell-based vaccine production platforms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376217/
53763,"Afriflu2—Second international workshop on influenza vaccination in the African continent—8 November 2012, Cape Town (South Africa)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985472/
53764,Guillain-Barré Syndrome During the 2009–2010 H1N1 Influenza Vaccination Campaign: Population-based Surveillance Among 45 Million Americans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888111/
53765,Influenza Viruses with Rearranged Genomes as Live-Attenuated Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624320/
53766,Circulating inflammatory monocytes contribute to impaired influenza vaccine responses in HIV-infected participants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728748/
53767,Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121810/
53768,"Knowledge, Attitudes and Practices of Flu Vaccination in Hemodialysis Patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912544/
53769,"Vaccine Effectiveness Against Pediatric Influenza-A–Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022–2023 Season: VISION Network",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10954409/
53770,Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638537/
53771,The 2015 global production capacity of seasonal and pandemic influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357707/
53772,The COVID-19 Vaccine and Pregnant Minority Women in the US: Implications for Improving Vaccine Confidence and Uptake,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784552/
53773,Influenza Vaccination Coverage and Intention to Receive Hypothetical Ebola and COVID-19 Vaccines among Medical Students,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310166/
53774,Sex Differences in Influenza: The Challenge Study Experience,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844587/
53775,Waning Immunity and Microbial Vaccines—Workshop of the National Institute of Allergy and Infectious Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498725/
53776,Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906546/
53777,The Power of First Impressions: Can Influenza Imprinting during Infancy Inform Vaccine Design?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563765/
53778,Effectiveness of 2012–2013 influenza vaccine against influenza-like illness in general population: Estimation in a French web-based cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130275/
53779,Public Willingness to Take a Vaccine or Drug Under Emergency Use Authorization during the 2009 H1N1 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998968/
53780,"Prevalence of High Risk Indications for Influenza Vaccine Varies by Age, Race, and Income",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939262/
53781,Vaccine-Associated Anaphylaxis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896995/
53782,Prevalence and Predictors of Seasonal Influenza Vaccine Uptake in Saudi Arabia Post COVID-19: A Web-Based Online Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964926/
53783,Virus detection and its association with symptoms during influenza‐like illness in a sample of healthy adults enrolled in a randomised controlled vaccine trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779839/
53784,Predicting regional influenza epidemics with uncertainty estimation using commuting data in Japan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062106/
53785,Inactivated Eyedrop Influenza Vaccine Adjuvanted with Poly(I:C) Is Safe and Effective for Inducing Protective Systemic and Mucosal Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565664/
53786,DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627301/
53787,How to boost the boosters? A survey-experiment on the effectiveness of different policies aimed at enhancing acceptance of a “Seasonal” vaccination against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251947/
53788,"Knowledge, Attitudes, Perceptions and Vaccination Acceptance/Hesitancy among the Community Pharmacists of Palermo’s Province, Italy: From Influenza to COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949300/
53789,"Guillain-Barré Syndrome After High-Dose Influenza Vaccine Administration in the United States, 2018–2019 Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882024/
53790,Vaccination and Voting Patterns in the U.S.: Analysis of COVID-19 and Flu Surveys From 2010 to 2022,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991323/
53791,VLP‐factory™ and ADDomer©: Self‐assembling Virus‐Like Particle (VLP) Technologies for Multiple Protein and Peptide Epitope Display,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733710/
53792,Curr Protoc. 2022 Aug; 2(8): e552. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536559/
53793,Curr Protoc. 2022 Aug; 2(8): e551. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536557/
53794,Viral Emerging Diseases: Challenges in Developing Vaccination Strategies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494754/
53795,Adherence to and early adverse events of COVID-19 vaccine in a cohort of 600 Italian breastfeeding and pregnant physicians,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746389/
53796,Individual Differences in Self-Regulatory Failure and Menstrual Dysfunction Predict Upper Respiratory Infection Symptoms and Antibody Response to Flu Immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2464776/
53797,"Comparative performance of between-population vaccine allocation
strategies with applications for emerging pandemics",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075509/
53798,Influenza vaccine for children and adults with bronchiectasis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389290/
53799,Differential recognition of influenza A virus H1N1 neuraminidase by DNA vaccine-induced antibodies in pigs and ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258320/
53800,"Examining Influenza Vaccination Patterns and Barriers: Insights into Knowledge, Attitudes, and Practices among Diabetic Adults (A Cross-Sectional Survey)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674532/
53801,The composition of immune cells serves as a predictor of adaptive immunity in a cohort of 50‐ to 74‐year‐old adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913285/
53802,Safety and immunogenicity of a quadrivalent influenza vaccine in adults 65 y of age and older,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612218/
53803,Multifunctional particle-constituted microneedle arrays as cutaneous or mucosal vaccine adjuvant-delivery systems,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994742/
53804,The potential risks and impact of the start of the 2015–2016 influenza season in the WHO European Region: a rapid risk assessment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910174/
53805,"Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812706/
53806,4’-Fluorouridine mitigates lethal infection with pandemic human and highly pathogenic avian influenza viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138230/
53807,Generation of a Genetically Stable High-Fidelity Influenza Vaccine Strain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331824/
53808,“We don’t routinely check vaccination background in adults”: a national qualitative study of barriers and facilitators to vaccine delivery and uptake in adult migrants through UK primary care,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557795/
53809,"Effects of Vaccination and the New Neuraminidase Inhibitor, Laninamivir, on Influenza Infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974732/
53810,Vaccines with the MF59 Adjuvant Do Not Stimulate Antibody Responses against Squalene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1563566/
53811,A broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutinin-specific memory B cells to evolve,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027281/
53812,"High prevalence of IgE sensitization to inactivated influenza vaccines, yet robust IgG4 responses, in a healthy pediatric population",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835421/
53813,An exploratory study to assess patterns of influenza- and pneumonia-related mortality among the Italian elderly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916782/
53814,The importance of influenza vaccination during the COVID‐19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652850/
53815,Influenza and the influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025633/
53816,Influence of Prior Influenza Vaccination on Current Influenza Vaccine Effectiveness in Children Aged 1 to 5 Years,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706378/
53817,"Influenza Vaccine Effectiveness in Preventing Influenza A(H3N2)-Related Hospitalizations in Adults Targeted for Vaccination by Type of Vaccine: A Hospital-Based Test-Negative Study, 2011–2012 A(H3N2) Predominant Influenza Season, Valencia, Spain",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230985/
53818,Dynamic Perspectives on the Search for a Universal Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452315/
53819,Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005(H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512608/
53820,Heterologous viral protein interactions within licensed seasonal influenza virus vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954117/
53821,Influenza Vaccination for Cardiovascular Prevention: Further Insights from the IAMI Trial and an Updated Meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310360/
53822,Intranasal Immunization with Recombinant HA and Mast Cell Activator C48/80 Elicits Protective Immunity against 2009 Pandemic H1N1 Influenza in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098841/
53823,AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures in Human Peripheral Blood Mononuclear Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500554/
53824,Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750650/
53825,"Effect of mass media on influenza vaccine coverage
in the season 2014/2015: a regional survey in Lazio, Italy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718357/
53826,Opportunities and challenges for commercializing microarray patches for vaccination from a MAP developer’s perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196745/
53827,"Parental Acceptance, Parental Hesitancy, and Uptake of Seasonal Influenza Vaccination among Children Aged 6–59 Months: A Systematic Review and Meta-Analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459009/
53828,Factors in vaccination intention against the pandemic influenza A/H1N1,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314046/
53829,Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322188/
53830,Lessons learned from the H1N1 2009 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322531/
53831,Benefits of influenza vaccination during pregnancy for pregnant women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552345/
53832,Influenza Vaccination Results in Differential Hemagglutinin Stalk-Specific Fc-Mediated Functions in Individuals Living With or Without HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062095/
53833,Determinants of non-vaccination against seasonal influenza in Canadian adults: findings from the 2015–2016 Influenza Immunization Coverage Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153712/
53834,Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults: A Cross-sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097760/
53835,Assessment of Antigen-Specific and Cross-Reactive Antibody Responses to an MF59-Adjuvanted A/H5N1 Prepandemic Influenza Vaccine in Adult and Elderly Subjects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535861/
53836,The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863092/
53837,Association of Seasonal Severity and Vaccine Effectiveness With Influenza Vaccination Rates in Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865258/
53838,Elderly people: propensity to be vaccinated for seasonal influenza in Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482847/
53839,Rates of immunization against pandemic and seasonal influenza in persons at high risk of severe influenza illness: a cross-sectional study among patients of the French Sentinelles general practitioners,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621692/
53840,Development and pilot testing of a text message vaccine reminder system for use during an influenza pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067886/
53841,Structural and antigenic characterization of a computationally-optimized H5 hemagglutinin influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736729/
53842,A cell‐based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634691/
53843,Nanovaccines against Viral Infectious Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784285/
53844,"Interim Effectiveness Estimates of 2023 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalizations — REVELAC–i Network, March–July 2023",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511266/
53845,Excess pneumonia and influenza hospitalizations associated with influenza epidemics in Portugal from season 1998/1999 to 2014/2015,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818339/
53846,A Novel Vaccine Adjuvant for Recombinant Flu Antigens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693274/
53847,"Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659565/
53848,Strategies targeting hemagglutinin cocktail as a potential universal influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558277/
53849,Effects of Anti- vs. Pro-vaccine Narratives on Responses by Recipients Varying in Numeracy: A Cross-sectional Survey-Based Experiment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623596/
53850,Vulnerable Groups Within a Vulnerable Population: Awareness of the A(H1N1)pdm09 Pandemic and Willingness to Be Vaccinated Among Pregnant Women in Ivory Coast,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572881/
53851,Influenza Vaccine Effectiveness Estimates among US Department of Defense Adult Beneficiaries over Four Consecutive Influenza Seasons: A Test-Negative Design Study with Different Control Groups,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781181/
53852,Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115403/
53853,Murine Cross-Reactive Nonneutralizing Polyclonal IgG1 Antibodies Induced by Influenza Vaccine Inhibit the Cross-Protective Effect of IgG2 against Heterologous Virus in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307094/
53854,Letter to the editor: Potential causes of the decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144940/
53855,Antibody-dependent cell-mediated cytotoxicity antibody responses to inactivated and live-attenuated influenza vaccination in children during 2014-15,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028493/
53856,"Influenza Vaccination Coverage Among Pregnant Women — United States, 2016–17 Influenza Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657675/
53857,Perceptions and predictors of intention to receive the COVID-19 vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087864/
53858,Reflections on the 1976 Swine Flu Vaccination Program,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291400/
53859,Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481571/
53860,Incidence of influenza virus infection among pregnant women: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450114/
53861,BMC Pregnancy Childbirth. 2017; 17: 192. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474848/
53862,Global Predictors of COVID-19 Vaccine Hesitancy: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415631/
53863,Molecular characterization of haemagglutinin genes of influenza B viruses circulating in Ghana during 2016 and 2017,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506629/
53864,"COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734610/
53865,"MicroRNA-451a in extracellular, blood-resident vesicles attenuates macrophage and dendritic cell responses to influenza whole-virus vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290151/
53866,"Influenza vaccination type, live, attenuated influenza vaccine (LAIV) versus inactivated influenza vaccine (IIV), received by children, United States, 2011-12 through 2013-14 influenza seasons",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597891/
53867,Prevention and control of influenza in persons with chronic obstructive pulmonary disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2692112/
53868,Vaccines within vaccines: The use of adenovirus types 4 and 7 as influenza vaccine vectors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130277/
53869,Marketing paediatric influenza vaccination: results of a major metropolitan trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941652/
53870,Blood Inflammatory Biomarkers Differentiate Inpatient and Outpatient Coronavirus Disease 2019 From Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026548/
53871,Development and Validation of a Clinical Prediction Tool for Seasonal Influenza Vaccination in England,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324952/
53872,"Genetic characterization of influenza A(H3N2) viruses circulating in coastal Kenya, 2009‐2017",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182596/
53873,Review on Drug Regulatory Science Promoting COVID-19 Vaccine Development in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779850/
53874,Estimating the full health and economic benefits of current and future influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373290/
53875,Economic evaluation of pediatric influenza immunization program compared with other pediatric immunization programs: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963059/
53876,"Impact of the COVID‐19 Pandemic on Influenza Circulation During the 2020/21 and 2021/22 Seasons, in Europe",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11081882/
53877,"Trends in Influenza Vaccine Uptake and Severe Influenza-Related Outcomes at Kaiser Permanente Southern California, 2007-2017",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817914/
53878,Towards Identification of the Mechanisms of Action of Parasite-Derived Peptide GK1 on the Immunogenicity of an Influenza Vaccine ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745017/
53879,A unique nanoparticulate TLR9 agonist enables a HA split vaccine to confer FcγR-mediated protection against heterologous lethal influenza virus infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599278/
53880,A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal Reactogenicity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318308/
53881,"A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335735/
53882,Influenza vaccination and major cardiovascular risk: a systematic review and meta-analysis of clinical trials studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658159/
53883,New Insights into the Generation of CD4 Memory May Shape Future Vaccine Strategies for Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827017/
53884,Immune Response to Influenza A/H1N1 Vaccine in Inflammatory Bowel Disease Patients Treated with Anti TNF-α Agents: Effects of Combined Therapy with Immunosuppressants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862353/
53885,Pregnant Women’s Knowledge of and Attitudes towards Influenza Vaccination during the COVID-19 Pandemic in Poland,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031437/
53886,Safety of Tdap vaccine in pregnant women: an observational study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838681/
53887,A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632566/
53888,Inactivated Whole Virus Influenza A (H5N1) Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2738456/
53889,A guideline for economic evaluations of vaccines and immunization programs in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746533/
53890,The Effect of Antipyretics on Immune Response and Fever Following Receipt of Inactivated Influenza Vaccine in Young Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050004/
53891,Influenza vaccine in pregnant women: immunization coverage and associated factors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872968/
53892,"Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848562/
53893,Influenza vaccination from the perspective of health care workers at university hospitals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361510/
53894,A qualitative study exploring healthcare providers’ and trainees’ barriers to COVID-19 and influenza vaccine uptake,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359157/
53895,A Prospective Study Investigating the Impact of Obesity on the Immune Response to the Quadrivalent Influenza Vaccine in Children and Adolescents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142924/
53896,"Negative Effect of Age, but Not of Latent Cytomegalovirus Infection on the Antibody Response to a Novel Influenza Vaccine Strain in Healthy Adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796903/
53897,Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821287/
53898,"Knowledge, Attitude, Practice and Barriers Associated with Influenza Vaccination among Health Care Professionals Working at Tertiary Care Hospitals in Lahore, Pakistan: A Multicenter Analytical Cross-Sectional Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861556/
53899,Influenza Vaccination Effectiveness in Paediatric ‘Healthy’ Patients: A Population-Based Study in Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031219/
53900,Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require Antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215256/
53901,Having a real say: findings from first nations community panels on pandemic influenza vaccine distribution,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691077/
53902,Homologous Sequential Immunization Using Salmonella Oral Administration Followed by an Intranasal Boost with Ferritin-Based Nanoparticles Enhanced the Humoral Immune Response against H1N1 Influenza Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269571/
53903,H9 Influenza Viruses: An Emerging Challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263090/
53904,Simple models to include influenza vaccination history when evaluating the effect of influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365179/
53905,"Seasonal influenza vaccination in pregnant women: knowledge, attitudes, and behaviors in Italy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223411/
53906,Egg-adaptive mutations of human influenza H3N2 virus are contingent on natural evolution,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536752/
53907,Nurses’ Influenza Vaccination and Hesitancy: A Systematic Review of Qualitative Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320778/
53908,Racing to immunity: Journey to a COVID‐19 vaccine and lessons for the future,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753785/
53909,Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485968/
53910,Functional and Binding H1N1pdm09-Specific Antibody Responses in Occasionally and Repeatedly Vaccinated Healthcare Workers: A Five-Year Study (2009-2014),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685392/
53911,Efforts at COVID-19 Vaccine Development: Challenges and Successes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762169/
53912,Factors Associated with Antenatal Influenza Vaccination in a Medically Underserved Population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204164/
53913,High-Resolution Temporal Response Patterns to Influenza Vaccine Reveal a Distinct Human Plasma Cell Gene Signature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728595/
53914,"A randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529122/
53915,Epidemiological and virological surveillance of influenza viruses in China during 2020–2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244124/
53916,Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512263/
53917,Characterization of humoral immune responses and degree of protection induced by influenza vaccine in cotton rats: Effects of low vaccine dose and single vs booster vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416045/
53918,Influenza Neuraminidase Characteristics and Potential as a Vaccine Target,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635103/
53919,Induction of H7N9-Cross-Reactive Antibody-Dependent Cellular Cytotoxicity Antibodies by Human Seasonal Influenza A Viruses that are Directed Toward the Nucleoprotein,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853654/
53920,"SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364403/
53921,Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922242/
53922,Determinants of healthcare provider recommendations for influenza vaccinations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721324/
53923,Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418051/
53924,Adherence and Concordance of Influenza and Pertussis Vaccination Coverage in Pregnant Women in Spain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406959/
53925,Development and Evaluation of an Influenza Virus Subtype H7N2 Vaccine Candidate for Pandemic Preparedness ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2168170/
53926,Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674105/
53927,Novel linear DNA vaccines induce protective immune responses against lethal infection with influenza virus type A/H5N1,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597034/
53928,An effective strategy for influenza vaccination of healthcare workers in Australia: experience at a large health service without a mandatory policy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328539/
53929,Alignment of vaccine codes using an ontology of vaccine descriptions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580193/
53930,Pharmacometric analysis of seasonal influenza epidemics and the effect of vaccination using sentinel surveillance data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752114/
53931,Obesity and Metabolic Dysregulation in Children Provide Protective Influenza Vaccine Responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777815/
53932,Hemagglutinin stalk-binding antibodies enhance effectiveness of neuraminidase inhibitors against influenza via Fc-dependent effector functions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418849/
53933,Structural basis of pre-existing immunity to the 2009 H1N1 pandemic influenza virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897825/
53934,Impact of sex on humoral immunity with live influenza B virus vaccines in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10897209/
53935,"Incidence of influenza virus infections confirmed by serology in children and adult in a suburb community, northern China, 2018‐2019 influenza season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902260/
53936,CpG Improves Influenza Vaccine Efficacy in Young Adult but Not Aged Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774967/
53937,"Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982–2012: A Systematic Analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807087/
53938,PLoS Med. 2016 Jun; 13(6): e1002060. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898729/
53939,"Time to Change Dosing of Inactivated Quadrivalent Influenza Vaccine in Young Children: Evidence From a Phase III, Randomized, Controlled Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907868/
53940,IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037454/
53941,Evidence of effectiveness from a large county-wide school-based influenza immunization campaign,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825850/
53942,"Influenza vaccination coverage rates among adults before and after the 2009 influenza pandemic and the reasons for non-vaccination in Beijing, China: A cross-sectional study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708734/
53943,Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301105/
53944,"Allergic adverse events following 2015 seasonal influenza vaccine, Victoria, Australia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479975/
53945,A campaign aimed at increasing seasonal influenza vaccination coverage among post graduate medical residents in an Italian teaching hospital,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605827/
53946,Summary of the NACI Seasonal Influenza Vaccine Statement for 2019–2020,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587699/
53947,Interventions to increase seasonal influenza vaccine coverage in healthcare workers: A systematic review and meta-regression analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964628/
53948,Effectiveness of Multistrain Probiotic Formulation on Common Infectious Disease Symptoms and Gut Microbiota Modulation in Flu-Vaccinated Healthy Elderly Subjects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814717/
53949,Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self‐reported severity and duration of illness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379636/
53950,COVID-19 vaccine Mandates: An Australian attitudinal study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629747/
53951,Integrative genomic analysis of the human immune response to influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3713456/
53952,eLife. 2016; 5: e18898. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005031/
53953,"Improved influenza vaccination coverage among health-care workers: evidence from a web-based survey in China, 2019/2020 season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189132/
53954,An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146241/
53955,A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181825/
53956,Predictive Markers of Immunogenicity and Efficacy for Human Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226531/
53957,Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286902/
53958,"Molecular evolution of influenza B virus during 2011–2017 in Chaoyang, Beijing, suggesting the free influenza vaccine policy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384887/
53959,Comparing the Attitude toward the COVID-19 and the 2020/21 and 2019/20 Flu Vaccination Campaigns among Italian Healthcare Workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618503/
53960,The Coming of Age of Nucleic Acid Vaccines during COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580386/
53961,mSystems. 2023 Mar-Apr; 8(2): e00928-22. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134841/
53962,Decreasing influenza vaccine coverage among adults with high-risk chronic diseases in Spain from 2014 to 2017,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012160/
53963,How Can Vaccines Against Influenza and Other Viral Diseases Be Made More Effective?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006352/
53964,Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422453/
53965,Advances in COVID-19 mRNA vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940982/
53966,Developments in the formulation and delivery of spray dried vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647985/
53967,Systems Biology of Seasonal Influenza Vaccination in Humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/
53968,Immunogenicity and Protective Efficacy of a Live Attenuated H5N1 Vaccine in Nonhuman Primates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669169/
53969,"A Cross-Sectional Survey of Knowledge, Attitude, and Practices Regarding Influenza Vaccination Among Jordanians Aged 18-64 Years with Chronic Diseases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631359/
53970,Podcast: Need for Quality Evidence for Decision-Making on Seasonal Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11058138/
53971,"COVID-19, seasonal influenza and measles: potential triple burden and the role of flu and MMR vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731639/
53972,Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph Nodes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899203/
53973,Deaths following vaccination: What does the evidence show?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599698/
53974,Epidemiology of respiratory viral infections in children enrolled in a study of influenza vaccine effectiveness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181477/
53975,Assessing the prior event rate ratio method via probabilistic bias analysis on a Bayesian network,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027899/
53976,Pregnancy as a risk factor for severe influenza infection: an individual participant data meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679491/
53977,Assessing vaccine safety during a pandemic: Recent experience and lessons learned for the future,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184950/
53978,Viral receptor-binding site antibodies with diverse germline origins,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441819/
53979,"The COVID-19 Vaccine: Trust, doubt, and hope for a future beyond the pandemic in Germany",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989326/
53980,An Improved Inactivated Influenza Vaccine with Enhanced Cross Protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094167/
53981,A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2590646/
53982,"Dose sparing and the lack of a dose–response relationship with an influenza vaccine in adult and elderly patients – a randomized, double‐blind clinical trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555868/
53983,Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465931/
53984,Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173246/
53985,"H5N1 Virus-Like Particle Vaccine Elicits Cross-Reactive Neutralizing Antibodies That Preferentially Bind to the Oligomeric Form of Influenza Virus Hemagglutinin in Humans


",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194932/
53986,A pilot study on COVID-19 vaccine hesitancy among healthcare workers in the US,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200349/
53987,"Risk of Confirmed Guillain-Barré Syndrome Following Receipt of Monovalent Inactivated Influenza A (H1N1) and Seasonal Influenza Vaccines in the Vaccine Safety Datalink Project, 2009–2010",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272801/
53988,Microneedles: A New Generation Vaccine Delivery System,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070939/
53989,Covid-19 Pandemic: Maximizing Future Vaccination Treatments Considering Aging and Frailty,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530612/
53990,Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537287/
53991,"Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): past, present, and future implications",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324553/
53992,Mice with diverse microbial exposure histories as a model for preclinical vaccine testing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665115/
53993,Efforts to Improve the Seasonal Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712773/
53994,COVID-19 and Respiratory Virus Co-Infections: A Systematic Review of the Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142898/
53995,Cost-Effectiveness and Public Health Impact of Influenza Vaccine Strategies for US Seniors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302117/
53996,Incidence and seroprevalence of seasonal influenza a viruses in Egypt: Results of a community‐based cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178055/
53997,High-Affinity H7 Head and Stalk Domain–Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine After Priming With Live Attenuated Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577047/
53998,"Trends in COVID-19 vaccination intent and factors associated with deliberation and reluctance among adult homeless shelter residents and staff, 1 November 2020 to 28 February 2021 – King County, Washington",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590934/
53999,Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccine Among Patients Treated by Maintenance Hemodialysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6926162/
54000,Memory Immune Responses against Pandemic (H1N1) 2009 Influenza Virus Induced by a Whole Particle Vaccine in Cynomolgus Monkeys Carrying Mafa-A1*052∶02,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356377/
54001,Coadministration of Seasonal Influenza Vaccine and MVA-NP+M1 Simultaneously Achieves Potent Humoral and Cell-Mediated Responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978791/
54002,A recombinant herpes virus expressing influenza hemagglutinin confers protection and induces antibody-dependent cellular cytotoxicity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403974/
54003,Semantic Network Analysis of Vaccine Sentiment in Online Social Media,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548132/
54004,Reduced Antibody Responses to the Pandemic (H1N1) 2009 Vaccine after Recent Seasonal Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165229/
54005,"Vaccine Effectiveness against Medically Attended Laboratory-Confirmed Influenza in Japan, 2011–2012 Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923823/
54006,"Prevalence and Incidence of Respiratory Syncytial Virus and Other Respiratory
Viral Infections in Children Aged 6 Months to 10 Years With Influenza-like Illness
Enrolled in a Randomized Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429758/
54007,Resources for assessing parents’ vaccine hesitancy: a systematic review of the literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595070/
54008,Seasonal influenza vaccination among people with diabetes: influence of patients’ characteristics and healthcare use on behavioral changes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644174/
54009,A comparison of epidemiology and clinical outcomes between influenza A H1N1pdm09 and H3N2 based on multicenter surveillance from 2014 to 2018 in South Korea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767957/
54010,SARS-CoV-2 does not replicate in embryonated hen’s eggs or in MDCK cell lines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331139/
54011,Implementation of a program to improve influenza vaccination rates among medical students: a comparative study involving two university affiliated hospitals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437549/
54012,Broad protection against influenza infection by vectored immunoprophylaxis in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030719/
54013,Genetic and antigenic divergence in the influenza A(H3N2) virus circulating between 2016 and 2017 in Thailand,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734729/
54014,"Serious outcomes of medically attended, laboratory‐confirmed influenza illness among school‐aged children with and without asthma, 2007‐2018",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040974/
54015,Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514327/
54016,Viva la Revolución: Rethinking Influenza A Virus Antigenic Drift,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199585/
54017,A Single Intramuscular Dose of a Plant-Made Virus-Like Particle Vaccine Elicits a Balanced Humoral and Cellular Response and Protects Young and Aged Mice from Influenza H1N1 Virus Challenge despite a Modest/Absent Humoral Response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717192/
54018,Alternative Vaccination Locations: Who Uses Them and Can They Increase Flu Vaccination Rates?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2700851/
54019,The Efficiency of Bacterial Vaccines on Mortality during the ‘Spanish’ Influenza Pandemic of 1918–19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568242/
54020,Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259263/
54021,High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215371/
54022,Effect of disease-modifying antirheumatic drug therapy on immune response to trivalent influenza vaccine in rheumatoid arthritis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663159/
54023,Characterizing Emerging Canine H3 Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182277/
54024,Evaluation of Influenza Virus A/H3N2 and B Vaccines on the Basis of Cross-Reactivity of Postvaccination Human Serum Antibodies against Influenza Viruses A/H3N2 and B Isolated in MDCK Cells and Embryonated Hen Eggs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3370437/
54025,The Reemergent 1977 H1N1 Strain and the Gain-of-Function Debate,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542197/
54026,Vaccination induced antibodies to recombinant avian influenza A virus M2 protein or synthetic M2e peptide do not bind to the M2 protein on the virus or virus infected cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701469/
54027,The impact of timing of maternal influenza immunization on infant antibody levels at birth,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330660/
54028,Generation of a DSF-Guided Refolded Bacterially Expressed Hemagglutinin Ectodomain of Influenza Virus A/Puerto Rico/8/1934 H1N1 as a Model for Influenza Vaccine Antigens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610769/
54029,Antigenic Differences between AS03 Adjuvanted Influenza A (H1N1) Pandemic Vaccines: Implications for Pandemrix-Associated Narcolepsy Risk,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266499/
54030,Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteins,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341118/
54031,Multi-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918916/
54032,The Rise of Vectored Vaccines: A Legacy of the COVID-19 Global Crisis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538930/
54033,“Any idea how fast ‘It’s just a mask!’ can turn into ‘It’s just a vaccine!’”: From mask mandates to vaccine mandates during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552554/
54034,"Recent Advances in Cancer Vaccines: Challenges, Achievements, and Futuristic Prospects",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788126/
54035,"Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016–2017 season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444786/
54036,A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237356/
54037,The expanding role of mass spectrometry in the field of vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027533/
54038,Avian influenza viruses in humans: lessons from past outbreaks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992886/
54039,"Inactivated and live, attenuated influenza vaccines protect mice against influenza:Streptococcus pyogenes super-infections",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084433/
54040,Immunological dynamics after subcutaneous immunization with a squalene‐based oil‐in‐water adjuvant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496326/
54041,Geographical heterogeneity and influenza infection within households,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094897/
54042,Plasmablast antibody repertoires in elderly influenza vaccine responders exhibit restricted diversity but increased breadth of binding across influenza strains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026060/
54043,A Single Immunization With Modified Vaccinia Virus Ankara–Based Influenza Virus H7 Vaccine Affords Protection in the Influenza A(H7N9) Pneumonia Ferret Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402375/
54044,Determinants of influenza vaccine hesitancy among pregnant women in Europe: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477621/
54045,"Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664604/
54046,Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700460/
54047,Variations in influenza vaccination coverage among the high-risk population in Sweden in 2003/4 and 2004/5: a population survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906854/
54048,Seasonal Influenza Vaccine and Protection against Pandemic (H1N1) 2009-Associated Illness among US Military Personnel,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873284/
54049,Maternal vaccination for the prevention of influenza: current status and hopes for the future,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021628/
54050,"National burden of hospitalized and non‐hospitalized influenza‐associated severe acute respiratory illness in Kenya, 2012‐2014",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818348/
54051,Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a phase I randomized clinical trial in healthy Serbian adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861805/
54052,Trust During the Early Stages of the 2009 H1N1 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943629/
54053,Mimotopes selected with neutralizing antibodies against multiple subtypes of influenza A,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320565/
54054,Effects of the Nature of Adjuvant and Site of Parenteral Immunization on the Serum and Mucosal Immune Responses Induced by a Nasal Boost with a Vaccine Alone,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC95648/
54055,Non-familial paid caregivers as potential flu carriers and cause of spread: the primary prevention of flu measured through their adhesion to flu vaccination campaigns—A Florentine experience,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816408/
54056,Microbiota and the Response to Vaccines Against Respiratory Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122122/
54057,Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435640/
54058,Factors Associated with Influenza Vaccination Uptake among U.S. Adults: Focus on Nativity and Race/Ethnicity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157050/
54059,"Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553998/
54060,Characterisation of a wild-type influenza (A/H1N1) virus strain as an experimental challenge agent in humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322439/
54061,The sustainability of influenza vaccination programs: considerations and perspectives from Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910445/
54062,Insights from Avian Influenza: A Review of Its Multifaceted Nature and Future Pandemic Preparedness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10975894/
54063,"Impact of the COVID-19 Pandemic on Influenza Vaccination Coverage of Healthcare Personnel in Alicante, Spain",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11055171/
54064,Intra-season waning of immunity following the seasonal influenza vaccine in early and late vaccine recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556766/
54065,"Timing of influenza epidemics and vaccines in the American tropics, 2002–2008, 2011–2014",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814866/
54066,Cost Effectiveness and Budget Impact Analyses of Influenza Vaccination for Prisoners in Thailand: An Application of System Dynamic Modelling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068611/
54067,Development of Influenza B Universal Vaccine Candidates Using the “Mosaic” Hemagglutinin Approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613766/
54068,"Pediatric health care professionals’ vaccine knowledge, awareness and attitude: a survey within the Italian Society of Pediatric Allergy and Immunology",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426584/
54069,Uptake of COVID-19 and influenza vaccines in relation to preexisting chronic conditions in the European countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10785450/
54070,Parental childhood vaccine hesitancy and predicting uptake of vaccinations: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641700/
54071,Efficacy of Vaccination with Different Combinations of MF59-Adjuvanted and Nonadjuvanted Seasonal and Pandemic Influenza Vaccines against Pandemic H1N1 (2009) Influenza Virus Infection in Ferrets ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3067945/
54072,Attenuated influenza virions expressing the SARS-CoV-2 receptor-binding domain induce neutralizing antibodies in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430565/
54073,Viruses. 2020 Sep; 12(9): 987. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552029/
54074,"Influenza, Tdap, and COVID-19 Vaccination Coverage and Hesitancy Among Pregnant Women — United States, April 2023",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545430/
54075,Social and political determinants of vaccine hesitancy: Lessons learned from the H1N1 pandemic of 2009-2010,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132648/
54076,"Influenza vaccination for patients with chronic obstructive pulmonary disease: understanding immunogenicity, efficacy and effectiveness",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933683/
54077,Influenza epidemiology in Italy two years after the 2009–2010 pandemic: Need to improve vaccination coverage,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891712/
54078,Decreased Serologic Response in Vaccinated Military Recruits during 2011 Correspond to Genetic Drift in Concurrent Circulating Pandemic A/H1N1 Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326053/
54079,Understanding Low Vaccine Uptake in the Context of Public Health in High-Income Countries: A Scoping Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10975033/
54080,Journey to vaccination: a protocol for a multinational qualitative study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913205/
54081,Sociodemographic and psychological determinants of influenza vaccine intention among recipients of autologous and allogeneic haematopoietic stem cell transplant: a cross-sectional survey of UK transplant recipients using a modified health belief model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089289/
54082,Experimental Infection Using Mouse-Adapted Influenza B Virus in a Mouse Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232149/
54083,Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860935/
54084,"Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446950/
54085,Influenza H1 Mosaic Hemagglutinin Vaccine Induces Broad Immunity and Protection in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963302/
54086,Influences on Attitudes Regarding COVID-19 Vaccination in Germany,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146249/
54087,Persistence of Immunogenicity of a Monovalent Influenza Virus A/H1N1 2009 Vaccine in Healthy Volunteers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294609/
54088,"Evaluation of Oral Immunization with Recombinant Avian Influenza Virus HA1 Displayed on the Lactococcus lactis Surface and Combined with the Mucosal Adjuvant Cholera Toxin Subunit B
",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3147322/
54089,"Inequity of antenatal influenza and pertussis vaccine coverage in Australia: the Links2HealthierBubs record linkage cohort study, 2012–2017",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164451/
54090,Layered Protein Nanoparticles Containing Influenza B HA stalk Inducted Sustained Cross-Protection against Viruses Spanning Both Viral Lineages,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822777/
54091,Archetype analysis of older adult immunization decision-making and implementation in 34 countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252137/
54092,Passive immune neutralization strategies for prevention and control of influenza A infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292042/
54093,Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446962/
54094,Ovalbumin content of influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927356/
54095,The Health Belief Model Predicts Intention to Receive the COVID-19 Vaccine in Saudi Arabia: Results from a Cross-Sectional Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402432/
54096,Humanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157703/
54097,"Efficacy, duration of protection, birth outcomes, and infant growth associated with influenza vaccination in pregnancy: a pooled analysis of three randomised controlled trials",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284303/
54098,Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313889/
54099,"Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357764/
54100,The Current Status of Vaccine Uptake and the Impact of COVID-19 on Intention to Vaccination in Patients with COPD in Beijing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688833/
54101,Flu Vaccine Production Gets a Shot in the Arm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1367863/
54102,Safety of Influenza Vaccine in Patients With Cancer Receiving Pembrolizumab,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462591/
54103,"Phase I Evaluation of Intranasal Trivalent Inactivated Influenza Vaccine with Nontoxigenic Escherichia coli Enterotoxin and Novel Biovector as Mucosal Adjuvants, Using Adult Volunteers",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1472052/
54104,Long-term maintenance of lung resident memory T cells is mediated by persistent antigen,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726002/
54105,Practices and predictors of 2009 H1N1 vaccination in cancer patients: a nationwide survey in Korea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941709/
54106,Stabilization of Influenza Vaccine Enhances Protection by Microneedle Delivery in the Mouse Skin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745577/
54107,COVID-19 vaccination intention and hesitancy: Mistrust on COVID-19 vaccine benefit a major driver for vaccine hesitancy among healthcare workers; a cross-sectional study in North India,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351420/
54108,"The ""influenza vaccine"" – benefit, risk, costs",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086668/
54109,No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10962584/
54110,Aqueous and oil-adjuvant influenza vaccines and isoimmunization to group A substance.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2130617/
54111,Summary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2130617/
54112,The Role of Systems Vaccinology in Understanding the Immune Defects to Vaccination in Solid Organ Transplant Recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723964/
54113,Extracting postmarketing adverse events from safety reports in the vaccine adverse event reporting system (VAERS) using deep learning,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279785/
54114,Major Issues and Challenges of Influenza Pandemic Preparedness in Developing Countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600290/
54115,Development and Effects of Influenza Antiviral Drugs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913928/
54116,Fabrication of microneedle patches with lyophilized influenza vaccine suspended in organic solvent,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050834/
54117,Has influenza B/Yamagata become extinct and what implications might this have for quadrivalent influenza vaccines?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524051/
54118,"Prevention of Influenza Hospitalization Among Adults in the United States, 2015–2016: Results From the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743848/
54119,"Influenza viruses and coronaviruses: Knowns, unknowns, and common research challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718010/
54120,"Genetic Diversity and Evolutionary Kinetics of Influenza A Virus H3N2 Subtypes Circulating in Riyadh, Saudi Arabia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054866/
54121,"H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521248/
54122,A Qualitative Study of Vaccine Acceptability and Decision Making among Pregnant Women in Morocco during the A (H1N1) pdm09 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196726/
54123,Designing spatial and temporal control of vaccine responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477997/
54124,Continued Circulation of Highly Pathogenic H5 Influenza Viruses in Vietnamese Live Bird Markets in 2018–2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384249/
54125,Determinants of COVID-19 Vaccine Acceptance Among the General Adult Population in Saudi Arabia Based on the Health Belief Model: A Web-Based Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500336/
54126,Pandemic-response adenoviral vector and RNA vaccine manufacturing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891260/
54127,Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588819/
54128,The Effect of Age and Recent Influenza Vaccination History on the Immunogenicity and Efficacy of 2009–10 Seasonal Trivalent Inactivated Influenza Vaccination in Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595209/
54129,"Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — United States, 2021–22",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590294/
54130,Potential Cost-Effectiveness of Maternal Influenza Immunisation in Low-Income Countries: An Explorative Modelling Study and Value of Information Analysis to Guide Future Clinical Research,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10975179/
54131,Increased vaccine uptake and less perceived barriers toward vaccination in long-term care facilities that use multi-intervention manual for influenza campaigns,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993224/
54132,Factors associated with influenza vaccination among healthcare workers in acute care hospitals in Canada,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907810/
54133,Adoption of preventive behaviors in response to the 2009 H1N1 influenza pandemic: a multiethnic perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415697/
54134,The Influence of COVID-19 Pandemic on Influenza Immunization in Saudi Arabia: Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440749/
54135,Group 1 and group 2 hemagglutinin stalk antibody response according to age,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258341/
54136,The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159335/
54137,Is It Possible to Develop a “Universal” Influenza Virus Vaccine?: Potential for a Universal Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829045/
54138,Broad and Protective Influenza B Virus Neuraminidase Antibodies in Humans after Vaccination and their Clonal Persistence as Plasma Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414695/
54139,Panel 8: Vaccines and Immunology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153269/
54140,Influenza Vaccine Prevents Medically Attended Influenza-Associated Acute Respiratory Illness in Adults Aged ≥50 Years,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432432/
54141,A case study of an influenza vaccination program for health care workers in Vietnam,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444161/
54142,Serum Proinflammatory Cytokine Responses to Influenza Virus Vaccine among Women during Pregnancy versus Non-Pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878156/
54143,Quantifying the annual incidence and underestimation of seasonal influenza: A modelling approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347407/
54144,Flu vaccine associated with nine deaths in Japan this year,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149165/
54145,Determination of H5N1 vaccine potency using reference antisera from heterologous strains of influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941667/
54146,Determinants of 2009 A/H1N1 Influenza Vaccination Among Pregnant Women in Hong Kong,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560965/
54147,Impact of Estrogen Therapy on Lymphocyte Homeostasis and the Response to Seasonal Influenza Vaccine in Post-Menopausal Women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747494/
54148,Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655854/
54149,Dueling biological and social contagions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333634/
54150,Neutralizing and Neuraminidase Antibodies Correlate With Protection Against Influenza During a Late Season A/H3N2 Outbreak Among Unvaccinated Military Recruits,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819518/
54151,Estimating the Impact of Low Influenza Activity in 2020 on Population Immunity and Future Influenza Seasons in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743127/
54152,Seasonal and pandemic influenza during pregnancy and risk of fetal death: A Norwegian registry-based cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192880/
54153,Vaccine or Garlic–Is It a Choice? Awareness of Medical Personnel on Prevention of Influenza Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865668/
54154,Looking ahead: Caregivers’ COVID-19 vaccination intention for children 5 years old and younger using the health belief model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806122/
54155,"Intradermal vaccination using the novel microneedle device MicronJet600: Past, present, and future",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514308/
54156,"Impact of PM2.5 and ozone on incidence of influenza in Shijiazhuang, China: a time-series study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458314/
54157,Neonatal vaccine effectiveness and the role of adjuvants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678067/
54158,"Surveillance of Influenza and Other Airborne Transmission Viruses during the 2021/2022 Season in Hospitalized Subjects in Tuscany, Italy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142596/
54159,Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case–control study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760253/
54160,Influenza vaccination coverage estimates in the fee-for service Medicare beneficiary population 2006 – 2016: Using population-based administrative data to support a geographic based near real-time tool,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150049/
54161,A review of vaccine effects on women in light of the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486065/
54162,H1 Hemagglutinin Priming Provides Long-Lasting Heterosubtypic Immunity against H5N1 Challenge in the Mouse Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773984/
54163,Recombinant Hemagglutinin and Virus-Like Particle Vaccines for H7N9 Influenza Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627708/
54164,Influenza Vaccination Uptake and Prognostic Factors among Health Professionals in Italy: Results from the Nationwide Surveillance PASSI 2015–2018,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386716/
54165,Prior Infection of Chickens with H1N1 or H1N2 Avian Influenza Elicits Partial Heterologous Protection against Highly Pathogenic H5N1,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519904/
54166,"Investigating Attitudes, Motivations and Key Influencers for COVID-19 Vaccination Uptake among Late Adopters in Urban Zimbabwe",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958877/
54167,"Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927599/
54168,Forecasting influenza hemagglutinin mutations through the lens of anomaly detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495359/
54169,"Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110585/
54170,Missed opportunities for concomitant HPV vaccination among childhood cancer survivors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855920/
54171,"Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296151/
54172,Vaccine Hesitancy in the Time of COVID-19: Attitudes and Intentions of Teens and Parents Regarding the COVID-19 Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777704/
54173,The impact of repeated vaccination on relative influenza vaccine effectiveness among vaccinated adults in the United Kingdom,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987024/
54174,The United States vaccine supply: challenges in preparing for an avian influenza pandemic.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259164/
54175,Toward precision adjuvants: optimizing science and safety,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970548/
54176,Avian Influenza A(H5N1) Virus in Egypt,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766899/
54177,In vitro evolution of an influenza broadly neutralizing antibody is modulated by hemagglutinin receptor specificity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440694/
54178,Use of financial incentives to increase adult vaccination coverage: A narrative review of lessons learned from COVID-19 and other adult vaccination efforts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535879/
54179,Impact of COVID-19 Pandemic on Flu and COVID-19 Vaccination Intentions among University Students,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909275/
54180,Acceptance of intradermal inactivated influenza vaccines among hospital staff following 2 seasonal vaccination campaigns,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054788/
54181,"Technology Resource, Distribution, and Development Characteristics of Global Influenza Virus Vaccine: A Patent Bibliometric Analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570820/
54182,"Evaluations for In Vitro Correlates of Immunogenicity of Inactivated Influenza A H5, H7 and H9 Vaccines in Humans",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519816/
54183,From empiricism to rational design: a personal perspective of the evolution of vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096907/
54184,"Knowledge, Attitudes, and Practices of Healthcare Workers in Jordan towards the COVID-19 Vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875156/
54185,"Improving influenza virological surveillance in Europe: strain-based reporting of antigenic and genetic characterisation data, 11 European countries, influenza season 2013/14",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073191/
54186,Euro Surveill. 2016 Oct 20; 21(42): 30379. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291155/
54187,Anti-Influenza Serum and Mucosal Antibody Responses after Administration of Live Attenuated or Inactivated Influenza Vaccines to HIV-Infected Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290334/
54188,Sex-Specific Immune Responses to Seasonal Influenza Vaccination in Diabetic Individuals: Implications for Vaccine Efficacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597737/
54189,"Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133686/
54190,Can Routine Offering of Influenza Vaccination in Office-Based Settings Reduce Racial and Ethnic Disparities in Adult Influenza Vaccination?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242874/
54191,Comparison of response rates on invitation mode of a web-based survey on influenza vaccine adverse events among healthcare workers: a pilot study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011252/
54192,Does a major change to a COVID-19 vaccine program alter vaccine intention? A qualitative investigation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674511/
54193,Enhanced generation of influenza-specific tissue resident memory CD8 T cells in NK-depleted mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076325/
54194,"Potential SARS-CoV-2 vaccines: Concept, progress, and challenges",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006194/
54195,Evaluating the Impact of Statin Use on Influenza Vaccine Effectiveness and Influenza Infection in Older Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371308/
54196,Hemagglutinin destabilization in H3N2 vaccine reference viruses skews antigenicity and prevents airborne transmission in ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058244/
54197,Detection of Influenza and Other Respiratory Viruses Carried Out in the Influenza Project – Monitoring Vaccine Effectiveness (I-MOVE),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121447/
54198,Enhanced isolation of influenza viruses in qualified cells improves the probability of well-matched vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660794/
54199,The first influenza pandemic of the 21st century,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850175/
54200,A Non-VH1-69 Heterosubtypic Neutralizing Human Monoclonal Antibody Protects Mice against H1N1 and H5N1 Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319592/
54201,Social determinants of flu vaccine uptake among racial/ethnic minorities in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683944/
54202,US healthcare costs attributable to type A and type B influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612050/
54203,"Identifying COVID-19 and H1N1 vaccination hesitancy or refusal among health care providers across North America, the United Kingdom, Europe, and Australia: a scoping review protocol",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728757/
54204,Virological Surveillance of Influenza in the eight epidemic seasons after the 2009 pandemic in Emilia-Romagna (Northern Italy),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233653/
54205,Healthcare Workers’ Attitudes towards Mandatory COVID-19 Vaccination: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142794/
54206,A Systematic Evaluation of Different Methods for Calculating Adolescent Vaccination Levels Using Immunization Information System Data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804092/
54207,Summary of the NACI Supplemental Statement on Mammalian Cell Culture-Based Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723313/
54208,Induction of protective immunity against influenza A/Jiangxi-Donghu/346/2013 (H10N8) in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721922/
54209,Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157591/
54210,Expression of Influenza M2e-NP Recombinant Fusion Protein in Escherichia coli BL21 (DE3) and Its Binding to Antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784878/
54211,Influenza Vaccine Responses in Older Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061971/
54212,Vax attacks: How conspiracy theory belief undermines vaccine support,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713072/
54213,"Unraveling the association between vaccine attitude, vaccine conspiracies and self-reported side effects following COVID-19 vaccination among nurses and physicians in Jordan",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10755110/
54214,Optimizing antiviral treatment for seasonal influenza in the USA: a mathematical modeling analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917004/
54215,Maternal influenza immunization in Malawi: Piloting a maternal influenza immunization program costing tool by examining a prospective program,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744963/
54216,iBRAB: In silico based-designed broad-spectrum Fab against H1N1 influenza A virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774956/
54217,Complete Influenza Vaccination Trends for Children Six to Twenty-Three Months,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751428/
54218,2009–2010 Seasonal Influenza Vaccination Coverage Among College Students From 8 Universities in North Carolina,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507424/
54219,Immune-regulatory microRNA expression levels within circulating extracellular vesicles correspond with the appearance of local symptoms after seasonal flu vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615615/
54220,"Influenza Vaccine Effectiveness and Waning Effect in Hospitalized Older Adults. Valencia Region, Spain, 2018/2019 Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908304/
54221,Global Prevalence and Drivers of Dental Students’ COVID-19 Vaccine Hesitancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226539/
54222,Protective Effects of Influenza Vaccine against Colorectal Cancer in Populations with Chronic Kidney Disease: A Nationwide Population-Based Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136409/
54223,Asia-Pacific Alliance for the Control of Influenza (APACI),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806651/
54224,Increased Influenza Vaccination Coverage among Members of the Athens Medical Association Amidst COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148125/
54225,Immunogenicity and safety of an intramuscular split-virion quadrivalent inactivated influenza vaccine in individuals aged ≥ 6 months in India,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605869/
54226,"Canada can release pandemic vaccine earlier if necessary, chief public health officer says",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2774378/
54227,"Influenza vaccine effectiveness in reducing severe outcomes over six influenza seasons, a case-case analysis, Spain, 2010/11 to 2015/16",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208006/
54228,Immunogenicity and Efficacy of A/H1N1pdm Vaccine Among Subjects With Severe Motor and Intellectual Disability in the 2010/11 Influenza Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884898/
54229,Predictors of COVID-19 vaccine uptake among people who inject drugs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868393/
54230,Vaccine market and production capabilities in the Americas,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042620/
54231,Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444935/
54232,Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015–2016 Season in Canada,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853508/
54233,Vaccine Procurement: A Conceptual Framework Based on Literature Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707219/
54234,Enhancement of the Local CD8+ T-Cellular Immune Response to Mycobacterium tuberculosis in BCG-Primed Mice after Intranasal Administration of Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626046/
54235,Impact of the COVID-19 Pandemic on Influenza Vaccination and Associated Factors among Pregnant Women: A Cross-Sectional Study in Korea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054036/
54236,"Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029577/
54237,Exploiting unique features of microneedles to modulate immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10753036/
54238,T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183197/
54239,Emulsified Nanoparticles Containing Inactivated Influenza Virus and CpG Oligodeoxynucleotides Critically Influences the Host Immune Responses in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924384/
54240,A pilot study of the immune response to whole inactivated avian influenza H7N1 virus vaccine in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710795/
54241,Joint visualization of seasonal influenza serology and phylogeny to inform vaccine composition,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073671/
54242,Variation in the human immune system is largely driven by non-heritable influences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302727/
54243,Vaccine uptake and barriers to vaccination among at-risk adult populations in the US,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248946/
54244,Flu vaccination campaign poses monitoring difficulties,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761477/
54245,Potential Cost-Effectiveness of a Universal Influenza Vaccine in Older Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293081/
54246,Summary of the National Advisory Committee on Immunization (NACI) Supplemental Statement on Recombinant Influenza Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10729781/
54247,Influenza vaccine in chronic obstructive pulmonary disease among elderly male veterans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726500/
54248,Racial and ethnic disparities in influenza vaccination coverage among pregnant women in the United States: The contribution of vaccine-related attitudes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10881081/
54249,"“Maternal Vaccination Greatly Depends on Your Trust in the Healthcare System”: A Qualitative Study on the Acceptability of Maternal Vaccines among Pregnant Women and Healthcare Workers in Barcelona, Spain",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783547/
54250,Pandemic Influenza A H1N1 2009 Infection versus Vaccination: A Cohort Study Comparing Immune Responses in Pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310855/
54251,Dissecting Fc signatures of protection in neonates following maternal influenza vaccination in a placebo-controlled trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026287/
54252,Challenges in the Vaccination of the Elderly and Strategies for Improvement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204411/
54253,MVA-Based H5N1 Vaccine Affords Cross-Clade Protection in Mice against Influenza A/H5N1 Viruses at Low Doses and after Single Immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771904/
54254,mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785933/
54255,Development and Scalable Production of Newcastle Disease Virus-Vectored Vaccines for Human and Veterinary Use,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143368/
54256,Lymphocyte blastogenic responses to influenza virus antigens after influenza infection and vaccination in humans.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC422269/
54257,Summary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC422269/
54258,Sex-specific patterns of gene expression following influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131249/
54259,Combinatorial liposomal peptide vaccine induces IgA and confers protection against influenza virus and bacterial super‐infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432089/
54260,Strategies to increase influenza vaccination rates: outcomes of a nationwide cross-sectional survey of UK general practice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358626/
54261,Multi-Centre Observational Study of Transplacental Transmission of Influenza Antibodies following Vaccination with AS03A-Adjuvanted H1N1 2009 Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3553100/
54262,Adjuvanting influenza hemagglutinin vaccine with a human pulmonary surfactant-mimicking synthetic compound SF-10 induces local and systemic cell-mediated immunity in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784949/
54263,"Beliefs and Opinions of Health Care Workers and Students Regarding Influenza and Influenza Vaccination in Tuscany, Central Italy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494245/
54264,The Impact of the 2004–2005 Influenza Vaccine Shortage in the Veterans Health Administration,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2305749/
54265,"IL-15 enhances cross-reactive antibody recall responses to seasonal H3 influenza viruses
in vitro",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801566/
54266,High-dose influenza vaccine favors acute plasmablast responses rather than long-term cellular responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996724/
54267,Polymeric Nanoparticle-Based Vaccine Adjuvants and Delivery Vehicles,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107186/
54268,Influence of Birth Cohort on Effectiveness of 2015–2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009604/
54269,Enhanced passive safety surveillance of the quadrivalent inactivated split-virion influenza vaccine (IIV4) in Finland during the 2019/20 influenza season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885465/
54270,Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948190/
54271,Preventing and Controlling Influenza with Available Interventions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636328/
54272,Polyvalent DNA Vaccines Expressing HA Antigens of H5N1 Influenza Viruses with an Optimized Leader Sequence Elicit Cross-Protective Antibody Responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244406/
54273,Impact of Pre-Existing Immunity on Live Attenuated Influenza Vaccine-Induced Cross-Protective Immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563680/
54274,Diseases of the Respiratory System,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161410/
54275,Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656349/
54276,Cluster Analysis: Vaccination Attitudes and Beliefs of Healthcare Personnel,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987325/
54277,Vaccine preferences driving vaccine-decision making of different target groups: a systematic review of choice-based experiments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397865/
54278,Extension of influenza immunization program to children in England – Future plans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084989/
54279,Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826078/
54280,Seasonal Influenza Vaccination for Children in Thailand: A Cost-Effectiveness Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444096/
54281,“Breathing” Hemagglutinin Reveals Cryptic Epitopes for Universal Influenza Vaccine Design,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112349/
54282,Influenza pandemics and avian flu,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1283192/
54283,BMJ. 2005 Nov 19; 331(7526): 1182. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1285098/
54284,Potential effect of virus interference on influenza vaccine effectiveness estimates in test-negative designs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151296/
54285,"Influenza vaccination in community pharmacy: A cross-sectional survey of Canadian adults’ knowledge, attitude and beliefs",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11086734/
54286,"Physician Attitudes Toward Adult Vaccines and Other Preventive Practices, United States, 2012",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765981/
54287,Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186056/
54288,"Impact of influenza vaccination in the Netherlands, 2007–2016: Vaccinees consult their general practitioner for clinically diagnosed influenza, acute respiratory infections, and pneumonia more often than non-vaccinees",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162646/
54289,Epistaxis and gross haematuria with severe thrombocytopaenia associated with influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510128/
54290,Efficacious Recombinant Influenza Vaccines Produced by High Yield Bacterial Expression: A Solution to Global Pandemic and Seasonal Needs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2373928/
54291,The potential role of using vaccine patches to induce immunity: Platform and pathways to innovation and commercialization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814398/
54292,Deimmunization of flagellin for repeated administration as a vaccine adjuvant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438039/
54293,Influenza vaccination acceptance among diverse pregnant women and its impact on infant immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162045/
54294,An opportunity to incentivize innovation to increase vaccine safety in the United States by improving vaccine delivery using vaccine patches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172634/
54295,Factors Associated with Seasonal Influenza Vaccination in Pregnant Women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441002/
54296,Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766387/
54297,A randomized controlled trial of antibody response to 2018–19 cell-based vs. egg-based quadrivalent inactivated influenza vaccine in children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367053/
54298,"Trends in place of early-season influenza vaccination among adults, 2014–15 through 2018–19 influenza seasons – the importance of medical and nonmedical settings for vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077541/
54299,Enhanced passive safety surveillance of a trivalent and a quadrivalent influenza vaccine in Denmark and Finland during the 2018/2019 season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018492/
54300,Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021–2022 Influenza Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10893961/
54301,Psychological predictors of vaccination intentions among U.S. undergraduates and online panel workers during the 2020 COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631617/
54302,"Diagnostic accuracy of an app-guided, self-administered test for influenza among individuals presenting to general practice with influenza-like illness: study protocol",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678361/
54303,Antigenic drift of hemagglutinin and neuraminidase in seasonal H1N1 influenza viruses from Saudi Arabia in 2014 to 2015,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228267/
54304,Elderly men with moderate and intense training lifestyle present sustained higher antibody responses to influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005841/
54305,Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605943/
54306,Standard Trivalent Influenza Virus Protein Vaccination Does Not Prime Antibody-Dependent Cellular Cytotoxicity in Macaques,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838265/
54307,Effect of COVID-19 Pandemic on Influenza Vaccination Intention: A Meta-Analysis and Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026798/
54308,Safety of Guidelines Recommending Live Attenuated Influenza Vaccine for Routine Use in Children and Adolescents with Asthma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786490/
54309,Vaccination of healthcare workers: A review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685699/
54310,Preparedness against pandemic influenza: Production of an oil-in-water emulsion adjuvant in Brazil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269237/
54311,"High-dose influenza vaccine use among patients receiving hemodialysis in the United States, 2010 – 2013",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176722/
54312,Roads to advanced vaccines: influenza case study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609253/
54313,Preparing for the unpredictable: The continuing need for pandemic influenza preparedness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130966/
54314,Role of vaccinating poultry against avian flu,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1309693/
54315,"A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399443/
54316,"Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078828/
54317,Computational tools for modern vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227725/
54318,Prospects for Universal Influenza Virus Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294695/
54319,Tackling influenza in Ghana,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324878/
54320,"Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012–2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554197/
54321,"Mathematical modeling for estimating influenza vaccine efficacy: A case study of the Valencian Community, Spain.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11058883/
54322,The repeated setbacks of HIV vaccine development laid the groundwork for SARS-CoV-2 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935961/
54323,High COVID-19 Vaccine Hesitancy Among Healthcare Workers: Should Such a Trend Require Closer Attention by Policymakers?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519358/
54324,Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949042/
54325,Pathogenicity and Vaccine Efficacy of Different Clades of Asian H5N1 Avian Influenza A Viruses in Domestic Ducks  ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2573247/
54326,"Interventions to Improve Knowledge, Attitudes, and Uptake of Recommended Vaccines during Pregnancy and Postpartum: A Scoping Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10747157/
54327,Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169434/
54328,Adv Ther. 2022; 39(1): 822–830. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600099/
54329,Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and “Universal” Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319262/
54330,An Exploratory Assessment of Factors with Which Influenza Vaccine Uptake Is Associated in Hungarian Adults 65 Years Old and Older: Findings from European Health Interview Surveys,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224319/
54331,Cold-Adapted Live Attenuated SARS-Cov-2 Vaccine Completely Protects Human ACE2 Transgenic Mice from SARS-Cov-2 Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712048/
54332,"Influenza-associated severe acute respiratory infections among children under five years old in Morocco, September 2017 to March 2019",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448308/
54333,Protection of Mice against Lethal Challenge with 2009 H1N1 Influenza A Virus by 1918-Like and Classical Swine H1N1 Based Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813279/
54334,Evaluating Influenza Vaccination Practices among COPD Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10820400/
54335,Efficient Vaccine Distribution Based on a Hybrid Compartmental Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883786/
54336,Oral Modeling of an Adenovirus-Based Quadrivalent Influenza Vaccine in Ferrets and Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929087/
54337,Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848608/
54338,Immunization of Pigs with a Particle-Mediated DNA Vaccine to Influenza A Virus Protects against Challenge with Homologous Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC124630/
54339,Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010–11,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5218812/
54340,Influenza and Measles-MMR: two case study of the trend and impact of vaccine-related Twitter posts in Spanish during 2015-2018,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128558/
54341,Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823859/
54342,Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779819/
54343,Systems Vaccinology: Enabling rational vaccine design with systems biological approaches,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581890/
54344,"Global patterns of seasonal influenza activity, duration of activity and virus (sub)type circulation from 2010 to 2020",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178051/
54345,Acceptability of a Fentanyl Vaccine to Prevent Opioid Overdose and Need for Personalized Decision-Making,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376272/
54346,Correlates of seasonal flu vaccination among U.S. home health aides,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529783/
54347,"Influenza and Tdap Vaccination Coverage Among Pregnant Women — United States, April 2020",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537555/
54348,The Influenza Vaccine May Protect Pregnant and Postpartum Women against Severe COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875780/
54349,Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus H5N1 Influenza Vaccine in Chronically Ill and Immunocompromised Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4054238/
54350,Efficacy of Heterologous Prime-Boost Vaccination with H3N2 Influenza Viruses in Pre-Immune Individuals: Studies in the Pig Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552030/
54351,"Influenza incidence and vaccine effectiveness during the Southern Hemisphere Influenza season—Chile, 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834235/
54352,"A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708628/
54353,"Public health spending, primary care, and perceived risk promoted vaccination against H1N1",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664079/
54354,"Medics as a Positive Deviant in Influenza Vaccination: The Role of Vaccine Beliefs, Self-Efficacy and Contextual Variables",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148145/
54355,Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195096/
54356,Immunogenicity and Protection of Oral Influenza Vaccines Formulated into Microparticles,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558794/
54357,Cost Analysis of Public Health Influenza Vaccine Clinics in Ontario,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973894/
54358,Influenza vaccines in low and middle income countries: A systematic review of economic evaluations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890229/
54359,Highly pathogenic avian influenza A/Guangdong/17SF003/2016 is immunogenic and induces cross-protection against antigenically divergent H7N9 viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910538/
54360,Vaccines the tugboat for prevention-based animal production,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149732/
54361,Virosome: An engineered virus for vaccine delivery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172599/
54362,"No Association between 2008–09 Influenza Vaccine and Influenza A(H1N1)pdm09 Virus Infection, Manitoba, Canada, 2009",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358049/
54363,Industry and Government Perspective in Influenza Control,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC387432/
54364,Development of a stable liquid formulation of live attenuated influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940209/
54365,Multi-Clade H5N1 Virus-Like Particles: Immunogenicity and Protection against H5N1 Virus and Effects of Beta-Propiolactone,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070352/
54366,Antigenic and immunogenic properties of recombinant hemagglutinin proteins from H1N1 A/Brisbane/59/07 and B/Florida/04/06 when produced in various protein expression systems,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379008/
54367,COVID-19 Anti-Vaccine Sentiments: Analyses of Comments from Social Media,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622531/
54368,Recent and advanced nano-technological strategies for COVID-19 vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015106/
54369,High dose of plasmid IL-15 inhibits immune responses in an influenza non-human primates immunogenicity model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118595/
54370,Can a Two-Dose Influenza Vaccine Regimen Better Protect Older Adults? An Agent-Based Modeling Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697266/
54371,Influenza vaccination uptake and factors influencing vaccination decision among patients with chronic kidney or liver disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043408/
54372,Needle-free delivery of an inactivated avian influenza H5N3 virus vaccine elicits potent antibody responses in chickens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788664/
54373,The importance of cultural tailoring of communicators and media outlets in an influenza vaccination awareness campaign: a digital randomized trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935604/
54374,A Recombinant Influenza A Virus Expressing Domain III of West Nile Virus Induces Protective Immune Responses against Influenza and West Nile Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082541/
54375,A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115584/
54376,Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583547/
54377,Influenza Vaccine-Induced CNS Demyelination in a 50-Year-Old Male,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159247/
54378,Protection against Lethal Influenza with a Viral Mimic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719819/
54379,Socioeconomic Impact of Seasonal (Epidemic) Influenza and the Role of Over-the-Counter Medicines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149741/
54380,Assessing Residual Bias in Estimating Influenza Vaccine Effectiveness: Comparison of High-dose versus Standard Dose Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310582/
54381,Immunological Correlates of Prevention of the Onset of Seasonal H3N2 Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205605/
54382,Vaccinations in pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181831/
54383,The upcoming influenza season and protection from vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544939/
54384,The risk of major structural birth defects associated with seasonal influenza vaccination during pregnancy: A population‐based cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796878/
54385,Considerations for sustainable influenza vaccine production in developing countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359512/
54386,"Registry Cohort Study to Determine Risk for Multiple Sclerosis after Vaccination for Pandemic Influenza A(H1N1) with Arepanrix, Manitoba, Canada",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038732/
54387,Escherichia coli-derived virus-like particles in vaccine development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627247/
54388,Mapping Host-Related Correlates of Influenza Vaccine-Induced Immune Response: An Umbrella Review of the Available Systematic Reviews and Meta-Analyses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963823/
54389,Prospective hospital-based case–control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009–2010 using matched hospital and test-negative controls,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464893/
54390,"Development of an effective contemporary trivalent avian influenza vaccine against circulating H5N1, H5N8, and H9N2 in Egypt",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6869764/
54391,Improving public health information for patients: shared decision making and influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569735/
54392,"Corowa-kun: A messenger app chatbot delivers COVID-19 vaccine information, Japan 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174339/
54393,Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452323/
54394,A Novel Synthetic Receptor-Based Immunoassay for Influenza Vaccine Quantification,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570553/
54395,Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395544/
54396,"Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106412/
54397,Epidemiology and Relative Severity of Influenza Subtypes in Singapore in the Post-Pandemic Period from 2009 to 2010,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850443/
54398,Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10802964/
54399,Factors influencing seasonal influenza vaccination behaviour among elderly people: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111770/
54400,Cost-effectiveness of dual influenza and pneumococcal vaccination in 50-year-olds,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981678/
54401,"Industry must be responsible for bird flu vaccine, says UK government",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1382531/
54402,Paradoxical aging in HIV: immune senescence of B Cells is most prominent in young age,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425129/
54403,Is influenza vaccination associated with nephrotic syndrome relapse in children? A multicenter prospective study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709736/
54404,Human Vaccines & Immunotherapeutics: News,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906344/
54405,Peri-Pandemic Acceptance of Influenza and COVID-19 Vaccination by Swiss Healthcare Workers in Primary Care 2020/21: A Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684700/
54406,Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412240/
54407,Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694854/
54408,Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826668/
54409,Mucosal Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens Provides Protection against Mycobacterium tuberculosis in Mice and Guinea Pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073308/
54410,Plant Viruses as Adjuvants for Next-Generation Vaccines and Immunotherapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458565/
54411,O/W Nanoemulsion as an Adjuvant for an Inactivated H3N2 Influenza Vaccine: Based on Particle Properties and Mode of Carrying,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104212/
54412,Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil – comparison of outcomes from different static model types,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425677/
54413,Tailoring interventions to suit self-reported format preference does not decrease vaccine hesitancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030039/
54414,Highly conserved M2e and hemagglutinin epitope-based recombinant proteins induce protection against influenza virus infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110499/
54415,Effect of Patient Portal Reminders Sent by a Health Care System on Influenza Vaccination Rates: A Randomized Clinical Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235900/
54416,Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: Pooled analysis of 28 clinical trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443104/
54417,Perceptions of and hesitancy toward COVID-19 vaccination in older Chinese adults in Hong Kong: a qualitative study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985396/
54418,"A phase 1, open-label safety and immunogenicity study of an AS03-adjuvanted trivalent inactivated influenza vaccine in children aged 6 to 35 months",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186022/
54419,Assessing Antigenic Drift of Seasonal Influenza A(H3N2) and A(H1N1)pdm09 Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594909/
54420,Exploring COVID-19 Vaccine Hesitancy Amongst Black Americans: Contributing Factors and Motivators,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618913/
54421,Risk of Guillain–Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282476/
54422,A De-O-acylated Lipooligosaccharide-Based Adjuvant System Promotes Antibody and Th1-Type Immune Responses to H1N1 Pandemic Influenza Vaccine in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116492/
54423,Modulation of Immunogenicity and Conformation of HA1 Subunit of Influenza A Virus H1/N1 Hemagglutinin in Tubular Immunostimulating Complexes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618544/
54424,Plasma Cell and Serum Antibody Responses to Influenza Vaccine in Preterm and Full-term Infants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603201/
54425,Cross-Protective Efficacy of Monovalent Live Influenza B Vaccines against Genetically Different Lineages of B/Victoria and B/Yamagata in Ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136522/
54426,COVID-19 and Parent Intention to Vaccinate Their Children Against Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706108/
54427,Multifactorial influences underpinning a decision on COVID-19 vaccination among healthcare workers: a qualitative analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621075/
54428,Matrix MTM adjuvanted virosomal H5N1 vaccine induces balanced Th1/Th2 CD4+ T cell responses in man,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896793/
54429,US school/academic institution disaster and pandemic preparedness and seasonal influenza vaccination among school nurses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132726/
54430,"Genomic Analyses Uncover Evolutionary Features of Influenza A/H3N2 Viruses in Yunnan Province, China, from 2017 to 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10820241/
54431,"Single-Dose Vaccination Among Infants and Toddlers Provides Modest Protection Against Influenza Illness, Which Wanes After 5 Months",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205610/
54432,Cluster randomized trial of influenza vaccination in patients with acute heart failure in China: A mixed-methods feasibility study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275428/
54433,Intranasal COVID-19 vaccines: From bench to bed,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785603/
54434,Impact of European vaccination policies on seasonal influenza vaccination coverage rates: An update seven years later,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314402/
54435,Influenza Vaccination Rates Among Patients With a History of Cancer: Analysis of the National Health Interview Survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312520/
54436,Vaccine models predict rules for updating vaccines against evolving pathogens such as SARS-CoV-2 and influenza in the context of pre-existing immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574365/
54437,Post-Marketing Active Surveillance of Adverse Reactions Following Influenza Cell-Based Quadrivalent Vaccine: An Italian Prospective Observational Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147936/
54438,A Cost-Effectiveness Analysis of Antenatal Influenza Vaccination among HIV-Infected and HIV-Uninfected Pregnant Women in South Africa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939109/
54439,Influenza vaccination allocation in tropical settings under constrained resources,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10871372/
54440,School-Based Influenza Vaccination: Parents’ Perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970961/
54441,"What Are the Primary Limitations in B-Cell Affinity Maturation, and How Much Affinity Maturation Can We Drive with Vaccination?: Is Affinity Maturation a Self-Defeating Process for Eliciting Broad Protection?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899041/
54442,Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144728/
54443,Cost-Effectiveness of Adjuvanted Versus Nonadjuvanted Influenza Vaccine in Adult Hemodialysis Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085888/
54444,Bacillus Calmette–Guérin-Induced Trained Immunity Is Not Protective for Experimental Influenza A/Anhui/1/2013 (H7N9) Infection in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936970/
54445,Front Immunol. 2018; 9: 2471. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211335/
54446,Ten years of vaccinovigilance in Italy: an overview of the pharmacovigilance data from 2008 to 2017,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445254/
54447,Taiwan’s Annual Seasonal Influenza Mass Vaccination Program—Lessons for Pandemic Planning,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129648/
54448,Increasing influenza vaccination coverage in healthcare workers: a review on campaign strategies and their effect,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720031/
54449,Impact of Immunosuppression on Recall Immune Responses to Influenza Vaccination in Stable Renal Transplant Recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843769/
54450,Influenza A Virus Attenuation by Codon Deoptimization of the NS Gene for Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178899/
54451,Heterovariant Cross-Reactive B-Cell Responses Induced by the 2009 Pandemic Influenza Virus A Subtype H1N1 Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532823/
54452,65 years of influenza surveillance by a World Health Organization‐coordinated global network,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086847/
54453,The WHO global influenza surveillance and response system (GISRS)—A future perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086842/
54454,Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371628/
54455,Use of Information and Communication Technology Strategies to Increase Vaccination Coverage in Older Adults: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384530/
54456,DNA Vaccine Encoding Hemagglutinin Provides Protective Immunity against H5N1 Influenza Virus Infection in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC104453/
54457,Characterization of Reverse Genetics-Derived Cold-Adapted Master Donor Virus A/Leningrad/134/17/57 (H2N2) and Reassortants with H5N1 Surface Genes in a Mouse Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018889/
54458,Cell-mediated Protection in Influenza Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291410/
54459,Heterosubtypic Immunity To Influenza A Virus: Where Do We Stand?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584237/
54460,Implementation of a Military Emergency Department Influenza Vaccination Program: Lessons from Failure,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384502/
54461,Dynamic interactions of influenza viruses in Hong Kong during 1998-2018,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316359/
54462,Adenovirus vector-based vaccine for infectious diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585960/
54463,Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936145/
54464,Canada and the pharmaceutical industry in the time of COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631262/
54465,"An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519190/
54466,"The Effects of Birth Year, Age and Sex on Hemagglutination Inhibition Antibody Responses to Influenza Vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161215/
54467,Sex and Gender Impact Immune Responses to Vaccines Among the Elderly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630198/
54468,Immune history and influenza virus susceptibility,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467731/
54469,Facilitating the development of urgently required combination vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11099297/
54470,Prevention and Control of Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121144/
54471,Custom-made vaccines at speed,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129312/
54472,Safety and immunogenicity of influenza vaccine among HIV-infected adults: Conventional vaccine vs. intradermal vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049744/
54473,Rural parents' vaccination-related attitudes and intention to vaccinate middle and high school children against influenza following educational influenza vaccination intervention,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323494/
54474,Race-related differences in antibody responses to the inactivated influenza vaccine are linked to distinct pre-vaccination gene expression profiles in blood,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325335/
54475,Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292422/
54476,BMJ Open. 2019; 9(2): e023118corr1. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398688/
54477,Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245146/
54478,Acute upper respiratory tract viral illness and influenza immunization in homes for the elderly.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2271825/
54479,Summary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2271825/
54480,Fitness Determinants of Influenza A Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535923/
54481,Using the 4 pillars™ practice transformation program to increase adult influenza vaccination and reduce missed opportunities in a randomized cluster trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094034/
54482,"Safety of Tetanus, Diphtheria, and Acellular Pertussis and Influenza Vaccinations in Pregnancy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618722/
54483,Motivators and barriers to vaccination of health professionals against seasonal influenza in primary healthcare,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234642/
54484,Improving Influenza and Pneumococcal Vaccination Rates in Ambulatory Specialty Practices,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589825/
54485,The influenza virus hemagglutinin head evolves faster than the stalk domain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041311/
54486,Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589955/
54487,Characterization of Influenza A and B Viruses Circulating in Southern China During the 2017–2018 Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272714/
54488,The Impact of Immunosenescence on Humoral Immune Response Variation after Influenza A/H1N1 Vaccination in Older Subjects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376784/
54489,Influenza Vaccination Is Associated With Lower Incidental Asthma Risk in Patients With Atopic Dermatitis: A Nationwide Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548273/
54490,Humoral and cell-mediated immune responses to monovalent 2009 influenza A/H1N1 and seasonal trivalent influenza vaccines in high risk children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652684/
54491,Influenza vaccination coverage among splenectomized patients: an Italian study on the role of active recall in the vaccination compliance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930075/
54492,How to ensure vaccine safety: An evaluation of China’s vaccine regulation system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344949/
54493,Influenza Vaccination Guidelines and Vaccine Sales in Southeast Asia: 2008–2011,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528727/
54494,"Five years of non-prescription oseltamivir: effects on resistance, immunization and stockpiling",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314044/
54495,Technology transfer programme for influenza vaccines – Lessons from the past to inform the future,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406834/
54496,Pandemic Preparedness & the Development of Vaccines for H5N1 Influenza at The Midwest Research Institute,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188397/
54497,Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974491/
54498,Immunogenicity of influenza vaccines administered to pregnant women in randomized clinical trials in Mali and South Africa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505225/
54499,Probability of Success and Timelines for the Development of Vaccines for Emerging and Reemerged Viral Infectious Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707230/
54500,Vaccination in Hajj: An Overview of the Recent Findings,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5200976/
54501,Antigenic Pressure on H3N2 Influenza Virus Drift Strains Imposes Constraints on Binding to Sialylated Receptors but Not Phosphorylated Glycans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819937/
54502,Vaccine-preventable infections in Systemic Lupus Erythematosus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964666/
54503,"The new pandemic influenza A/(H1N1)pdm09 virus: is it really ""new""?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910438/
54504,Computational design and evaluation of mRNA- and protein-based conjugate vaccines for influenza A and SARS-CoV-2 viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651613/
54505,"Evaluation of the efficacy, safety and influencing factors of concomitant and sequential administration of viral respiratory infectious disease vaccines: a systematic review and meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10764558/
54506,"Comparison of Immunogenicity and Safety between a Single Dose and One Booster Trivalent Inactivated Influenza Vaccination in Patients with Chronic Kidney Disease: A 20-Week, Open-Label Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996510/
54507,Statistical inference of a convergent antibody repertoire response to influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891843/
54508,"Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071822/
54509,Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160963/
54510,Gap between cognitions and behaviors among children’s guardians of influenza vaccination: The role of social influence and vaccine-related knowledge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980667/
54511,B‐ and T‐cell memory elicited by a seasonal live attenuated reassortant influenza vaccine: assessment of local antibody avidity and virus‐specific memory T‐cells using trogocytosis‐based method,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942081/
54512,"Vaccinating in the Emergency Department, a Model to Overcome Influenza Vaccine Hesitancy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032353/
54513,Immunogenicity and effectiveness of a bivalent influenza A/H1N2 vaccine strain against seasonal human influenza A viruses in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636361/
54514,Chitosan Nanoparticle Encapsulated Hemagglutinin-Split Influenza Virus Mucosal Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969489/
54515,Administering Influenza Vaccine to HIV Patients: Does Timing Matter?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960000/
54516,"Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861783/
54517,Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526067/
54518,Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432866/
54519,"2017/18 and 2018/19 seasonal influenza vaccine safety surveillance, Canadian National Vaccine Safety (CANVAS) Network",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336108/
54520,Determinants of acceptance of Coronavirus disease-2019 (COVID-19) vaccine among Lebanese health care workers using health belief model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863223/
54521,"Survey of influenza vaccine knowledge, attitudes, and beliefs among pregnant women in the 2016–17 season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869019/
54522,COVID-19 vaccine status and hesitancy in pharmacy students,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920303/
54523,Parental intention to vaccinate children against seasonal influenza in the Eastern Mediterranean region: A cross-sectional study using the health belief model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395193/
54524,Vaccination decreases the risk of influenza A virus reassortment but not genetic variation in pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439680/
54525,Assessment of the belief and attitudes of Iranian healthcare personnel’s toward the influenza infection and influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797887/
54526,Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563311/
54527,"Systemic sclerosis and vaccinations: a three-year register-based cohort study about vaccination rate and uptake from Liguria referral center, northwest Italy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993060/
54528,"Impact of influenza vaccination programmes among the elderly population on primary care, Portugal, Spain and the Netherlands: 2015/16 to 2017/18 influenza seasons",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852314/
54529,Acceptance of seasonal influenza vaccination and associated factors among pregnant women in the context of COVID-19 pandemic in China: a multi-center cross-sectional study based on health belief model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564270/
54530,Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747268/
54531,"Shedding of Live Vaccine Virus, Comparative Safety, and Influenza-Specific Antibody Responses after Administration of Live Attenuated and Inactivated Trivalent Influenza Vaccines to HIV-Infected Children",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615200/
54532,Influenza vaccination for all pregnant women? So far the less biased evidence does not favour it,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773390/
54533,Effect of 25-Hydroxyvitamin D Status on Serological Response to Influenza Vaccine in Prostate Cancer Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718551/
54534,Universal Influenza Virus Vaccines That Target the Conserved Hemagglutinin Stalk and Conserved Sites in the Head Domain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452318/
54535,Nanocarriers-Assisted Needle-Free Vaccine Delivery Through Oral and Intranasal Transmucosal Routes: A Novel Therapeutic Conduit,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787087/
54536,Influenza immunization of chronically ill children in pediatric tertiary care hospitals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443054/
54537,"A cross-sectional survey to evaluate knowledge, attitudes and practices (KAP) regarding seasonal influenza vaccination among European travellers to resource-limited destinations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912811/
54538,Seasonal influenza vaccine exposure in pregnancy: 5-year results from a pregnancy registry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920223/
54539,Addressing racial inequality and its effects on vaccination rate: A trial comparing a pharmacist and peer educational program (MOTIVATE) in diverse older adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397332/
54540,Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717671/
54541,"Seasonal influenza vaccine uptake among Chinese in Hong Kong: barriers, enablers and vaccination rates",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482890/
54542,Skewed risk perceptions in pregnant women: the case of influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785668/
54543,"Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829534/
54544,Inflammatory Responses to Trivalent Influenza Virus Vaccine Among Pregnant Women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204610/
54545,"Knowledge, Attitudes, and Perception towards COVID-19 Vaccination among the Adult Population: A Cross-Sectional Study in Turkey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877322/
54546,Examining General Vaccine Acceptance and COVID-19 Vaccine Intention: Comparison across Pharmacies in California and Ohio,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037570/
54547,The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335656/
54548,Influenza Vaccine Effectiveness in the Inpatient Setting: Evaluation of Potential Bias in the Test-Negative Design by Use of Alternate Control Groups,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567846/
54549,The Role of Adult Vaccines as Part of Antimicrobial Stewardship: A Scoping Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525636/
54550,"Memory B Cell Activation, Broad Anti-influenza Antibodies, and Bystander Activation Revealed by Single-Cell Transcriptomics",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891556/
54551,"Estimating vaccine effectiveness against laboratory-confirmed influenza among children and adolescents in Lower Saxony and Saxony-Anhalt, 2012–2016",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134507/
54552,European community pharmacists practice in tackling influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11068921/
54553,NS1-Truncated Live Attenuated Virus Vaccine Provides Robust Protection to Aged Mice from Viral Challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457311/
54554,"Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013–2014 Through 2015–2016",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192403/
54555,"Seasonal influenza vaccination coverage among adult populations, United States, 2005-2011",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824626/
54556,Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046074/
54557,Three-year COVID-19 and flu vaccinations among medical residents in a tertiary hospital in Italy: The threat of acceptance decline in seasonal campaigns,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503443/
54558,Identification of broad binding class I HLA supertype epitopes to provide universal coverage of influenza A virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2856764/
54559,Vaccines for preventing influenza in people with cystic fibrosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066935/
54560,Effectiveness of Nonadjuvanted Monovalent Influenza A(H1N1)pdm09 Vaccines for Preventing Reverse Transcription Polymerase Chain Reaction–Confirmed Pandemic Influenza Hospitalizations: Case-Control Study of Children and Adults at 10 US Influenza Surveillance Network Sites,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314184/
54561,Clin Infect Dis. 2014 Jul 15; 59(2): 323. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900132/
54562,"Association of influenza vaccine uptake with health, access to health care, and medical mistreatment among adults from low-income neighborhoods in New Haven, CT: A classification tree analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390513/
54563,"A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015872/
54564,Narrative review on century of respiratory pandemics from Spanish flu to COVID-19 and impact of nanotechnology on COVID-19 diagnosis and immune system boosting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589879/
54565,"Data, disease and diplomacy: GISAID's innovative contribution to global health",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607375/
54566,HIV-dependent depletion of influenza-specific memory B cells impacts B cell responsiveness to seasonal influenza immunisation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879526/
54567,"Mid-season real-time estimates of seasonal influenza vaccine effectiveness in persons 65 years and older in register-based surveillance, Stockholm County, Sweden, and Finland, January 2017",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356437/
54568,Euro Surveill. 2017 Mar 2; 22(9): 30475. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356431/
54569,Using electronic biology based platform to predict flu vaccine efficacy for 2018/2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865198/
54570,Vaccines for preventing influenza in people with asthma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6999427/
54571,A Lipid/DNA Adjuvant–Inactivated Influenza Virus Vaccine Protects Rhesus Macaques From Uncontrolled Virus Replication After Heterosubtypic Influenza A Virus Challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093312/
54572,The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503029/
54573,"Influenza Vaccine Effectiveness Against Influenza A(H3N2) Hospitalizations in Children in Hong Kong in a Prolonged Season, 2016/2017",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894077/
54574,Mucosal Adjuvants For Vaccines To Control Upper Respiratory Infections In The Elderly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989367/
54575,Vaccination of the Stem Cell Transplant (SCT) recipient and the Hematologic Malignancy patient,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814287/
54576,"An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073703/
54577,"Preparedness for the Spread of Influenza: Prohibition of Traffic, School Closure, and Vaccination of Children in the Commuter Towns of Tokyo",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2443241/
54578,Anti-Influenza Strategies Based on Nanoparticle Applications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761763/
54579,Modelling the influenza disease burden in people aged 50–64 and ≥65 years in Australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692809/
54580,Building the global vaccine manufacturing capacity needed to respond to pandemics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903906/
54581,"Endocine™, N3OA and N3OASq; Three Mucosal Adjuvants That Enhance the Immune Response to Nasal Influenza Vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738562/
54582,Is It Possible? A Different Approach to Creating a Universal Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611052/
54583,Factors influencing flu vaccination in nursing students at Palermo University,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888385/
54584,Inactivated vaccines. 2. Laboratory indices of protection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2495389/
54585,Summary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2495389/
54586,"The association between vaccination confidence, vaccination behavior, and willingness to recommend vaccines among Finnish healthcare workers",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822763/
54587,"Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279702/
54588,Bivalent vaccination with NA1 and NA2 neuraminidase virus-like particles is protective against challenge with H1N1 and H3N2 influenza A viruses in a murine model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479372/
54589,Attitudes toward and Uptake of H1N1 Vaccine among Health Care Workers during the 2009 H1N1 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245279/
54590,Summary of the NACI Seasonal Influenza Vaccine Statement for 2020–2021,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279128/
54591,Comparison of Two High-Dose Versus Two Standard-Dose Influenza Vaccines in Adult Allogeneic Hematopoietic Cell Transplant Recipients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10724468/
54592,"Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009–2011",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694016/
54593,Vaccine Effectiveness Against Laboratory-Confirmed Influenza Hospitalizations Among Elderly Adults During the 2010–2011 Season,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749748/
54594,Do we need nasal vaccines against COVID 19 to suppress the transmission of infections?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803331/
54595,Establishment of a cohort for deep phenotyping of the immune response to influenza vaccination among elderly individuals recruited from the general population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512809/
54596,Next Generation Influenza Vaccines: Looking into the Crystal Ball,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563445/
54597,Evaluating interest in an influenza A(H5N1) vaccine among laboratory workers who work with highly-pathogenic avian influenza viruses in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759037/
54598,"Protecting patients, protecting healthcare workers: a review of the role of influenza vaccination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418836/
54599,Predictors and temporal trend of flu vaccination in auto-immune rheumatic diseases in the UK: a nationwide prospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152422/
54600,Simulation Study of the Effect of Influenza and Influenza Vaccination on Risk of Acquiring Guillain-Barré Syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313628/
54601,Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5475249/
54602,Mol Ther. 2022 Aug 3; 30(8): 2874. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372314/
54603,Cross Protection against Influenza A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular Proteins,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569442/
54604,Parental risk perception and influenza vaccination of children in daycare centres,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152552/
54605,Effect of expanded US recommendations for seasonal influenza vaccination: comparison of two pediatric emergency departments in the United States and Canada,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176865/
54606,Intracellular delivery of HA1 subunit antigen through attenuated Salmonella Gallinarum act as a bivalent vaccine against fowl typhoid and low pathogenic H5N3 virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545839/
54607,Host Factors Impact Vaccine Efficacy: Implications for Seasonal and Universal Influenza Vaccine Programs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803252/
54608,Immunostimulant Patch Enhances Immune Responses to Influenza Virus Vaccine in Aged Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC434114/
54609,Influenza A (H1N1) 2009: Impact on Frankfurt in due consideration of health care and public health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868035/
54610,Pharmacist-Administered Influenza Vaccination in Children and Corresponding Regulations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505660/
54611,Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2519082/
54612,Bacterial Outer Membrane Vesicles (OMVs)-Based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631769/
54613,mRNA: Vaccine or Gene Therapy? The Safety Regulatory Issues,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342157/
54614,Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564061/
54615,Post-Pandemic Seroprevalence of Pandemic Influenza A (H1N1) 2009 Infection (Swine Flu) among Children <18 Years in Germany,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168498/
54616,Structural analysis of influenza vaccine virus-like particles reveals a multicomponent organization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037804/
54617,"Vaccination History, Body Mass Index, Age, and Baseline Gene Expression Predict Influenza Vaccination Outcomes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697051/
54618,Production of Neuraminidase Virus Like Particles by Stably Transformed Insect Cells: A Simple Process for NA-Based Influenza Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198613/
54619,Interpretation of vaccine associated neurological adverse events: a methodological and historical review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366487/
54620,Topological N-glycosylation and site-specific N-glycan sulfation of influenza proteins in the highly expressed H1N1 candidate vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579265/
54621,Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446656/
54622,National safety surveillance of quadrivalent recombinant influenza vaccine in Taiwan during NH 20/21,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106408/
54623,"Knowledge, attitudes, and practices towards influenza among Chinese adults during the epidemic of COVID-19: a cross-sectional online survey",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078711/
54624,Factors influencing acceptance of influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746514/
54625,Plant-made vaccines and reagents for the One Health initiative,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718809/
54626,Current advances in the development of SARS-CoV-2 vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757035/
54627,Immunogenicity and efficacy of fowlpox-vectored and inactivated avian influenza vaccines alone or in a prime-boost schedule in chickens with maternal antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258031/
54628,Concerns for others increases the likelihood of vaccination against influenza and COVID-19 more in sparsely rather than densely populated areas,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817150/
54629,Dummheit,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748339/
54630,Detection and discrimination of influenza B Victoria lineage deletion variant viruses by real-time RT-PCR,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565853/
54631,Euro Surveill. 2020 Oct 22; 25(42): 201022e. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7651871/
54632,Risk of presentation to hospital with epileptic seizures after vaccination with monovalent AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix): self controlled case series study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532724/
54633,Designed nanoparticles elicit cross-reactive antibody responses to conserved influenza virus hemagglutinin stem epitopes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491405/
54634,Cross-Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110255/
54635,Serological Memory and Long-term Protection to Novel H1N1 Influenza Virus After Skin Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144165/
54636,"Influenza Vaccine Effectiveness in a Low-Income, Urban Community Cohort",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706631/
54637,Clin Infect Dis. 2017 Jul 15; 65(2): 356. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190905/
54638,Cytotoxic lymphocytes and antibody-dependent complement-mediated cytotoxicity induced by administration of influenza vaccine.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC551319/
54639,Summary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC551319/
54640,Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492002/
54641,Should my patient with inflammatory bowel disease on immunosuppressive therapy be vaccinated against influenza virus?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852234/
54642,A novel hemagglutinin protein produced in bacteria protects chickens against H5N1 highly pathogenic avian influenza viruses by inducing H5 subtype-specific neutralizing antibodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315377/
54643,PLoS One. 2017; 12(4): e0176249. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393861/
54644,WHO supports fair access to influenza A (H1N1) vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739921/
54645,"AddaVax Formulated with PolyI:C as a Potential Adjuvant of MDCK-based Influenza Vaccine Enhances Local, Cellular, and Antibody Protective Immune Response in Mice",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584644/
54646,Live Attenuated Influenza Virus Expressing Human Interleukin-2 Reveals Increased Immunogenic Potential in Young and Aged Hosts ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1642586/
54647,Association between inactivated influenza vaccine and primary care consultations for autoimmune rheumatic disease flares: a self-controlled case series study using data from the Clinical Practice Research Datalink,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691866/
54648,Cost-effectiveness for high dose quadrivalent versus the adjuvanted quadrivalent influenza vaccine in the Italian older adult population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679352/
54649,Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310092/
54650,Influenza and COVID-19 co-infection and vaccine effectiveness against severe cases: a mathematical modeling study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10945002/
54651,"Co-Administration of Influenza and COVID-19 Vaccines: Policy Review and Vaccination Coverage Trends in the European Union, UK, US, and Canada between 2019 and 2023",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10891656/
54652,Progress in the development of influenza vaccines: Memorandum from a WHO Meeting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491014/
54653,Summary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491014/
54654,"Estimating age‐specific influenza‐related hospitalization rates during the pandemic (H1N1) 2009 in Davidson Co, TN",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773818/
54655,"Adjuvants in the Driver’s Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494256/
54656,Immunogenicity and safety of intradermal influenza vaccine in immunocompromized patients: a meta-analysis of randomized controlled trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607009/
54657,HIV-1 and influenza antibodies: seeing antigens in new ways,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2796958/
54658,Complications of Viral Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172971/
54659,Vaccination against Human Influenza A/H3N2 Virus Prevents the Induction of Heterosubtypic Immunity against Lethal Infection with Avian Influenza A/H5N1 Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678248/
54660,"Increasing Influenza and Pneumococcal Vaccination Uptake in Seniors Using Point-of-Care Informational Interventions in Primary Care in Singapore: A Pragmatic, Cluster-Randomized Crossover Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836784/
54661,Population-Based Incidence of Guillain-Barré Syndrome During Mass Immunization With Viral Vaccines: A Pooled Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850251/
54662,"COVID-19 and flu vaccination in Romania, post pandemic lessons in healthcare workers and general population",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10919663/
54663,"The current status, challenges, and future developments of new tuberculosis vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067889/
54664,DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214651/
54665,A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391461/
54666,Do we have enough evidence how seasonal influenza is transmitted and can be prevented in hospitals to implement a comprehensive policy?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130638/
54667,Efficacy of a heterologous vaccine and adjuvant in ferrets challenged with influenza virus H5N1,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412077/
54668,Self-reported diabetes and herpes zoster are associated with a weak humoral response to the seasonal influenza A H1N1 vaccine antigen among the elderly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651912/
54669,Gastrointestinal Delivery of Baculovirus Displaying Influenza Virus Hemagglutinin Protects Mice against Heterologous H5N1 Infection ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2838147/
54670,Analgesic and adjuvant properties of exercise with vaccinations in healthy young population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189097/
54671,Willingness to receive a hypothetical avian influenza vaccine among US military personnel in mid-deployment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162042/
54672,The Global Interest in Vaccines and Its Prediction and Perspectives in the Era of COVID-19. Real-Time Surveillance Using Google Trends,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345601/
54673,Epidemic of influenza A(H1N1)pdm09 analyzed by full genome sequences and the first case of oseltamivir-resistant strain in Myanmar 2017,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055873/
54674,"Fourth meeting of the Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) network and first scientific conference on acute respiratory infections in the Eastern Mediterranean Region, 11–14 December, 2017, Amman, Jordan",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102739/
54675,Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza a virus in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621599/
54676,"Real-time real-world analysis of seasonal influenza vaccine effectiveness: method development and assessment of a population-based cohort in Stockholm County, Sweden, seasons 2011/12 to 2014/15",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114721/
54677,An Overview of the Use of Nanoparticles in Vaccine Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304030/
54678,Quadrivalent influenza vaccine in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130263/
54679,Immunogenicity and Cross-Protective Efficacy Induced by an Inactivated Recombinant Avian Influenza A/H5N1 (Clade 2.3.4.4b) Vaccine against Co-Circulating Influenza A/H5Nx Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538193/
54680,Immunity Against Heterosubtypic Influenza Virus Induced By Adenovirus And MVA Expressing Nucleoprotein And Matrix Protein-1,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595699/
54681,Influenza and pneumococcus vaccination rates in pediatric dialysis patients in Europe: recommendations vs reality A European Pediatric Dialysis Working Group and European Society for Pediatric Nephrology Dialysis Working Group study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10734874/
54682,Exercise after influenza or COVID-19 vaccination increases serum antibody without an increase in side effects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816799/
54683,The surge of universal influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5375619/
54684,COVID-19 Vaccination Coverage and Associated Factors in Patients with Multiple Sclerosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10893319/
54685,The Magnitude of Local Immunity in the Lungs of Mice Induced by Live Attenuated Influenza Vaccines Is Determined by Local Viral Replication and Induction of Cytokines  ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014215/
54686,Factors associated with 2009 pandemic influenza A (H1N1) vaccination acceptance among university students from India during the post-pandemic phase,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161886/
54687,An evaluation of the feasibility and usability of a proof of concept mobile app for adverse event reporting post influenza vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964836/
54688,"Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018–2019 season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302525/
54689,Status and Challenges for Vaccination against Avian H9N2 Influenza Virus in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505450/
54690,Baseline CD3+CD56+ (NKT-like) Cells and the Outcome of Influenza Vaccination in Children Undergoing Chemotherapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276261/
54691,Adverse Events following Immunization with COVID-19 Vaccines: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398801/
54692,Electroporation of Synthetic DNA Antigens Offers Protection in Nonhuman Primates Challenged with Highly Pathogenic Avian Influenza Virus  ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668454/
54693,Intranasal influenza vaccine: Why does Canada have different recommendations from the USA on its use?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815092/
54694,"Influenza A (H1N1) 2009 monovalent and seasonal influenza vaccination among adults 25 to 64 years of age with high-risk conditions—United States, 2010",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820774/
54695,Healthcare Workers and Nonhealthcare Workers Pro-Vaccination Attitude and Its Associated Factors towards COVID-19 Vaccine Globally: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576430/
54696,Single Cell Profiling Reveals PTEN Overexpression in Influenza-Specific B cells in Aging HIV-infected individuals on Anti-retroviral Therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385500/
54697,Development of an enzyme‐linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780761/
54698,"Estimated influenza illnesses and hospitalizations averted by influenza vaccination among children aged 6–59 months in Suzhou, China, 2011/12 to 2015/16 influenza seasons",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728434/
54699,Attitudes of Healthcare Workers toward Influenza Vaccination in the COVID-19 Era,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231023/
54700,Mucosal Delivery of Inactivated Influenza Vaccine Induces  B-Cell-Dependent Heterosubtypic Cross-Protection  against Lethal Influenza A H5N1 Virus Infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC114919/
54701,Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318334/
54702,The influence of partial public reimbursement on vaccination uptake in the older population: a cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328256/
54703,"Uptake of influenza vaccination among persons with inflammatory bowel disease, multiple sclerosis or rheumatoid arthritis: a population-based matched cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157981/
54704,Evaluation of MDCK Cell-Derived Influenza H7N9 Vaccine Candidates in Ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370571/
54705,Obesity Impairs the Adaptive Immune Response to Influenza Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711276/
54706,Development of a new candidate H5N1 avian influenza virus for pre‐pandemic vaccine production,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941393/
54707,Factors associated with parental acceptance of influenza vaccination for their children: the evidence from four cities of China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899639/
54708,Structural vaccinology: structure-based design of influenza A virus hemagglutinin subtype-specific subunit vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875251/
54709,Thrombotic events following Covid-19 vaccines compared to Influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904150/
54710,The epidemiology of seasonal influenza after the 2009 influenza pandemic in Africa: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351825/
54711,FluMum: a prospective cohort study of mother–infant pairs assessing the effectiveness of maternal influenza vaccination in prevention of influenza in early infancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078783/
54712,mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559634/
54713,Comparative Efficacy of Neutralizing Antibodies Elicited by Recombinant Hemagglutinin Proteins from Avian H5N1 Influenza Virus ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2447076/
54714,Active vaccination campaign to increase seasonal influenza vaccination coverage: a monocenter experience in a cohort of Italian patients with systemic autoimmune diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540136/
54715,COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461057/
54716,A Comparative Analysis of Influenza-Associated Disease Burden with Different Influenza Vaccination Strategies for the Elderly Population in South Korea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503807/
54717,A survey of systemic lupus erythematosus patients' attitudes toward influenza and pneumococcal vaccination in Southwest China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807807/
54718,Coverage and parental perceptions of influenza vaccination among parents of children aged 6 to 23 months in Hong Kong,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228458/
54719,Genetic drift evolution under vaccination pressure among H5N1 Egyptian isolates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146449/
54720,The 2009 Influenza A (H1N1) Pandemic: What Have We Learned in the Past 6 Months,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917128/
54721,The Potential of Influenza HA-Specific Immunity in Mitigating Lethality of Postinfluenza Pneumococcal Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963476/
54722,Burden of influenza hospitalization among high-risk groups in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520810/
54723,"Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578608/
54724,Advancements in protein nanoparticle vaccine platforms to combat infectious disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052270/
54725,Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931496/
54726,Trends of influenza B during the 2010–2016 seasons in 2 regions of north and south Italy: The impact of the vaccine mismatch on influenza immunisation strategy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861802/
54727,Estimated cost-effectiveness and burden of disease associated with quadrivalent cell-based and egg-based influenza vaccines in Spain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553711/
54728,Improving uptake of influenza vaccination among older people: a randomised controlled trial.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1314411/
54729,Phylogenetic analysis and docking study of neuraminidase gene of influenza A/H1N1 viruses circulating in Iran from 2010 to 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407273/
54730,Exploring the Continuum of Vaccine Hesitancy Between African American and White Adults: Results of a Qualitative Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309123/
54731,Restrained expansion of the recall germinal center response as biomarker of protection for influenza vaccination in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855462/
54732,"Antibody Responses toward the Major Antigenic Sites of Influenza B Virus Hemagglutinin in Mice, Ferrets, and Humans",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321909/
54733,Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770550/
54734,Developing vaccines against pandemic influenza.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1088574/
54735,Maintenance of a High Influenza Vaccination Rate and Improvement in Health Outcomes in a Pediatric Sickle Cell Disease Clinic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581069/
54736,Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054797/
54737,"Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: A systematic review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149986/
54738,Transcutaneous delivery and thermostability of a dry trivalent inactivated influenza vaccine patch,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941894/
54739,"The Influence of Recommendation of Medical and Non-Medical Authorities on the Decision to Vaccinate against Influenza from a Social Vaccinology Perspective: Cross-Sectional, Representative Study of Polish Society",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221997/
54740,Assessment of the influenza vaccine (VAXIGRIP) in triggering a humoural immune response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694918/
54741,Nasal alum-adjuvanted vaccine promotes IL-33 release from alveolar epithelial cells that elicits IgA production via type 2 immune responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432758/
54742,Rationing vaccine during an avian influenza pandemic: why it won't be easy.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259161/
54743,Perspectives on Maternal Vaccination from Obstetrical Clinicians: A Qualitative Multi-site Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628390/
54744,H5N1 vaccines in humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795810/
54745,Prevention of influenza complications in patients with liver disease: a retrospective cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10771385/
54746,"Evolving Horizons: Adenovirus Vectors’ Timeless Influence on Cancer, Gene Therapy and Vaccines",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10747483/
54747,"Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157658/
54748,Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548996/
54749,Public acceptability of COVID-19 vaccines and its predictors in Middle ‎Eastern/North African (MENA) countries: a systematic review‎,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196809/
54750,"Estimated Influenza Illnesses and Hospitalizations Averted by Influenza Vaccination — United States, 2012–13 Influenza Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585588/
54751,The Prevalence and Determinants of Hesitancy for Regular COVID-19 Vaccination among Primary Healthcare Patients with Asthma or COPD in Greece: A Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11054093/
54752,The cellular and humoral immune response to influenza vaccination is comparable in asthmatic and healthy subjects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872026/
54753,Reduction of influenza A(H3N2)-associated symptoms by influenza vaccination in school aged-children during the 2014-2015 winter season dominated by mismatched H3N2 viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605825/
54754,Validation of influenza and pneumococcal vaccine status in adults based on self-report,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2870540/
54755,Evaluation of the Pathogenicity and the Escape from Vaccine Protection of a New Antigenic Variant Derived from the European Human-Like Reassortant Swine H1N2 Influenza Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599989/
54756,Acceptance of COVID-19 vaccination during pregnancy among Thai pregnant women and their spouses: a prospective survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943925/
54757,Early Changes in Interferon Gene Expression and Antibody Responses Following Influenza Vaccination in Pregnant Women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915434/
54758,Antigen Targeting to Human HLA Class II Molecules Increases Efficacy of DNA Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073356/
54759,Influenza and Pneumococcal Vaccination and the Risk of COVID-19: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776999/
54760,Racial/Ethnic Differences in Receipt of Influenza and Pneumococcal Vaccination among Long‐Stay Nursing Home Residents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051976/
54761,Racial and Ethnic Disparities in Influenza Vaccination among Adults with Chronic Medical Conditions Vary by Age in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5231366/
54762,"The Effect of Preexisting Immunity on Virus Detection and Immune Responses in a Phase II, Randomized Trial of a Russian-Backbone, Live, Attenuated Influenza Vaccine in Bangladeshi Children",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695513/
54763,Assessment of Route of Administration and Dose Escalation for an Adenovirus-Based Influenza A Virus (H5N1) Vaccine in Chickens ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944471/
54764,"Seroprevalence of influenza viruses in Shandong, Northern China during the COVID-19 pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510416/
54765,"A late sharp increase in influenza detections and low interim vaccine effectiveness against the circulating A(H3N2) strain, Denmark, 2021/22 influenza season up to 25 March 2022",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012088/
54766,"Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304916/
54767,"Trends in Pneumonia and Influenza-associated Hospitalizations in South Korea, 2002-2005",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259720/
54768,"Impact of Timing of Influenza Vaccination in Pregnancy on Transplacental Antibody Transfer, Influenza Incidence, and Birth Outcomes: A Randomized Trial in Rural Nepal",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051462/
54769,Intranasal Delivery of Influenza rNP Adjuvanted with c-di-AMP Induces Strong Humoral and Cellular Immune Responses and Provides Protection against Virus Challenge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139298/
54770,COVID-19 vaccine uptake and attitudes towards mandates in a nationally representative U.S. sample,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051757/
54771,Current and New Approaches for Mucosal Vaccine Delivery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149853/
54772,"Effectiveness of Booster and Influenza Vaccines against COVID-19 among Healthcare Workers, Taiwan",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514369/
54773,Adverse reactions to 1975 bivalent influenza vaccine in children.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1879753/
54774,Summary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1879753/
54775,"2009 Pandemic Influenza A Vaccination of Pregnant Women—King County, Washington State, 2009–2010",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478077/
54776,Preclinical Evaluation of a Replication-Deficient Intranasal ΔNS1 H5N1 Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694350/
54777,"The emergence and consistency of influenza strains causing influenza like illness in Himachal Pradesh, India",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908990/
54778,Vaccines for the elderly: current use and future challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778733/
54779,Live Attenuated and Inactivated Influenza Vaccines in Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296173/
54780,High-throughput sequencing-based neutralization assay reveals how repeated vaccinations impact titers to recent human H1N1 influenza strains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10942427/
54781,"Hospitalization following outpatient medical care for influenza: US influenza vaccine effectiveness network, 2011‐12—2015‐16",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379632/
54782,Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036962/
54783,Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524133/
54784,Why are vaccines against many human viral diseases still unavailable; an historic perspective?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166819/
54785,Intranasal Adenovirus-Vectored Vaccine for Induction of Long-Lasting Humoral Immunity-Mediated Broad Protection against Influenza in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136366/
54786,"Knowledge, Attitudes, and Sources of Information on Vaccines in Spanish Nursing Students: A Cross-Sectional Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036398/
54787,Structural and Antigenic Variation among Diverse Clade 2 H5N1 Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3785507/
54788,Higher Memory Responses in HIV-Infected and Kidney Transplanted Patients than in Healthy Subjects following Priming with the Pandemic Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407205/
54789,Characterization of Clade 7.2 H5 Avian Influenza Viruses That Continue To Circulate in Chickens in China,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068530/
54790,Differences in Influenza-Specific CD4 T-Cell Mediated Immunity Following Acute Infection Versus Inactivated Vaccination in Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205642/
54791,Using general practice data to monitor influenza vaccination coverage in the medically at risk: a data linkage study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756341/
54792,Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348046/
54793,"Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154102/
54794,Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651345/
54795,Impact of Preexisting Adenovirus Vector Immunity on Immunogenicity and Protection Conferred with an Adenovirus-Based H5N1 Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303828/
54796,Epidemiological and economic impact of pandemic influenza in Chicago: Priorities for vaccine interventions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453424/
54797,Tetramerizing tGCN4 domain facilitates production of Influenza A H1N1 M2e higher order soluble oligomers that show enhanced immunogenicity in vivo,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573259/
54798,J Biol Chem. 2021 Jan-Jun; 296: 100407. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949144/
54799,"A Game Theoretic Analysis of Competition Between Vaccine and Drug
Companies during Disease Contraction and Recovery",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189729/
54800,"Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227723/
54801,Prolonged Protection against Intranasal Challenge with Influenza Virus following Systemic Immunization or Combinations of Mucosal and Systemic Immunizations with a Heat-Labile Toxin Mutant ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668290/
54802,Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940749/
54803,"Early influenza vaccine effectiveness estimates using routinely collected data, Alberta, Canada, 2023/24 season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10785209/
54804,The Human Vaccines Project: Towards a comprehensive understanding of the human immune response to immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183335/
54805,"Long-Term Immunogenicity after One and Two Doses of a Monovalent MF59-Adjuvanted A/H1N1 Influenza Virus Vaccine Coadministered with the Seasonal 2009-2010 Nonadjuvanted Influenza Virus Vaccine in HIV-Infected Children, Adolescents, and Young Adults in a Randomized Controlled Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165232/
54806,Mucosal Immunity against Neuraminidase Prevents Influenza B Virus Transmission in Guinea Pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529633/
54807,The need and challenges for development of vaccines against emerging infectious diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066445/
54808,Genetic and potential antigenic evolution of influenza A(H1N1)pdm09 viruses circulating in Kenya during 2009–2018 influenza seasons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10724140/
54809,"Randomized Controlled Trial to Compare Immunogenicity of Standard-Dose Intramuscular Versus Intradermal Trivalent Inactivated Influenza Vaccine in HIV-Infected Men Who Have Sex With Men in Bangkok, Thailand",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707082/
54810,Exploring the relationship between newspaper coverage of vaccines and childhood vaccination rates in Spain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227710/
54811,Uneventful Coadministration of Seasonal Influenza and COVID-19 BNT162b2 Vaccines Two Weeks Post-Influenza Vaccination in an Egg-Allergic Subject: A Case Report,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222373/
54812,COVID-19 vaccine hesitancy in Iranian patients with multiple sclerosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896865/
54813,"COVID-19 Vaccination and Intent Among Pregnant Women, United States,
April 2021",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357823/
54814,Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141626/
54815,Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385993/
54816,Post-exposure treatment with whole inactivated H5N1 avian influenza virus protects against lethal homologous virus infection in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942574/
54817,Declining responsiveness to influenza vaccination with progression of human pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295331/
54818,Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223024/
54819,An Interspecific Nicotiana Hybrid as a Useful and Cost-Effective Platform for Production of Animal Vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334924/
54820,Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049400/
54821,Prevalence of seasonal influenza vaccination and associated factors in people with chronic diseases in Hong Kong,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152076/
54822,Linking Emergency Preparedness and Health Care Worker Vaccination Against Influenza: A Novel Approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106101/
54823,"Influenza vaccine effectiveness against medically attended influenza illness in Beijing, China, 2014/15 season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647950/
54824,"Cationic lipid/DNA complexes (JVRS-100) combined with influenza vaccine (Fluzone®) increases antibody response, cellular immunity, and antigenically drifted protection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690618/
54825,Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158440/
54826,"Intranasal Nanoparticle Vaccination Elicits a Persistent, Polyfunctional CD4 T Cell Response in the Murine Lung Specific for a Highly Conserved Influenza Virus Antigen That Is Sufficient To Mediate Protection from Influenza Virus Challenge",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373229/
54827,Pregnancy Downregulates Plasmablast Metabolic Gene Expression Following Influenza Without Altering Long-Term Antibody Function,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457062/
54828,Oral mucosa immunity: ultimate strategy to stop spreading of pandemic viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622784/
54829,Back to the Future for Influenza Preimmunity—Looking Back at Influenza Virus History to Infer the Outcome of Future Infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410066/
54830,Studies with inactivated influenza vaccines purified by zonal centrifugation: 2. Efficacy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427700/
54831,Summary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427700/
54832,Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384143/
54833,"Improvement of the efficacy of influenza vaccination (H5N1) in chicken by using extract of Cochinchina momordica seed (ECMS)
				",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1859872/
54834,Seasonal influenza immunization in early infancy?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533639/
54835,Correlation between Human Leukocyte Antigen Class II Alleles and HAI Titers Detected Post-Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3739771/
54836,Immune reconstitution and vaccination outcome in HIV-1 infected children: Present knowledge and future directions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656066/
54837,Association between Psychological Flexibility and Health Beliefs in the Uptake of Influenza Vaccination among People with Chronic Respiratory Diseases in Hong Kong,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772175/
54838,Association study between herpes zoster reporting and mRNA COVID‐19 vaccines (BNT162b2 and mRNA‐1273),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111438/
54839,Superior Immunogenicity of Inactivated Whole Virus H5N1 Influenza Vaccine is Primarily Controlled by Toll-like Receptor Signalling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2516931/
54840,Revealing the True Incidence of Pandemic A(H1N1)pdm09 Influenza in Finland during the First Two Seasons — An Analysis Based on a Dynamic Transmission Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807082/
54841,A Viable Recombinant Rhabdovirus Lacking Its Glycoprotein Gene and Expressing Influenza Virus Hemagglutinin and Neuraminidase Is a Potent Influenza Vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325733/
54842,Why Are CD8 T Cell Epitopes of Human Influenza A Virus Conserved?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401462/
54843,Novel Whole-Cell Inactivated Neisseria Gonorrhoeae Microparticles as Vaccine Formulation in Microneedle-Based Transdermal Immunization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161099/
54844,Pathogenicity testing of influenza candidate vaccine viruses in the ferret model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791157/
54845,Factors associated with pediatric vaccine hesitancy of parents: a cross-sectional study in Turkey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828060/
54846,"Predictors of Influenza and Pneumococcal Vaccination Among
Participants in the Women’s Health Initiative",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031837/
54847,"Influenza Vaccination Coverage Among Pregnant Women — United States, 2013–14 Influenza Season",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779455/
54848,How Do You Know Which Health Care Effectiveness Research You Can Trust? A Guide to Study Design for the Perplexed,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492215/
54849,The anti-influenza M2e antibody response is promoted by XCR1 targeting in pig skin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550447/
54850,Side Effects of COVID-19 Inactivated Virus vs. Adenoviral Vector Vaccines: Experience of Algerian Healthcare Workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149155/
54851,"Effects of Vaccine Program against Pandemic Influenza A(H1N1) Virus, United States, 2009–2010",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647645/
54852,Cross-protection against drifted influenza viruses: Options offered by adjuvanted and intradermal vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891715/
54853,"Representativeness, Vaccination Uptake, and COVID-19 Clinical Outcomes 2020-2021 in the UK Oxford-Royal College of General Practitioners Research and Surveillance Network: Cohort Profile Summary",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9770023/
54854,"COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916486/
54855,How to Improve Influenza Vaccination Rates in the U.S.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249250/
54856,Balancing the influenza neuraminidase and hemagglutinin responses by exchanging the vaccine virus backbone,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084346/
54857,"Health Literacy, Vaccine Confidence and Influenza Vaccination Uptake among Nursing Home Staff: A Cross-Sectional Study Conducted in Tuscany",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348841/
54858,Mouse Models Reveal Role of T-Cytotoxic and T-Reg Cells in Immune Response to Influenza: Implications for Vaccine Design,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356589/
54859,Characterizing Anchoring Bias in Vaccine Comparator Selection Due to Health Care Utilization With COVID-19 and Influenza: Observational Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250064/
54860,Maurice Hilleman: Creator of Vaccines That Changed the World,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150172/
54861,"Complement-Dependent Lysis of Influenza A Virus-Infected Cells by Broadly Cross-Reactive Human Monoclonal Antibodies

",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3233150/
54862,J Virol. 2012 Feb; 86(3): 1901. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264357/
54863,"Receipt and effectiveness of influenza vaccination reminders for adults, 2011‐2012 season, United States",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086857/
54864,Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10803065/
54865,Determinants of influenza vaccination uptake among Italian healthcare workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903913/
54866,"Hemagglutinin Gene Clade 3C.2a Influenza A(H3N2) Viruses, Alachua County, Florida, USA, 2014–15",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696699/
54867,Immunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482911/
54868,"Influenza Vaccination among Patients with Diabetes or Ischemic Heart Disease in Thailand: Coverage, Knowledge and Associated Factors ",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144710/
54869,Regression approaches in the test-negative study design for assessment of influenza vaccine effectiveness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545127/
54870,Synthetic Biology-derived triterpenes as efficacious immunomodulating adjuvants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553918/
54871,Implementing sequence-based antigenic distance calculation into immunological shape space model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303933/
54872,The Development of mRNA Vaccines for Infectious Diseases: Recent Updates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668227/
54873,Adjuvant influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427695/
54874,Summary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427695/
54875,Cross-Protection of Chicken Immunoglobulin Y Antibodies against H5N1 and H1N1 Viruses Passively Administered in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3147324/
54876,Immunogenicity and Efficacy of Flagellin-Fused Vaccine Candidates Targeting 2009 Pandemic H1N1 Influenza in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110246/
54877,RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679288/
54878,Student Column: Using Academic Detailing to Improve Childhood Influenza Vaccination Rates in San Diego,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315861/
54879,Cocirculation of A(H3N2) and B/Victoria increased morbidity in hospitalized patients in the 2019–2020 A(H1N1)pdm09 predominant influenza season in Israel,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107483/
54880,Intranasal administration of immunogenic poly-epitope from influenza H1N1 and H3N2 viruses adjuvanted with chitin and chitosan microparticles in BALB/c mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591766/
54881,"Evaluation of Immune Response Against Inactivated Avian Influenza (H9N2) Vaccine, by Using Chitosan Nanoparticles",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744467/
54882,The efficacy of live influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427704/
54883,Summary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427704/
54884,Antigen Nature and Complexity Influence Human Antibody Light Chain Usage and Specificity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876604/
54885,Cost Effectiveness of the 4 Pillars™ Practice Transformation Program to Improve Vaccination of Adults Aged ≥65 years,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397321/
54886,Erratic Flu Vaccination Emerges from Short-Sighted Behavior in Contact Networks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029241/
54887,Use of defined TLR ligands as adjuvants within human vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872835/
54888,Contributions of Antinucleoprotein IgG to Heterosubtypic Immunity against Influenza Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159153/
54889,Single Dose of Consensus Hemagglutinin-Based Virus-Like Particles Vaccine Protects Chickens against Divergent H5 Subtype Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711813/
54890,Racial/Ethnic Disparities in Health Care Receipt Among Male Cancer Survivors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682605/
54891,Immunology and efficacy of MF59-adjuvanted vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343625/
54892,Response to influenza virus vaccination in vertical HIV infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1717114/
54893,"How Does the Public Evaluate Vaccines for Low-Incidence, Severe-Outcome Diseases? A General-Population Choice Experiment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744670/
54894,Patient. 2023; 16(3): 287. ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320800/
54895,Infodemiology of Influenza-like Illness: Utilizing Google Trends’ Big Data for Epidemic Surveillance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11012909/
54896,Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885691/
54897,Effect of Information about COVID-19 Vaccine Effectiveness and Side Effects on Behavioural Intentions: Two Online Experiments,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070148/
54898,Understanding Australian healthcare workers’ uptake of influenza vaccination: examination of public hospital policies and procedures,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507749/
54899,Healthcare Workers’ Willingness to Receive Influenza Vaccination in the Context of the COVID-19 Pandemic: A Survey in Southern Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310353/
54900,"Prevalence of influenza-specific vaccination hesitancy among adults in the United States, 2018",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10941755/
54901,Studies with inactivated influenza vaccines purified by zonal centrifugation: 1. Adverse reactions and serological responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427720/
54902,Summary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427720/
54903,A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379059/
54904,An M2 Cytoplasmic Tail Mutant as a Live Attenuated Influenza Vaccine against Pandemic (H1N1) 2009 Influenza Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132197/
54905,Quantification of Viral Proteins of the Avian H7 Subtype of Influenza Virus—An Isotope Dilution Mass Spectrometry Method Applicable for Producing more Rapid Vaccines in the Case of an Influenza Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815428/
54906,"University students’ perspectives, planned uptake, and hesitancy regarding the COVID-19 vaccine: A multi-methods study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330905/
54907,"Fielding vaccines—challenges and opportunities in outbreaks, complex emergencies, and mass gatherings",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746477/
54908,Pandemic Influenza Threat and Preparedness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291399/
54909,"Development and evaluation of an interprofessional student-led influenza vaccination clinic for medical, nursing and pharmacy students",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013193/
54910,Structural Insights for Anti-Influenza Vaccine Design,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458449/
54911,Swine Influenza A Viruses and the Tangled Relationship with Humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919397/
54912,Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691380/
54913,Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805130/
54914,Induction of Heterosubtypic Cross-Protection against Influenza by a Whole Inactivated Virus Vaccine: The Role of Viral Membrane Fusion Activity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267744/
54915,Comparison of influenza disease burden in older populations of Hong Kong and Brisbane: the impact of influenza and pneumococcal vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376732/
54916,Multi-period vaccine allocation model in a pandemic: A case study of COVID-19 in Australia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995313/
54917,"A Computer Simulation of Vaccine Prioritization, Allocation, and Rationing During the 2009 H1N1 Influenza Pandemic",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906666/
54918,The Impact of the COVID-19 Pandemic on Influenza Vaccination Attitudes and Actions in Spain’s Adult Population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611015/
54919,Impact of Mixed Equine Influenza Vaccination on Correlate of Protection in Horses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313876/
54920,Trivalent influenza vaccine adverse symptoms analysis based on MedDRA terminology using VAERS data in 2011,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192591/
54921,Effect of vibration associated with cryotherapy on vaccine-related pain and anxiety levels in adults: study protocol for a randomized clinical trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344641/
54922,Efficacy of Single Dose of a Bivalent Vaccine Containing Inactivated Newcastle Disease Virus and Reassortant Highly Pathogenic Avian Influenza H5N1 Virus against Lethal HPAI and NDV Infection in Chickens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585801/
54923,Adenovirus-Vectored Drug-Vaccine Duo as a Rapid-Response Tool for Conferring Seamless Protection against Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144911/
54924,The Relationship of COVID-19 Morbidity and Mortality with the History of Influenza Vaccination,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700421/
54925,Influenza Virus Inactivated by Heavy Ion Beam Irradiation Stimulates Antigen-Specific Immune Responses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11054185/
54926,Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504682/
54927,"Artificial Intelligence-Based Data-Driven Strategy to Accelerate Research, Development, and Clinical Trials of COVID Vaccine",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279074/
54928,"Assessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: scenarios for the US, UK and the Netherlands",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2373400/
54929,Hepatitis B core-based virus-like particles: A platform for vaccine development in plants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937989/
54930,How the Italian Twitter Conversation on Vaccines Changed During the First Phase of the Pandemic: A Mixed-Method Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157769/
54931,Reevaluation of immune activation in the era of cART and an aging HIV-infected population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846952/
54932,The Next Influenza Pandemic: Will we be Ready to Care for Our Children?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118918/
54933,A 5-year look-back at the notification and management of vaccine supply shortages in Germany,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052770/
54934,Glyco-engineered MDCK cells display preferred receptors of H3N2 influenza absent in eggs used for vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551000/
54935,High-Level Systemic Expression of Conserved Influenza Epitope in Plants on the Surface of Rod-Shaped Chimeric Particles,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014720/
54936,‘Rhyme or reason?’ Saying no to mass vaccination: subjective re-interpretation in the context of the A(H1N1) influenza pandemic in Sweden 2009–2010,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717451/
54937,Nucleic acid-based vaccine platforms against the coronavirus disease 19 (COVID-19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062302/
54938,"Influenza Vaccination in Children Younger than 5 Years in the Region of Murcia (Spain), a Comparative Analysis among Vaccinating and Non-Vaccinating Parents: Data from the FLUTETRA Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10892024/
54939,Peptide-Based Vaccines for Tuberculosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841753/
54940,"TGM2 inhibits the proliferation, migration and tumorigenesis of MDCK cells",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146566/
54941,The association between influenza vaccination and socioeconomic status in high income countries varies by the measure used: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637551/
54942,Influenza A Viruses Expressing Intra- or Intergroup Chimeric Hemagglutinins,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794680/
54943,Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242433/
54944,"Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2018–2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427721/
54945,Immunological profile of mice immunized with a polyvalent virosome-based influenza vaccine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463652/
54946,Predictors of Influenza Vaccination Uptake and the Role of Health Literacy among Health and Social Care Volunteers in the Province of Prato (Italy),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180793/
54947,Influence of Immune Priming and Egg Adaptation in the Vaccine on Antibody Responses to Circulating A(H1N1) pdm09 Viruses After Influenza Vaccination in Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974399/
54948,"Prenatal Maternal Immunization for Infant Protection: A Review of the Vaccines Recommended, Infant Immunity and Future Research Directions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10975994/
54949,Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794445/
54950,Increasing Influenza Vaccination Uptake by Sending Reminders: A Representative Cross-Sectional Study on the Preferences of Italian Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610822/
54951,What Is the State-of-the-Art in Clinical Trials on Vaccine Hesitancy 2015–2020?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065658/
54952,Influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173415/
54953,Associations Between Maternal Immunisation and Reduced Rates of Preterm Birth and Stillbirth: A Population Based Retrospective Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454544/
54954,The hamster as a model system for the study of influenza vaccines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2496317/
54955,Summary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2496317/
54956,"Factors Predicting Influenza Vaccination Adherence Among Patients Undergoing Dialysis in Taif City, Saudi Arabia: A Cross-Sectional Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331896/
54957,Immunogenicity and Safety of an Inactivated Trivalent Split Influenza Virus Vaccine in Young Children with Recurrent Wheezing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675982/
54958,Influenza-attributable burden in United Kingdom primary care,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714299/
54959,Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279616/
54960,"Influenza Vaccination Among Adults with Cardiovascular Disease in the
United States: Results from the Behavioral Risk Factor Surveillance System
2018–2019",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978868/
54961,Strategies to Increase Flu Vaccination Coverage among Healthcare Workers: A 4 Years Study in a Large Italian Teaching Hospital,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157643/
54962,"Economic analysis of pharmacist-administered influenza vaccines in Ontario, Canada",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207261/
54963,"Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores In Influenza Positive Patients",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831548/
54964,"A comparison of adverse effects of two influenza vaccines, and the influence on subsequent uptake",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1959874/
54965,Summary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1959874/
54966,Cost effectiveness of a practice-based intervention to improve vaccination rates in adults less than 65-years-old,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647965/
54967,Systems approaches to influenza-virus host interactions and the pathogenesis of highly virulent and pandemic viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596458/
54968,Blockage of regulatory T cells augments induction of protective immune responses by influenza virus-like particles in aged mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726911/
54969,"Spotlight influenza: Estimation of influenza vaccine effectiveness in elderly people with assessment of residual confounding by negative control outcomes, Finland, 2012/13 to 2019/20",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431990/
54970,"Improving influenza vaccine virus selectionReport of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14–16 June 2010",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954460/
54971,COVID-19 Vaccination and Intention to Vaccinate Among a Sample of College Students in New Jersey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077859/
54972,Medical students' attitude toward influenza vaccination: Results of a survey in the University of Bari (Italy),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557231/
54973,Pharmacists’ Perspectives on Providing the Influenza Vaccine in Community Pharmacies: A Qualitative Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585546/
54974,Promotion of influenza vaccination among health care workers: findings from a tertiary care children’s hospital in Italy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513703/
54975,Influenza vaccination: a ‘shot’ at INVESTing in cardiovascular health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083766/
54976,"Single-Dose Mucosal Immunization with a Candidate Universal Influenza Vaccine Provides Rapid Protection from Virulent H5N1, H3N2 and H1N1 Viruses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2953831/
54977,Maximum likelihood estimation of influenza vaccine effectiveness against transmission from the household and from the community,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801170/
54978,"Immunogenicity and safety of three 2010–2011 seasonal trivalent influenza vaccines in Chinese toddlers, children and older adults: A double-blind and randomized trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906273/
54979,Did the pandemic have an impact on influenza vaccination attitude? a survey among health care workers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084177/
54980,Secondary Bacterial Infections Associated with Influenza Pandemics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481322/
54981,Intention to Receive Influenza Vaccine After an Acute Respiratory Illness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673886/
54982,Development of Cross-Reactive Live Attenuated Influenza Vaccine Candidates against Both Lineages of Influenza B Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10821225/
54983,Rising above the mask wars: using nonpharmaceutical interventions to lessen the burden of influenza,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685305/
54984,Influenza vaccination and risk for cardiovascular events: a nationwide self-controlled case series study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803467/
54985,"A randomized, controlled, double-blind, cross-over, clinical trial of Q fever vaccine in selected Queensland abattoirs.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2271756/
54986,Summary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2271756/
54987,Shooting from the ‘Scrip: Scope of Practice Laws and Access to Immunizations in the Pharmacy Setting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147434/
54988,Understanding the Variability of Certain Biological Properties of H1N1pdm09 Influenza Viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954537/
54989,Attitudes towards policies to encourage influenza vaccination in long-term care facilities: a national survey of US adults age 50 to 80 years,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714674/
54990,COVID-19 Vaccination Willingness and Associated Factors in Japanese Primary Care Patients: A Cross-Sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160894/
54991,Influenza and Pneumococcal Vaccination Delivery in Older Hispanic Populations in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904430/
54992,Transmission and pathogenicity of novel reassortants derived from Eurasian avian-like and 2009 pandemic H1N1 influenza viruses in mice and guinea pigs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890009/
54993,Sterilizing immunity to influenza virus infection requires local antigen-specific T cell response in the lungs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011745/
54994,General determination of causation between Covid-19 vaccines and possible adverse events,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846216/
54995,Vaccination updates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1071112/
54996,"Determinants of healthcare workers’ willingness to recommend the seasonal influenza vaccine to diabetic patients: A cross-sectional survey in Ningbo, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343623/
54997,Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896600/
54998,Prevalence of influenza vaccination and its association with health conditions and risk factors among Kansas adults in 2013: a cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766727/
54999,"Disparities in Influenza Vaccination Coverage and Associated Factors Among Adults with Cardiovascular Disease, United States, 2011–2020",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616130/